

ACCESSION NUMBER:		0001144204-14-040167
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20140331
FILED AS OF DATE:		20140630
DATE AS OF CHANGE:		20140627
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Castle Brands Inc
		CENTRAL INDEX KEY:			0001311538
		STANDARD INDUSTRIAL CLASSIFICATION:	BEVERAGES [2080]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32849
		FILM NUMBER:		14946947
	BUSINESS ADDRESS:	
		STREET 1:		122 EAST 42ND STREET
		STREET 2:		SUITE 4700
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10168
		BUSINESS PHONE:		646-356-0200
	MAIL ADDRESS:	
		STREET 1:		122 EAST 42ND STREET
		STREET 2:		SUITE 4700
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10168









     








Washington
&nbsp;D.C. 20549










For the fiscal year ended March 31
 2014










its charter)



    
    
    

    

    
    


    
    
    

122&nbsp;East&nbsp;42nd &nbsp;Street
&nbsp;Suite&nbsp;4700
    
    

New&nbsp;York
&nbsp;New&nbsp;York
    
    

    
    
    


Registrant&rsquo;s telephone number
including area code (646)&nbsp;356-0200





Securities registered pursuant to Section&nbsp;12(b)
of the Act:



    
    
    

Common&nbsp;stock
&nbsp;$0.01&nbsp;par&nbsp;value
    
    


Securities registered pursuant to Section&nbsp;12(g)
of the Act:



Indicate
by check mark whether the registrant is a well-known seasoned issuer
 as defined in Rule&nbsp;405 of the Securities Act. Yes&nbsp;&nbsp;

Indicate
by check mark whether the registrant is not required to file reports pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Act.
Yes&nbsp;&nbsp;

Indicate
by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such
reports)
 and (2)&nbsp;has been subject to such filing requirements for the past 90&nbsp;days. Yes&nbsp;&nbsp;

Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site
 if any
 every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&sect;229.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&nbsp;&nbsp;Yes&nbsp;&nbsp;

Indicate
by check mark if disclosure of delinquent filers pursuant to Item&nbsp;405 of Regulation&nbsp;S-K is not contained herein
 and
will not be contained
 to the best of registrant&rsquo;s knowledge
 in definitive proxy or information statements incorporated
by reference in Part&nbsp;III of this Form&nbsp;10-K or any amendment to this Form&nbsp;10-K.&nbsp;


is a large accelerated filer
 accelerated filer
 a non-accelerated filer or a smaller reporting company.&nbsp;&nbsp;See the definitions
of &ldquo;large accelerated filer
&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2
of the Exchange Act.



    
    
    

    
    
    


Indicate
by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Act). Yes&nbsp;


common stock held by non-affiliates of the registrant based on the September 30
 2013 closing price was approximately $43
000
000&nbsp;based
on&nbsp;the closing price per share as reported on the NYSE MKT on such date. The registrant had 154
901
767 shares of common
stock outstanding at June 25
 2014.




 11
 12
 13
and 14)&nbsp;of this annual report on Form 10-K is incorporated by reference from the definitive Proxy Statement for the 2014 Annual
Meeting of Shareholders to be filed with the Securities and Exchange Commission no later than 120&nbsp;days after the end of the
registrant&rsquo;s fiscal year covered by this report.





    
    













    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
Market for Registrant&rsquo;s Common Equity
 Related Shareholder Matters and Issuer Purchases of Equity Securities
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
Directors
 Executive Officers and Corporate Governance
    

    
    
    

    
    
    

    
Certain Relationships and Related Transactions
 and Director Independence
    

    
    
    

    
    
    

    
    
    

    
    
    

    
Exhibits
 Financial Statement Schedules
    

    
    



    
    








premium brands in the following beverage alcohol categories: rum
 whiskey
 liqueurs
 vodka and tequila. We distribute our products
in all 50 U.S. states and the District of Columbia
 in thirteen primary international markets
 including Ireland
 Great Britain
Northern Ireland
 Germany
 Canada
 South Africa
 Bulgaria
 France
 Russia
 Finland
 Norway
 Sweden
 China and the Duty Free markets
and in a number of other countries in continental Europe and Latin America. We market the following brands
 among others
 Gosling&rsquo;s
 
 Gosling&rsquo;s Stormy Ginger Beer
 ready-to-drink
cocktail
 
TM

 Jefferson&rsquo;s Rye whiskey
 liqueurs
 Irish whiskey
 Knappogue
 
 Irish Cream
 vodka
 tequila
 liqueur
 Castello Mio




premium brands listed below.

. We are
the exclusive U.S. distributor for Gosling&rsquo;s rums
 including Gosling&rsquo;s Black Seal Dark Rum
 Gosling&rsquo;s Gold Bermuda
Rum and Gosling&rsquo;s Old Rum. The Gosling family produces these rums in Bermuda
 where Gosling&rsquo;s rums have been under
continuous production and ownership by the Gosling family for over 200&nbsp;years. We hold a 60% controlling interest in Gosling-Castle
Partners
 Inc.
 a global export venture between us and the Gosling family. Gosling-Castle Partners has the exclusive long-term
export and distribution rights for the Gosling&rsquo;s rum products for all countries other than Bermuda. The Gosling&rsquo;s rum
brands accounted for approximately 34% and 37% of our revenues for our 2014 and 2013 fiscal years
 respectively. We also distribute
Gosling&rsquo;s Stormy Ginger Beer
 an essential non-alcoholic ingredient in Gosling&rsquo;s trademarked Dark &lsquo;n Stormy&reg;
rum cocktail and the Gosling's Dark &lsquo;n Stormy&reg; cocktail in a ready-to-drink can.

Jefferson&rsquo;s bourbons and rye
. We develop and market three premium
 very small batch bourbons: Jefferson&rsquo;s
 Jefferson&rsquo;s Reserve and
Jefferson&rsquo;s Presidential Select. Each of these three distinct premium Kentucky bourbons
 is blended in batches of eight to
twelve barrels to produce specific flavor profiles. We also produce Jefferson's Straight Rye Whiskey
 a premium whiskey distilled
from 100% North American rye.

. We have
the long-term exclusive U.S. distribution rights (excluding duty free sales) for Pallini Limoncello and its related brand extensions.
Pallini Limoncello is a premium lemon liqueur
 which is served iced cold
 on the rocks or as an ingredient in a wide variety of
drinks
 ranging from martinis to iced tea. It is also used in cooking
 particularly for pastries and cakes. Pallini Limoncello
is crafted from an authentic family recipe. It is made with Italy&rsquo;s finest Sfusato Amalfitano lemons that are hand-selected
for optimal freshness and flavor. There are two other flavor extensions of this Italian liqueur: Pallini Peachcello
 made with
white peaches
 and Pallini Raspicello
 made from a combination of raspberries and other berries.

.
Our family of Clontarf Irish whiskeys currently represents a majority of our case sales of Irish whiskey. Clontarf
 an accessible
and smooth premium Irish whiskey
 is distilled using quality grains and pure Irish spring water. Clontarf is then aged in bourbon
barrels and mellowed through Irish oak charcoal. Clontarf is available in single malt and classic versions.

.
We developed our Knappogue Castle Whiskey
 a single malt Irish whiskey
 to build on both the popularity of single malt Scotch whisky
and the growth in the Irish whiskey category. Knappogue Castle Whiskey is distilled in pot stills using malted barley and is aged
twelve years. We have introduced Knappogue Twin Wood
 the first Sherry Finished Knappogue Castle Whiskey. The whiskey
is matured for sixteen years in two types of wood resulting in a perfectly balanced single malt Irish whiskey with a complex
 rich
taste and a slightly sweet sherry finish.

. Knappogue
Castle 1951 is a pure pot-still whiskey that was distilled in 1951 and then aged for 36&nbsp;years in sherry casks. The name comes
from an Irish castle
 formerly owned by Mark Edwin Andrews
 the originator of the brand and the father of Mark Andrews
 our chairman.


    
    


.
Brady&rsquo;s Irish Cream
 a high quality Irish cream
 is made in small batches using Irish whiskey
 dairy fresh cream and natural
flavors.

. Boru vodka
 a
premium vodka produced in Ireland
 was developed in 1998 and is named after the legendary High King of Ireland
 Brian Boru
 who
united the Irish clans and drove foreign invaders out of Ireland. It is five-times distilled using pure spring water for smoothness
and filtered through ten feet of charcoal made from Irish oak for increased purity.

. Celtic
Honey is a premium brand of Irish liqueur that is a unique combination of Irish spirits
 cognac and a taste of honey. Gaelic Heritage
Corporation Limited
 an affiliate of one of our bottlers
 has the exclusive rights to produce and supply us with Celtic Honey.

 In
May 2013
 we introduced Castello Mio
 a super premium sambuca. Castello Mio Sambuca is made by Brotto Distilleries S.r.L. (&ldquo;Brotto&rdquo;)
a family company with a tradition of crafting fine liqueurs in the Veneto region of Italy since the 1800&rsquo;s
 and is available
in the &ldquo;classico&rdquo; style as well as espresso.

.
 or &ldquo;Tierras&rdquo; is an organic
 super-premium
 USDA certified
organic tequila and is available as blanco
 reposado and a&ntilde;ejo. We are the exclusive U.S. importer and marketer of
Tierras.

. In 2011
we became the exclusive U.S. distributor for Gozio amaretto
 which is made from a secret recipe that combines selected fruits from
four continents.





Castle Brands into a profitable international spirits company
 with a distinctive portfolio of  premium and super
premium spirits brands. To achieve this
 we continue to seek to:


 We
continue to focus our distribution efforts
 sales expertise and targeted marketing activities on our more profitable brands and
markets;

 We believe that continued organic
growth will enable us to achieve long-term profitability. We focus on brands that have profitable growth potential and staying
power
 such as our rums and whiskies
 sales of which have grown approximately 40% over the past two fiscal years;

 We use our existing assets
expertise and resources to build consumer awareness and market penetration for our brands;

Our established distribution
network in all 50 U.S. states enables us to promote our brands nationally and makes us an attractive strategic partner for smaller
companies seeking U.S. distribution; and

selectively add new brand extensions and brands to our portfolio.
We intend to continue to introduce new brand extensions and expressions. We continue to explore strategic relationships
joint ventures and acquisitions to selectively expand our premium spirits portfolio. We expect that future acquisitions or agency
relations
 if any
 would involve some combination of cash
 debt and the issuance of our stock.. 






and supply process for beverage alcohol products. First
 all of our spirits products are distilled. This is a multi-stage process
that converts basic ingredients
 such as grain
 sugar cane or agave
 into alcohol. Next
 the alcohol is processed and/or aged in
various ways depending on the requirements of the specific brand. For our vodka
 this processing is designed to remove all other
chemicals
 so that the resulting liquid will be odorless and colorless
 and have a smooth quality with minimal harshness. Achieving
a high level of purity involves a series of distillations and filtration processes.


 rather than removing flavor
 various complex flavor profiles are achieved through one or more of the following
techniques: infusion of fruit
 addition of various flavoring substances
 and
 in the case of rums and whiskeys
 aging of the brands
in various types of casks for extended periods of time and the blending of several rums or whiskeys to achieve a unique flavor
profile for each brand. After the distillation
 purification and flavoring processes are completed
 the various liquids are bottled.
This involves several important stages
 including bottle and label design and procurement
 filling of the bottles and packaging
the bottles in various configurations for shipment.


    
    



in distillation
 bottling or other production facilities or equipment. Instead
 we have entered into relationships with several
companies to provide those services to us. We believe that these types of arrangements allow us to avoid committing significant
amounts of capital to fixed assets and permit us to have the flexibility to meet growing sales levels by dealing with companies
whose capacity significantly exceeds our current needs. These relationships vary on a brand-by-brand basis as discussed below.
As part of our ongoing cost-containment efforts
 we intend to continue to review each of our business relationships to determine
if we can increase the efficiency of our operations.




been produced by the Gosling&rsquo;s family in Hamilton
 Bermuda for over 200&nbsp;years and
 under our distribution
arrangements with Gosling's Export (Bermuda) Limited (&ldquo;Gosling&rsquo;s Export&rdquo;)
 they have retained the right to
act as the sole supplier to Gosling-Castle Partners Inc. with respect to our Gosling&rsquo;s rum requirements.
Gosling's sources&nbsp;its rums in the Caribbean and transports them to Bermuda where they are blended according to
proprietary recipes. The rums are then sent to Heaven Hill Distilleries
 Inc.&rsquo;s plant in Bardstown
 Kentucky where they
are bottled
 packaged
 stored and shipped to our third-party warehouse. In 2007
 Gosling&rsquo;s increased its blending
and storage facilities in Bermuda to accommodate our supply needs for the foreseeable future. We believe Heaven Hill has
ample capacity to meet our projected bottling needs for the foreseeable future. See &ldquo;Strategic brand-partner
relationships.&rdquo;




 we entered into
two long-term supply agreements with Irish Distillers Limited (&ldquo;IDL&rdquo;)
 a subsidiary of Pernod Ricard
 under which
it has agreed to supply us with the aged single malt and grain whiskeys used in our Knappogue Castle Whiskey and all of our
Clontarf Irish whiskey products. The first supply agreement provides for the production of blended Irish whiskeys for us
until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the
contract if it provides at least six years prior notice
 except for breach. Under this agreement
 we provide IDL with a
forecast of the estimated amount&nbsp;of liters of pure alcohol we require for the next four fiscal contract years and agree
to purchase that amount
 subject to certain annual adjustments. The second supply agreement provides for the production of
single malt Irish whiskeys for us until the contract is terminated by either party in accordance with the terms of the
agreement. IDL may terminate the contract if it provides at least thirteen years prior notice
 except for breach. Under this
agreement
 we provide IDL with a forecast of the estimated amount&nbsp;of liters of pure alcohol we require for the next
twelve fiscal contract years and agree to purchase that amount
 subject to certain annual adjustments. We are not obligated
to pay for any product not yet received. The whiskeys are then sent to Terra Limited (&ldquo;Terra&rdquo;) in Baileyboro
Ireland
 where they are bottled in bottles we designed and packaged for shipment. We believe that Terra
 which also acts
as bottler for certain of our Boru vodka and as producer and bottler of our Brady&rsquo;s Irish cream (and as bottler for
Celtic Honey
 which is supplied to us by one of Terra&rsquo;s affiliates)
 has sufficient bottling capacity to meet our
current needs
 and both Terra and IDL have the capacity to meet our anticipated future supply needs.


 storage
 sampling
testing
 filtering
 filling
 capping and labeling of bottles
 case packing
 warehousing and loading and inventory control for our
Boru vodkas and our Knappogue Castle and Clontarf Irish whiskeys at prices that are adjusted annually by mutual agreement based
on changes in raw materials and consumer price indexes increases up to 3.5% per annum. This agreement also provides for maintenance
of product specifications and minimum processing procedures
 including compliance with applicable food and alcohol regulations
and maintenance
 storage and stock control of all raw products and finished products delivered to Terra. Terra holds all alcohol
on its premises under its customs and excise bond. Our bottling and services agreement with Terra will expire on June 30
 2014.
We expect to continue to operate under the terms of the expiring contract as we negotiate a new agreement with Terra. We believe
we could obtain alternative sources of bottling and services if we are unable to renew the existing Terra contract.




 Jefferson&rsquo;s Reserve
bourbons
 Jefferson&rsquo;s Presidential Select and Jefferson&rsquo;s rye are bottled for us by Luxco
 Inc.
 (&ldquo;Luxco&rdquo;)
 in Cleveland
 OH
 from our stocks of aged bourbon and rye. We blend no more than eight to twelve barrels to produce specific
flavor profiles of each of our bourbon products. Bourbon has been in short supply in the U.S. in recent years
 and we have been
actively seeking alternate sourcing for future supply. We have recently acquired  stocks of aged bourbon
 which we anticipate will
supply our currently forecasted needs for Jefferson&rsquo;s and Jefferson&rsquo;s Reserve
 although there is no assurance we can source adequate amounts of bourbon
or rye
 if demand is greater than expected
 at satisfactory prices.




as successor in interest to I.L.A.R. S.p.A.
 an Italian company based in Rome and owned since 1875
by the Pallini family
 produces Pallini Limoncello
 Raspicello and Peachcello. Pallini bottles the liqueurs at its plant in Rome
and ships them to us under our long-term exclusive U.S. marketing and distribution agreement. We believe that Pallini has adequate
facilities to produce and bottle sufficient Limoncello
 Peachcello and Raspicello to meet our foreseeable needs. See &ldquo;Strategic
brand-partner relationships.&rdquo; &nbsp;


    
    





Plc
 a leading European producer of grain neutral spirits
 to provide us with the distilled alcohol used
in our Boru vodka. The supply agreement provides for Cargill to produce natural spirit for us with specified levels of alcohol
content pursuant to specifications set forth in the agreement and at specified prices through its expiration in December&nbsp;2014
in quantities designated by us. We believe that Cargill has sufficient distilling capacity to meet our needs for Boru vodka for
the foreseeable future. In the event that we do not renew the Cargill agreement
 we believe that we will be able to obtain grain
neutral spirits from another supplier.


delivered from Cargill to the bottling premises at Terra
 where it is filtered in several proprietary ways
 pure water is
added to achieve the desired proof. Depending on the size of the bottle
 Boru vodka is then either bottled at Terra or
shipped in bulk to the U.S. and bottled at Luxco
 where we bottle certain sizes for the U.S. market. We believe that both
Terra and Luxco have sufficient bottling capacity to meet our current needs
 and both have the capacity to meet our
anticipated future supply needs. As described above
 our bottling and services agreement with Terra will expire on June
30
 2014. We expect to continue to operate under the terms of the expiring contract as we negotiate a new agreement with
Terra. We believe we could obtain alternative sources of bottling and services if we are unable to renew the existing
Terra contract.




us by Terra. Fresh cream is combined with Irish whiskey
 grain neutral spirits and various flavorings to our specifications
 and
then bottled by Terra in bottles designed for us. We believe that Terra has the capacity to meet our foreseeable supply needs for
this brand. As described above
 our bottling and services agreement with Terra will expire on June 30
 2014. We expect to continue
to operate under the terms of the expiring contract as we negotiate a new agreement with Terra. We believe we could obtain alternative
sources of bottling and services if we are unable to renew the existing Terra contract.




 an
affiliate of Terra
 has a contractual right to act as the sole supplier to us of Celtic Honey. Gaelic Heritage mixes the ingredients
comprising Celtic Honey using a proprietary formula and then Terra bottles it for them in bottles designed for us. We believe that
the necessary ingredients are available to Gaelic Heritage in sufficient supply and that Terra&rsquo;s bottling capacity is currently
adequate to meet our projected supply needs. See &ldquo;Strategic brand-partner relationships.&rdquo;




us by Brotto in Carnuda
 Italy. Grain neutral spirits
 sugar and various natural flavor essences are combined to our specifications
and then bottled by Brotto in bottles designed for us. We believe that Brotto has the capacity to meet our foreseeable supply needs
for this brand.




Gozio amaretto. Gozio amaretto is produced by Distillerie Franciacorta
 a spirits company founded in 1901 and owned by the Gozio
family. The company is located in Franciacorta
 in the Italian Region of Lombardy. We believe that Distillerie Franciacorta has
sufficient capacity to meet our foreseeable supply needs for this brand.




&ldquo;Tierras&rdquo; is being produced for us in Mexico by Autentica Tequilera S.A. de C.V. Autentica Tequilera currently sources
organic agave from third-parties
 and together with its affiliates is in the process of cultivating its own supply of organic agave.
Autentica Tequilera distills and bottles the tequila at its facility in the Jalisco region of Mexico. Tierras is available as blanco
reposado and a&ntilde;ejo. The blanco is unaged
 the reposado is aged in oak barrels at the distillery for up to one year
 and
the a&ntilde;ejo is aged in oak barrels at the distillery for at least one year. We believe that
 given the ability of Autentica
Tequilera to purchase organic agave and its anticipated cultivation of organic agave
 Autentica Tequilera has sufficient capacity
to meet our foreseeable supply needs for this brand.




that we have developed with our sales team and our independent distributors and brokers is one of our strengths. We currently have
distribution and brokerage relationships with third-party distributors in all 50 U.S. states
 as well as distribution arrangements
in approximately 20 other countries.


    
    




 Importers of
beverage alcohol in the U.S. must sell their products through a three-tier distribution system. Typically
 an imported brand is
first sold to a U.S. importer
 who then sells it to a network of distributors
 or wholesalers
 covering the U.S.
 in either &ldquo;open&rdquo;
states or &ldquo;control&rdquo; states. In the 33 open states
 the distributors are generally large
 privately-held companies.
In the 17 control states
 the states themselves function as the distributor
 and regulate suppliers such as us. The distributors
and wholesalers in turn sell to individual retailers
 such as liquor stores
 restaurants
 bars
 supermarkets and other outlets
licensed to sell beverage alcohol. In larger states such as New York
 more than one distributor may handle a brand in separate
geographical areas. In control states
 importers sell their products directly to state liquor authorities
 which distribute the
products and either operate retail outlets or license the retail sales function to private companies
 while maintaining strict
control over pricing and profit.


consolidated dramatically over the last ten years due to merger and acquisition activity. There are currently eight major
spirits companies
 each of which own and operate their own importing businesses. All companies
 including these large
companies
 are required by law to sell their products through wholesale distributors in the U.S. The major companies are
exerting increasing influence over the regional distributors and as a result
 it has become more difficult for smaller
companies to get their products recognized by the distributors. We believe our established distribution network in all 50
states allows us to overcome a significant barrier to entry in the U.S. beverage alcohol market and enhances our
attractiveness as a strategic partner for smaller companies lacking comparable distribution.


 our U.S. sales represented
approximately 84.8% of our revenues
 and we expect them to remain relatively consistent as a percentage of our total sales in the
near future. See note 17 to our accompanying consolidated financial statements.

 We currently
hold the federal importer and wholesaler license required by the Alcohol and Tobacco Tax and Trade Bureau of the U.S. Treasury
Department
 and the requisite state license in all 50 states and the District of Columbia.


in large bonded warehouses and shipped nationally by an extensive network of licensed and bonded carriers.


In the U.S.
 we are required by law to use state-licensed distributors or
 in the control states
 state-owned agencies performing
this function
 to sell our brands to retail outlets. As a result
 we depend on distributors for sales
 for product placement and
for retail store penetration. We currently have no distribution agreements or minimum sales requirements with any of our U.S. alcohol
distributors
 and they are under no obligation to place our products or market our brands. All of the distributors also distribute
our competitors&rsquo; products and brands. As a result
 we must foster and maintain our relationships with our distributors. Through
our internal sales team
 we have established relationships for our brands with wholesale distributors in each state
 and our products
are currently sold in the U.S. by approximately 80 wholesale distributors
 as well as by various state beverage alcohol control
agencies.




 most countries
permit sales directly from the brand owner to retail establishments
 including liquor stores
 chain stores
 restaurants and pubs
without requiring that sales go through a wholesaler tier. In our international markets
 we rely primarily on established spirits
distributors in much the same way as we do in the U.S. We have contracted with an international beverage alcohol broker to represent
our brands in approximately twenty international markets. We use Terra and other bonded warehouses and logistic providers to handle
the billing
 inventory and shipping for us for some products in certain of our non-U.S. markets.


 the beverage alcohol industry
has undergone consolidation internationally
 with considerable realignment of brands and brand ownership. The number of major spirits
companies internationally has been reduced significantly due to mergers and brand ownership consolidation. While there are still
a substantial number of companies owning one or more brands
 most business is now done by the eight major companies
 each of which
owns and operates its own distribution company that distributes in the major international markets. These captive distribution
companies focus primarily on the brands of the companies that own them.


route to market in our international operations
 we do not believe that we are at a significant disadvantage
 because the local
importers/distributors typically have established relationships with the retail accounts and are able to provide extensive customer
service
 in store merchandising and on premise promotions. Also
 even though we must compensate our wholesalers and distributors
in each market in which we sell our brands
 we are
 as a result of using these distributors
 still able to benefit from substantially
lower infrastructure costs and centralized billing and collection.


Great Britain
 Northern Ireland
 Germany
 Canada
 Switzerland
 Bulgaria
 Ukraine
 France
 Russia
 Finland
 Norway
 Sweden
 U.A.E.
China and the Duty Free markets. We also have sales in other countries in continental Europe
 Latin America
 the Caribbean and
Asia. For fiscal 2014
 non-U.S. sales represented approximately 15.2% of our revenues. See note 17 to our accompanying consolidated
financial statements.


    
    





 Southern Wine
and Spirits and related entities
 accounted for approximately 31.9% of our consolidated revenues for fiscal 2014.




in the U.S.
 our primary market
 international markets hold potential for future growth and are part of our global strategy.


17 people
 including six regional U.S. vice presidents with an average of over 16&nbsp;years of industry experience with premium
beverage alcohol brands.


day-to-day management of our distributors
 which includes setting quotas
 coordinating promotional plans for our brands
 maintaining
adequate levels of stock
 brand education and training and sales calls with distributor personnel. Our sales team also maintains
relationships with key retail customers through independent sales calls. They also schedule promotional events
 create local brand
promotion plans
 host in-store tastings where permitted and provide wait staff and bartender training and education for our brands.

Advertising
 marketing and promotion


 we must effectively
communicate with three distinct audiences: our distributors
 the retail trade and the end consumer. Advertising
 marketing and
promotional activities help to establish and reinforce the image of our brands in our efforts to build substantial brand value.
We believe our execution of disciplined and strategic branding and marketing campaigns will continue to drive our future sales.


 in-house marketing
sales and customer service personnel who work together with third party design and advertising firms to maintain a high degree
of focus on each of our product categories and build brand awareness through innovative marketing activities. We use a range of
marketing strategies and tactics to build brand equity and increase sales
 including consumer and trade advertising
 price promotions
point-of-sale materials
 event sponsorship
 in-store and on-premise promotions and public relations
 as well as a variety of other
traditional and non-traditional marketing techniques
 including social media marketing
 to support our brands.


 we also
employ three other marketing methods to support our brands: public relations
 event sponsorships and tastings. Our significant
U.S. public relations efforts have helped gain editorial coverage for our brands
 which increases brand awareness. Event sponsorship
is an economical way for us to have influential consumers taste our brands. We actively contribute product to trend-setting events
where our brand has exclusivity in the brand category. We also conduct hundreds of in-store and on-premise promotions each year.


with an assortment of point-of-sale materials. The combination of trade and consumer programs
 supported by attractive point-of-sale
materials
 also establishes greater credibility for us with our distributors and retailers. &nbsp;




and established spirits brand owners seeking opportunities to increase their sales beyond their home markets and achieve global
growth. This ability is a key component of our growth strategy and one of our competitive strengths. Our original relationship
with the Boru vodka brand was as its exclusive U.S. distributor. To date
 we have also established strategic relationships for
Gosling&rsquo;s rum
 Pallini liqueurs
 Celtic Honey liqueur
 Tierras tequila and Gozio amaretto
 as described below
 and we intend
to seek to expand our brand portfolio through similar future arrangements.




 we entered into an exclusive national
distribution agreement with Gosling&rsquo;s Export for the Gosling&rsquo;s rum products. We subsequently purchased a 60% controlling
interest in Gosling-Castle Partners
 Inc.
 a strategic export venture with the Gosling family. Gosling's Export holds the exclusive
distribution rights for Gosling&rsquo;s rum and related products on a worldwide basis (other than in Bermuda)
 through Gosling-Castle
Partners
 and assigned to Gosling-Castle Partners all of Gosling&rsquo;s Export&rsquo;s interest in our January&nbsp;2005 U.S.
distribution agreement with them. The export agreement expires in April 2020
 subject to a 15&nbsp;year extension if certain case
sale targets are met. Under the export agreement
 Gosling-Castle Partners is generally entitled to a share of the proceeds from
the sale
 if ever
 of the ownership of any of the Gosling&rsquo;s brands to a third-party
 through a sale of the stock of Gosling&rsquo;s
Export or its parent
 with the size of such share depending upon the number of case sales made during the twelve months preceding
the sale. Also
 prior to selling the ownership of any of their brands that are subject to these agreements
 Gosling&rsquo;s Export
must first offer such brand to Gosling-Castle Partners and then to us. The Goslings
 through Gosling&rsquo;s Brothers Limited
have the right to act as the sole supplier to Gosling-Castle Partners for our Gosling&rsquo;s rum requirements.


    
    





 exclusive
marketing and distribution agreement with Pallini under which we distribute Pallini Limoncello
 Peachcello and Raspicello
liqueurs in the U.S. We began shipping these products in September&nbsp;2005.


 expires
on March 31
 2016
 subject to successive five-year renewals unless either party delivers a notice of non-renewal six
months prior to the end of the term. Under the agreement
 if minimum volume targets are not achieved and not cured
Pallini has the right to terminate the agreement without payment of termination fees to us. However
 if such targets are met
we have the right under the agreement to receive certain termination payments and other payments upon the non-renewal of
the agreement
 certain terminations of the agreement or the sale of the brand. The exclusive territory under the agreement is the fifty states
of the U.S. and the District of Columbia.




 we entered into
an importation and marketing agreement with Autentica Tequilera S.A. de C.V.
 under which we became the exclusive U.S. importer
of Tierras. In February 2013
 the agreement renewed for an additional five years in accordance with its terms. During the term
we have the right to purchase tequila at stipulated prices. Autentica Tequilera must maintain certain standards for its products
and we have input into the product and packaging. We are required to prepare periodic reports detailing the development of the
brand&rsquo;s sales. Under this agreement
 we have rights of first refusal for any new market for Tierras (except Mexico)
 and
any new Autentica Tequilera products in any market (except Mexico). We also have a right of first refusal on any sale of the Tierras
brand
 and a right to acquire up to 35% of the economic benefit of any such sale with a third-party based upon the achievement
of certain cumulative sales targets.




 we entered into an exclusive
distribution agreement with Distillerie Franciacorta Spa under which we are the exclusive distributor of Gozio Amaretto in the
U.S. The agreement has a five-year term
 with automatic five-year renewals based upon sales targets. During the term
 we have the
right to purchase Gozio Amaretto at stipulated prices and Distillerie Franciacorta Spa must maintain certain standards for its
products. We are required to prepare periodic reports detailing the development of the brand&rsquo;s sales and prepare annual strategic
marketing and growth plans.




business. We sell our products under a number of trademarks
 which we own or use under license. Our brands are protected by trademark
registrations or are the subject of pending applications for trademark registration in the U.S.
 the European Community and most
other countries where we distribute
 or plan to distribute
 our brands. The trademarks may be registered in the names of our subsidiaries
and related companies. Generally
 the term of a trademark registration varies from country to country
 and
 in the U.S.
 trademark
registrations need to be renewed every ten years. We expect to register our trademarks in additional markets as we expand our distribution
territories.


for brands owned by third parties
 such as the Gosling&rsquo;s rums
 the Pallini liqueurs
 Tierras tequila and Gozio amaretto.
The Gosling&rsquo;s rum brands
 Pallini liqueurs and Gozio amaretto are registered by their respective owners and we have the exclusive
right to distribute the Gosling&rsquo;s rums on a worldwide basis (other than in Bermuda) and the Pallini liqueur brands and Gozio
amaretto in the U.S. Gosling&rsquo;s also has a trademark for their signature rum cocktail
 Dark &lsquo;n Stormy. Autentica Tequiliera
holds the registered U.S. trademark for Tequila Tierras Autenticas de Jalisco and its distinctive label. See &ldquo;Strategic brand-partner
relationships.&rdquo;




with peak retail sales generally occurring in the fourth calendar quarter (our third fiscal quarter) primarily due to seasonal
holiday buying. Historically
 this holiday demand typically resulted in slightly higher sales for us in our second and/or third
fiscal quarters. However
 the growth of Gosling&rsquo;s rums in recent years has led to improved fourth fiscal quarter revenues.


    
    





competitive. We believe that we compete on the basis of quality
 price
 brand recognition and distribution strength. Our premium
brands compete with other alcoholic and nonalcoholic beverages for consumer purchases
 retail shelf space
 restaurant presence
and wholesaler attention. We compete with numerous multinational producers and distributors of beverage alcohol products
 many
of which have greater resources than us.


 the U.S.
wine and spirits industry has undergone dramatic consolidation and realignment of brands and brand ownership. The number of
major importers in the U.S. has declined significantly. Today there are eight major companies: Diageo PLC
 Pernod Ricard
S.A.
 Bacardi Limited
 Brown-Forman Corporation
 Beam Suntory Inc.
 Davide Campari Milano-S.p.A.
 Remy Cointreau S.A. and
Constellation Brands
 Inc.


position to partner with small to mid-size brands than the major importers. Despite our relative capital position and resources
we have been able to compete with these larger companies in pursuing agency distribution agreements and acquiring brands by being
more responsive to private and family-owned brands
 offering flexible transaction structures and providing brand owners the option
to retain local production and &ldquo;home&rdquo; market sales. Given our size relative to our major competitors
 most of which
have multi-billion dollar operations
 we believe that we can provide greater focus on smaller brands and tailor transaction structures
based on individual brand owner preferences. However
 our relative capital position and resources may limit our marketing capabilities
limit our ability to expand into new markets and limit our negotiating ability with our distributors.


segments of the market
 which typically have higher margins
 and having an established
 experienced sales force
 we believe we
are able to gain relatively significant attention from our distributors for a company of our size. Our U.S. regional vice presidents
who average over 16&nbsp;years of industry experience
 provide long-standing relationships with distributor personnel and with
their major customers. Finally
 the continued consolidation among the major companies is expected to create an opportunity for
small to mid-size wine and spirits companies
 such as ourselves
 as the major companies contract their portfolios to focus on fewer
brands.




Federal Alcohol Administration Act
 U.S. Customs Laws
 Internal Revenue Code of 1986
 and the Alcoholic Beverage Control Laws of
all fifty states.


and Tobacco Tax and Trade Bureau regulates the production
 blending
 bottling
 sales and advertising and transportation of alcohol
products. Also
 each state regulates the advertising
 promotion
 transportation
 sale and distribution of alcohol products within
its jurisdiction. We are also required to conduct business in the U.S. only with holders of licenses to import
 warehouse
 transport
distribute and sell spirits.


 we are subject to similar regulations
related to the production of spirits.


on the advertising
 marketing and sale of beverage alcohol. These regulations range from a complete prohibition of the marketing
of alcohol in some countries to restrictions on the advertising style
 media and messages used.


many markets
 varying from health warning labels to importer identification
 alcohol strength and other consumer information. All
beverage alcohol products sold in the U.S. must include warning statements related to risks of drinking beverage alcohol products.


 the state liquor
commissions act in place of distributors and decide which products are to be purchased and offered for sale in their respective
states. Products are selected for purchase and sale through listing procedures which are generally made available to new products
only at periodically scheduled listing interviews. Consumers may purchase products not selected for listings only through special
orders
 if at all.


is also subject to extensive federal and state taxation in the U.S. and internationally. Most foreign countries in which we do
business impose excise duties on wines and distilled spirits
 although the form of such taxation varies from a simple application
on units of alcohol by volume to intricate systems based on the imported or wholesale value of the product. Several countries impose
additional import duty on distilled spirits
 often discriminating between categories in the rate of such tariffs. Import and excise
duties may have a significant effect on our sales
 both through reducing the consumption of alcohol and through encouraging consumer
switching into lower-taxed categories of alcohol.


    
    



with applicable federal
 state and other regulations. However
 we operate in a highly regulated industry which may be subject to
more stringent interpretations of existing regulations. Future compliance costs due to regulatory changes could be significant.


produced primarily outside the U.S.
 adverse effects of regulatory changes are more likely to materially affect earnings and our
competitive market position rather than capital expenditures. Capital expenditures in our industry are normally associated with
either production facilities or brand acquisition costs. Because we are not a U.S. producer
 changes in regulations affecting production
facility operations may indirectly affect the costs of the brands we purchase for resale
 but we would not anticipate any resulting
material adverse impact upon our capital expenditures.


brands dominate our industry. The adoption of more restrictive marketing and sales regulations or increased excise taxes and customs
duties could materially adversely affect our earnings and competitive industry position. Large international conglomerates have
greater financial resources than we do and would be better able to absorb increased compliance costs.




 2014
 we had 45 full-time
employees
 29 of which were in sales and marketing and 16 of which were in management
 finance and administration. We had 41 full-time
employees as of March 31
 2013. As of March 31
 2014
 43 of our employees were located in the U.S. and two were located in Ireland.




beverage alcohol. Our product categories are rum
 whiskey
 liqueurs
 vodka and tequila. We report our operations in two geographical
areas: International and U.S. See note 17 to our accompanying consolidated financial statements.




 which was
incorporated in 2009. We are the successor to a Delaware corporation
 which was incorporated in Delaware in 2003.




 including our annual
reports on Form 10-K
 our quarterly reports on Form 10-Q
 our current reports on Form 8-K
 our proxy statements and reports filed
by our officers and directors under Section 16(a) of the Securities Exchange Act of 1934
 as amended
 and any amendments to those
filings
 are available
 free of charge
 on our investor website
 
 as soon as reasonably
practicable after we or our officers and directors electronically file or furnish such material with the SEC. You may also find
our code of business conduct
 nominating and governance charter and audit committee charter on our website. We do not intend for
information contained in our website
 or those of our subsidiaries
 to be a part of this annual report on Form 10-K. Shareholders
may request paper copies of these filings and corporate governance documents
 without charge
 by written request to Castle Brands
Inc.
 122 East 42nd St.
 Suite&nbsp;4700
 New York
 NY 10168
 Attn: Investor Relations.&nbsp;


 you may read and copy any materials
we file with the SEC at the SEC&rsquo;s Public Reference Room at 100 F Street
 NE.
 Washington
 DC 20549
 on official business
days during the hours of 10 a.m. to 3 p.m. You may obtain information on the operation of the Public Reference Room by calling
the SEC at 1-800-SEC-0330. The SEC maintains an Internet site (http://www.sec.gov) that contains reports
 proxy and information
statements
 and other information regarding issuers that file electronically with the SEC.


    
    






We have never been profitable
 and believe we will continue
to incur net losses for the foreseeable future.


including a net loss of $8.9&nbsp;million for fiscal 2014
 and had an accumulated loss of $139.6 million as of March 31
 2014.
We believe that we will continue to incur net losses as we expect to make continued significant investment in product development
and sales and marketing and to incur significant administrative expenses as we seek to grow our brands. We also anticipate that
our cash needs will exceed our income from sales for the near future. Some of our products may never achieve widespread market
acceptance and may not generate sales and profits to justify our investment. Also
 we may find that our expansion plans are more
costly than we anticipate and that they do not ultimately result in commensurate increases in our sales
 which would further increase
our losses. We expect we will continue to experience losses and negative cash flow
 some of which could be significant. Results
of operations will depend upon numerous factors
 some of which are beyond our control
 including market acceptance of our products
new product introductions and competition. We incur substantial operating expenses at the corporate level
 including costs directly
related to being an SEC reporting company.

Recent worldwide and domestic economic trends and financial
market conditions could adversely impact our financial performance.


experienced adverse conditions and may be subject to further deterioration for the foreseeable future. We are subject to risks
associated with these adverse conditions
 including economic slowdown and the disruption
 volatility and tightening of credit and
capital markets.


impact our major suppliers
 distributors and retailers. The inability of suppliers
 distributors or retailers to conduct business
or to access liquidity could impact our ability to distribute our products.


will improve in the near future. A prolonged downturn
 further worsening or broadening of the adverse conditions in the worldwide
and domestic economies could affect consumer spending patterns and purchases of our products
 and create or exacerbate credit issues
cash flow issues and other financial hardships for us and for our suppliers
 distributors
 retailers and consumers. Depending upon
their severity and duration
 these conditions could have a material adverse impact on our business
 liquidity
 financial condition
and results of operations.

We may require additional capital
 which we may not be able
to obtain on acceptable terms.&nbsp;&nbsp;Our inability to raise such capital
 as needed
 on beneficial terms or at all could restrict
our future growth and severely limit our operations.


companies in our industry.&nbsp;&nbsp;This may limit our operations and growth
 including our ability to continue to develop existing
brands
 service our debt obligations
 maintain adequate inventory levels
 fund potential acquisitions of new brands
 penetrate
new markets
 attract new customers and enter into new distribution relationships. If we have not generated sufficient cash from
operations to finance additional capital needs
 we will need to raise additional funds through private or public equity and/or
debt financing. We cannot assure you that
 if and when needed
 additional financing will be available to us on acceptable terms
or at all. If additional capital is needed and either unavailable or cost prohibitive
 our operations and growth may be limited
as we may need to change our business strategy to slow the rate of
 or eliminate
 our expansion or reduce or curtail our operations.
Also
 any additional financing we undertake could impose covenants upon us that restrict our operating flexibility
 and
 if we
issue equity securities to raise capital our existing shareholders may experience dilution and the new securities may have rights
preferences and privileges senior to those of our common stock.

If our brands do not achieve more widespread consumer acceptance
our growth may be limited.


cycle and have not achieved extensive brand recognition. Also
 brands we may acquire in the future are unlikely to have established
extensive brand recognition. Accordingly
 if consumers do not accept our brands
 we will not be able to penetrate our markets and
our growth may be limited.


    
    


We depend on a limited number of suppliers. Failure to obtain
satisfactory performance from our suppliers or loss of our existing suppliers could cause us to lose sales
 incur additional costs
and lose credibility in the marketplace. We also have annual purchase obligations with certain suppliers.


suppliers for the sourcing of all of our products
 including both our own proprietary brands and those we distribute for others.
These suppliers consist of third-party distillers
 bottlers and producers in the U.S.
 Bermuda
 the Caribbean
 Australia and Europe.
We rely on the owners of Gosling&rsquo;s rum
 Pallini liqueurs
 Gozio amaretto and Tierras tequila to produce their brands for
us. For our proprietary products
 we may rely on a single supplier to fulfill one or all of the manufacturing functions for a brand.
For instance
 Cargill is the sole producer for Boru vodka; IDL is the sole provider of our single malt
 blended
and grain Irish whiskeys; Gaelic Heritage Corporation Limited is the sole producer of our Celtic Honey Irish liqueur; and Terra
Limited is not only the sole producer of our Brady&rsquo;s Irish cream liqueur but also the only bottler of our Irish whiskeys.
We do not have long-term written agreements with all of our suppliers. We do not currently have a long-term source for supply of
aged bourbon or rye and there can be no assurance we can source adequate amounts of aged bourbon or rye at satisfactory prices
or at all. Also
 if we fail to complete purchases of products ordered annually
 certain suppliers have the right to bill us for
product not purchased during the period. The termination of our written or oral agreements or an adverse change in the terms of
these agreements could have a negative impact on our business. If our suppliers increase their prices
 we may not have alternative
sources of supply and may not be able to raise the prices of our products to cover all or even a portion of the increased costs.
Also
 our suppliers&rsquo; failure to perform satisfactorily or handle increased orders
 delays in shipments of products from international
suppliers or the loss of our existing suppliers
 especially our key suppliers
 could cause us to fail to meet orders for our products
lose sales
 incur additional costs and/or expose us to product quality issues. In turn
 this could cause us to lose credibility
in the marketplace and damage our relationships with distributors
 ultimately leading to a decline in our business and results
of operations. If we are not able to renegotiate these contracts on acceptable terms or find suitable alternatives
 our business
could be negatively impacted.

We depend on our independent wholesale distributors to distribute
our products. The failure or inability of even a few of our distributors to adequately distribute our products within their territories
could harm our sales and result in a decline in our results of operations.


distributors or
 in 17 states known as &ldquo;control states
&rdquo; state-owned agencies performing this function
 to sell our
products to retail outlets
 including liquor stores
 bars
 restaurants and national chains in the U.S. We have established relationships
for our brands with wholesale distributors in each state; however
 failure to maintain those relationships could significantly
and adversely affect our business
 sales and growth. Over the past decade there has been increasing consolidation
 both intrastate
and interstate
 among distributors. As a result
 many states now have only two or three significant distributors. Also
 there are
several distributors that now control distribution for several states. For the year ended March 31
 2014
 sales to one customer
accounted for 31.9% of revenues. As a result
 if we fail to maintain good relations with a distributor
 our products could in some
instances be frozen out of one or more markets entirely. The ultimate success of our products also depends in large part on our
distributors&rsquo; ability and desire to distribute our products to our desired U.S. target markets
 as we rely significantly
on them for product placement and retail store penetration. We have no formal distribution agreements or minimum sales requirements
with any of our distributors and they are under no obligation to place our products or market our brands. Moreover
 all of them
also distribute competitive brands and product lines. We cannot assure you that our U.S. alcohol distributors will continue to
purchase our products
 commit sufficient time and resources to promote and market our brands and product lines or that they can
or will sell them to our desired or targeted markets. If they do not
 our sales will be harmed
 resulting in a decline in our results
of operations.


do not require the use of independent distributors by law
 we have chosen to conduct our sales through distributors in all of our
markets and
 accordingly
 we face similar risks to those set forth above with respect to our international distribution. Some of
these international markets may have only a limited number of viable distributors.

The sales of our products could decrease significantly if
we cannot secure and maintain listings in the control states.


 the state liquor
commissions act in place of distributors and decide which products are to be purchased and offered for sale in their respective
states. Products selected for listing must generally reach certain volumes and/or profit levels to maintain their listings. Products
are selected for purchase and sale through listing procedures which are generally made available to new products only at periodically
scheduled listing interviews. Products not selected for listings can only be purchased by consumers in the applicable control state
through special orders
 if at all. If
 in the future
 we are unable to maintain our current listings in the control states
 or
secure and maintain listings in those states for any additional products we may acquire
 sales of our products could decrease significantly.


If we are unable to identify and successfully acquire additional
brands that are complementary to our existing portfolio
 our growth could be limited
 and
 even if additional brands are acquired
we may not realize planned benefits due to integration difficulties or other operating issues.


acquisition of additional brands that are complementary to our existing portfolio through acquisitions of such brands or their
corporate owners
 directly or through mergers
 joint ventures
 long-term exclusive distribution arrangements and/or other strategic
relationships. If we are unable to identify suitable brand candidates and successfully execute our acquisition strategy
 our growth
could be limited. Also
 even if we are successful in acquiring additional brands
 we may not be able to achieve or maintain profitability
levels that justify our investment in
 or realize operating and economic efficiencies or other planned benefits with respect to
those additional brands. The addition of new products or businesses entails numerous risks with respect to integration and other
operating issues
 any of which could have a detrimental effect on our results of operations and/or the value of our equity. These
risks include:



    
    
    

    
    
    



    
    




    
    
    

    
    
    

    
    
adverse effects on existing business relationships with suppliers
 distributors and retail customers;

    
    
    

    
    
    



 there are special risks associated
with the acquisition of additional brands through joint venture arrangements. We may not have a majority interest in
 or control
of
 future joint ventures in which we may enter. There is
 therefore
 risk that our joint venture partners may at any time have
economic
 business or legal interests or goals that are inconsistent with our interests or goals or those of the joint venture.
There is also risk that our current or future joint venture partners may be unable to meet their economic or other obligations
and that we may be required to fulfill those obligations alone.


of additional brands will also be dependent upon the availability of capital to complete the necessary acquisition arrangements.
We intend to finance our brand acquisitions through a combination of our available cash resources
 third -party financing and
in appropriate circumstances
 the further issuance of equity and/or debt securities; however
 our ability to finance such acquisitions
may be limited by the terms of our other equity and/or debt securities. Acquiring additional brands could have a significant effect
on our financial position
 and could cause substantial fluctuations in our quarterly and yearly operating results. Also
 acquisitions
could result in the recording of significant goodwill and intangible assets on our financial statements
 the amortization or impairment
of which would reduce reported earnings in subsequent years.

Currency exchange rate fluctuations and devaluations may
have a significant adverse effect on our revenues
 sales
 costs of goods and overall financial results.


 non-U.S. operations accounted
for approximately 15.2% of our revenues. Therefore
 gains and losses on the conversion of foreign payments into U.S. dollars could
cause fluctuations in our results of operations
 and fluctuating exchange rates could cause reduced revenues and/or gross margins
from non-U.S. dollar-denominated international sales and inventory purchases. Also
 for fiscal 2014
 Euro denominated sales accounted
for approximately 9.3% of our total revenue
 so a substantial change in the rate of exchange between the U.S. dollar and the Euro
could have a significant adverse affect on our financial results. Our ability to acquire spirits and produce and sell our products
at favorable prices will also depend in part on the relative strength of the U.S. dollar. We do not currently hedge against these
risks.

We must maintain a relatively large inventory of our products
to support customer delivery requirements
 and if this inventory is lost due to theft
 fire or other damage or becomes obsolete
our results of operations would be negatively impacted.


to meet customer delivery requirements for our products. We are always at risk of loss of that inventory due to theft
 fire or
other damage
 and any such loss
 whether insured against or not
 could cause us to fail to meet our orders and harm our sales and
operating results. Also
 our inventory may become obsolete as we introduce new products
 cease to produce old products or modify
the design of our products&rsquo; packaging
 which would increase our operating losses and negatively impact our results of operations.

Either our or our strategic partners&rsquo; failure to protect
our respective trademarks and trade secrets could compromise our competitive position and decrease the value of our brand portfolio.


on our
 and with respect to our agency or joint venture brands
 our strategic partners&rsquo;
 ability to develop favorable consumer
recognition of our brands and trademarks. Although both we and our strategic partners actively apply for registration of our brands
and trademarks
 they could be imitated in ways that we cannot prevent. Also
 we rely on trade secrets and proprietary know-how
concepts and formulas. Our methods of protecting this information may not be adequate. Moreover
 we may face claims of misappropriation
or infringement of third parties&rsquo; rights that could interfere with our use of this information. Defending these claims may
be costly and
 if unsuccessful
 may prevent us from continuing to use this proprietary information in the future and result in
a judgment or monetary damages being levied against us. We do not maintain non-competition agreements with all of our key personnel
or with some of our key suppliers. If competitors independently develop or otherwise obtain access to our or our strategic partners&rsquo;
trade secrets
 proprietary know-how or recipes
 the appeal
 and thus the value
 of our brand portfolio could be reduced
 negatively
impacting our sales and growth potential.

An impairment in the carrying value of goodwill or other
acquired intangible assets could negatively affect our operating results and shareholders&rsquo; equity.


the fair value of acquired businesses in excess of identifiable assets and liabilities as of the acquisition date
 net of any cumulative
impairments. The carrying value of other intangible assets represents the fair value of trademarks
 trade names and other acquired
intangible assets as of the acquisition date
 net of impairments and accumulated amortization. Goodwill and other acquired intangible
assets expected to contribute indefinitely to our cash flows are not amortized
 but must be evaluated for impairment by our management
at least annually. If carrying value exceeds current fair value as determined based on the discounted future cash flows of the
related business
 the intangible asset is considered impaired and is reduced to fair value via a non-cash charge to earnings. If
the value of goodwill or other acquired intangible assets is impaired
 our earnings and shareholders&rsquo; equity could be adversely
affected.


    
    



A failure of one or more of our key information technology
systems
 networks
 processes
 associated sites or service providers could have a material adverse impact on our business.


systems
 networks
 and services
 including internet sites
 data hosting and processing facilities and tools
 hardware (including
laptops and mobile devices)
 software and technical applications and platforms
 some of which are managed
 hosted
 provided and/or
used by third-parties or their vendors
 to assist us in the management of our business. The various uses of these IT systems
 networks
and services include
 but are not limited to: hosting our internal network and communication systems; ordering and managing materials
from suppliers; supply/demand planning; production; shipping product to customers; hosting our branded websites and marketing products
to consumers; collecting and storing customer
 consumer
 employee
 investor
 and other data; processing transactions; summarizing
and reporting results of operations; hosting
 processing
 and sharing confidential and proprietary research
 business plans
 and
financial information; complying with regulatory
 legal or tax requirements; providing data security; and handling other processes
necessary to manage our business.

sophisticated cyber crime pose a potential risk to the security of our IT systems
 networks
 and services
 as well as the confidentiality
availability
 and integrity of our data. If the IT systems
 networks
 or service providers we rely upon fail to function properly
or if we suffer a loss or disclosure of business or other sensitive information
 due to any number of causes
 ranging from catastrophic
events to power outages to security breaches
 and our business continuity plans do not effectively address these failures on a
timely basis
 we may suffer interruptions in our ability to manage operations and reputational
 competitive and/or business harm
which may adversely affect our business operations and/or financial condition. In addition
 such events could result in unauthorized
disclosure of material confidential information
 and we may suffer financial and reputational damage because of lost or misappropriated
confidential information belonging to us or to our partners
 our employees
 customers
 suppliers or consumers. In any of these
events
 we could also be required to spend significant financial and other resources to remedy the damage caused by a security
breach or to repair or replace networks and IT systems.

Our failure to attract or retain key executive or employee
talent could adversely affect our business.


abilities of our senior management team
 other key employees
 and a high-quality employee base
 as well as our ability to attract
motivate
 reward
 and retain them. We do not maintain and do not intend to obtain key man insurance on the life of any executive
or employee. Difficulties in hiring or retaining key executive or employee talent
 or the unexpected loss of experienced employees
could have an adverse impact our business performance. In addition
 we could experience business disruption and/or increased costs
related to organizational changes
 reductions in workforce
 or other cost-cutting measures.



Demand for our products may be adversely affected by many
factors
 including changes in consumer preferences and trends.


variety of factors including changes in demographic and social trends
 public health initiatives
 product innovations
 changes
in vacation or leisure activity patterns and a downturn in economic conditions
 which may reduce consumers&rsquo; willingness to
purchase distilled spirits or cause a shift in consumer preferences toward beer
 wine or non-alcoholic beverages. Our success depends
in part on fulfilling available opportunities to meet consumer needs and anticipating changes in consumer preferences with successful
new products and product innovations.

Our business performance is substantially dependent upon
the continued growth of rum and whiskey sales.


on rum and whiskey sales. Changes in consumer preferences regarding these categories of beverage alcohol products may have an adverse
effect on our sales and financial condition. Given the importance of our rum and whiskey brands to our overall Company success
a significant or sustained decline in volume or selling price of these products would likely have a negative effect on our growth
and our stock price. Additionally
 should we not be successful in our efforts to maintain and increase the relevance of the brands
in the minds of today&rsquo;s and tomorrow&rsquo;s consumer
 our business and operating results could suffer.

We face substantial competition in our industry and many
factors may prevent us from competing successfully.


and quality
 brand image
 price
 service and ability to innovate in response to consumer preferences. The global spirits industry
is highly competitive and is dominated by several large
 well-funded international companies. It is possible that our competitors
may either respond to industry conditions or consumer trends more rapidly or effectively or resort to price competition to sustain
market share
 which could adversely affect our sales and profitability.


    
    


Adverse public opinion about alcohol could reduce demand
for our products.


 in the past
advocated successfully for more stringent labeling requirements
 higher taxes and other regulations designed to discourage alcohol
consumption. More restrictive regulations
 negative publicity regarding alcohol consumption and/or changes in consumer perceptions
of the relative healthfulness or safety of beverage alcohol could decrease sales and consumption of alcohol and thus the demand
for our products. This could
 in turn
 significantly decrease both our revenues and our revenue growth
 causing a decline in our
results of operations.

Class action or other litigation relating to alcohol abuse
or the misuse of alcohol could adversely affect our business.


action or similar litigation alleging that the continued excessive use or abuse of beverage alcohol has caused death or serious
health problems. It is also possible that governments could assert that the use of alcohol has significantly increased government
funded health care costs. Litigation or assertions of this type have adversely affected companies in the tobacco industry
 and
it is possible that we
 as well as our suppliers
 could be named in litigation of this type.


 lawsuits have been brought in a number
of states alleging that beverage alcohol manufacturers and marketers have improperly targeted underage consumers in their advertising.
Plaintiffs in these cases allege that the defendants&rsquo; advertisements
 marketing and promotions violate the consumer protection
or deceptive trade practices statutes in each of these states and seek repayment of the family funds expended by the underage consumers.
While we have not been named in these lawsuits
 we could be named in similar lawsuits in the future. Any class action or other
litigation asserted against us could be expensive and time-consuming to defend against
 depleting our cash and diverting our personnel
resources and
 if the plaintiffs in such actions were to prevail
 our business could be harmed significantly.

Regulatory decisions and legal
 regulatory and tax changes
could limit our business activities
 increase our operating costs and reduce our margins.


in all of the countries in which we operate. This may include regulations regarding production
 distribution
 marketing
 advertising
and labeling of beverage alcohol products. We are required to comply with these regulations and to maintain various permits and
licenses. We are also required to conduct business only with holders of licenses to import
 warehouse
 transport
 distribute and
sell beverage alcohol products. We cannot assure you that these and other governmental regulations applicable to our industry will
not change or become more stringent. Moreover
 because these laws and regulations are subject to interpretation
 we may not be
able to predict when and to what extent liability may arise. Additionally
 due to increasing public concern over alcohol-related
societal problems
 including driving while intoxicated
 underage drinking
 alcoholism and health consequences from the abuse of
alcohol
 various levels of government may seek to impose additional restrictions or limits on advertising or other marketing activities
promoting beverage alcohol products. Failure to comply with any of the current or future regulations and requirements relating
to our industry and products could result in monetary penalties
 suspension or even revocation of our licenses and permits. Costs
of compliance with changes in regulations could be significant and could harm our business
 as we could find it necessary to raise
our prices in order to maintain profit margins
 which could lower the demand for our products and reduce our sales and profit potential.


 the distribution of beverage alcohol
products is subject to extensive taxation both in the U.S. and internationally (and
 in the U.S.
 at both the federal and state
government levels)
 and beverage alcohol products themselves are the subject of national import and excise duties in most countries
around the world. An increase in taxation or in import or excise duties could also significantly harm our sales revenue and margins
both through the reduction of overall consumption and by encouraging consumers to switch to lower-taxed categories of beverage
alcohol.

We could face product liability or other related liabilities
that increase our costs of operations and harm our reputation.


and will attempt to limit contractually our liability for damages arising from our products
 these measures may not be sufficient
for us to successfully avoid or limit liability. Our product liability insurance coverage is limited to $1.0&nbsp;million per occurrence
and $2.0&nbsp;million in the aggregate and our general liability umbrella policy is capped at $10.0&nbsp;million. Further
 any
contractual indemnification and insurance coverage we have from parties supplying our products is limited
 as a practical matter
to the creditworthiness of the indemnifying party and the insured limits of any insurance provided by these suppliers. In any event
extensive product liability claims could be costly to defend and/or costly to resolve and could harm our reputation.

Contamination of our products and/or counterfeit or confusingly
similar products could harm the image and integrity of
 or decrease customer support for
 our brands and decrease our sales.


the positive image that consumers have of them. Contamination
 whether arising accidentally or through deliberate third-party action
or other events that harm the integrity or consumer support for our brands
 could affect the demand for our products. Contaminants
in raw materials purchased from third parties and used in the production of our products or defects in the distillation and fermentation
processes could lead to low beverage quality as well as illness among
 or injury to
 consumers of our products and could result
in reduced sales of the affected brand or all of our brands. Also
 to the extent that third parties sell products that are either
counterfeit versions of our brands or brands that look like our brands
 consumers of our brands could confuse our products with
products that they consider inferior. This could cause them to refrain from purchasing our brands in the future and in turn could
impair our brand equity and adversely affect our sales and operations.


    
    




We may not be able to maintain our listing on the NYSE MKT
which may limit the ability of our shareholders to sell their common stock.


listing criteria
 we may be delisted and trading of our common stock could be conducted in the OTC Bulletin Board or the interdealer
quotation systems of the OTC Markets Group Inc. In such case
 a shareholder likely would find it more difficult to trade our common
stock or to obtain accurate market quotations for it. If our common stock is delisted
 it will become subject to the Securities
and Exchange Commission&rsquo;s &ldquo;penny stock rules
&rdquo; which impose sales practice requirements on broker-dealers that
sell that common stock to persons other than established customers and &ldquo;accredited investors.&rdquo; Application of this
rule could make broker-dealers unable or unwilling to sell our common stock and limit the ability of shareholders to sell their
common stock in the secondary market.

Our executive officers
 directors and principal shareholders
own a substantial percentage of our voting stock
 which allows them to control matters requiring shareholder approval. They could
make business decisions for us that cause our stock price to decline and may act by written consent.


 2014
 our executive
officers
 directors and principal shareholders beneficially owned approximately 49% of our common stock
 including options
that are exercisable within 60&nbsp;days of the date of this annual report and assuming full exercise of such options and
conversion of our 5% October 2013 Convertible notes held by such persons. As a result
 if they act in concert
 they
could control matters requiring approval by our shareholders
 including the election of directors
 and could have the ability
to prevent or cause a corporate transaction
 even if other shareholders oppose such action. Also
 our articles
of incorporation permit our shareholders to act by written consent. This concentration of voting power could also have
the effect of delaying
 deterring
 or preventing a change of control or other business combination
 which could cause our
stock price to decline.

Provisions in our articles of incorporation
 our bylaws and
Florida law could make it more difficult for a third party to acquire us
 discourage a takeover and adversely affect existing shareholders.


 our bylaws
and the Florida Business Corporation Act contain provisions that may have the effect of making more difficult
 delaying
 or deterring
attempts by others to obtain control of our company
 even when these attempts may be in the best interests of our shareholders.
These include provisions limiting the shareholders&rsquo; powers to remove directors. Our articles of incorporation also authorize
our board of directors
 without shareholder approval
 to issue one or more series of preferred stock
 which could have voting and
conversion rights that adversely affect or dilute the voting power of the holders of our common stock. Florida law also imposes
conditions on certain &quot;affiliated transactions&rdquo; with &ldquo;interested shareholders.&rdquo;


be adopted in the future could deter unsolicited takeovers or delay or prevent changes in our control or management
 including
transactions in which shareholders might otherwise receive a premium for their shares over then current market prices. These provisions
may also limit the ability of shareholders to approve transactions that they may deem to be in their best interests.

Negative publicity could affect our stock price and business
performance.


company
 brands
 marketing
 personnel
 operations
 business performance
 or prospects could negatively affect our corporate reputation
stock price
 ability to attract high quality talent
 and/or the performance of our business
 regardless of its accuracy or inaccuracy.
Adverse publicity or negative commentary on social media outlets could cause consumers to avoid our brands and/or choose brands
offered by our competitors
 which could negatively affect our financial results.


    
    









York
 NY
 where we lease approximately 4
800 square feet of office space under a lease that expires in April&nbsp;2016. We also
lease approximately 750 square feet of office space in Dublin
 Ireland under a lease that expires in October&nbsp;2016 and approximately
1
000 square feet of office space in Houston
 TX under a lease that expires in January 2015.




wholly-owned subsidiaries is currently subject to litigation which
 in the opinion of our management
 is likely to have a material
adverse effect on us.


 however
 become involved in litigation
from time to time relating to claims arising in the ordinary course of our business. These claims
 even if not meritorious
 could
result in the expenditure of significant financial and managerial resources.







Item&nbsp;5. Market for Registrant&rsquo;s Common Equity
Related Shareholder Matters and Issuer Purchases of Equity Securities




under the symbol &ldquo;ROX.&rdquo; The following table sets forth the high and low sales prices for our common stock for the periods
specified.



    
    
    


 2013)
    
    

    
 2013)
    
    

    
 2013)
    
    

    
 2014)
    
    

    
    
    

    
    
    

    
 2012)
    
    

    
 2012)
    
    

    
 2012)
    
    

    
 2013)
    
    





 2013
 there were approximately
200 record holders of our common stock.




in fiscal 2014 or 2013 and we do not intend to pay any cash dividends with respect to our common stock in the foreseeable future.
We currently intend to retain any earnings for use in the operation of our business and to fund future growth. Any future determination
to pay cash dividends will be at our board&rsquo;s discretion and will depend upon our financial condition
 operating results
capital requirements and such other factors as our board deems relevant. Further
 our ability to declare and pay cash dividends
is restricted by certain covenants in our loan agreements.


    
    





at March 31
 2014 regarding compensation plans under which our equity securities are authorized for issuance.



    
 options


 options
&nbsp;warrants

    

    
12
951
809
    
9
720
000

    
    
    
    

    
12
951
809
    
9
720
000





 we are not required
to provide the information required by this Item.

Item&nbsp;7. Management&rsquo;s Discussion and Analysis of
Financial Condition and Results of Operations





Castle Brands into a profitable international spirits company
 with a distinctive portfolio of  premium and super
premium spirits brands. To achieve this
 we continue to seek to:


 We
continue to focus our distribution efforts
 sales expertise and targeted marketing activities on our more profitable brands and
markets;

 We believe that continued organic
growth will enable us to achieve long-term profitability. We focus on brands that have profitable growth potential and staying
power
 such as our rums and whiskies
 sales of which have grown approximately 40% over the past two fiscal years;

 We use our existing assets
expertise and resources to build consumer awareness and market penetration for our brands;

Our established distribution
network in all 50 U.S. states enables us to promote our brands nationally and makes us an attractive strategic partner for smaller
companies seeking U.S. distribution; and

selectively add new brand extensions and brands to our portfolio.
We intend to continue to introduce new brand extensions and expressions. We continue to explore strategic relationships
joint ventures and acquisitions to selectively expand our premium spirits portfolio. We expect that future acquisitions or agency
relations
 if any
 would involve some combination of cash
 debt and the issuance of our stock.. 








 we entered into an Equity
Distribution Agreement (the &quot;Distribution Agreement&quot;) with Barrington Research Associates
 Inc. (&quot;Barrington&quot;)
as sales agent
 under which we may issue and sell over time and from time to time
 to or through Barrington
 shares (the &quot;Shares&quot;)
of our common stock
 $0.01 par value per share (&quot;Common Stock&quot;) having a gross sales price of up to $6.0 million.


Agreement may be effected by any method permitted by law deemed to be an &quot;at-the-market&quot; offering as defined
in Rule 415 of the Securities Act of 1933
 as amended
 including without limitation directly on the NYSE MKT LLC or any other existing
trading market for the Common Stock or through a market maker
 up to the amount specified
 and otherwise to or through Barrington
in accordance with the placement notices delivered by us to Barrington. Also
 with our prior consent
 some of the
Common Stock issued pursuant to the Distribution Agreement may be sold in privately negotiated transactions.


    
    



 2013 and June 25
2014
 we sold&nbsp;6.6 million Shares of Common Stock pursuant to the Distribution Agreement for gross proceeds of $5.7 million
before deducting sales agent and offering expenses of $0.2 million. We used a portion of the proceeds to finance the acquisition
of an additional $4.3 million in bourbon inventory in support of the growth of our Jefferson's bourbon brand.





 in accordance with certain
terms of the warrants issued in connection with our June 2011 private placement (the &ldquo;2011 Warrants&rdquo;)
 the down-round
provisions included in the terms of the 2011 Warrants were no longer in effect&nbsp;as a result of the historical volume weighted
average price and trading volume of our Common Stock.&nbsp;As a result
 we then reclassed the fair value of the outstanding warrant
liability of&nbsp;$6.2 million to equity
 resulting in an increase to additional paid-in capital.&nbsp;Further
 we were no longer
required to recognize any change in fair value of the 2011 Warrants in future reporting periods.


 2014
 we issued
10.1 million shares of Common Stock and received $3.8 million in cash upon the exercise of 2011 Warrants. On April 2
 2014
 we
called for cancellation all remaining 1.7 million unexercised 2011 Warrants as of April 21
 2014. All of these warrants were exercised
prior to cancellation and we issued approximately 1.7 million shares of Common Stock and received $0.6 million in
cash upon the exercise thereof.





 2014
 our Board of Directors
approved the mandatory conversion of all outstanding shares of our 10% Series A Convertible Preferred Stock
 par value $ 0.01 per
share (&ldquo;Series A Preferred Stock&rdquo;) pursuant to their terms
 effective on or about February 24
 2014. Pursuant to the
mandatory conversion
 all outstanding shares of Series A Preferred Stock
 and accrued dividends thereon
 converted into approximately
26.2 million shares of Common Stock.




 we entered into a 5%
Convertible Subordinated Note Purchase Agreement (the &quot;Note Purchase Agreement&quot;)
 with the purchasers
party thereto (the &quot;Purchasers&quot;)
 which provides for the issuance of an aggregate initial principal amount of $2.1 million unsecured
subordinated notes (the &quot;Convertible Notes&quot;). We used a portion of the proceeds to finance the acquisition of additional
bourbon inventory in support of the growth of our Jefferson's bourbon brand.&nbsp;


a rate of 5% per annum and mature on December 15
 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible
in whole or in part from time to time at the option of the holders thereof into shares of our Common Stock at a conversion price
of $0.90 per share (the &quot;Conversion Price&quot;). The Convertible Notes may be prepaid in whole or in part at any time without
penalty or premium
 but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events
of default
 which
 if uncured
 entitle each noteholder to accelerate the due date of the unpaid principal amount of
 and all accrued
and unpaid interest on
 the Convertible Notes. We issued the Convertible Notes&nbsp;on October 31
 2013.


parties of ours
 including an affiliate of Dr. Phillip Frost ($500
000)
 a director of ours and our principal shareholder
 Mark
E. Andrews
 III ($50
000)
 a director of ours and our Chairman
 an affiliate of Richard J. Lampen ($50
000)
 a director of ours
and our President and Chief Executive Officer
 an affiliate of Glenn Halpryn ($200
000)
 a director of ours
 Dennis Scholl ($100
000)
a director of ours
 and Vector Group Ltd. ($200
000)
 a more than 5% shareholder of ours
 of which Richard Lampen is an executive
officer and Henry Beinstein
 a director of ours
 is a director.


of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Common Stock (as reported
on the principal market or exchange on which the Common Stock is listed or quoted for trading) exceeds $50
000 per trading day
and (ii) the volume weighted average price of the Common Stock for at least twenty (20) trading days during any thirty (30) consecutive
trading day period exceeds 250% of the then-current Conversion Price. Any forced conversion will be applied ratably to the holders
of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder&rsquo;s then-current note holdings.




 in connection with
our execution and delivery of the Note Purchase Agreement
 we and our wholly owned subsidiary
 Castle Brands (USA) Corp. (&quot;CB-USA&quot;)
entered into a Fourth Amendment
 Waiver and Consent (the&nbsp;&quot;Fourth Amendment&quot;) to the Loan and Security Agreement
(as amended
 the &quot;Keltic Loan Agreement&quot;)
 dated as of August 19
 2011
 with Keltic Financial Partners II
 LP
 a Delaware
limited partnership ( &quot;Keltic&quot;) 
 to amend certain terms of our existing $8.0 million revolving credit&nbsp;facility
(the &quot;Keltic Facility&quot;) and $4.0 million term loan to finance purchases of aged whiskies (the &ldquo;Bourbon Term Loan&rdquo;).
The Fourth Amendment modifies certain aspects of the EBITDA covenant contained in the Loan Agreement
 permits us to incur indebtedness
in an aggregate original principal amount of $2.1 million&nbsp;pursuant to the terms of the Note Purchase Agreement and Convertible
Notes and permits the us to make regularly scheduled payments of principal and interest and voluntary prepayments on the Convertible
Notes
 subject to certain conditions set forth in the Fourth Amendment.





    
    






 we entered into a Fifth
Amendment to the Keltic Loan Agreement with Keltic
 to
 among other things
 amend certain terms of our existing $8.0 million revolving
facility and $4.0 million&nbsp;term loan with Keltic to provide for the issuances of letters of credit under the Keltic Loan Agreement.

Expansion of Gosling&rsquo;s Stormy Ginger
Beer


 cocktail
 through GCP
 we have recently begun producing Gosling&rsquo;s Stormy
Ginger Beer in Germany and the U.K for international sales including Australia
 Germany
 the U.K.
 the Netherlands
 Denmark
 Italy
Ireland and Dubai.




our products to our network of wholesale distributors or
 in control states
 state-operated agencies
 which
 in turn
 distribute
our products to retail outlets. In the U.S.
 our sales price per case includes excise tax and import duties
 which are also reflected
as a corresponding increase in our cost of sales. Most of our international sales are sold &ldquo;in bond&rdquo;
 with the excise
taxes paid by our customers upon shipment
 thereby resulting in lower relative revenue as well as a lower relative cost of sales
although some of our United Kingdom sales are sold &ldquo;tax paid&rdquo;
 as in the U.S. The difference between sales and net
sales principally reflects adjustments for various distributor incentives.


at which we sell our products
 our ability to control our cost of sales
 the relative mix of our case sales by brand and geography
and the impact of foreign currency fluctuations. Our cost of sales is principally driven by our cost of procurement
 bottling and
packaging
 which differs by brand
 as well as freight and warehousing costs. We purchase certain products
 such as Gosling&rsquo;s
rums
 Pallini liqueurs
 Gozio amaretto and Tierras tequila
 as finished goods. For other products
 such as Jefferson&rsquo;s bourbons
we purchase the components
 including the distilled spirits
 bottles and packaging materials
 and have arrangements with third
parties for bottling and packaging. Our U.S. sales typically have a higher absolute gross margin than in other markets
 as sales
prices per case are generally higher in the U.S.


and marketing expenditures and compensation paid to our marketing and sales personnel. Our selling expense
 as a percentage of
sales and per case
 is higher than that of our competitors because of our brand development costs
 level of marketing expenditures
and established sales force versus our relatively small base of case sales and sales volumes. However
 we believe that maintaining
an infrastructure capable of supporting future growth is the correct long-term approach for us.


expense to increase in the coming years
 we expect selling expense as a percentage of revenues and on a per case basis to decline
as our volumes expand and our sales team sells a larger number of brands.


to corporate and administrative functions that support our operations and includes administrative payroll
 occupancy and related
expenses and professional services. We expect general and administrative expense in fiscal 2015 to be comparable to fiscal 2014
as we continue to control core spending. We expect our general and administrative expense as a percentage of sales to decline due
to economies of scale.


the U.S. and internationally over the next several years through organic growth
 and through the extension of our product line
via line extensions
 acquisitions and distribution agreements. We will seek to maintain liquidity and manage our working capital
and overall capital resources during this period of anticipated growth to achieve our long-term objectives
 although there is no
assurance that we will be able to do so.


trends will create growth opportunities for us
 including:



    
    
    

    
    
increased barriers to entry
 particularly in the U.S.
 due to continued consolidation and the difficulty in establishing an extensive distribution network
 such as the one we maintain; and

    
    
the trend by small private and family-owned spirits brand owners to partner with
 or be acquired by
 a company with global distribution. We expect to be an attractive alternative to our larger competitors for these brand owners as one of the few modestly-sized publicly-traded spirits companies.



with other brands
 acquiring smaller and emerging brands and growing existing brands. To identify potential partner and acquisition
candidates we plan to rely on our management&rsquo;s industry experience and our extensive network of industry contacts. We also
plan to maintain and grow our U.S. and international distribution channels so that we are more attractive to spirits companies
who are looking for a route to market for their products. We expect to compete for foreign and small private and family-owned spirits
brands by offering flexible and creative structures
 which present an alternative to the larger spirits companies.


    
    



through a combination of our available cash resources
 third party financing and
 in appropriate circumstances
 the further issuance
of equity and/or debt securities. Acquiring additional brands could have a significant effect on our financial position
 and could
cause substantial fluctuations in our quarterly and yearly operating results. Also
 the pursuit of acquisitions and other new business
relationships may require significant management attention. We may not be able to successfully identify attractive acquisition
candidates
 obtain financing on favorable terms or complete these types of transactions in a timely manner and on terms acceptable
to us
 if at all.




regarding our beverage alcohol case sales for the periods presented based on nine-liter equivalent cases
 which is a standard industry
metric:



    



    
    
    

    
    
    

    
307
584
302
602

    
81
790
69
457

    
    
    

    
389
374
372
059

    
    
    

    
166
939
152
696

    
55
145
69
600

    
91
832
86
431

    
70
592
53
798

    
1
153
1
337

    
3
709
7
469

    
    
    

    
    
    

    
389
374
372
059

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    



sales of non-beverage alcohol products for the periods presented:



    



    
    
    

    
    
    

    
403
195
248
309

    
26
323
16
272

    
    
    

    
429
518
264
581

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    



    
    





our reported amounts of assets and liabilities
 amounts of sales and expenses and disclosure of contingent assets and liabilities
in our financial statements. On an ongoing basis
 we evaluate these estimates and assumptions based on historical experience and
other factors and circumstances. We believe our estimates and assumptions are reasonable under the circumstances; however
 actual
results may differ from these estimates.


discussed below are most important to the portrayal of our financial condition and results of operations in that they require our
most difficult
 subjective or complex judgments and form the basis for the accounting policies deemed to be most critical to our
operations.




when the product is shipped to a customer (generally a distributor)
 title and risk of loss has passed to the customer under the
terms of sale (FOB shipping point or FOB destination) and collection is reasonably assured. We do not offer a right of return but
will accept returns if we shipped the wrong product or wrong quantity. Revenue is not recognized on shipments to control states
in the U.S. until such time as the product is sold through to the retail channel.




net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated
on the trade accounts receivable balances and charged to the allowance for doubtful accounts. We calculate this allowance based
on our history of write-offs
 level of past due accounts based on contractual terms of the receivables and our relationships with
and economic status of
 our customers.




 which consists of distilled
spirits
 bulk wine
 dry good raw materials (bottles
 labels and caps)
 packaging and finished goods
 is valued at the lower of
cost or market
 using the weighted average cost method. We assess the valuation of our inventories and reduce the carrying value
of those inventories that are obsolete or in excess of our forecasted usage to their estimated realizable value. We estimate the
net realizable value of such inventories based on analyses and assumptions including
 but not limited to
 historical usage
 future
demand and market requirements. Reduction to the carrying value of inventories is recorded in cost of goods sold.




 2014 and 2013
 we recorded
$0.5 million of goodwill that arose from acquisitions. Goodwill represents the excess of purchase price and related costs over
the value assigned to the net tangible and identifiable intangible assets of businesses acquired. Intangible assets with indefinite
lives consist primarily of rights
 trademarks
 trade names and formulations. We are required to analyze our goodwill and other
intangible assets with indefinite lives for impairment on an annual basis as well as when events and circumstances indicate that
an impairment may have occurred. Certain factors that may occur and indicate that an impairment exists include
 but are not limited
to
 operating results that are lower than expected and adverse industry or market economic trends. We evaluate the recoverability
of goodwill and indefinite lived intangible assets using a two-step impairment test approach at the reporting unit level. In the
first step the fair value for the reporting unit is compared to its book value including goodwill. If the fair value of the reporting
unit is less than the book value
 a second step is performed which compares the implied fair value of the reporting unit&rsquo;s
goodwill to the book value of the goodwill. The fair value for the goodwill is determined based on the difference between the fair
values of the reporting units and the net fair values of the identifiable assets and liabilities of such reporting units. If the
fair value of the goodwill is less than the book value
 the difference is recognized as an impairment.


determined at each of March 31
 2014 and 2013 by weighting a combination of the present value of our discounted anticipated future
operating cash flows and values based on market multiples of revenue and earnings before interest
 taxes
 depreciation and amortization
(&ldquo;EBITDA&rdquo;) of comparable companies. Other than the write downs of intangible and goodwill related to the wine brands
discussed below
 we did not record any impairment on goodwill or other intangible assets for fiscal 2014 or 2013.


    
    



lives are amortized over their respective estimated useful lives to the estimated residual values and reviewed for impairment whenever
events or changes in circumstances indicate that the carrying value may not be recoverable. We are required to amortize intangible
assets with estimable useful lives over their respective estimated useful lives to the estimated residual values and to review
intangible assets with estimable useful lives for impairment in accordance with the Financial Accounting Standards Board (&ldquo;FASB&rdquo;)
Accounting Standards Codification (&ldquo;ASC&rdquo;) 310
 &ldquo;Accounting for the Impairment or Disposal of Long-lived Assets.&rdquo;


 we determined to reduce
our sales and marketing efforts on our wine brands
 which do not provide a material contribution to our results of operations.
We made this decision to optimize our resources and focus on our faster growing and more profitable spirits brands
 and to reduce
the levels of working capital required to maintain necessary inventory levels of bulk wine and finished goods. We intend to continue
selling existing finished goods wine inventory through our current sales channels
 but are actively seeking buyers for large lots
and for our bulk wine. In connection with this decision
 we recognized a loss of $1.7 million
 consisting of $0.8 million on the
write-down of net intangible assets and $0.9 million in goodwill
 as well as $0.3 million charged to the provision for obsolete
inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the year ended March 31
 2013.




regarding stock-based compensation
 which requires all share-based payments
 including grants of stock options
 to be recognized
in the income statement as an operating expense
 based on their fair values on the grant date. Stock-based compensation was $0.4
million and $0.3 million for fiscal 2014 and 2013
 respectively. We used the Black-Scholes option-pricing model to estimate the
fair value of options granted. The assumptions used in valuing the options granted during fiscal 2014 and 2013 are included in
note 13 to our consolidated financial statements.




 &ldquo;Financial Instruments&rdquo;
(&ldquo;ASC 825&rdquo;)
 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged
in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. We
believe that there is no material difference between the fair value and the reported amounts of financial instruments in the balance
sheets due to the short-term maturity of these instruments
 or with respect to the debt
 as compared to the current borrowing rates
available to us.




 for the
periods indicated
 the percentage of net sales of certain items in our consolidated financial statements.



    



    
    
    


 net
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    


 net
    
    

    
    
    


 net
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    



    
    



loss attributable to common shareholders&nbsp;to EBITDA
 as adjusted:



    



    
    
    

    
(9
291
346
(6
193
225

    
    
    


 net
1
062
219
587
308


 net
(590
414
(118
349

    
860
254
920
305

    
(7
959
287
(4
803
961

    
403
049
86
869

    
200
000
684
830

    
393
914
282
314

    
    
1
715
728

    
502
518
22
549

    
284
962
247
431

    
5
392
594
(302
734

    
935
035
610
492

    
384
599
744
468


 as adjusted
537
384
(712
014



 taxes
 depreciation
and amortization
 or EBITDA
 adjusted for allowances for doubtful accounts and obsolete inventory
 loss on wine assets
 non-cash
compensation expense
&nbsp;loss from equity investment in non-consolidated affiliate
 foreign exchange
 net change in fair value
of warrant liability
 net income attributable to noncontrolling interests and dividend to preferred shareholders&nbsp;is a key
metric we use in evaluating our financial performance. EBITDA is considered a non-GAAP financial measure as defined by Regulation
G promulgated by the SEC under the Securities Act of 1933
 as amended. We consider EBITDA
 as adjusted
 important in evaluating
our performance on a consistent basis across various periods. Due to the significance of non-cash and non-recurring items
 EBITDA
as adjusted
 enables our Board of Directors and management to monitor and evaluate the business on a consistent basis. We use EBITDA
as adjusted
 as a primary measure
 among others
 to analyze and evaluate financial and strategic planning decisions regarding future
operating investments and allocation of capital resources. We believe that EBITDA
 as adjusted
 eliminates items that are not indicative
of our core operating performance or are based on management&rsquo;s estimates
 such as allowance accounts
 are due to changes
in valuation
 such as the effects of changes in foreign exchange or fair value of warrant liability
 or do not involve a cash outlay
such as stock-based compensation expense. Our presentation of EBITDA
 as adjusted
 should not be construed as an inference that
our future results will be unaffected by unusual or non-recurring items or by non-cash items
 such as non-cash compensation
 which
is expected to remain a key element in our long-term incentive compensation program. &nbsp;EBITDA
 as adjusted
 should be considered
in addition to
 rather than as a substitute for
 income from operations
 net income and cash flows from operating activities.


 as adjusted
 improved&nbsp;to
income of $0.5 million for the year ended March 31
 2014
 as compared to a loss of ($0.7) million for the comparable prior-year
period
 primarily as a result of our increased sales and gross profit.



 Net sales increased 16.2%
to $48.1 million for the year ended March 31
 2014
 as compared to $41.4 million for the comparable prior-year period
 due to the
overall growth of our Gosling's
 Jefferson's
 Clontarf and Brady's brands. Our international case sales as a percentage of total
case sales increased to 21.0% for the year ended March 31
 2014 from 18.7% for the comparable prior-year period due to strong growth
in Irish whiskey sales in international markets. The overall sales growth was partially offset by a decrease in vodka sales due
to continued price competition.&nbsp;We continue to focus on our faster growing brands and markets
 both in the U.S. and internationally.


    
    



or decrease
 as applicable
 in case sales by product category for the year ended March 31
 2014 as compared to the year ended March
31
 2013:&nbsp;




    
    
    

    
    
    

    
    
    
    
    

    
14
309
5
467
    
    

    
5
401
4
574
    
    

    
16
727
11
071
    
    

    
(14
456
(11
462
    
    

    
    
    
    
    

    
(3
760
(3
760
    
    

    
    
    
    
    

    
    
    
    
    

    
17
313
4
982
    
    


 Gross profit increased
22.9% to $17.6 million for the year ended March 31
 2014 from $14.3 million for the comparable prior-year period
 while our gross
margin increased to 36.6% for the year ended March 31
 2014 compared to 34.6% for the comparable prior-year period. The increase
in gross profit was primarily due to increased sales in the current period
 while the increase in gross margin was due to an increase
in sales of our more profitable brands
 in particular the Jefferson&rsquo;s brands. During the year ended March 31
 2014
 we recorded
a net allowance for obsolete and slow moving inventory of $0.2 million
 as compared to $0.7 million for the prior year period.
We recorded these allowances on both raw materials and finished goods
 primarily in connection with label and packaging changes
made to certain brands
 as well as certain cost variances. The allowance recorded in the prior year period included $0.3 million
incurred in connection with our determination to cease supporting our wine brands. The net charges have been recorded as an increase
to Cost of Sales in both periods. Net of the allowance for obsolete inventory
 our gross margin for the year ended March 31
 2014
was 37.0% as compared to 36.2% for the comparable prior-year period.


 Selling expense
increased 11.2% to $12.5 million for the year ended March 31
 2014 from $11.3 million for the comparable prior-year period
 primarily
due&nbsp;to a $0.7 million increase in shipping costs due to increased sales vaolume
 a $0.3 million increase in employee costs
and a $0.1 million increase in advertising
 marketing and promotion expense in support of our overall volume growth. The increase
in sales resulted in a net decrease of selling expense as a percentage of net sales to 26.0% for the year ended March 31
 2014
as compared to 27.2% for the comparable prior-year period.

.

the year ended March 31
 2014 from $4.8 million for the comparable prior-year period
 primarily due to a $0.3 million increase
in bad debt expense due to the insolvency of certain international distributors and the write-off of uncollectable receivables
from wine sales
 as well as an overall increase in the allowance due to the increase in overall sales. Also
 the year ended March
31
 2014 included a $0.1 million increase in each of professional fees
 insurance and occupancy costs and employee expense. The
increase in sales in the current period resulted in general and administrative expense as a percentage of net sales decreasing
to 11.5% for the year ended March 31
 2014 as compared to 11.6% for the comparable prior-year period.


 Depreciation
and amortization was $0.9 million for the each of the years ended March 31
 2014 and 2013.

. As a
result of the foregoing
 loss from operations improved 70.0% to ($1.3) million for the year ended March 31
 2014 from ($4.4)
million for the comparable prior-year period
 which prior-year period included a ($1.7) million loss on wine assets. Net
of the loss on wine assets
 loss from operations improved 50.0% from ($2.7) million for the comparable prior-year period. As
a result of our focus on our stronger growth markets and better performing brands
 and expected growth from our
existing brands
 we anticipate improved results of operations in the near term as compared to comparable prior-year periods
although there is no assurance that we will attain such results.

Net change in fair value of
warrant liability.
Changes in the fair value of the 2011 Warrants were recognized in earnings for each reporting period. For the year ended
March 31
 2014
 we recorded a non-cash charge for&nbsp;loss on the change in the value of the warrants of ($5.4) million
 as
compared to a gain of $0.3 million for the comparable prior-year period
 primarily due to the effects of our increased share
price on the Black-Scholes valuation. In November 2013
 in accordance with certain terms of the 2011 Warrants
 the down-round
provisions included in the terms of the warrant&nbsp;ceased to be&nbsp;in effect due to the historical VWAP and trading
volume of our Common Stock. As a result
 the then outstanding warrant liability of $6.2 million was eliminated and recognized
as an increase to additional paid-in capital. For the year ended March 31
 2014
 holders of 2011 Warrants exercised 10.1
million 2011 Warrants and received shares of Common Stock. We received $3.8 million in cash upon the exercise of these
warrants. In April 2014
 we called for cancellation all remaining 1.7 million unexercised 2011 Warrants pursuant to their
terms
 after satisfying applicable conditions. Pursuant to the call for cancellation
 holders of all 1.7 million unexercised
2011 Warrants exercised and received 1.7 million shares of Common Stock. We received $0.6 million in cash upon the exercise
of these warrants. As a result
 all outstanding 2011 Warrants have been exercised as of the date of this report. Accordingly
we are no longer required to recognize any changes in fair value of the 2011 Warrants in future reporting periods.


    
    


Income tax benefit
 net.
the deferred tax asset valuation allowance allocated to GCP as of March 31
 2014 due to our determination that it was &ldquo;more
likely than not&rdquo; that the GCP&rsquo;s deferred tax assets would be realized. &ldquo;More likely than not&rdquo; is defined
as greater than 50% probability of occurrence. Our determination as to the ultimate realization of the deferred tax assets is dependent
upon our judgment and evaluation of both positive and negative evidence
 forecasts of future taxable income
 applicable tax planning
strategies
 and an assessment of current and future economic and business conditions. In 2014
 GCP was in a position of cumulative
profitability on a pre-tax basis
 considering its operating results for the three years ended March 31
 2014. We concluded that
this record of cumulative profitability in recent years
 in addition to a long range forecast showing continued profitability for
GCP
 provided sufficient positive evidence that the net U.S. federal tax benefits more likely than not would be realized. Accordingly
in the year ended March 31
 2014
 we released the valuation allowance against GCP&rsquo;s net federal deferred assets
 resulting
in a $0.5 million benefit in provision for income taxes for the year ended March 31
 2014.

Loss&nbsp;from equity investment
in non-consolidated affiliate.
 through CB-USA
 we formed DP Castle Partners
 LLC (&ldquo;DPCP&rdquo;)
with Drink Pie
 LLC to manage the manufacturing and marketing of Travis Hasse&rsquo;s Original Apple Pie Liqueur
 Cherry Pie
Liqueur and any future line extensions of the brand. We have accounted for our investment in DPCP on the equity method of
accounting. Results from this investment were de minimis in each of the years ended March 31
 2014 and 2013. In December
2013
 we determined to cease marketing and selling these brands and returned the remaining inventory to Drink Pie
 LLC. In
connection with the discontinuation of marketing and sales efforts
 we recognized a loss of $0.5 million from our investment
in DPCP
 including a $0.1 million loss on investment and write-offs of $0.4 million on the remaining receivable balances due
from DPCP
 for the year ended March 31
 2014.

 Foreign
exchange loss for the year ended March 31
 2014 was ($0.3) million as compared to a loss of ($0.2) million for the comparable prior-year
period due to the net effects of fluctuations of the U.S. dollar against the Euro and their effects on our Euro-denominated intercompany
balances due to our foreign subsidiaries for inventory purchases.

Interest expense
 net.
expense
 net of ($1.1) million for the year ended March 31
 2014 as compared to ($0.6) million for the comparable prior-year period
due to increased balances outstanding under our credit facilities. Due to expected balances on the Keltic Facility and other indebtedness
we expect interest expense
 net to increase in the near term as compared to prior-year periods.

Net income attributable to noncontrolling
interests.
 2014 was ($0.9) million as compared
to ($0.6) million for the comparable prior-year period
 both the result of allocated net income recorded by our 60% owned subsidiary
Gosling-Castle Partners
 Inc.

Dividend to preferred
shareholders.
 2014 and 2013
 we recognized a dividend on our Series A Preferred
Stock of $0.4 million
 as compared to $0.7 million in the prior-year period
 as required by the terms of the preferred stock.
Accrued dividends on our Series A Preferred Stock were only payable in Common Stock upon conversion or liquidation. Pursuant
to the mandatory conversion described above in 
 all outstanding shares of Series A Preferred Stock
 and
accrued dividends thereon
 converted into Common Stock in February 2014. Accordingly
 we will no longer recognize a dividend
to preferred shareholders in future reporting periods.


As a result of the net effects of the foregoing
 especially the non-cash charge for loss on the net change in fair value of warrant
liability in the current year
 offset by the loss on wine assets in the prior year
 net loss attributable to common shareholders
increased to ($9.3) million&nbsp;for the year ended March 31
 2014 as compared to ($6.2) million for the comparable prior-year
period. Net loss per common share
 basic and diluted
 was ($0.08) per share for the year ended March 31
 2014 as compared to ($0.06)
per share for the comparable prior-year period. Net loss per common share
 basic and diluted
 as reported in the current period
was improved by the issuance of 43.0 million shares of Common Stock in connection with the Distribution Agreement
 the conversion
of Series A Preferred Stock and the warrant exercise described above.






 we have incurred significant
operating and net losses and have not generated positive cash flows from operations. For the year ended March 31
 2014
 we had
a net loss of $8.4 million
 and used cash of $5.8 million in operating activities. As of March 31
 2014
 we had cash and cash equivalents
of $0.9 and had an accumulated deficit of $140.0 million.


    
    





of Financial Condition and Results of&nbsp;Operations &ndash; Recent Events for a discussion of our recent financing activities.


 we entered into a Second
Amendment to the Keltic Facility
 providing for an increase in available borrowings (subject to certain terms and conditions) under
the Keltic Facility for working capital purposes from $7.0 million to $8.0 million and the Bourbon Term Loan in the initial aggregate
principal amount of $2.5 million
 which was used for the purchase of bourbon inventory on March 11
 2013. Unless sooner terminated
in accordance with their respective terms
 the Keltic Facility and Bourbon Term Loan expire on December 31
 2016 (the &quot;Maturity
Date&quot;). We may borrow up to the maximum amount of the Keltic Facility
 provided that we have a sufficient borrowing base (as
defined in the Keltic Loan Agreement). The Keltic Facility interest rate is the rate that
 when annualized
 is the greatest of
(a) the Prime Rate plus 3.25%
 (b) the LIBOR Rate plus 5.75% and (c) 6.50%. The Bourbon Term Loan interest rate is the rate that
when annualized
 is the greatest of (a) the Prime Rate plus 4.25%
 (b) the LIBOR Rate plus 6.75% and (c) 7.50%. Interest is payable
monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Keltic Facility and the
Bourbon Term Loan. After the occurrence and during the continuance of any &quot;Default&quot; or &quot;Event of Default&quot; (as
defined under the loan agreement) we are required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic
Facility or Bourbon Term Loan
 as applicable
 interest rate. The Keltic Facility currently bears interest at 6.50% and the Bourbon
Term Loan currently bears interest at 7.50%. We are required to pay down the principal balance of the Bourbon Term Loan within
15 banking days from the completion of a bottling run of bourbon from our bourbon inventory stock purchased on or about the date
of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon
Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan
are due and payable in full on the Maturity Date.&nbsp;In addition to closing fees
&nbsp;Keltic receives an annual facility fee
and a collateral management fee (each as set forth in the Keltic Loan Agreement).


borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative
covenants. The Keltic Loan Agreement includes negative covenants that
 among other things
 restrict our ability to create additional
indebtedness
 dispose of properties
 incur liens
 and make distributions or cash dividends. At March 31
 2014
 we were in compliance
in all material respects
&nbsp;with the covenants under the Keltic Loan Agreement.&nbsp;


funding the Bourbon Term Loan that Keltic had entered into a participation agreement providing for an aggregate of $750
000
of the initial $2.5 million principal amount of the Bourbon Term Loan to be purchased by junior participants. Certain related
parties of ours purchased a portion of these junior participations in the Bourbon Term Loan
 including Frost Gamma
Investments Trust ($500
000)
 Mark E. Andrews
 III ($50
000) and an affiliate of Richard J. Lampen ($50
000). Under the terms
of the participation agreement
 the junior participants receive interest at the rate of 11% per annum. We are not a party to
the participation agreement. However
 we are party to a fee letter with the junior participants (including the related party
junior participants) pursuant to which we pay the junior participants an aggregate commitment fee of $45
000 paid in three
equal annual installments of $15
000.


 we entered into a Third
Amendment (the &quot;Third Amendment&quot;) to the Keltic Loan Agreement in order to modify certain aspects of the borrowing base
calculation and covenants with respect to the Keltic Facility and permit us to make regularly scheduled payments of principal and
interest and voluntary prepayments on the Junior Loan (as defined below)
 subject to certain conditions set forth in the Third
Amendment. In addition
 the Third Amendment provided us with the ability to increase the maximum aggregate principal amount of
the Bourbon Term Loan from $2.5 million to up to $4.0 million following the identification of junior participants to purchase a
portion of the increased Bourbon Term Loan amount. We paid Keltic an aggregate $25
000 amendment fee in connection with
the execution of the Third Amendment.


 we entered into a
Loan Agreement (the &quot;Junior Loan Agreement&quot;)
 by and between us and the lending parties thereto (the &quot;Junior Lenders&quot;)
which provides for an aggregate $1.25 million unsecured loan (the &quot;Junior Loan&quot;) to us. The Junior Loan bears interest
at a rate of 11% per annum
 payable quarterly in arrears commencing November 1
 2013
 and matures on October 15
 2015. The Junior
Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date
of prepayment. The Junior Loan Agreement contains customary events of default
 which
 if uncured
 entitle each Junior Lender to
accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the portion of the Junior Loan
made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of 2% per annum on the then outstanding Junior
Loan balance (pro-rated for any period of less than one year)
 payable pro rata among the Junior Lenders on the date of the Junior
Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust
 Mark
E. Andrews
 III and an affiliate of Richard J. Lampen. In connection with the Junior Loan Agreement
 the Junior Lenders entered
into the subordination agreement with Keltic; we are not a party to the subordination agreement.


    
    



 Gosling-Castle Partners
Inc.
 a 60% owned subsidiary
 issued a promissory note in the aggregate principal amount of $0.2 million to Gosling's Export (Bermuda)
Limited in exchange for credits issued on certain inventory purchases. This note matures on April 1
 2020
 is payable at maturity
subject to certain acceleration events
 and calls for annual interest of 5%
 to be accrued and paid at maturity.


aggregating &euro;0.4 million or $0.5 million (translated at the March 31
 2014 exchange rate) with an Irish bank
 including overdraft
coverage
 creditors&rsquo; insurance
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable
on demand
 continue until terminated by either party
 are subject to annual review
 and call for interest at the lender&rsquo;s
AA1 Rate minus 1.70%.




 2014
 we had
shareholders&rsquo; equity of $19.9 million as compared to $12.9 million at March 31
 2013. This increase is primarily due
to&nbsp;the reclassification&nbsp;of our previous $6.2 million warrant liability as additional paid-in capital
 the net
issuance of $4.3 million of Common Stock under the Distribution Agreement and the exercise of $3.8 million of our 2011
Warrants
 partially offset by our total comprehensive loss for the year ended March 31
 2014
 including the $5.4 million loss
on the fair value of warrant liability.


at March 31
 2014 as compared to $13.9 million as of March 31
 2013. This&nbsp;increase is primarily due to a $1.8 million increase
in accounts receivable
 a $0.9 million increase in inventory
 a $0.6 million increase in prepaid expenses
&nbsp;a $0.5 million
increase in deferred tax assets
 a net $1.0 million decrease in accounts payable
 accrued expenses and due to related parties
and a $0.1 million decrease in our foreign revolving credit facility
 partially offset by a $0.2 million decrease in due from shareholders
and affiliates.


 2014
 we had cash and cash
equivalents of approximately $0.9 million
 as compared to $0.4 million as of March 31
 2013. The increase is primarily attributable
to the equity and debt issued
 partially offset by the funding of our operations and working capital needs for the year ended March 31
 2014.
At March 31
 2014
 we also had approximately $0.4 million of cash restricted from withdrawal and held by a bank in Ireland as collateral
for overdraft coverage
 creditors&rsquo; insurance
 revolving credit and other working capital purposes.


 between April 1
 2014 and
June 27
 2014
 we received $0.6 million in cash upon the exercise of 2011 Warrants to purchase 1.7 million shares of Common Stock.


liquidity over the near-to-mid term:


    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    



the growth of existing brands through sales and marketing initiatives that we expect will generate cash flows from operations in
the next few years. As part of this plan
 we seek to grow our business through expansion to new markets
 growth in existing markets
and strengthened distributor relationships.&nbsp;As our brands continue to grow
 our working capital requirements will increase.
In particular
 the growth of our Jefferson&rsquo;s brands requires a significant amount of working capital relative to our other
brands
 as we are required to purchase and hold ever increasing amounts of aged bulk bourbon to meet growing demand. While we are
seeking solutions to our long-term bourbon supply needs
 we are required to purchase and hold several years&rsquo; worth of bulk
bourbon in inventory until such time as it is aged to our specific brand taste profiles
 increasing our working capital requirements
and negatively impacting cash flows.


agency relationships to leverage our existing distribution platform. We intend to finance our brand acquisitions through a combination
of our available cash resources
 borrowings and
 in appropriate circumstances
 additional issuances of equity and/or debt securities.
Acquiring additional brands could have a significant effect on our financial position
 could materially reduce our liquidity and
could cause substantial fluctuations in our quarterly and yearly operating results. We continue to look to control expenses
 seek
improvements in routes to market and contain production costs to improve cash flows.


 2014
 we had
borrowed $2.0 million of the $8.0 million available under the Keltic Facility
 leaving $6.0 million in then potential
availability for working capital needs. As of the date of this report
 we had borrowed $6.2 million of the $8.0 million
available under the Keltic Facility
 leaving $4.0 million in potential availability for working capital needs. We believe our
current cash and working capital
 the availability under the Keltic Facility
&nbsp;the proceeds that have been raised
 and
the additional funds available to be raised
 under the Distribution Agreement
 will enable us to fund our losses until we achieve profitability
 ensure continuity of supply of our brands
 and
support new brand initiatives and marketing programs through at least March 2015.


    
    









sources and uses of cash during the periods presented:



    



    
    
    

    
    

    
    
    

    
(5
820
(4
986

    
    
    

    
6
494
5
237

    
    
    

    
    
    

    
    
    

    
    
    


 A substantial
portion of available cash has been used to fund our operating activities. In general
 these cash funding requirements are based
on operating losses
 driven chiefly by the costs in maintaining our distribution system and our sales and marketing activities.
We have also utilized cash to fund our inventories. In general
 these cash outlays for inventories are only partially offset by
increases in our accounts payable to our suppliers.


 the production cycle for our
owned brands is up to three months from the time we obtain the distilled spirits and other materials needed to bottle and package
our products to the time we receive products available for sale
 in part due to the international nature of our business. We do
not produce Gosling&rsquo;s rums
 Pallini liqueurs
 Tierras tequila
 or Gozio amaretto. Instead
 we receive the finished product
directly from the owners of such brands. From the time we have products available for sale
 an additional two to three months may
be required before we sell our inventory and collect payment from customers. Further
 our inventory at March 31
 2014 included
significant additional stores of bulk bourbon purchased in advance of forecasted production requirements. We expect to reduce the
bulk bourbon in the normal course of future sales
 generating positive cash flows in future periods.


 2014
 net
cash used in operating activities was $5.8 million
 consisting primarily of a net loss of $7.9 million
 a $2.0 million increase
in accounts receivable
 a $1.2 million increase in inventory
 a $0.6 million decrease in accounts payable and accrued expenses
a $0.6 million increase in prepaid expenses
 a $0.2 million increase in other assets and $0.6 million in deferred tax benefit.
These uses of cash were partially offset by a change in fair value of warrant liability of $5.4 million
 a $0.5 million loss on
equity investment in non-consolidated affiliate
 stock based compensation expense of $0.4 million
 depreciation and amortization
expense of $0.9 million
 and a provision for obsolete inventories of $0.2 million. &nbsp;


 2013
 net
cash used in operating activities was $5.0 million
 consisting primarily of a net loss of $4.8 million
 a $4.0 million increase
in inventory
 a $0.9 million increase in accounts receivable
 a $0.2 million increase in other assets
 a $0.2 million increase
in due from affiliates and a $0.3 million credit for the net change in fair value of warrant liability. These uses of cash were
partially offset by a net $0.9 million increase in accounts payable and accrued expenses
 an $0.8 million increase in due to related
parties
 a $1.7 million loss on wine assets
 $0.7 million in allowance for obsolete inventory and depreciation and amortization
expense of $0.9 million.

 Net
cash used in investing activities was $0.2 million for the year ended March 31
 2014
 representing $0.3 million used in the acquisition
of fixed and intangible assets
 partially offset by $0.06 million from a change in restricted cash.


$0.3 million for the year ended March 31
 2013
 representing approximately $0.1 million used in the acquisition of fixed and intangible
assets and approximately $0.1 million in payments under a contingent consideration agreement.

 Net
cash provided by financing activities for the year ended March 31
 2014 was $6.5 million
 consisting of $4.3 million in net proceeds
from the issuance of Common Stock pursuant to the Distribution Agreement
 $0.4 million in proceeds from the exercise of 2011 Warrants
$2.1 million from the issuance of 5% Convertible Notes
 $1.25 million from issuance of the Junior Loan
 offset by the $4.5 million
paid on the Keltic Facility
 $0.5 million paid on the Bourbon Term Loan and $0.1 million paid on the foreign revolving credit facilities.


for the year ended March 31
 2013 was $5.2 million representing $2.6 million drawn on the Keltic Facility
 $2.5 million in proceeds
from an inventory term loan and $0.1 million drawn on the foreign revolving credit facility.


    
    





We have credit facilities with availability aggregating approximately &euro;0.4 million ($0.5 million) with an Irish bank
 including
overdraft
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable on demand
 continue until
terminated by either party
 are subject to annual review and call for interest at the lender&rsquo;s AA1 Rate minus 1.70%. We have
deposited &euro;0.4 million ($0.5 million) with the bank to secure these borrowings.


with the covenants of our Irish bank facilities as of March 31
 2014.

 For a discussion
of the Keltic Facility
 please see 

 For a
discussion of the Bourbon Term Loan
 please see 

 For
a discussion of the Junior Loan Agreement
 in &ldquo;Liquidity and Capital Resources&rdquo;
above.

5% Convertible Subordinated Notes.

 in &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; above.


For a discussion of the Gosling-Castle Partners note
 in &ldquo;Liquidity and Capital Resources&rdquo;
above.




operations are the Euro in Ireland and the British Pound in the United Kingdom. With respect to our consolidated financial statements
the translation from the applicable foreign currencies to U.S. Dollars is performed for balance sheet accounts using exchange rates
in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period.
The resulting translation adjustments are recorded as a component of other comprehensive income.


amounts in Euros or British Pounds
 we have for your convenience also in certain cases provided a conversion of those amounts to
U.S. Dollars in parentheses. Where the numbers refer to a specific balance sheet account date or financial statement account period
we have used the exchange rate that was used to perform the conversions in connection with the applicable financial statement.
In all other instances
 unless otherwise indicated
 the conversions have been made using the exchange rates as of March 31
 2014
each as calculated from the Interbank exchange rates as reported by Oanda.com. On March 31
 2014
 the exchange rate of the Euro
and the British Pound in exchange for U.S. Dollars was &euro;1.00 = U.S.$1.37516 (equivalent to U.S.$1.00 = &euro;0.72707) and&nbsp;&nbsp;&pound;1.00
= U.S.$1.66368 (equivalent to U.S.$1.00 = &pound;0.60089).


as representations that the Euro and British Pound amounts actually represent U.S. Dollar amounts or could be converted into U.S.
Dollars at the rates indicated.




are not materially impacted by moderate changes in the inflation rate. Inflation and changing prices did not have a material impact
on our operations during fiscal 2014 or 2013. Severe increases in inflation
 however
 could affect the global and U.S. economies
and could have an adverse impact on our business
 financial condition and results of operations.




accounting standards in the &ldquo;Accounting standards adopted&rdquo; and &ldquo;Recent accounting pronouncements&rdquo; sections
of note 1 of the &ldquo;Notes to Consolidated Financial Statements&rdquo; in the accompanying consolidated financial statements.


    
    





statements&rdquo; within the meaning of the Private Securities Litigation Reform Act of 1995. These statements
 which involve risks
and uncertainties
 relate to the discussion of our business strategies and our expectations concerning future operations
 margins
profitability
 liquidity and capital resources and to analyses and other information that are based on forecasts of future results
and estimates of amounts not yet determinable. We use words such as &ldquo;may&rdquo;
 &ldquo;will&rdquo;
 &ldquo;should&rdquo;
&ldquo;expects&rdquo;
 &ldquo;intends&rdquo;
 &ldquo;plans&rdquo;
 &ldquo;anticipates&rdquo;
 &ldquo;believes&rdquo;
 &ldquo;estimates&rdquo;
&ldquo;seeks&rdquo;
 &ldquo;expects&rdquo;
 &ldquo;predicts&rdquo;
 &ldquo;could&rdquo;
 &ldquo;projects&rdquo;
 &ldquo;potential&rdquo;
and similar terms and phrases
 including references to assumptions
 in this report to identify forward-looking statements. These
forward-looking statements are made based on expectations and beliefs concerning future events affecting us and are subject to
uncertainties
 risks and factors relating to our operations and business environments
 all of which are difficult to predict and
many of which are beyond our control
 that could cause our actual results to differ materially from those matters expressed or
implied by these forward-looking statements. These risks and other factors include those listed under &ldquo;Risk Factors&rdquo;
and as follows:



    
    
    

    
    
    

    
    
our potential need for additional capital
 which
 if not available on acceptable terms or at all
 could restrict our future growth and severely limit our operations;

    
    
our brands could fail to achieve more widespread consumer acceptance
 which may limit our growth;

    
    
our dependence on a limited number of suppliers
 who may not perform satisfactorily or may end their relationships with us
 which could result in lost sales
 incurrence of additional costs or lost credibility in the marketplace;

    
    
    

    
    
    

    
    
the possibility that we cannot secure and maintain listings in control states
 which could cause the sales of our products to decrease significantly;

    
    
the potential limitation to our growth if we are unable to identify and successfully acquire additional brands that are complementary to our existing portfolio
 or integrate such brands after acquisitions;

    
    
currency exchange rate fluctuations and devaluations may significantly adversely affect our revenues
 sales
 costs of goods and overall financial results;

    
    
our need to maintain a relatively large inventory of our products to support customer delivery requirements
 which could negatively impact our operations if such inventory is lost due to theft
 fire or other damage;

    
    
the possibility that we or our strategic partners will fail to protect our respective trademarks and trade secrets
 which could compromise our competitive position and decrease the value of our brand portfolio;

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
adverse regulatory decisions and legal
 regulatory or tax changes could limit our business activities
 increase our operating costs and reduce our margins;



or revise these forward-looking statements for any reason
 or to update the reasons actual results could differ materially from
those anticipated in
 or implied by
 these forward-looking statements
 even if new information becomes available in the future.

Item 7A. Quantitative and Qualitative Disclosures about Market
Risk


 we are not required to provide
the information required by this Item.


    
    








    
    

    
    

Consolidated Balance Sheets as of March 31
 2014 and 2013
    

Consolidated Statements of Operations for the years ended March 31
 2014 and 2013
    

Consolidated Statements of Comprehensive Loss for the years ended March 31
 2014 and 2013
    

Consolidated Statements of Changes in Equity for the years ended March 31
 2014 and 2013
    

Consolidated Statements of Cash Flows for the years ended March 31
 2014 and 2013
    

    
    



    
    








of Castle Brands Inc. and subsidiaries (the &quot;Company&quot;) as of March 31
 2014 and 2013
 and the related consolidated statements
of operations
 comprehensive loss
 changes in shareholders' equity and cash flows for each of the years in the two-year period
ended March 31
 2014.&nbsp;&nbsp;These financial statements are the responsibility of the Company's management.&nbsp;&nbsp;Our
responsibility is to express an opinion on these financial statements based on our audits.


the Public Company Accounting Oversight Board (United States).&nbsp;&nbsp;Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. &nbsp;The Company
is not required to have
 nor were we engaged to perform
 an audit of its internal control over financial reporting.&nbsp;&nbsp;Our
audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate
in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over
financial reporting.&nbsp;&nbsp;Accordingly
 we express no such opinion.&nbsp;&nbsp;An audit includes examining
 on a test basis
evidence supporting the amounts and disclosures in the financial statements.&nbsp;&nbsp;An audit also includes assessing the accounting
principles used and significant estimates made by management
 as well as evaluating the overall financial statement presentation.&nbsp;&nbsp;We
believe that our audits provide a reasonable basis for our opinion.


 the financial statements referred to above present
fairly
 in all material respects
 the consolidated financial position of the Company as of March 31
 2014 and 2013
 and the consolidated
results of its operations and its cash flows for each of the years in the two-year period ended March 31
 2014
 in conformity with
accounting principles generally accepted in the United States of America.



 New York

 2014&nbsp;


    
    









    

 



    
    
    

    
    
    

    
    
    

    
908
501
439
323


418&nbsp;and&nbsp;$70
692
 respectively
8
858
146
7
025
358

    
115
288
303
226


473&nbsp;and $461
660
&nbsp;respectively
14
650
029
13
731
962

    
473
330
    

    
1
575
947
983
834

    
    
    

    
26
581
241
22
483
703

    
    
    

    
568
395
516
641

    
    
    


&nbsp;at&nbsp;equity
    
116
700


058
005 and $5
404
000
 respectively
8
178
888
8
805
913

    
496
226
490
286

    
416
565
451
346

    
280
195
252
506

    
    
    

    
36
521
510
33
117
095

    
    
    

    
    
    

    
    
    

    
20
205
89
407

    
4
483
764
5
301
524

    
1
073
188
793
243

    
1
936
241
2
351
957

    
    
    

    
7
513
398
8
536
131

    
    
    

    
    
    

    
1
953
037
6
501
321


375&nbsp;and&nbsp;$600
000&nbsp;of&nbsp;related-party&nbsp;participation&nbsp;at March&nbsp;31
 2014 and &nbsp;2013
&nbsp;respectively)
2
015
000
2
496
000


000&nbsp;of&nbsp;related&nbsp;party&nbsp;participation&nbsp;at March 31
 2014)
1
250
000
    


100
000 of related party participation at March 31
 2014)
2
125
000
    

    
211
580
211
580

    
    
795
374

    
1
518
304
1
666
456

    
    
    

    
16
586
319
20
206
862

    
    
    

    
    
    

    
    
    

    
    
    


 $.01 par value
 25
000
000 shares authorized
 0 and 6
701 shares of series A convertible preferred stock issued and outstanding at March 31
 2014&nbsp;&nbsp;and 2013
 respectively (liquidation value of $0 and $7
876
530 at March 31
 2014 and &nbsp;2013
 respectively)
    
67
013


 $.01 par value
 300
000
000 and 225
000
000 shares authorized at March 31
 2014 and 2013
 respectively
 151
841
133&nbsp;&nbsp;and 108
773
034 shares issued and outstanding at March 31
 2014 and &nbsp;2013
 respectively
1
518
411
1
087
730

    
157
485
965
142
661
542

    
(139
561
969
(130
270
623

    
(1
724
916
(1
918
094

    
    
    

    
17
717
491
11
627
568

    
    
    

    
2
217
700
1
282
665

    
    
    

    
19
935
191
12
910
233

    
    
    

    
36
521
510
33
117
095



financial statements.


    
    








    



    
    
    


 net*
48
140
483
41
442
994

    
30
336
667
26
438
238

    
200
000
684
830

    
    
    

    
17
603
816
14
319
926

    
    
    

    
12
529
684
11
265
108

    
5
533
711
4
820
845

    
860
254
920
305

    
    
1
715
728

    
    
    

    
(1
319
833
(4
402
060

    
    
    

    
(502
518
(22
549

    
(284
962
(247
431


 net
(1
062
219
(587
308

    
(5
392
594
302
734


 net
590
414
118
349

    
    
    

    
(7
971
712
(4
838
265

    
(935
035
(610
492

    
    
    

    
(8
906
747
(5
448
757

    
    
    

    
(384
599
(744
468

    
    
    

    
(9
291
346
(6
193
225

    
    
    


 basic and diluted
 attributable to common shareholders
    
    

    
    
    


 basic and diluted
 attributable to common shareholders
116
511
444
108
508
652



 net and Cost of sales include excise taxes of $6
420
730
and $5
964
374 for the years ended March 31
 2014 and 2013
 respectively.


financial statements.


    
    



Consolidated Statements of Comprehensive
Loss




    



    
    
    

    
(7
971
712
(4
838
265

    
    
    

    
    
    

    
193
178
(116
438

    
    
    

    
193
178
(116
438

    
    
    

    
(7
778
534
(4
954
703




financial statements.


    
    








    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    

    
Preferred
    Stock
    
    
    
    
    
    

    
    
    
    
    
    
    
(Loss)
    Income
    
    

BALANCE
 MARCH 31
 2012
6
897
68
965
108
052
067
1
080
520
141
639
228
(124
076
608
(1
801
656
672
173
17
582
622

    
    
    
    
    
    
(5
448
757
    
610
492
(4
838
265

    
    
    
    
    
    
    
(116
438
    
(116
438

Conversion of series A preferred
    stock and accrued dividends
    
(1
952
720
967
7
210
(4
468
    
    
    
    

Accrued dividends - series
    A convertible preferred stock
    
    
    
    
744
468
(744
468
    
    
    

    
    
    
    
    
282
314
    
    
    
282
314

    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    

BALANCE
 MARCH 31
 2013
6
701
67
013
108
773
034
1
087
730
142
661
542
(130
270
623
(1
918
094
1
282
665
12
910
233

    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
(8
906
747
    
935
035
(7
971
712

    
    
    
    
    
    
    
193
178
    
193
178

Issuance of common stock
    net of issuance costs
    
    
5
394
608
53
946
4
293
356
    
    
    
4
347
302

Conversion of series A preferred
    stock and accrued dividends
(6
701
(67
013
27
465
610
274
656
(207
643
    
    
    
    

    
    
    
10
127
123
101
271
3
747
061
    
    
    
3
848
332

    
    
    
80
758
    
25
168
    
    
    
25
976

Accrued dividends - series
    A convertible preferred stock
    
    
    
    
384
599
(384
599
    
    
    

Reclassification of liability
    to equity-warrant
    
    
    
    
6
187
968
    
    
    
6
187
968

    
    
    
    
    
393
914
    
    
    
393
914

    
    
    
    
    
    
    
    
    
    

BALANCE
    MARCH 31
 2014
    
    
151
841
133
1
518
411
157
485
965
(139
561
969
(1
724
916
2
217
700
19
935
191




financial statements.


    
    








    



    
    
    

    
    
    

    
(7
971
712
(4
838
265

    
    
    

    
860
254
920
305

    
    
1
715
728

    
133
726
86
869

    
161
178
96
556

    
5
392
594
(302
734


 net
(590
414
(118
349

    
502
518
22
549

    
284
962
247
431

    
393
914
282
314

    
200
000
684
830


 assets and liabilities:
    
    

    
(1
959
593
(861
330

    
(193
680
(180
586

    
(1
246
553
(4
028
581

    
(591
188
(200
405

    
(188
867
(152
061

    
(597
127
880
012

    
6
379
(8
400

    
(416
064
767
687

    
    
    

    
2
152
039
(148
165

    
    
    

    
(5
819
673
(4
986
430

    
    
    

    
    
    

    
(234
693
(93
869

    
(26
980
(53
564

    
60
137
    

    
(5
940
(145
800

    
    
    

    
(207
476
(293
963

    
    
    

    
    
    

    
(4
548
284
2
651
490

    
(481
000
2
496
000

    
1
250
000
    

    
2
125
000
    

    
(73
797
89
866

    
4
531
643
    

    
(184
341
    

    
3
848
332
    

    
25
976
    

    
    
    

    
6
493
529
5
237
356

    
    
    

    
2
798
(2
002

    
469
178
(45
039

    
439
323
484
362

    
    
    

    
908
501
439
323

    
    
    

    
    
    

    
    
    

    
8
349
539
219
172

    
    
794
457

    
    
    

    
867
782
442
204

    
14
848
25
000




financial statements.


    
    





ORGANIZATION AND SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES



    
    
Description of
    business
 its
    wholly-owned     domestic subsidiaries
 Castle     Brands (USA) Corp. (&ldquo;CB-USA&rdquo;) and McLain &amp; Kyne
 Ltd.
    (&ldquo;McLain &amp;     Kyne&rdquo;)
 the Company&rsquo;s     wholly-owned foreign subsidiaries
 Castle Brands Spirits Group
    Limited     (&ldquo;CB-IRL&rdquo;) and Castle Brands Spirits     Marketing and Sales Company Limited
 and the Company&rsquo;s
    60 %     ownership interest in Gosling-Castle Partners
 Inc.     (&ldquo;GCP&rdquo;)
 with adjustments for income or loss
    allocated     based upon percentage of ownership. The accounts of the     subsidiaries have been included as of the date of
    acquisition.     All significant intercompany transactions and balances have     been eliminated.




    
    
 &mdash; The Company is principally engaged in the importation
 marketing and sale of premium and super premium brands of rums
 whiskey
 liqueurs
 vodka and tequila in the United States
 Canada
 Europe and Asia.




    
    
 &mdash; Gosling&rsquo;s rums
 a family of premium rums with a 200-year history
 including the award-winning Gosling&rsquo;s Black Seal rum
 for which the Company is
 through its export venture GCP
 the exclusive marketer outside of Bermuda
 and Gosling&rsquo;s Stormy Ginger Beer
 an essential non-alcoholic ingredient in Gosling&rsquo;s trademarked Dark &lsquo;n Stormy&reg; rum cocktail.

    
    
    

    
    
 &mdash; three premium small batch bourbons:
Jefferson&rsquo;s
 Jefferson&rsquo;s Reserve and Jefferson&rsquo;s Presidential Select
 Jefferson&rsquo;s Rye
 an aged rye whiskey;
the Clontarf Irish whiskeys
 a family of premium Irish whiskeys
 available in single malt and classic pure grain versions; Knappogue
Castle Whiskey
 a vintage-dated premium single-malt Irish whiskey; and Knappogue Castle 1951
 a pure pot-still whiskey that has
been aged for 36 years.

 &mdash; Brady&rsquo;s Irish Cream
a premium Irish cream liqueur; Castello Mio
 a super premium Sambuca
 Celtic Honey
 a premium Irish liqueur; pursuant to an exclusive
U.S. marketing arrangement
 Pallini Limoncello
 Raspicello and Peachcello premium Italian liqueurs; and pursuant to a U.S. distribution agreement
 Gozio amaretto
a premium Italian liqueur.

 &mdash; Boru vodka
 an ultra-pure
 five-times
distilled and specially filtered premium vodka. Boru is produced in Ireland.

 &mdash; a USDA certified organic
 super-premium
tequila
 Tequila Tierras Autenticas de Jalisco or Tierras. The Company is the exclusive U.S. importer and marketer of Tierras
which is available as blanco
 reposado and a&ntilde;ejo.
&nbsp;




    
    
    




    
    
 - Equity investments are carried at original cost adjusted for the Company&rsquo;s proportionate share of the investees&rsquo; income
 losses and distributions. The Company assesses the carrying value of its equity investments when an indicator of a loss in value is present and records a loss in value of the investment when the assessment indicates that an other-than-temporary decline in the investment exists. The Company classifies its equity earnings of non-consolidated affiliate equity investment as a component of net income or loss.




    
    
 &mdash; The Company records trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect anticipated losses on the trade accounts receivable balances. The Company calculates this allowance based on its history of write-offs
 level of past due accounts based on contractual terms of the receivables and its relationships with and economic status of its customers.




    
    
 &mdash; Revenue from product sales is recognized when the product is shipped to a customer (generally a distributor)
 title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination)
 and collection is reasonably assured. Revenue is not recognized on shipments to control states in the United States until such time as product is sold through to the retail channel.




    
    
 &mdash; Inventories are comprised of distilled spirits
 bulk wine
 dry good raw materials (bottles
 labels
 corks and caps)
 packaging and finished goods
 and are valued at the lower of cost or market
 using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company&rsquo;s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including
 but not limited to
 historical usage
 expected future demand and market requirements. A change to the carrying value of inventories is recorded in cost of goods sold. See Note 3.



    
    



 2014 and 2013
 the
Company recorded allowances for obsolete and slow moving inventory of $200
000 and $684
830
 respectively. The Company recorded
these allowances on both raw materials and finished goods
 primarily in connection with the disposition of wine brands
 label and
packaging changes made to certain brands
 as well as wine spoilage and certain cost variances. The charges have been recorded as
increases to Cost of Sales in the respective years.



    
    
 &mdash; Equipment consists of office equipment
 computers and software and furniture and fixtures. When assets are retired or otherwise disposed of
 the cost and related depreciation is removed from the accounts
 and any resulting gain or loss is recognized in the statement of operations. Equipment is depreciated using the straight-line method over the estimated useful lives of the assets ranging from three to five years.




    
    
 &mdash; Goodwill represents the excess of purchase price including related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. Goodwill and other identifiable intangible assets with indefinite lives are not amortized
 but instead are tested for impairment annually
 or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives
 generally on a straight-line basis
 and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

    
    
    

    
    
Under Financial Accounting Standards Board (&ldquo;FASB&rdquo;)
Accounting Standards Codification (&ldquo;ASC&rdquo;) 350
 &ldquo;Intangibles - Goodwill and Other&rdquo;
 impairment of goodwill
must be tested at least annually by comparing the fair values of the applicable reporting units with the carrying amount of their
net assets
 including goodwill. The required two-step approach uses accounting judgments and estimates of future operating results.
Changes in estimates or the application of alternative assumptions could produce significantly different results. The estimates
that most significantly affect the fair value calculation are related to revenue growth
 cost of sales
 selling and marketing expenses
and discount rates. Impairment testing is done at the reporting level. If the carrying amount of the reporting unit&rsquo;s net
assets exceeds the unit&rsquo;s fair value
 an impairment loss is recognized in an amount equal to the excess of the carrying amount
of goodwill over its implied fair value. The implied fair value of goodwill is determined in the same manner as the amount of goodwill
recognized in a business combination with the fair value of the reporting unit deemed to be the purchase price paid. Rights
 trademarks
trade names and formulations are indefinite lived intangible assets not subject to amortization and are tested for impairment at
least annually. The impairment test consists of a comparison of the fair value of the asset group allocated to each reporting unit
with its allocated carrying amount.


at March 31
 2014 and 2013 by weighting a combination of the present value of the Company&rsquo;s discounted anticipated future
operating cash flows and values based on market multiples of revenue and earnings before interest
 taxes
 depreciation and amortization
(&ldquo;EBITDA&rdquo;) of comparable companies. Other than the write-downs of intangible and goodwill related to the wine brands
discussed in Note 7
 the Company did not record any impairment on goodwill or other intangible assets for the years ended March
31
 2014 and 2013.
&nbsp;

    
    
 &mdash; Under&nbsp;ASC&nbsp;310
 &ldquo;Accounting for the Impairment or Disposal of Long-lived Assets&rdquo;
 the Company periodically reviews whether changes have occurred that would require revisions to the carrying amounts of its definite lived
 long-lived assets. When the sum of the expected future cash flows is less than the carrying amount of the asset
 an impairment loss is recognized based on the fair value of the asset. The Company did not record an impairment on long-lived assets for the years ended March 31
 2014 and 2013.

    
    
    

    
    
In March 2013
 the Company determined to reduce its sales and marketing efforts on its wine brands
 which do not provide a material contribution to the Company&rsquo;s results of operations. The Company made this decision to optimize its resources and focus on its faster growing and more profitable spirits brands
 and to reduce the levels of working capital required to maintain necessary inventory levels of bulk wine and finished goods. The Company intends to continue selling existing finished goods wine inventory through its current sales channels
 but is actively seeking buyers for large lots and for its bulk wine. In connection with this decision
 the Company recognized a loss of $1
715
728
 consisting of $817
156 on the write-down of net intangible assets and $898
572 in goodwill
 as well as $326
869 charged to the provision for obsolete inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the year ended March 31
 2013.



    
    




    
    
 &mdash; The Company reflects as inventory costs freight-in and related external handling charges relating to the purchase of raw materials and finished goods. These costs are charged to cost of sales at the time the underlying product is sold. The Company also incurs shipping costs in connection with its various marketing activities
 including the shipment of point of sale materials to the Company&rsquo;s regional sales managers and customers
 and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $1
879
881 and $1
171
290 for the years ended March 31
 2014 and 2013
 respectively.

    
    
    

    
    
 &mdash; Excise taxes and duty are computed at standard rates based on alcohol proof per gallon/liter and are paid after finished goods are imported into the United States and then transferred out of &ldquo;bond.&rdquo; Excise taxes and duty are recorded to inventory as a component of the cost of the underlying finished goods. When the underlying products are sold &ldquo;ex warehouse&rdquo;
 the sales price reflects the taxes paid and the inventoried excise taxes and duties are charged to cost of sales.




    
    
 &mdash; The Company incurs charges from its distributors for a variety of transactions and services rendered by the distributor
 including product depletions
 product samples for various promotional purposes
 in-store tastings and training where legal
 and local advertising where legal. Such charges are reflected as selling expense as incurred. Also
 the Company has entered into arrangements with certain of its distributors whereby the purchase of a particular product or products by a distributor is accompanied by a percentage of the sale being composed of promotional goods or as a predetermined discount percentage of dollars off invoice. In such cases
 the cost of the promotional goods is charged to cost of sales and dollars off invoice are a reduction to revenue.




    
    
 &mdash; The functional currency for the Company&rsquo;s foreign operations is the Euro in Ireland and the British Pound in the United Kingdom. Under ASC 830
 &ldquo;Foreign Currency Matters&rdquo;
 the translation from the applicable foreign currencies to U.S. Dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. The resulting translation adjustments are recorded as a component of other comprehensive income. Gains or losses resulting from foreign currency transactions are shown as a separate line item in the consolidated statements of operations.




    
    
 &mdash; ASC 825
 &ldquo;Financial Instruments&rdquo;
 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company&rsquo;s balance sheets due to the short term maturity of these instruments
 or with respect to the Company&rsquo;s debt
 as compared to the current borrowing rates available to the Company.

    
    
    

    
    
    
value in accordance with authoritative guidance
 which accomplishes the following key objectives:




    
    
    

    
    
    

    
    
    

    
    
    






    
    
    








    
    
    

    
    
Level 2 &mdash; inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets
 and inputs that are directly or indirectly observable for the asset or liability for substantially the full term of the financial instrument.

    
    
    




    
    
 &mdash; Under ASC 740
 &ldquo;Income Taxes&rdquo;
 deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided to the extent a deferred tax asset is not considered recoverable.

    
    
    

    
    
    
of ASC 740 and has recognized no adjustment for uncertain tax provisions. The Company recognizes interest and penalties related
to uncertain tax positions in general and administrative expense; however
 no such provisions for accrued interest and penalties
related to uncertain tax positions have been recorded as of March 31
 2014.






    
    
 &mdash; The costs of research
 development and product improvement are charged to expense as incurred and are included in selling expense.



    
    







    
    
 &mdash; Advertising costs are expensed
    when the advertising first appears in its respective medium. Advertising expense
 which is included in selling expense
 was
    $2
052
819 and $2
212
774 for the years ended March 31
 2014 and 2013
 respectively.




    
    
 &mdash; The preparation of financial statements
    in conformity with U.S. Generally Accepted Accounting Principles (&ldquo;GAAP&rdquo;) requires management to make estimates
    and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
    at the date of the financial statements
 and the reported amounts of revenues and expenses during the reporting period. Actual
    results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment
    tests
 derivative instruments and equity issuances
 warrant valuation
 stock-based compensation
 allowances for doubtful accounts
    and inventory obsolescence
 depreciation
 amortization and expense accruals.

    
    
    

    
    
 &mdash; The Company depends on a limited number of third-party suppliers
    for the sourcing of all of its products
 including both its own proprietary brands and those it distributes for others. The
    Company does not have long-term written agreements with all of its suppliers. Also
 if the Company fails to complete purchases
    of products ordered annually
 certain suppliers have the right to bill it for product not purchased during the period. Suppliers&rsquo;
    failure to perform satisfactorily or handle increased orders
 delays in shipments of products from international suppliers
    or the loss of existing suppliers
 especially key suppliers
 could have material adverse effects on the Company&rsquo;s operating
    results. The inability to maintain
 renew on acceptable terms or find suitable alternatives to the Company&rsquo;s contracts
    with suppliers could have a material adverse effect on its operating results.




    
    
 &mdash; On April 10
 2014
 the
    FASB issued final guidance to change the criteria for reporting discontinued operations while enhancing disclosures in this
    area (Accounting Standards Update (&ldquo;ASU&rdquo;) No. 2014-08). Under the new guidance
 only disposals representing a
    strategic shift
 such as a major line of business
 a major geographical area or a major equity investment
 should be presented
    as discontinued operations. The guidance will be applied prospectively to new disposals and new classifications of disposal
    groups as held for sale after the effective date. The guidance is effective for annual financial statements with fiscal years
    beginning on or after December 15
 2014 with early adoption permitted for disposals or classifications as held for sale which
    have not been reported in financial statements previously issued or available for issuance. The Company will adopt the guidance
    effective April 1
 2015 and the adoption of this guidance is not expected to have a material impact on the Company&rsquo;s
    results of operations
 cash flows or financial condition.






On March 13
 2014
 the Emerging Issues Task Force (the &ldquo;Task Force&rdquo;) reached a
                                                                               final consensus to amend the accounting guidance for stock compensation tied to performance targets (Issue No. 13-D). The
                                                                               objective of this guidance is to clarify the accounting treatment of certain types of performance conditions in stock-based
                                                                               compensation awards
 more specifically
 when performance targets can be achieved after the requisite service period. The Task
                                                                               Force concluded that performance criteria subsequent to a service period vesting requirement should be treated as
                                                                               vesting conditions
 and as a result
 this type of performance condition may delay expense recognition until achievement of
                                                                               the performance target is probable. Issue No. 13-D will be effective for all entities for reporting periods (including
                                                                               interim periods) beginning after December 15
 2015
 and early adoption is permitted. The adoption of this guidance is not
                                                                               expected have a material impact on the Company&rsquo;s results of operations






    
    
 &mdash; In July
    2012
 the FASB issued ASU 2012-02
 &ldquo;Intangibles&mdash;Goodwill and Other
    (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.&rdquo; The amended guidance simplifies how entities
    test indefinite-lived intangible assets other than goodwill for impairment.&nbsp;After an assessment
    of certain qualitative factors
 if it is determined to be more likely than not that an indefinite-lived asset is impaired
    entities must perform the quantitative impairment test. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Otherwise
 the quantitative test is
    optional. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This new guidance was effective for the Company as of April 1
 2013. The adoption
    of this standard did not have a material impact on the Company&rsquo;s results of operations
 cash flows or financial condition.




In October 2012
 the FASB issued ASU 2012-04
 &ldquo;Technical Corrections and
                                                                               Improvements.&rdquo; The amendments in this update cover a wide range of topics in the ASC. These amendments
                                                                               include technical corrections and improvements to the ASC and conforming amendments related to fair value measurements. This
                                                                               new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact
                                                                               on the Company&rsquo;s results of operations




In January 2013
 the FASB issued ASU 2013-01
 &ldquo;Clarifying the Scope of Disclosures
                                                                               about Offsetting Assets and Liabilities&rdquo;. This update is intended to improve the comparability of statements of
                                                                               financial position prepared in accordance with U.S. GAAP and International Financial Reporting Standards
 requiring both
                                                                               gross and net presentation of offsetting assets and liabilities. The new requirements are effective for fiscal years
                                                                               beginning on or after January 1
 2013
 and for interim periods within those fiscal years. As this guidance only affects
                                                                               disclosures
 the adoption of this standard did not have a material impact on the Company&rsquo;s results of operations
 cash




    
    





    
    
In February 2013
 the FASB issued amendments to the accounting guidance for presentation of comprehensive income to improve the reporting of reclassifications out of accumulated other comprehensive income. The amendments do not change the current requirements for reporting net income or other comprehensive income
 but do require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition
 an entity is required to present
 either on the face of the statement where the net income is presented or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income
 an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about these amounts. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&rsquo;s results of operations
 cash flows or financial condition.

    
    
    

    
    
In July 2013
 the FASB issued ASU 2013-11
 &ldquo;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force)&rdquo; (&ldquo;ASU 2013-11&rdquo;)
 which requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward
 or similar tax loss or tax credit carryforward
 rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 does not require new recurring disclosures. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&rsquo;s results of operations
 cash flows or financial condition.






    
    
 &mdash; Certain prior year balances
    have been reclassified to conform to the current year presentation.



BASIC AND DILUTED NET LOSS PER COMMON
SHARE


loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed
giving effect to all potentially dilutive common shares that were outstanding during the period that are not anti-dilutive. Potentially
dilutive common shares consist of incremental shares issuable upon exercise of stock options and warrants or conversion of convertible
preferred stock outstanding and related accrued dividends. In computing diluted net loss per share for the years ended March 31
2014 and 2013
 no adjustment has been made to the weighted average outstanding common shares as the assumed exercise of outstanding
options and warrants and the assumed conversion of convertible preferred stock and related accrued dividends is anti-dilutive.


net loss per share are as follows:



    



    
    
    

    
11
174
007
8
120
765

    
1
777
802
11
874
087

    
    
25
879
807

    
2
361
111
    

    
    
    

    
15
312
920
45
874
659






    



    
    
    

    
4
502
234
5
191
147

    
10
147
795
8
540
815

    
    
    

    
14
650
029
13
731
962



 2014 and 2013
 19% and 19%
 respectively
 of
raw materials and 5% and 4%
 respectively
 of finished goods were located outside of the United States.


    
    



 the Company
acquired $2
496
000 and $780
000 of bulk bourbon whiskey
 respectively
 in support of its anticipated near and mid-term needs.


inventory based on analyses and assumptions including
 but not limited to
 historical usage
 expected future demand and market
requirements.


or market.



Investment in DP Castle Partners
 LLC


 CB-USA formed DP Castle Partners
 LLC (&ldquo;DPCP&rdquo;)
with Drink Pie
 LLC to manage the manufacturing and marketing of Travis Hasse&rsquo;s Original Apple Pie Liqueur
 Cherry Pie Liqueur
and any future line extensions of the brand. DPCP paid a per case royalty fee to Drink Pie
 LLC under a licensing agreement. CB-USA
purchased the finished product from DPCP FOB &ndash; Production and CB-USA bore the risk of loss on both inventory and third-party
receivables. Revenues and cost of sales were recorded at their respective gross amounts on the books and records of CB-USA. For
the years ended March 31
 2014 and 2013
 CB-USA purchased $170
880 and $867
280
 respectively
 in finished goods from DPCP under
the distribution agreement. As of&nbsp;March 31
 2013
 DPCP was indebted to CB-USA in the amount of $268
598
 which is included
in due to shareholders and affiliates on the accompanying condensed consolidated balance sheet. At March 31
 2014
 CB-USA owned
20 % of now inactive&nbsp;DPCP. CB-USA also earned a defined rate of interest on its capital contribution to DPCP
 based on its
ownership in DPCP. For the years ended March 31
 2014 and 2013
 CB-USA earned $4
200 and $8
400
 respectively
 in interest income
on its capital contribution to DPCP. The Company&nbsp;accounted for this investment under the equity method of accounting. The
investment balance was $116
700 at&nbsp;March 31
 2013. In December 2013
 CB-USA determined to cease marketing and selling these
brands and returned the remaining inventory to Drink Pie
 LLC. In connection with the discontinuation of marketing and sales efforts
the Company recognized a loss of $502
518 from its investment in DPCP
 including a $120
900 loss on investment and write offs of
$399
618 on the remaining receivable balances due from DPCP.






 2006
 the Company acquired all of the outstanding
capital stock of McLain &amp; Kyne. The Company was required to pay contingent consideration based on the case sales of Jefferson&rsquo;s
Presidential Select bourbon for a specified amount of cases. As of June 30
 2013
 the Company had reached the specified case sale
threshold for contingent consideration under the agreement. Accordingly
 no further contingent consideration will be due. For the
years ended March 31
 2014 and 2013
 the sellers earned $5
940 and $145
800
 respectively
 under this agreement. The earn-out payments
have been recorded as an increase to goodwill.

EQUIPMENT
 NET






    



    
    
    

    
2
317
310
2
026
028

    
10
325
10
325

    
    
    

    
2
327
635
2
036
353

    
1
759
240
1
519
712

    
    
    

    
568
395
516
641



 2014 and
2013 totaled $204
180 and $187
539
 respectively.


    
    





 the Company determined to
reduce its sales and marketing efforts on its wine brands
 which do not provide a material contribution to the Company&rsquo;s
results of operations. The Company made this decision to optimize its resources and focus on its faster growing and more profitable
spirits brands
 and to reduce the levels of working capital required to maintain necessary inventory levels of bulk wine and finished
goods. The Company intends to continue selling existing finished goods wine inventory through its current sales channels
 but is
actively seeking buyers for large lots and for its bulk wine. In connection with this decision
 the Company recognized a loss of
$1
715
728
 consisting of $817
156 on the write-down of net intangible assets and $898
572 in goodwill
 as well as $326
869 charged
to the provision for obsolete inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the
year ended March 31
 2013.


for the years ended March 31
 2014 and 2013 were as follows:



    
    


 2012
1
243
058

    
(898
572

    
145
800

    
 2013
490
286

    
    

    
5
940


 2014
496
226







    



    
    
    

    
170
000
170
000

    
535
947
535
947

    
8
271
555
8
271
555

    
96
959
96
959

    
994
000
994
000

    
55
460
28
480

    
    
    

    
10
123
921
10
096
941

    
6
058
005
5
404
000

    
    
    

    
4
065
916
4
692
941

    
4
112
972
4
112
972

    
    
    

    
8
178
888
8
805
913






    



    
    
    

    
170
000
170
000

    
262
098
230
379

    
4
961
170
4
409
220

    
20
350
16
280

    
644
387
578
121

    
    
    

    
    
    

    
6
058
005
5
404
000



consists of product formulations.


 2014 and
2013 totaled $654
005 and $732
783
 respectively.


    
    



five fiscal years is as follows:





    

    
634
757

    
632
365

    
631
562

    
631
405

    
613
072

    
    

    
3
143
161





 2014 and 2013
 the Company had&nbsp;&euro;302
920
or $416
565 (translated at the March 31
 2014 exchange rate) and&nbsp;&euro;352
255 or $451
346 (translated at the March 31
 2013
exchange rate)
 respectively
 of cash restricted from withdrawal and held by a bank in Ireland as collateral for overdraft coverage
creditors&rsquo; insurance
 customs and excise guaranty and a revolving credit facility as described in Note 9A below.






    



    
    
    

    
    
    

    
20
205
89
407

    
211
580
211
580

    
1
953
037
6
501
321

    
2
015
000
2
496
000

    
1
250
000
    

    
2
125
000
    

    
    
    

    
7
574
822
9
298
308




    
    
The Company has arranged various facilities aggregating &euro;302
714 or $416
280 (translated at the March 31
 2014 exchange rate) with an Irish bank
 including overdraft coverage
 creditors&rsquo; insurance
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable on demand
 continue until terminated by either party
 are subject to annual review
 and call for interest at the lender&rsquo;s AA1 Rate minus 1.70 %. The balance on the credit facilities included in notes payable totaled &euro;14
693
 or $20
205 (translated at the March 31
 2014 exchange rate)
 and &euro;69
761
 or $89
407
 (translated at the March 31
 2013 exchange rate)
 at March 31
 2014 and 2013
 respectively.

    
    
    

    
    
In December 2009
 GCP issued a promissory note (the &ldquo;GCP Note&rdquo;) in the aggregate principal amount of $211
580 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1
 2020
 is payable at maturity
 subject to certain acceleration events
 and calls for annual interest of 5%
 to be accrued and paid at maturity. At March 31
 2014 and 2013
 $10
579 of accrued interest was converted to amounts due to affiliates. At March 31
 2014 and 2013
 $211
580 of principal due on the GCP Note is included in long-term liabilities.

    
    
    

    
    
In August 2011
 the Company and CB-USA entered into the Keltic Facility (&ldquo;Keltic Facility&rdquo;)
 a revolving loan agreement with Keltic Financial Partners II
 LP (&quot;Keltic&quot;)
 providing for availability (subject to certain terms and conditions) of a facility of up to $5
000
000 for the purpose of providing the Company and CB-USA with working capital. In July 2012
 the Keltic Facility was amended to increase availability to $7
000
000
 among other changes. In March 2013
 the Keltic Facility was amended to increase availability to $8
000
000
 among other changes. In August 2013
 the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below)
 subject to certain conditions set forth in the amendment
 to modify&nbsp;certain aspects of the EBITDA covenant contained in the loan agreement
 permit the Company to incur indebtedness in an aggregate original principal amount of $2
125
000 pursuant to the terms of the Note Purchase Agreement and Convertible Notes (as each term is defined below in Note 9F)
 and permit&nbsp;the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Convertible Notes
 subject to certain conditions set forth in the amendment. In November 2013
 the Keltic Facility was further amended
 to
 among other things
&nbsp;provide for the issuances of letters of credit&nbsp;thereunder.



    
    



and collectively as the Borrower. The Keltic Facility expires on December 31
 2016. The Borrower may borrow up to the maximum amount
of the Keltic Facility
 provided that the Borrower has a sufficient borrowing base (as defined under the loan agreement). The Keltic
Facility interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 3.25%
 (b) the LIBOR Rate
plus 5.75% and (c) 6.50%. For the year ended March 31
 2014
 the Company paid interest at 6.5%. Interest is payable monthly in
arrears
 on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence
and during the continuance of any &quot;Default&quot; or &quot;Event of Default&quot; (as defined under the loan agreement)
 the
Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic Facility interest rate.
There have been no Events of Default under the Keltic Facility. The Company paid a $40
000 commitment fee in connection with the
first amendment
&nbsp;a $70
000 closing and commitment fee in connection with the second amendment&nbsp;and a $25
000 closing and
commitment fee in connection with the third amendment. Keltic also receives an annual facility fee in an amount equal to 1% per
annum of the maximum revolving facility amount and a collateral management fee of $1
000 per month (increased to $2
000 after the
occurrence of and during the continuance of an Event of Default). The loan agreement contains standard borrower representations
and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan
agreement includes negative covenants that
 among other things
 restrict the Borrower&rsquo;s ability to create additional indebtedness
dispose of properties
 incur liens and make distributions or cash dividends. At March 31
 2014
 the Company was in compliance
in all material respects
 with the covenants under the Keltic Facility. At March 31
 2014 and 2013
 $1
953
037 and $6
501
321
respectively
 due on the Keltic Facility is included in long-term liabilities.



    
    
In March 2013
 the Company and CB-USA entered into an inventory term loan of $2
496
000 (the &quot;Bourbon Term Loan&quot;) that was used to purchase&nbsp;bourbon inventory on March 11
 2013. Unless sooner terminated in accordance with its terms
 the Bourbon Term Loan matures on December 31
 2016. The Bourbon Term Loan interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 4.25%
 (b) the LIBOR Rate plus 6.75% and (c) 7.50%. For the year ended March 31
 2014
 the Company paid interest of 7.5%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. After the occurrence and during the continuance of any &quot;Default&quot; or &quot;Event of Default&quot; (as defined under the loan agreement)
 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31
 2016.



Term Loan that Keltic had entered into a participation agreement (the &quot;Participation Agreement&quot;) providing for an initial
aggregate of $750
000 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased
a portion of these junior participations in the Bourbon Term Loan
 including Frost Gamma Investments Trust ($500
000)
 an entity
affiliated with Phillip Frost
 M.D.
 a director and principal shareholder of the Company
 Mark E. Andrews
 III ($50
000)
 a director
of the Company and the Company&rsquo;s Chairman
 and an affiliate of Richard J. Lampen ($50
000)
 a director of the Company and
the Company&rsquo;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the
Participation Agreement
 the junior participants receive interest at the rate of 11% per annum. Neither the Company nor CB-USA
is a party to the Participation Agreement. However
 the Borrower is party to a fee letter (the &quot;Fee Letter&quot;) with the
junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior
participants an aggregate commitment fee of $45
000 in three equal annual installments of $15
000. In August 2013
 the Bourbon
Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon
Term Loan from $2
500
000 to up to $4
000
000 to finance the purchase of aged whiskies following the identification of junior participants
to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable
totaled $2
015
000 and $2
496
000 at March 31
 2014 and 2013
 respectively.



    
    
In August 2013
 the Company entered into a Loan Agreement (the
    &quot;Junior Loan Agreement&quot;)
 by and between the Company and the lending parties thereto (the &quot;Junior
    Lenders&quot;)
 which provides for an aggregate $1
250
000 unsecured loan (the &quot;Junior Loan&quot;) to the Company. The
    Junior Loan bears interest at a rate of 11 % per annum
 payable quarterly in arrears commencing November 1
 2013
 and matures
    on October 15
 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with
    payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default
 which
    if uncured
 entitle each Junior Lender to accelerate the due date of the unpaid principal amount of
 and all accrued and
    unpaid interest on
 the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a
    funding fee of 2% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year)
    payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries
    thereof. The Junior Lenders include Frost Gamma Investments Trust ($200
000)
 Mark E. Andrews
 III ($50
000) and an affiliate
    of Richard J. Lampen ($50
000). In connection with the Junior Loan Agreement
 the Junior Lenders entered into a subordination
    agreement with Keltic; the Company is not a party to the subordination agreement. At March 31
 2014
 $1
250
000 of principal
    due on the Junior Loan is included in long-term liabilities.



    
    




    
    
In October 2013
 the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the &quot;Note Purchase Agreement&quot;)
 by and among the Company and the purchasers party thereto
 which provided for the issuance of an aggregate initial principal amount of $2
125
000 unsecured subordinated notes (the &quot;Convertible Notes&quot;) by the Company. The Convertible Notes bear interest at a rate of 5% per annum
 payable quarterly beginning on December 15
 2013 until their maturity date of December 15
 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&rsquo;s common stock at a conversion price of $0.90 per share (the &quot;Conversion Price&quot;). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium
 but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default
 which
 if uncured
 entitle each note holder to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the Convertible Notes.



certain related parties of the Company
 including an affiliate of Dr. Phillip Frost ($500
000)
 Mark E. Andrews
 III ($50
000)
an affiliate of Richard J. Lampen ($50
000)
 an affiliate of Glenn Halpryn ($200
000)
 a director of the Company
 Dennis Scholl
($100
000)
 a director of the Company
 and Vector Group Ltd. ($200
000)
 a more than 5% shareholder of the Company
 of which Richard
Lampen is an executive officer and Henry Beinstein
 a director of the Company
 is a director.


the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company&rsquo;s common
stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50
000
per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any
thirty (30) consecutive trading day period exceeds 250% of the then-current conversion price. Any forced conversion will be applied
ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder&rsquo;s then-current
note holdings.


 each&nbsp;purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement
  by and among Keltic and certain other junior lenders to the Company;
the Company is not a party to the Subordination Agreement. At March 31
 2014
 $2
125
000 of principal due on the Convertible Notes
is included in long-term liabilities.







    

    
20
205

    
1
250
000

    
3
968
037

    
    

    
2
125
000

    
211
580

    
    

    
7
574
822




 -
In November 2013
 the Company entered into an Equity Distribution Agreement (the &quot;Distribution Agreement&quot;) with Barrington
Research Associates
 Inc. (&quot;Barrington&quot;)
 as sales agent
 under which the Company may issue and sell over time and from
time to time
 to or through Barrington
 shares (the &quot;Shares&quot;) of its common stock&nbsp;having a gross sales price of
up to $6.0 million.



Agreement
 may be effected by any method permitted by law deemed to be an &quot;at-the-market&quot; offering as defined
in Rule 415 of the Securities Act of 1933
 as amended
 including without limitation directly on the NYSE MKT LLC or any other existing
trading market for the common stock or through a market maker
 up to the amount specified
 and otherwise to or through Barrington
in accordance with the placement notices delivered by the Company to Barrington. Also
 with the prior consent of the Company
 some
or all of the&nbsp;Shares may be sold in privately negotiated transactions. Under the Distribution Agreement
 Barrington will be
entitled to compensation of 2.0 % of the gross proceeds from the sale of all of the Shares sold through Barrington
 as sales agent
pursuant to the Distribution Agreement. Also
 the Company will reimburse Barrington for certain expenses incurred in connection
with the matters contemplated by the Distribution Agreement
 up to an aggregate of $50
000
 plus up to an additional $7
500 per
calendar quarter related to ongoing maintenance; provided
 however
 that such reimbursement amount shall not exceed 8% of the aggregate
gross proceeds received by the Company under the Distribution Agreement.


    
    



through March 31
 2014
 the Company sold 5
394
608 Shares pursuant to the Distribution Agreement
 with total gross proceeds of
$4
531
643
 before deducting sales agent and offering expenses of $184
341.

 &ndash;
In June 2011 the Company entered&nbsp;into agreements relating to a private placement (the &ldquo;June 2011 Private Placement&rdquo;)
of&nbsp;an aggregate of approximately $7
100
000 of newly-designated 10% Series A Convertible Preferred Stock
 par value $0.01
per share (&ldquo;Series A Preferred Stock&rdquo;). As part of the June 2011 Private Placement
 the Company completed a private
offering&nbsp;to third-party&nbsp;investors of $2
155
000 of Series A Preferred Stock for its stated value of $1
000 per share
and warrants (&ldquo;2011 Warrants&rdquo;) to purchase 50% of the number of shares of the Company&rsquo;s common stock
 issuable
upon conversion of such Series A Preferred Stock. Subject to adjustment (including dilutive issuances)
 the Series A Preferred
Stock was convertible into common stock at a conversion price of $0.304 per share and the 2011 Warrants had an exercise price
of $0.38 per share.


entitled to receive cumulative dividends at the rate per share (as a percentage of the stated value per share) of 10% per annum
whether or not declared by the Company&rsquo;s Board of Directors
 which were only payable in shares of the Company&rsquo;s common
stock upon conversion of the Series A Preferred Stock or upon a liquidation.&nbsp;For the years ended March 31
 2014 and 2013
the Company recorded accrued dividends of $384
599 and $744
468
 respectively
 included as an increase in the accumulated deficit
and in additional paid-in capital on the accompanying consolidated balance sheets.


to purchase or any right to reprice
 or otherwise dispose of or issue (or announce any sale
 grant or option to purchase or other
disposition)
 any common stock or common stock equivalents entitling any person to acquire common stock at an effective price per
share that was lower than the then conversion price of the Series A Preferred Stock
 the holders of the Series A Preferred Stock
and 2011 Warrants were entitled to an adjusted conversion price and additional shares of common stock upon exercise the 2011 Warrants.&nbsp;These
warrants were subject to liability accounting. See Note 13B.


stock exceeded $100
000 per trading day and the Volume Weighted Average Price (as defined in the articles of designation of the
Series A&nbsp;Preferred Stock) for at least 20 trading days during any 30 consecutive trading day period exceeded $0.76 (subject
to adjustment)
 the Company could convert all or any portion of the outstanding Series A Preferred Stock into shares of common
stock. The Company&rsquo;s common stock exceeded these thresholds
 and on February 11
 2014
 the Company&rsquo;s Board of Directors
approved the mandatory conversion of all outstanding shares of the Series A Preferred Stock pursuant to their terms
 effective
on or about February 24
 2014. Pursuant to the mandatory conversion
 all 6
271 outstanding shares of Series A Preferred
Stock
 and accrued dividends thereon
 converted into 25
760
881 shares of common stock.

 &ndash;
In the current year period prior to the February 11
 2014 mandatory conversion
 holders of Series A Preferred Stock converted 430
shares of Series A Preferred Stock
 and accrued dividends thereon
 into 1
704
729 shares of common stock.


 2013
 holders of
Series A Preferred Stock converted 195.132 shares of Series A Preferred Stock
 and accrued dividends thereon
&nbsp;into 720
967
shares of common stock.




to reduce its exposure to foreign currency fluctuations. The Company recognizes in the balance sheet derivative contracts at fair
value
 and reflects any net gains and losses currently in earnings. At March 31
 2014 and 2013
 the Company had no forward contracts
outstanding. Gain or loss on foreign currency forward contracts
 which was de minimis during the periods presented
 is included
in other income and expense.




 &ldquo;Income
Taxes&rdquo;
 which requires the recognition of tax benefits or expense on the temporary differences between the tax basis and
book basis of its assets and liabilities. Deferred tax assets and liabilities are measured using the enacted tax rates expected
to apply to taxable income in the years in which those differences are expected to be recovered or settled.


and state tax jurisdictions. The Company has various foreign subsidiaries for which tax years 2007 through 2014 remain open to
examination in certain foreign tax jurisdictions.


31
 2014 and 2013 consists of federal
 state and local taxes attributable to GCP
 which does not file a consolidated income tax
return with the Company
 and foreign taxes. As of March 31
 2014
 the Company had federal net operating loss carryforwards of approximately
$86
800
000 for U.S. tax purposes
 which expire through 2034
 and foreign net operating loss carryforwards of approximately $19
800
000
which carry forward without limit of time. Utilization of the U.S. tax losses may be limited by the &ldquo;change of ownership&rdquo;
rules as set forth in section 382 of the Internal Revenue Code.


    
    



 on a financial statement basis
 from foreign
sources totaled $168
233 for the year ended March 31
 2014 and the pre-tax loss
 on a financial statement basis
 from foreign sources
totaled $412
182 for the year ended March&nbsp;31
 2013.


subsidiaries at March 31
 2014 and 2013.


federal statutory rate of 34%.


    



    
    
    

    
    
    


 at 34%
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    


 net of federal benefit
    
    

    
    
    

    
    
    



 the Company recorded
a deferred tax liability on the ascribed value of the acquired intangible assets of $2
222
222
 increasing the value of the asset.
The deferred tax liability is being reversed over the amortization period of the intangible asset (15&nbsp;years). For each of
the years ended March 31
 2014 and 2013
 the Company recognized $590
414 and $118
349 of income tax benefit
 net.


tax assets and deferred tax liabilities are presented below.



    



    
    
    

    
    
    

    
72
000
103
000

    
5
000
5
000

    
304
000
280
000

    
2
125
000
1
967
000

    
206
000
206
000

    
34
706
000
31
623
000

    
1
974
000
1
957
000

    
2
000
2
000

    
    
    

    
39
394
000
36
143
000

    
(38
921
000
(36
143
000

    
    
    

    
473
000
    

    
    
    

    
    
    

    
(629
444
(629
444

    
(888
863
(1
037
012

    
    
    

    
(1
518
307
(1
666
456



    
    



 2013
the Company recorded a full valuation allowance against its deferred tax assets as it believed it was more likely than not that
such deferred tax assets would not be realized. The Company released its deferred tax asset valuation allowance allocated to GCP
as of March 31
 2014 due to management&rsquo;s determination that it was &ldquo;more likely than not&rdquo; that the GCP&rsquo;s
deferred tax assets would be realized. &ldquo;More likely than not&rdquo; is defined as greater than 50% probability of occurrence.
Management considered the guidance in paragraphs 21-23 of ASC 740-10-30 in forming its conclusion. A determination as to the ultimate
realization of the deferred tax assets is dependent upon management&rsquo;s judgment and evaluation of both positive and negative
evidence
 forecasts of future taxable income
 applicable tax planning strategies
 and an assessment of current and future economic
and business conditions. In 2014
 GCP was in a position of cumulative profitability on a pre-tax basis
 considering its operating
results for the three years ended March 31
 2014. Management concluded that this record of cumulative profitability in recent years
in addition to a long range forecast showing continued profitability for GCP
 provided sufficient positive evidence that the net
U.S. federal tax benefits more likely than not would be realized. Accordingly
 in the year ended March 31
 2014
 the Company released
the valuation allowance against GCP&rsquo;s net federal deferred assets
 resulting in a $473
330 benefit in provision for income
taxes for the year ended March 31
 2014. In addition
 at March 31
 2014
 the Company changed its estimate of the cumulative deferred
tax asset allocated to the amortization of intangibles. The Company&rsquo;s income tax benefit and effective tax rate for the years
ended March 31
 2014 and 2013 reflect the impact of this valuation allowance reversal and change in estimate.


31
 2014 and 2013 was approximately $38
921
000 and $36
143
000
 respectively. The net change in the total valuation allowance
for the years ended March 31
 2014 and 2013 was $2
778
000 and $1
846
000
 respectively. The Company does not offset its deferred
tax assets and liabilities because its deferred tax assets and liabilities are in different taxable entities which do not file
consolidated returns.





    
    
 &mdash; In July&nbsp;2003
    the Company implemented the 2003 Stock Incentive Plan (the &ldquo;2003 Plan&rdquo;)
 which provides for awards of incentive
    and non-qualified stock options
 restricted stock and stock appreciation rights for its officers
 employees
 consultants and
    directors to attract and retain such individuals. Stock option grants under the Plan are granted with an exercise price at
    or above the fair market value of the underlying common stock at the date of grant
 generally vest over a three to five year
    period and expire ten years after the grant date.

    
    
    

    
    

 there
were 2
000
000 shares of common stock reserved and available for distribution under the Plan. In January&nbsp;2009
 the
Company&rsquo;s shareholders approved an amendment to the Plan to increase the number of shares available under the Plan from
2
000
000 to 12
000
000 and to establish the maximum number of shares issuable to any one individual in any particular year.
As of August 2013
 no new awards may be issued under the 2003 Plan.

    
    
    

    
    

 the
Company&rsquo;s shareholders approved the 2013 Incentive Compensation Plan (&ldquo;2013 plan&rdquo;) which provides for
awards of incentive and non-qualified stock options
 restricted stock and stock appreciation rights for its officers
employees
 consultants and directors to attract and retain such individuals. As of March 31
 2014
 280
000 shares had been
issued under the 2013 Plan
 with 9
720
000 shares remaining available for issuance.







2014 and 2013 amounted to $393
914 and $282
314
 respectively
 of which $81
567 and $51
075
 respectively
 is included in selling
expense and $312
347 and $231
239
 respectively
 is included in general and administrative expense for the years ended March 31
2014 and 2013
 respectively. At March 31
 2014
 total unrecognized compensation cost amounted to approximately $947
916
 representing
5
662
560 unvested options. This cost is expected to be recognized over a weighted-average period of 2.18&nbsp;years. There were
80
758 options exercised during the year ended March 31
 2014 and no options exercised during the year ended March 31
 2013. The
Company did not recognize any related tax benefit for the years ended March 31
 2014 and 2013
 as the option exercises were de
minimis.

 &mdash;
A summary of the options outstanding under the 2003 and 2013 Plans is as follows:



    



    
    
    

    
    
    
    
    

    
    
    
    
    

    
    
    
    
    

    
    
    
    
    

    
8
120
765
    
6
330
599
    

    
3
300
000
    
1
800
166
    

    
(80
758
    
    
    

    
(166
000
    
(10
000
    

    
    
    
    
    


    period
11
174
007
    
8
120
765
    

    
    
    
    
    

    
5
511
447
    
4
248
958
    

    
    
    
    
    

    
    
    
    
    



    
    



outstanding and exercisable at March 31
 2014:




    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
621
500
    
    
    
    
    
    
    
621
500
    
    
    
    
    
    
    
607
685
    

    
    
    
    
9
975
007
    
    
    
    
    
    
    
4
592
447
    
    
    
    
    
    
    
3
992
631
    

    
    
    
    
348
000
    
    
    
    
    
    
    
68
000
    
    
    
    
    
    
    
1
020
    

    
    
    
    
21
000
    
    
    
    
    
    
    
21
000
    
    
    
    
    
    
    
    
    

    
    
    
    
17
000
    
    
    
    
    
    
    
17
000
    
    
    
    
    
    
    
    
    

    
    
    
    
184
000
    
    
    
    
    
    
    
184
000
    
    
    
    
    
    
    
    
    

    
    
    
    
7
500
    
    
    
    
    
    
    
7
500
    
    
    
    
    
    
    
    
    

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

    
    
    
    
11
174
007
    
    
    
    
    
    
    
5
511
447
    
    
    
    
    
    
    
4
601
336
    




 2014 were 5
511
447.
The weighted average exercise price of these options was $0.63. The weighted average remaining life of the options outstanding
was 7.19&nbsp;years and of the options exercisable was 5.77&nbsp;years.


unvested options for the years ended March 31
 2014 and 2013:



    
    
    

    
    
    

    
    
    

    
    
    


 2012
3
593
999
    

    
    
    

    
1
800
166
    

    
(8
750
    

    
(1
513
608
    

    
    
    


 2013
3
871
807
    

    
    
    

    
3
300
000
    

    
(10
000
    

    
(1
499
247
    

    
    
    


 2014
5
662
560
    

    
    
    



the grant date using the Black-Scholes option pricing model and is affected by assumptions regarding a number of complex and subjective
variables. The use of an option pricing model also requires the use of a number of complex assumptions including expected volatility
risk-free interest rate
 expected dividends
 and expected term. Expected volatility is based on the Company&rsquo;s historical
volatility and the volatility of a peer group of companies over the expected life of the option. The expected term and vesting
of the options represents the estimated period of time until exercise. The expected term was determined using the simplified method
available under current guidance. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of
grant for the expected term of the option. The Company has not paid dividends on its common stock in the past and does not plan
to pay any dividends on its common stock in the near future. Current authoritative guidance also requires the Company to estimate
forfeitures at the time of grant and revise these estimates
 if necessary
 in subsequent periods if actual forfeitures differ from
those estimates. The Company estimates forfeitures based on its expectation of future experience while considering its historical
experience.


    
    



the Black-Scholes option pricing model utilizing the following weighted average assumptions:



    



    
    
    

    
    
    

    
    
    

    
    
    

    
    
    




    
    
    


2011 Warrants issued in connection
with the Series A Preferred Stock


Series A Preferred Stock had an exercise price of $0.38 per share
 subject to adjustment
 and&nbsp;were exercisable for a
period of five years.&nbsp;The exercise price of the 2011 Warrants was  equal to 125% of the conversion price of the
Series A Preferred Stock.


issued in June 2011 in the consolidated financial statements as a liability&nbsp;at their initial fair value of $487
022 and
accounted for the 2011 Warrants issued in October 2011 as a liability&nbsp;at their initial fair value of $780
972. Changes
In
November 2013
 in accordance with certain terms of the 2011 Warrants
 the down-round provisions included in the terms of the
warrant ceased to be in force or effect as a result of the historical volume weighted average price and trading volume of the
Company&rsquo;s common stock. The Company then reclassed the fair value of the outstanding warrant liability of $6
187
968 to
equity
 resulting in an increase to additional paid-in capital. Further
 the Company is no longer required to
recognize any change in fair value of the 2011 Warrants in future reporting periods.


 2013
 the fair value of the 2011 Warrants
was included in the balance sheet under the caption Warrant liability&nbsp;of $795
374. For the year ended March 31
 2014 the Company
recorded a loss&nbsp;on the change in the value of the 2011 Warrants of $5
392
594; for the year ended March 31
 2013
 the Company
recorded a gain for the change in the value of the 2011 Warrants of $302
734.


under the valuation hierarchy and was estimated using the Black-Scholes option pricing model utilizing the following assumptions:



    
    



    
    
    

    
    
    

    
    
    

    
    
    

    
    
    


 &ndash; In the year
ended March 31
 2014
 holders of 2011 Warrants exercised 10
127
123 2011 Warrants and received shares of common stock. The Company
received $3
848
332 in cash upon the exercise of these warrants. These exercised warrants had a weighted average fair market value
of $0.50 at exercise date.


 the Company
called all remaining 2011 Warrants for cancellation in April 2014.


31
 2014
 1
543
214 warrant shares expired unexercised with a weighted average fair market value of $0.00.


    
    



warrants for the periods presented:



    
    
    

    
    
    

    
    
    

    
    
    

    
    
    


 March&nbsp;31
 2012
13
448
139
    

    
    
    

    
    
    

    
    
    

    
(1
543
214
    

    
    
    


 March 31
 2013
11
904
925
    

    
    
    

    
    
    

    
(10
127
123
    

    
    
    

    
    
    


 March 31
 2014
1
777
802
    






    
    

 as successor in interest to I.L.A.R. S.p.A.
 is a shareholder in
    the Company and one of the officers of Pallini is a director of the Company. In January 2011
 CB-USA entered into an
    agreement (&quot;New Agreement&quot;) with Pallini regarding the importation and distribution of certain Pallini brand
    products. The terms of the New Agreement were effective as of April 1
 2010.

    
    
    

    
    
Under the New Agreement
 the Company is permitted
to import Pallini Limoncello and its flavor extensions at a set price
 updated annually
 and is obligated to set aside a portion
of the gross margin toward a marketing fund for Pallini. The New Agreement also encompasses the hiring of a Pallini Brand Manager
at the Company with Pallini reimbursing the costs of this position up to a stipulated annual amount. These reimbursements are included
in selling expense.


 2014 and 2013
 the Company
purchased goods from Pallini for $3
467
812 and $3
685
192
 respectively. As of March 31
 2014 and 2013
 Pallini owed the Company
$115
288 and $34
628
 respectively
 for its share of marketing expense
 which is included in due from shareholders and affiliates
on the consolidated balance sheet. As of March 31
 2014 and 2013
 the Company was indebted to Pallini for $229
557 and $967
188
respectively
 which is included in due to shareholders and affiliates on the consolidated balance sheet.
&nbsp;

In November&nbsp;2008
the Company entered into a management services agreement with Vector Group Ltd.
 a more than 5% shareholder
 under which Vector
Group agreed to make available to the Company the services of Richard J. Lampen
 Vector Group&rsquo;s executive vice president
effective October&nbsp;11
 2008 to serve as the Company&rsquo;s president and chief executive officer and to provide certain other
financial and accounting services
 including assistance with complying with Section&nbsp;404 of the Sarbanes-Oxley Act of 2002.
In consideration for such services
 the Company agreed to pay Vector Group an annual fee of $100
000
 plus any direct
 out-of-pocket
costs
 fees and other expenses incurred by Vector Group or Mr.&nbsp;Lampen in connection with providing such services
 and to
indemnify Vector Group for any liabilities arising out of the provision of the services. The agreement is terminable by either
party upon 30&nbsp;days&rsquo; prior written notice. For the years ended March 31
 2014 and 2013
 Vector Group was paid $104
746
and $113
406
 respectively
 under this agreement. These charges have been included in general and administrative expense.




    
    
In November&nbsp;2008
 the Company entered into an agreement to reimburse Ladenburg Thalmann Financial Services Inc. (&ldquo;LTS&rdquo;) for its costs in providing certain administrative
 legal and financial services to the Company. For the years ended March 31
 2014 and 2013
 LTS was paid $126
000 and $154
972
 respectively
 under this agreement. Mr.&nbsp;Lampen
 the Company&rsquo;s president and chief executive officer and a director
 is the president and chief executive officer and a director of LTS and two other directors of the Company serve as directors of LTS
 including Phillip Frost
 M.D. who is the Chairman and principal shareholder of LTS.




    
    
As described in Note 9D
 in March 2013
 the Company entered into a Participation Agreement with certain related parties. As described in Notes 9E and 9F
 in August and October 2013
 the Company entered into various notes with certain related parties.






    
    
The Company has entered into a supply agreement with Irish Distillers Limited (&ldquo;IDL&rdquo;)
 which provides for the production of blended Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least six years prior notice to the Company
 except for breach. Under this agreement
 the Company provides IDL with a forecast of the estimated amount of liters of pure alcohol it requires for the next four fiscal contract years and agrees to purchase 90% of that amount
 subject to certain annual adjustments. For the contract year ending June 30
 2014
 the Company has contracted to purchase approximately &euro;704
900 or $969
351&nbsp;(translated at the March 31
 2014 exchange rate) in bulk Irish whiskey
 of which &euro;662
351
&nbsp;or $910
838
&nbsp;has been purchased as of March 31
 2014. The Company is not obligated to pay IDL for any product not yet received. During the term of this supply agreement
 IDL has the right to limit additional purchases above the commitment amount.



    
    




    
    


        which provides for the production of single malt Irish whiskeys for the Company until the contract is terminated by either party
        in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least thirteen years prior notice
        to the Company
 except for breach. Under this agreement
 the Company provides IDL with a forecast of the estimated amount of liters
        of pure alcohol it requires for the next twelve fiscal contract years and agrees to purchase 80% of that amount
 subject to certain
        annual adjustments. For the contract year ending June 30
 2014
 the Company has contracted to purchase approximately &euro;245
103
        or $337
056&nbsp;(translated at the March 31
 2014 exchange rate) in bulk Irish whiskey
 of which &euro;172
700
 or&nbsp;$237
491
&nbsp;has
        been purchased as of March 31
 2014. The Company is not obligated to pay IDL for any product not yet received. During the term
        of this supply agreement
 IDL has the right to limit additional purchases above the commitment amount.
        

    
    
The Company has a distribution agreement with Gaelic Heritage Corporation
 Ltd.
 an international supplier
 to be the sole-producer of Celtic Honey
 one of the Company&rsquo;s products
 for an indefinite period.




    
    
The Company leases office space in New York
 NY
 Dublin
 Ireland and Houston
 TX. The New York
 NY lease began on May 1
 2010 and expires on April 30
 2016 and provides for monthly payments of $19
975. The Dublin lease commenced on March 1
 2009 and extends through October 31
 2016 and provides for monthly payments of&nbsp;&euro;1
100 or $1
513 (translated at the March 31
 2014 exchange rate). The Houston
 TX lease commenced on February 24
 2000 and extends through January 31
 2015 and provides for monthly payments of $1
875. The Company has also entered into non-cancelable operating leases for certain office equipment.



initial or remaining terms in excess of one year are as follows:





    

    
276
606

    
262
646

    
30
963

    
    

    
570
215



 the
Company is obligated to pay its pro-rata share of utility and maintenance expenses on the leased premises. Rent expense under operating
leases amounted to approximately $356
280 and $325
082 for the years ended March 31
 2014 and 2013
 respectively
 and is included
in general and administrative expense.



    
    
Under the amended terms of the agreement under which the Company purchased McLain &amp; Kyne
 the Company was obligated to pay an earn-out to the sellers based on the financial performance of the acquired business. As of June 30
 2013
 the Company had reached the specified case sale threshold for contingent consideration under the agreement. Accordingly
 no further contingent consideration will be due. For the years ended March 31
 2014 and 2013
 the sellers earned $5
940 and $145
800
 respectively
 under this agreement.




    
    
As described in Note 9C
 in August 2011
 the Company and CB-USA entered
    into the Keltic Facility
 as amended in July 2012
 March 2013
  August 2013 and November 2013.






    
    
 &mdash; The Company maintains its cash and cash equivalents balances at various large financial institutions that
 at times
 may exceed federally and internationally insured limits. The Company exceeded the limits in effect at March 31
 2014 by approximately $725
000 and exceeded the limits in effect by approximately $300
000 at March 31
 2013.

    
    
    

    
    
 &mdash; Sales to one customer
 the Southern Wine and Spirits of America
 Inc. family of companies
 accounted for approximately 31.9% and 30.2% of the Company&rsquo;s revenues for the years ended March 31
 2014 and 2013
 respectively
 and approximately 35.1 % and 29.1% of accounts receivable at March 31
 2014 and 2013
 respectively.



    
    





of premium beverage alcohol. The Company&rsquo;s product categories are rum
 liqueur
 whiskey
 vodka
 tequila and wine. The Company
reports its operations in two geographic areas: International and United States.


revenues and assets generated in or held in the U.S. and foreign countries. The following table sets forth the amounts and percentage
of consolidated revenue
 consolidated results from operations
 consolidated net loss attributable to common shareholders
 consolidated
income tax benefit and consolidated assets from the U.S. and foreign countries and consolidated revenue by category.



    



    
    
    

    
    
    
    
    

    
7
305
516
    
5
444
798
    

    
40
834
967
    
35
998
196
    

    
    
    
    
    

    
48
140
483
    
41
442
994
    

    
    
    
    
    

    
    
    
    
    

    
    
    
(26
329
    

    
(1
319
567
    
(4
375
731
    

    
    
    
    
    

    
(1
319
833
    
(4
402
060
    

    
    
    
    
    

    
    
    
    
    

    
(153
419
    
(145
784
    

    
(8
753
328
    
(5
302
973
    

    
    
    
    
    

    
(8
906
747
    
(5
448
757
    

    
    
    
    
    


 net:
    
    
    
    

    
590
414
    
118
349
    

    
    
    
    
    

    
    
    
    
    

    
16
643
640
    
15
324
904
    

    
13
521
875
    
9
421
168
    

    
8
992
277
    
8
803
111
    

    
2
852
956
    
3
565
070
    

    
218
552
    
242
537
    

    
284
806
    
689
637
    

    
5
626
377
    
3
396
567
    

    
    
    
    
    

    
48
140
483
    
41
442
994
    




    



    
    
    

    
    
    
    
    

    
2
201
343
    
1
941
537
    

    
34
320
167
    
31
175
558
    

    
    
    
    
    

    
36
521
510
    
33
117
095
    





    
    





 - Between
April 1
 2014 and June 25
 2014
 the Company sold an additional&nbsp;1
172
799 Shares pursuant to the Distribution Agreement
 with
total gross proceeds of $1
169
735
 before deducting sales agent and offering expenses of $37
295.

 &ndash; On April 2
2014
 the Company called for cancellation all 1
657
802 unexercised 2011 Warrants pursuant to the terms of such 2011 Warrants after
satisfying applicable conditions. Holders of the Warrants had until 6:30 p.m. New York City time on April 21
 2014 to exercise
such Warrants at $0.38 per share in cash. Pursuant to the call for cancellation
 holders of all 1
657
802 unexercised 2011 Warrants
exercised and received 1
657
802 shares of common stock. The Company received $629
965 in cash upon the exercise of these warrants.


    
    


Item&nbsp;9. Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure








(as defined in Rules&nbsp;13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934
 as amended (the &ldquo;Exchange
Act&rdquo;)) that are designed to ensure that information that would be required to be disclosed in Exchange Act reports is recorded
processed
 summarized and reported within the time periods specified in the SEC&rsquo;s rules and forms
 and that such information
is accumulated and communicated to our management
 including the Chief Executive Officer and Chief Financial Officer (our Principal
Executive Officer and Principal Financial Officer
 respectively)
 as appropriate
 to allow timely decisions regarding required
disclosure.


 2014
 we carried out an evaluation
under the supervision and with the participation of our management
 including the Principal Executive Officer and Principal Financial
Officer
 of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing
 our
Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective
as of the end of the period covered by this Annual Report.

Management&rsquo;s Report on Internal Control
over Financial Reporting


and maintaining adequate internal control over financial reporting. As defined in the securities laws
 internal control over financial
reporting is a process designed by
 or under the supervision of
 our Principal Executive and Principal Financial Officers and effected
by our Board of Directors
 management
 and other personnel
 to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles
and includes those policies and procedures that (i)&nbsp;pertain to the maintenance of records that in reasonable detail accurately
and fairly reflect the transactions and dispositions of our assets; (ii)&nbsp;provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles
and that our receipts and expenditures are being made only in accordance with authorizations of management and directors; and (iii)&nbsp;provide
reasonable assurance regarding prevention or timely detection of unauthorized acquisition
 use or disposition of our assets that
could have a material effect on the financial statements.


is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external reporting purposes in accordance with generally accepted accounting principles.


 internal
control over financial reporting may not prevent or detect misstatements. Therefore
 even those systems determined to be effective
can provide only reasonable assurance with respect to financial statement preparation and presentation. Also
 projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in
conditions
 or that the degree of compliance with the policies or procedures may deteriorate.


effectiveness of the internal controls over financial reporting (as defined in Rule&nbsp;13a-15(f) promulgated under the Exchange
Act) as of March 31
 2014
 issued by the
Committee of Sponsoring Organizations of the Treadway Commission.


 including the Principal Executive
and Principal Financial Officers
 have concluded that our internal control over financial reporting was effective as of March 31



Changes in Internal Control over Financial
Reporting


control over financial reporting that occurred in the fourth fiscal quarter that has materially affected
 or is reasonably likely
to materially affect
 our internal control over financial reporting.


    
    







    
    




Item&nbsp;10. Directors
 Executive Officers and Corporate
Governance


is incorporated by reference from our definitive proxy statement for our 2014 annual meeting of shareholders
 which will be filed
no later than 120 days after March 31
 2014.




is incorporated by reference from our definitive proxy statement for our 2014 annual meeting of shareholders
 which will be filed
no later than 120 days after March 31
 2014.

Item&nbsp;12. Security Ownership of Certain Beneficial Owners
and Management and Related Shareholder Matters


plans is set forth in Item 5 of this annual report&nbsp;on Form 10-K and is&nbsp;incorporated herein&nbsp;by reference.


required by this Item&nbsp;12 is incorporated by reference from our definitive proxy statement for our 2014 annual meeting of shareholders
which will be filed no later than 120 days after March 31
 2014.

Item&nbsp;13. Certain Relationships and Related Transactions
and Director Independence


by this Item&nbsp;13 is incorporated by reference from our definitive proxy statement for our 2014 annual meeting of shareholders
which will be filed no later than 120 days after March 31
 2014.




by this Item&nbsp;14 is incorporated by reference from our definitive proxy statement for our 2014 annual meeting of shareholders
which will be filed no later than 120 days after March 31
 2014.



Item&nbsp;15. Exhibits
 Financial Statement Schedules



    
    
    




    
    
Financial Statements &mdash; See Index to Financial Statements at Item
    8 on page 33 of this annual report on Form 10-K.




    
    
    




    
    
Exhibits &mdash; The following exhibits are filed as part of
 or incorporated by reference into
 this annual report on Form 10-K:




    
    
    

    
    
    

    
    
    

    
    
    

    
    
Equity Distribution Agreement
 dated November 14
 2013
 between Castle Brands Inc. and Barrington Research Associates
 Inc.
 as sales agent (incorporated by reference to Exhibit 1.1 to our current report on Form 8-K filed with the SEC on November 14
 2013)

    
    
    

    
    
Agreement and Plan of Merger dated February 9
 2010 between Castle Brands Inc.
 a Delaware corporation
 and Castle Brands (Florida) Inc.
 a Florida corporation (incorporated by reference to Exhibit 2.1 to our current report on Form 8-K filed with the SEC on February 12
 2010)

    
    
    

    
    
    

    
    
    



    
    




    
    
Bylaws of the Company (incorporated by reference to Appendix E to our definitive proxy statement on Schedule 14A filed with the SEC on December 30
 2009)

    
    
    

    
    
Form of Common Stock Certificate (incorporated by reference to Exhibit 4.3 to our Post-Effective Amendment No. 1 to Form S-8 (File No. 333-160380) filed with the SEC on March 10
 2010)

    
    
    

    
    
Form of Common Stock Purchase Warrant to be issued by the Company (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
Loan and Security Agreement
 dated as of August 19
 2011
 among Keltic Financial Partners II
 LP
 the Company and Castle Brands (USA) Corp. (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on July 26
 2012)

    
    
    

    
    
First Amendment to Loan and Security Agreement 
 dated as of July 23
 2012
 among Keltic Financial Partners II
 LP
 the Company and Castle Brands (USA) Corp. (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on August 25
 2011)

    
    
    

    
    
Second Amendment to Loan and Security Agreement
 dated as of March 11
 2013
 among Keltic Financial Partners II
 LP
 the Company and Castle Brands (USA) Corp. (incorporated by reference to exhibit 4.1 to our current report on Form 8-K filed with the SEC on March 14
 2013)

    
    
    

    
    
Amended and Restated Revolving Credit Note
 dated as of March 11
 2013
 in favor of Keltic Financial Partners II
 LP (incorporated by reference to exhibit 4.2 to our current report on Form 8-K filed with the SEC on March 14
 2013)

    
    
    

    
    
Third Amendment to Loan and Security Agreement
 dated as of August 7
 2013
 by and among Keltic Financial Partners II
 LP
 the Company and Castle Brands (USA) Corp. (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on August 9
 2013)

    
    
    

    
    
Amended and Restated Term Note
 dated as of August 7
 2013
 in favor of Keltic Financial Partners II
 LP (incorporated by reference to Exhibit 4.2 to our current report on Form 8-K filed with the SEC on August 9
 2013)

    
    
    

    
    
Loan Agreement
 dated as of August 7
 2013
 by and between the Company and the lending parties thereto
 including the form of promissory note attached as Exhibit B thereto (incorporated by reference to Exhibit 4.3 to our current report on Form 8-K filed with the SEC on August 9
 2013)

    
    
    

    
    
5% Convertible Subordinated Note Purchase Agreement 
 dated as of October 21
 2013
 among the Company and the parties set forth on the signature pages attached thereto (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on October 25
 2013)

    
    
    

    
    
Form of 5% Subordinated Convertible Note Due 2018
 issued by the Company (incorporated by reference to Exhibit 4.1 to our current report on Form 8-K filed with the SEC on November 1
 2013)

    
    
    

    
    
Fourth Amendment
 Waiver and Consent to the Loan and Security Agreement
 between the Company 
 Castle Brands (USA) Corp. and Keltic Financial Partners II
 LP 
 dated as of August 19
 2011 and effective as of October 21
 2013 (incorporated by reference to Exhibit 4.3 to our current report on Form 8-K filed with the SEC on October 25
 2013)

    
    
    

    
    
Fifth Amendment
 Waiver and Consent to Loan and Security Agreement
 dated as of November 14
 2013
 between Castle Brands Inc.
 Castle Brands (USA) Corp. and Keltic Financial Partners II
 LP (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on November 14
 2013)

    
    
    

    
    
Export Agreement
 dated as of February&nbsp;14
 2005 between Gosling Partners Inc. and Gosling&rsquo;s Export (Bermuda) Limited(Exhibit 10.1)(1)(2)

    
    
    

    
    
Amendment No.&nbsp;1 to Export Agreement
 dated as of February&nbsp;18
 2005
 by and among Gosling-Castle Partners Inc. and Gosling&rsquo;s Export (Bermuda) Limited(Exhibit 10.2)(1)(2)



    
    




    
    
National Distribution Agreement
 dated as of September&nbsp;3
 2004
 by and between Castle Brands (USA)&nbsp;Corp. and Gosling&rsquo;s Export (Bermuda) Limited(Exhibit 10.3)(1)(2)

    
    
    

    
    
Subscription Agreement
 dated as of February&nbsp;18
 2005
 by and between Castle Brands Inc. and Gosling-Castle Partners Inc.(Exhibit 10.4)(1)

    
    
    

    
    
Stockholders' Agreement
 dated February&nbsp;18
 2005
 by and among Gosling-Castle Partners Inc. and the persons listed on Schedule&nbsp;I thereto (Exhibit 10.5)(1)

    
    
    

    
    
Agreement
 dated as of January 12
 2011
 between Pallini SpA and Castle Brands (USA)&nbsp;Corp. (incorporated herein by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on January 18
 2011) (2)

    
    
    

    
    
Supply Agreement
 dated as of January&nbsp;1
 2005
 between Irish Distillers Limited and Castle Brands Spirits Group Limited and Castle Brands (USA) Corp.(Exhibit 10.8)(1)(2)

    
    
    

    
    
Amendment No.&nbsp;1 to Supply Agreement
 dated as of September&nbsp;20
 2005
 to the Supply Agreement
 dated as of January&nbsp;1
 2005
 among Irish Distillers Limited and Castle Brands Spirits Group Limited and Castle Brands (USA) Corp.(Exhibit 10.9)(1)

    
    
    

    
    
Amended and Restated Worldwide Distribution Agreement
 dated as of April 16
 2001
 by and between Great Spirits Company LLC and Gaelic Heritage Corporation Limited(Exhibit 10.10)(1)

    
    
    

    
    
Letter Agreement
 dated November&nbsp;7
 2008
 between Castle Brands Inc. and Vector Group Ltd. (incorporated by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on November&nbsp;12
 2008)

    
    
    

    
    
 (incorporated by
    reference to Exhibit 10.1 to our quarterly report on Form 10-Q filed on August 14
 2013)

    
    
    

    
    
Form of Castle Brands Inc. Stock Option Grant Agreement (incorporated by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on June 16
 2006)#

    
    
    

    
    
Stock Purchase Agreement
 dated as of October&nbsp;12
 2006
 among Chester F. Zoeller III
 Brittany Lynn Zoeller Carlson and Beth Allison Zoeller Willis and the Company (incorporated herein by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on October&nbsp;16
 2006)

    
    
    

    
    
Amended and Restated Employment Agreement
 dated as of November&nbsp;13
 2007
 between Castle Brands Inc. and Alfred J. Small (incorporated herein by reference to Exhibit&nbsp;10.2 to our current report on Form&nbsp;8-K filed with the SEC on November&nbsp;13
 2007)#

    
    
    

    
    
Third Amended and Restated Employment Agreement
 effective as of February 26
 2010
 by and between Castle Brands Inc. and Mark Andrews (incorporated by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on March 1
 2010)#

    
    
    

    
    
Amended and Restated Employment Agreement
 effective as of May&nbsp;2
 2005
 by and between Castle Brands Inc. and T. Kelley Spillane(1)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of May 6
 2010
 between Castle Brands Inc. and Alfred J. Small (incorporated herein by reference to Exhibit&nbsp;10.2 to our current report on Form&nbsp;8-K filed with the SEC on May 7
 2010)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of May&nbsp;6
 2010
 by and between Castle Brands Inc. and T.&nbsp;&nbsp;Kelley Spillane (incorporated herein by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed with the SEC on May 7
 2010)#

    
    
    

    
    
Reaffirmation Agreement
 dated as of October 21
 2013
 by and among Keltic Financial Partners II
 LP
 the Company
 Castle Brands (USA) Corp.
 the officers signatory thereto and certain junior lenders to the Company (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on October 25
 2013)

    
    
    

    
    
Castle Brands Inc. 2003 Stock Incentive Plan
 as amended
 (Exhibit&nbsp;10.29)(1)#

    
    
    

    
    
    

    
    
    

    
    
Amendment No. 2 to Castle Brands Inc. 2003 Stock Incentive Plan (incorporated by reference to Exhibit 10.24 to&nbsp;our annual report on Form 10-K for the fiscal year ended March 30
 2009 filed with the SEC on June 29
 2009)#

    
    
    

    
    
Amended and Restated Warrant Agreement
 dated September&nbsp;27
 2005
 by and between Castle Brands Inc. and Keltic Financial Partners
 LP (Exhibit&nbsp;10.52)(1)



    
    




    
    
Form of Restricted Stock Agreement (incorporated by reference to Exhibit 10.5 to our quarterly report on Form 10-Q filed with the SEC on February&nbsp;17
 2009)#

    
    
    

    
    
Amendment No. 2 to Bottling and Services Agreement
 dated as of July 23
 2009
 by and between Terra Limited and Castle Brands Spirits Company Limited (incorporated by reference to Exhibit 10.1 to&nbsp;our current report on Form 8-K filed on July 29
 2009)(2)

    
    
    

    
    
Employment Agreement
 made as of January 24
 2008
 by and between Castle Brands Inc. and John S. Glover (incorporated by reference to Exhibit 10.28 to Amendment No. 1 to our annual report on Form 10-K filed with the SEC on July 29
 2009)#

    
    
    

    
    
Securities Purchase Agreement dated as of June 8
 2011
 between the Company and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
Securities Purchase Agreement dated as of June 8
 2011
 between the Company and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.2 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
Securities Purchase Agreement dated as of June 8
 2011
 between the Company and each affiliate purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.3 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
Exchange Agreement dated as of June 8
 2011
 between the Company and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.4 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
Registration Rights Agreement dated as of June 8
 2011
 between the Company and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.5 to our current report on Form 8-K filed with the SEC on June 9
 2011)

    
    
    

    
    
First Amendment to Exchange Agreement
 dated as of June 13
 2011
 between the Company and Frost Gamma Investments Trust (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on June 14
 2011)

    
    
    

    
    
Form of Validity and Support Agreement
 dated as of August 19
 2011
 among Keltic Financial Partners II
 LP
 the Company
 Castle Brands (USA) Corp. and the officer signatory thereto (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on August 25
 2011)

    
    
    

    
    
Fee Letter
 dated as of March 11
 2013
 among the Company
 Castle Brands (USA) Corp. and the junior participants party thereto (incorporated by reference to exhibit 10.2 to our current report on Form 8-K filed with the SEC on March 14
 2013)

    
    
    

    
    
Amendment to Employment Agreement
 made as of July 26
 2011
 by and between Castle Brands Inc. and John S. Glover (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed with the SEC on July 27
 2011).#

    
    
    

    
    
Employment Letter
 dated July 29
 2011
 by and between Castle Brands USA Corp. and Maria Alejandra Pena (incorporated by reference to Exhibit 10.3 to our quarterly report on Form 10-Q filed with the SEC on November 14
 2011) #

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of May&nbsp;11
 2012
 by and between Castle Brands Inc. and T. Kelley Spillane (incorporated herein by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed on May 17
 2012)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of May 11
 2012
 between Castle Brands Inc. and Alfred J. Small (incorporated herein by reference to Exhibit 10.2 to our current report on Form 8-K filed on May 17
 2012)#

    
    
    

    
    
Amendment to the Third Amended and Restated Employment Agreement
 effective as of May 11
 2012
 by and between Castle Brands Inc. and Mark Andrews (incorporated by reference to Exhibit&nbsp;10.3 to our current report on Form&nbsp;8-K filed on May 17
 2012)#

    
    
    

    
    
Castle Brands Inc. 2013 Stock Incentive Plan (incorporated by reference to Exhibit A to our definitive proxy statement on Schedule 14A for the 2012 annual meeting of shareholders
 filed with the SEC on September 11
 2012)#

    
    
    

    
    
Amendment to Fourth Amended and Restated Employment Agreement
 dated as of January 24
 2014
 by and between Castle Brands Inc. and Mark Andrews (incorporated by reference to Exhibit&nbsp;10.1 to our current report on Form&nbsp;8-K filed on January 27
 2014)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of January 24
 2014
 by and between Castle Brands Inc. and John Glover (incorporated by reference to Exhibit&nbsp;10.2 to our current report on Form&nbsp;8-K filed on January 27
 2014)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of January 24
 2014
 by and between Castle Brands Inc. and T. Kelley Spillane (incorporated by reference to Exhibit&nbsp;10.3 to our current report on Form&nbsp;8-K filed on January 27
 2014)#

    
    
    

    
    
Amendment to Amended and Restated Employment Agreement
 dated as of January 24
 2014
 by and between Castle Brands Inc. and Alfred J. Small (incorporated by reference to Exhibit&nbsp;10.4 to our current report on Form&nbsp;8-K filed on January 27
 2014)#

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
Certification of CEO Pursuant to Rule&nbsp;13a-14(a)
 as Adopted Pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002*

    
    
    

    
    
Certification of CFO Pursuant to Rule&nbsp;13a-14(a)
 as Adopted Pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002*

    
    
    

    
    
Certification of CEO and CFO Pursuant to 18 U.S.C. Section&nbsp;1350
 as Adopted Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002*



    
    




    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    




    
    





    
    




    
Previously filed as an exhibit to our Registration Statement on Form S-1 (File No. 333-128676)
 which was declared effective on April 5
 2006
 and incorporated by reference herein.




    
Confidential portions of this document are omitted pursuant to a request for confidential treatment that has been granted by the Commission
 and have been filed separately with the Commission.



    
    





or 15(d) of the Securities Exchange Act of 1934
 the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized
 on June 27
 2014.



    
    

    
    

    
    
    

    
    
    

    
    
Senior Vice President
 Chief Financial

    
    
Officer
 Secretary and Treasurer (Principal

    
    
    

    
    
    





constitutes and appoints each of Richard J. Lampen and Alfred J. Small
 such person&rsquo;s true and lawful attorney-in-fact and
agent with full power of substitution and resubstitution
 for such person and in such person&rsquo;s name
 place and stead
 in
any and all capacities
 to sign any and all amendments to this report on Form 10-K
 and to file the same
 with all exhibits thereto
and all documents in connection therewith
 with the Securities and Exchange Commission
 granting unto each said attorney-in-fact
and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about
the premises
 as fully to all intents and purposes as such person might or could do in person
 hereby ratifying and confirming
all that any said attorney-in-fact and agent
 or any substitute or substitutes of any of them
 may lawfully do or cause to be done
by virtue hereof.


Exchange Act of 1934
 this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.



    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
Senior&nbsp;Vice&nbsp;President
&nbsp;Chief&nbsp;Financial
    
June 27
 2014

    
    
Officer
&nbsp;Secretary&nbsp;and&nbsp;Treasurer&nbsp;(Principal
    
    

    
    
    
    
    

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

Phillip Frost
 M.D.
    
    
    
June 27
 2014

Phillip Frost
 M.D.
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    

    
    
    
    
    

    
    
    
    
June 27
 2014

    
    
    
    
    



    














     




THIS
COMPOSITE ARTICLES OF INCORPORATION OF CASTLE BRANDS INC. (THE &ldquo;CORPORATION&rdquo;) REFLECTS THE PROVISIONS OF THE CORPORATION&rsquo;S
ARTICLES OF INCORPORATION AND ALL AMENDMENTS THERETO FILED WITH THE FLORIDA SECRETARY OF STATE ON OR PRIOR TO JUNE 30
 2014
 BUT
IS NOT AN AMENDMENT AND/OR RESTATEMENT THEREOF.


ARTICLES OF INCORPORATION
OF
CASTLE BRANDS INC.


NAME


is CASTLE BRANDS INC. (the &ldquo;


PURPOSE


the Corporation is formed is to engage in any lawful act or activity for which corporations may be organized under the Florida
Business Corporation Act (the &ldquo;


PRINCIPAL PLACE OF BUSINESS AND MAILING ADDRESS


principal office and the mailing address of the office of the Corporation is 122 East 42nd Street
 Suite 4700
 New York
 NY 10168.


CAPITAL STOCK


be authorized to issue Three Hundred and Twenty-Five Million (325
000
000) shares of capital stock
 of which (i) Three Hundred
Million (300
000
000) shares shall be common stock
&rdquo;)
 and (ii)
Twenty-Five Million (25
000
000) shares shall be preferred stock
 par value $.01 per share (the &ldquo;

.
Except as otherwise provided by law or by these Articles of Incorporation (including any certificate filed with the Secretary of
 of this
)
 the Common Stock shall have the exclusive right to vote for the election of directors and for all other
purposes. Each share of Common Stock shall entitle the holder thereof to one vote on all matters on which shareholders are entitled
generally to vote
 and the holders of Common Stock shall vote together as a single class. The holders of shares of Common Stock
shall not have cumulative voting rights.



    
    


Preferred
&rdquo;)
is hereby authorized to fix by resolution or resolutions the voting powers
 if any
 designations
 powers
 preferences and the relative
participating
 optional or other special rights
 if any
 and the qualifications
 limitations or restrictions thereof
 of any unissued
series of Preferred Stock; and to fix the number of shares constituting such series
 and to increase or decrease the number of
shares of any such series (but not below the number of shares thereof then outstanding). The powers
 preferences and relative
participating
 optional and other special rights of each series of Preferred Stock
 and the qualifications
 limitations or restrictions
thereof
 if any
 may differ from those of any and all other series at any time outstanding.


REGISTERED AGENT AND OFFICE


of the Corporation&rsquo;s initial registered office is 11380 Prosperity Farms Road #221E
 Palm Beach Gardens
 Florida 33410
 and
the name of its initial registered agent at such office is Corporate Creations Network Inc.


BOARD OF DIRECTORS


of the Corporation shall be managed by or under the direction of the Board except as otherwise provided herein or required by law.

Board of
Directors
stock as set forth in these Articles of Incorporation to elect additional directors under specified circumstances
 the number of
directors of the Corporation shall be fixed
 and may be increased or decreased from time to time
 by resolution of the Board.

Election
of Directors
 the election of directors
of the Corporation need not be by written ballot.

Terms of
Directors
 and directors who are elected in the interim to
fill vacancies and newly created directorships shall hold office until the next annual meeting of shareholders and until their
successors are elected and qualified or until their earlier resignation or removal.


1&middot;A#6977|26 &quot; \l 3 (1) Notwithstanding the foregoing
 whenever
 pursuant to the provisions of 
of these Articles of Incorporation
 the holders of any one or more series of Preferred Stock shall have the right
 voting separately
as a series or together with holders of other such series
 to elect directors at an annual or special meeting of shareholders
the election
 term of office
 filling of vacancies and other features of such directorships shall be governed by the terms of these
Articles of Incorporation and any certificate of designations applicable thereto.



    
    



when the holders of any series of Preferred Stock have the right to elect additional directors as provided for or fixed pursuant
 hereof
 then upon commencement and for the duration of the period during which such
right continues: (i) the then otherwise total authorized number of directors of the Corporation shall automatically be increased
by such specified number of directors
 and the holders of such Preferred Stock shall be entitled to elect the additional directors
so provided for or fixed pursuant to said provisions
 and (ii) each such additional director shall serve until such director&rsquo;s
successor shall have been duly elected and qualified
 or until such director&rsquo;s right to hold such office terminates pursuant
to said provisions
 whichever occurs earlier
 subject to such director&rsquo;s earlier death
 disqualification
 resignation or
removal. Except as otherwise provided by the Board in the resolution or resolutions establishing such series
 whenever the holders
of any series of Preferred Stock having such right to elect additional directors are divested of such right pursuant to the provisions
of such stock
 the terms of office of all such additional directors elected by the holders of such stock
 or elected to fill any
vacancies resulting from the death
 resignation
 disqualification or removal of such additional directors
 shall forthwith terminate
and the total and authorized number of directors of the Corporation shall be reduced accordingly.

.
Subject to the rights of the holders of any series of Preferred Stock
 any and all vacancies on the Board
 however occurring
 including
without limitation
 by reason of an increase in size of the Board
 or the death
 resignation
 disqualification or removal of a
director
 shall be filled solely by the affirmative vote of a majority of the remaining directors then in office
 even if less
than a quorum of the Board. Any director appointed in accordance with the preceding sentence shall hold office until such director&rsquo;s
successor shall have been duly elected and qualified or until his or her earlier resignation or removal. In the event of a vacancy
in the Board
 the remaining directors
 except as otherwise provided by law
 may exercise the powers of the full Board until the
vacancy is filled.

.
A director of the Corporation shall not be personally liable to the Corporation or its shareholders for monetary damages for breach
of fiduciary duty as a director
 except to the extent such exemption from liability or limitation thereof is not permitted under
the Act as the same exists or may hereafter be amended. Any amendment
 repeal or modification of the foregoing sentence shall not
adversely affect any right or protection of a director of the Corporation existing hereunder with respect to any act or omission
occurring prior to such amendment
 repeal or modification.



    
    



INDEMNIFICATION


who was or is a party or is threatened to be made a party to any threatened
 pending or completed action
 suit or proceeding
 whether
civil
 criminal
 administrative or investigative
 by reason of the fact that he is or was a director or officer of the Corporation
or is or was serving at the request of the Corporation as a director
 officer
 employee or agent of another corporation
 partnership
joint venture
 trust or other enterprise
 including service with respect to employee benefit plans
 whether the basis of such proceeding
is alleged action in an official capacity as a director
 officer
 employee or agent or in any other capacity while serving as a
director
 officer
 employee or agent
 shall be indemnified and held harmless by the Corporation to the fullest extent authorized
or permitted by the Act
 as the same exists or may hereafter be amended (but
 in the case of any such amendment
 only to the extent
that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to
provide prior to such amendment)
 against all expense
 liability and loss (including attorneys&rsquo; fees
 judgments
 fines
 excise
taxes or penalties and amounts paid or to be paid in settlement) actually and reasonably incurred by such person in connection
with such action
 suit or proceeding
 and such indemnification shall continue as to a person who has ceased to be a director
 officer
employee or agent and shall inure to the benefit of the heirs
 executors and administrators of such person; provided
 however
that
 except as provided in paragraph (b)
 the Corporation shall indemnify any such person seeking indemnification in connection
with an action
 suit or proceeding (or part thereof) initiated by such person only if such action
 suit or proceeding (or part
thereof) was authorized by the Board of the Corporation. The right to indemnification conferred in this Article shall be a contract
right and shall include the right to be paid by the Corporation the expenses incurred in defending any such action
 suit or proceeding
in advance of its final disposition; provided
 however
 that
 if the Act requires
 the payment of such expenses incurred by a director
or officer in his capacity as such in advance of the final disposition of any such action
 suit or proceeding shall be made only
upon receipt by the Corporation of an undertaking by or on behalf of such director or officer to repay all amounts so advanced
if it shall ultimately be determined that such director or officer is not entitled to be indemnified under this Article or otherwise.
The Corporation may
 to the extent authorized from time to time by the Board
 provide rights to indemnification and to the advancement
of expenses to employees and agents of the Corporation with the same scope and effect as the foregoing indemnification of directors
and officers.


paragraph (a) is not paid in full by the Corporation within thirty (30) days after a written claim has been received by the Corporation
the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and
 if successful
in whole or in part
 the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense
to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance
of its final disposition where the required undertaking
 if any is required
 has been tendered to the Corporation) that the claimant
has not met the standards of conduct which make it permissible under the Act for the Corporation to indemnify the claimant for
the amount claimed
 but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation
(including the Board
 independent legal counsel or its shareholders) to have made a determination prior to the commencement of
such action that indemnification of the claimant is proper in the circumstances because he has met the applicable standard of conduct
set forth in the Act
 nor an actual determination by the Corporation (including the Board
 independent legal counsel or its shareholders)
that the claimant has not met such applicable standard of conduct
 shall be a defense to the action or create a presumption that
the claimant has not met the applicable standard of conduct.


indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in
this Article shall not be exclusive of any other right which any person may have or hereafter acquire under any statute
 provision
of these Articles of Incorporation (as it may be amended)
 the By-laws
 agreement
 vote of shareholders or disinterested directors
or otherwise.



    
    



may maintain insurance
 at its expense
 to protect itself and any director
 officer
 employee or agent of the Corporation or another
corporation
 partnership
 joint venture
 trust or other enterprise against any such expense
 liability or loss
 whether or not
the Corporation would have the power to indemnify such person against such expense
 liability or loss under the Act.


repeal or modification of this Article Seventh shall not adversely affect any right or protection of a director of the Corporation
existing hereunder with respect to any act or omission occurring prior to such amendment
 repeal or modification.


MEETINGS OF THE SHAREHOLDERS


or permitted by the shareholders of the Corporation may be taken without a meeting
 without prior notice
 and without a vote
 if
a consent or consents in writing
 setting forth the action so taken
 shall be signed by the holders of outstanding stock having
not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares
entitled to vote thereon were present and voted.


BYLAWS AMENDMENT


not in limitation of the powers conferred upon it by the laws of the State of Florida
 the Board shall have the power to adopt
amend
 alter or repeal the Corporation&rsquo;s By-laws. The affirmative vote of at least a majority of the entire Board shall be
required to adopt
 amend
 alter or repeal the Corporation&rsquo;s By-laws.


AMENDMENTS


the right at any time and from time to time to amend
 alter
 change or repeal any provision contained in these Articles of Incorporation
and any other provisions authorized by the laws of the State of Florida at the time in force may be added or inserted
 in the manner
now or hereafter prescribed by statute and these Articles of Incorporation
 and all rights
 preferences and privileges conferred
upon shareholders
 directors or any other persons by and pursuant to these Articles of Incorporation are granted subject to this
reservation. No amendment or repeal of these Articles of Incorporation shall be made unless the same is first approved by the Board
pursuant to a resolution adopted by the Board in accordance with Section 607.1003 of the Act
 and
 except as otherwise provided
by law
 thereafter approved by the shareholders. Whenever any vote of the holders of voting stock is required
 and in addition
to any other vote of holders of voting stock that is required by these Articles of Incorporation or by law
 the affirmative vote
of a majority of the total votes eligible to be cast by holders of voting stock with respect to such amendment or repeal
 voting
together as a single class
 at a duly constituted meeting of shareholders called expressly for such purpose shall be required to
amend or repeal any provisions of these Articles of Incorporation .



    
    



INCORPORATOR


is Brian Heller
 and the address of the Incorporator is 4400 Biscayne Blvd.
 12th Floor
 Miami
 FL 33137.











    















     









    
    
    

    
    
    

    
    
Delaware
 USA

    
    
    

    
    
Delaware
 USA

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    



    


















CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM


by reference in the Registration Statements of Castle Brands Inc. on Form S-3 (No. 333-176005 and No. 333-143422) and Form
S-8 (Nos. 333-133567
 333-160380 and 333-189750) of our report dated June 27
 2014
 on our audits of the consolidated financial
statements as of March 31
 2014 and 2013 and for each of the years in the two year period ended March 31
 2014
 which report
is included in this Annual Report on Form 10-K.



    

New York
 New York

June 27
 2014



    













     








 Richard J. Lampen
 certify that:



    
    




    
Based on my knowledge
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;




    
Based on my knowledge
 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;




    
    




    
    
Designed such disclosure controls and procedures
 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly during the period in which this report is being prepared;




    
    
Designed such internal control over financial reporting
 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;




    
    
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures
 as of the end of the period covered by this report based on such evaluation; and




    
    
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected
 or is reasonably likely to materially affect
 the registrant&rsquo;s internal control over financial reporting.




    
The registrant&rsquo;s other certifying officer and I have disclosed
 based on our most recent evaluation of internal control over financial reporting
 to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):




    
    
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record
 process
 summarize and report financial information; and
    

    
    
    
    

    
    
    
Any fraud
 whether or not material
 that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.

    
    
    
    
    
    
    




Date: June 27
 2014&nbsp;
    

    
    

    
    

    
    



    














     








 Alfred J. Small
 certify that:



    
    
    




    
    
Based on my knowledge
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;




    
    
Based on my knowledge
 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;




    
    
    




    
    
Designed such disclosure controls and procedures
 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly during the period in which this report is being prepared;




    
    
Designed such internal control over financial reporting
 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;




    
    
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures
 as of the end of the period covered by this report based on such evaluation; and




    
    
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected
 or is reasonably likely to materially affect
 the registrant&rsquo;s internal control over financial reporting.




    
    
The registrant&rsquo;s other certifying officer and I have disclosed
 based on our most recent evaluation of internal control over financial reporting
 to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):




    
    
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record
 process
 summarize and report financial information; and
    

    
    
    
    

    
    
    
Any fraud
 whether or not material
 that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.

    
    
    
    
    
    
    




Date: June 27
 2014&nbsp;
    

    
    

    
    

    
    



    














     






18 U.S.C. SECTION 1350


SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002


 as adopted
pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002
 Richard J. Lampen
 the President and Chief Executive Officer of
Castle Brands Inc. (the &ldquo;Registrant&rdquo;) and Alfred J. Small
 Chief Financial Officer of the Registrant
 each hereby certifies
that:


on Form 10-K for the period ended March 31
 2014 (the &ldquo;Periodic Report&rdquo;) fully complies with the requirements of Section
13(a) or Section 15(d) of the Securities Exchange Act of 1934
 as amended; and


Report fairly presents
 in all material respects
 the financial condition and results of operations of the Registrant.


 2014



    
    
    

    
    
    

    
    
    

    
    
    




    





















      


      




      


      




      


      
      




      


      
      




      


      
      




      


      




      


      




      


      
      




      


      




      


      





      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      

        



      




      

        



      




      

        
        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        
        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        
        



      
      




      

        
        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      




      

        



      




      

        
        



      




      

        



      




      

        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      



    


    




        


        




    




        


        




    



 its wholly-owned domestic subsidiaries
 Castle Brands (USA) Corp. (&amp;#8220;CB-USA&amp;#8221;) and McLain &amp;amp; Kyne
 Ltd. (&amp;#8220;McLain &amp;amp; Kyne&amp;#8221;)
 the Company&amp;#8217;s wholly-owned foreign subsidiaries
 Castle Brands Spirits Group Limited (&amp;#8220;CB-IRL&amp;#8221;) and Castle Brands Spirits Marketing and Sales Company Limited
 and the Company&amp;#8217;s 60 % ownership interest in Gosling-Castle Partners
 Inc. (&amp;#8220;GCP&amp;#8221;)

 marketing and sale of premium and super premium brands of rums
 whiskey
 liqueurs
 vodka and tequila in the United States
 Canada

 a family of premium rums with a 200-year history
 including the award-winning Gosling&amp;#8217;s Black Seal rum
 for which the Company is
 through its export venture GCP
 the exclusive marketer outside of Bermuda
 and Gosling&amp;#8217;s Stormy Ginger Beer

 Jefferson&amp;#8217;s Reserve and Jefferson&amp;#8217;s Presidential Select
 Jefferson&amp;#8217;s Rye
 an aged rye whiskey; the Clontarf Irish whiskeys
 a family of premium Irish whiskeys
 available in single malt and classic pure grain versions; Knappogue Castle Whiskey
 a vintage-dated premium single-malt Irish whiskey; and Knappogue Castle 1951

 a premium Irish cream liqueur; Castello Mio
 a super premium Sambuca
 Celtic Honey
 a premium Irish liqueur; pursuant to an exclusive U.S. marketing arrangement
 Pallini Limoncello
 Raspicello and Peachcello premium Italian liqueurs; and pursuant to a U.S. distribution agreement
 Gozio amaretto

 an ultra-pure

 super-premium tequila
 Tequila Tierras Autenticas de Jalisco or Tierras. The Company is the exclusive U.S. importer and marketer of Tierras
 which is available as blanco



 title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination)

 bulk wine
 dry good raw materials (bottles
 labels
 corks and caps)
 packaging and finished goods
 and are valued at the lower of cost or market
 using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company&amp;#8217;s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including
 but not limited to
 historical usage

 2014 and 2013
 the Company recorded allowances for obsolete and slow moving inventory of $200
000 and $684
830
 respectively. The Company recorded these allowances on both raw materials and finished goods
 primarily in connection with the disposition of wine brands
 label and packaging changes made to certain brands

 computers and software and furniture and fixtures. When assets are retired or otherwise disposed of
 the cost and related depreciation is removed from the accounts

 but instead are tested for impairment annually
 or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives
 generally on a straight-line basis
 and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal&gt; Under Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 350
 &amp;#8220;Intangibles - Goodwill and Other&amp;#8221;
 impairment of goodwill must be tested at least annually by comparing the fair values of the applicable reporting units with the carrying amount of their net assets
 including goodwill. The required two-step approach uses accounting judgments and estimates of future operating results. Changes in estimates or the application of alternative assumptions could produce significantly different results. The estimates that most significantly affect the fair value calculation are related to revenue growth
 cost of sales
 selling and marketing expenses and discount rates. Impairment testing is done at the reporting level. If the carrying amount of the reporting unit&amp;#8217;s net assets exceeds the unit&amp;#8217;s fair value
 an impairment loss is recognized in an amount equal to the excess of the carrying amount of goodwill over its implied fair value. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination with the fair value of the reporting unit deemed to be the purchase price paid. Rights
 trademarks

 2014 and 2013 by weighting a combination of the present value of the Company&amp;#8217;s discounted anticipated future operating cash flows and values based on market multiples of revenue and earnings before interest
 taxes
 depreciation and amortization (&amp;#8220;EBITDA&amp;#8221;) of comparable companies. Other than the write-downs of intangible and goodwill related to the wine brands discussed in Note 7
 the Company did not record any impairment on goodwill or other intangible assets for the years ended March 31

 &amp;#8220;Accounting for the Impairment or Disposal of Long-lived Assets&amp;#8221;
 the Company periodically reviews whether changes have occurred that would require revisions to the carrying amounts of its definite lived
 long-lived assets. When the sum of the expected future cash flows is less than the carrying amount of the asset
 an impairment loss is recognized based on the fair value of the asset. The Company did not record an impairment on long-lived assets for the years ended March 31
 2014 and 2013.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&lt;font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman, Times, Serif&gt; In March 2013
 the Company determined to reduce its sales and marketing efforts on its wine brands
 which do not provide a material contribution to the Company&amp;#8217;s results of operations. The Company made this decision to optimize its resources and focus on its faster growing and more profitable spirits brands
 and to reduce the levels of working capital required to maintain necessary inventory levels of bulk wine and finished goods. The Company intends to continue selling existing finished goods wine inventory through its current sales channels
 but is actively seeking buyers for large lots and for its bulk wine. In connection with this decision
 the Company recognized a loss of $1
715
728
 consisting of $817
156 on the write-down of net intangible assets and $898
572 in goodwill
 as well as $326
869 charged to the provision for obsolete inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the year ended March 31

 including the shipment of point of sale materials to the Company&amp;#8217;s regional sales managers and customers
 and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $1
879
881 and $1
171
290 for the years ended March 31
 2014 and 2013


 including product depletions
 product samples for various promotional purposes
 in-store tastings and training where legal
 and local advertising where legal. Such charges are reflected as selling expense as incurred. Also
 the Company has entered into arrangements with certain of its distributors whereby the purchase of a particular product or products by a distributor is accompanied by a percentage of the sale being composed of promotional goods or as a predetermined discount percentage of dollars off invoice. In such cases

 &amp;#8220;Foreign Currency Matters&amp;#8221;

 &amp;#8220;Financial Instruments&amp;#8221;
 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company&amp;#8217;s balance sheets due to the short term maturity of these instruments
 or with respect to the Company&amp;#8217;s debt



 &amp;#8220;Income Taxes&amp;#8221;

 no such provisions for accrued interest and penalties related to uncertain tax positions have been recorded as of March 31


 which is included in selling expense
 was $2
052
819 and $2
212
774 for the years ended March 31
 2014 and 2013

 and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment tests
 derivative instruments and equity issuances
 warrant valuation
 stock-based compensation
 allowances for doubtful accounts and inventory obsolescence
 depreciation
 amortization and expense accruals.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&lt;font style=FONT-SIZE: 10pt&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=VERTICAL-ALIGN: top&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&lt;font style=FONT-SIZE: 10pt&gt;U.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&lt;font style=FONT-SIZE: 10pt&gt;&lt;u&gt;Uncertainties&lt;/u&gt; &amp;#151; The Company depends on a limited number of third-party suppliers for the sourcing of all of its products
 including both its own proprietary brands and those it distributes for others. The Company does not have long-term written agreements with all of its suppliers. Also
 if the Company fails to complete purchases of products ordered annually
 certain suppliers have the right to bill it for product not purchased during the period. Suppliers&amp;#8217; failure to perform satisfactorily or handle increased orders
 delays in shipments of products from international suppliers or the loss of existing suppliers
 especially key suppliers
 could have material adverse effects on the Company&amp;#8217;s operating results. The inability to maintain

 2014
 the FASB issued final guidance to change the criteria for reporting discontinued operations while enhancing disclosures in this area (Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2014-08). Under the new guidance
 only disposals representing a strategic shift
 such as a major line of business
 a major geographical area or a major equity investment
 should be presented as discontinued operations. The guidance will be applied prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The guidance is effective for annual financial statements with fiscal years beginning on or after December 15
 2014 with early adoption permitted for disposals or classifications as held for sale which have not been reported in financial statements previously issued or available for issuance. The Company will adopt the guidance effective April 1
 2015 and the adoption of this guidance is not expected to have a material impact on the Company&amp;#8217;s results of operations

 2014
 the Emerging Issues Task Force (the &amp;#8220;Task Force&amp;#8221;) reached a final consensus to amend the accounting guidance for stock compensation tied to performance targets (Issue No. 13-D). The objective of this guidance is to clarify the accounting treatment of certain types of performance conditions in stock-based compensation awards
 more specifically
 when performance targets can be achieved after the requisite service period. The Task Force concluded that performance criteria subsequent to a service period vesting requirement should be treated as vesting conditions
 and as a result
 this type of performance condition may delay expense recognition until achievement of the performance target is probable. Issue No. 13-D will be effective for all entities for reporting periods (including interim periods) beginning after December 15
 2015
 and early adoption is permitted. The adoption of this guidance is not expected have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2012-02
 &amp;#8220;Intangibles&amp;#151;Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.&amp;#8221; The amended guidance simplifies how entities test indefinite-lived intangible assets other than goodwill for impairment.&amp;#160;After an assessment of certain qualitative factors
 if it is determined to be more likely than not that an indefinite-lived asset is impaired
 entities must perform the quantitative impairment test. &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Otherwise
 the quantitative test is optional. &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2012-04
 &amp;#8220;Technical Corrections and Improvements.&amp;#8221; The amendments in this update cover a wide range of topics in the ASC. These amendments include technical corrections and improvements to the ASC and conforming amendments related to fair value measurements. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2013-01
 &amp;#8220;Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities&amp;#8221;. This update is intended to improve the comparability of statements of financial position prepared in accordance with U.S. GAAP and International Financial Reporting Standards
 requiring both gross and net presentation of offsetting assets and liabilities. The new requirements are effective for fiscal years beginning on or after January 1
 2013
 and for interim periods within those fiscal years. As this guidance only affects disclosures
 the adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued amendments to the accounting guidance for presentation of comprehensive income to improve the reporting of reclassifications out of accumulated other comprehensive income. The amendments do not change the current requirements for reporting net income or other comprehensive income
 but do require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition
 an entity is required to present
 either on the face of the statement where the net income is presented or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income
 an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about these amounts. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2013-11
 &amp;#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force)&amp;#8221; (&amp;#8220;ASU 2013-11&amp;#8221;)
 which requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward
 or similar tax loss or tax credit carryforward
 rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 does not require new recurring disclosures. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations


 2014 and 2013


174

120

777

874

879

361

312

874



502

191

147

540

650

731

 2014 and 2013

 respectively

 respectively

 the Company acquired $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
496
000&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;780
000&lt;/font&gt; of bulk bourbon whiskey
 respectively

 but not limited to
 historical usage



 CB-USA formed DP Castle Partners
 LLC (&amp;#8220;DPCP&amp;#8221;) with Drink Pie
 LLC to manage the manufacturing and marketing of Travis Hasse&amp;#8217;s Original Apple Pie Liqueur
 Cherry Pie Liqueur and any future line extensions of the brand. DPCP paid a per case royalty fee to Drink Pie
 LLC under a licensing agreement. CB-USA purchased the finished product from DPCP FOB &amp;#150; Production and CB-USA bore the risk of loss on both inventory and third-party receivables. Revenues and cost of sales were recorded at their respective gross amounts on the books and records of CB-USA. For the years ended March 31
 2014 and 2013
 CB-USA purchased $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;170
880&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;867
280&lt;/font&gt;
 respectively
 in finished goods from DPCP under the distribution agreement. As of&amp;#160;March 31
 2013
 DPCP was indebted to CB-USA in the amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;268
598&lt;/font&gt;
 which is included in due to shareholders and affiliates on the accompanying condensed consolidated balance sheet. At March 31
 2014
 CB-USA owned &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;20&lt;/font&gt; % of now inactive&amp;#160;DPCP. CB-USA also earned a defined rate of interest on its capital contribution to DPCP
 based on its ownership in DPCP. For the years ended March 31
 2014 and 2013
 CB-USA earned $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;4
200&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;8
400&lt;/font&gt;
 respectively
 in interest income on its capital contribution to DPCP. The Company&amp;#160;accounted for this investment under the equity method of accounting. The investment balance was $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;116
700&lt;/font&gt; at&amp;#160;March 31
 2013. In December 2013
 CB-USA determined to cease marketing and selling these brands and returned the remaining inventory to Drink Pie
 LLC. In connection with the discontinuation of marketing and sales efforts
 the Company recognized a loss of $502
518 from its investment in DPCP
 including a $120
900 loss on investment and write offs of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;399


 2006
 the Company acquired all of the outstanding capital stock of McLain &amp;amp; Kyne. The Company was required to pay contingent consideration based on the case sales of Jefferson&amp;#8217;s Presidential Select bourbon for a specified amount of cases. As of June 30
 2013
 the Company had reached the specified case sale threshold for contingent consideration under the agreement. Accordingly
 no further contingent consideration will be due. For the years ended March 31
 2014 and 2013
 the sellers earned $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5
940&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;145
800&lt;/font&gt;
 respectively


 the Company determined to reduce its sales and marketing efforts on its wine brands
 which do not provide a material contribution to the Company&amp;#8217;s results of operations. The Company made this decision to optimize its resources and focus on its faster growing and more profitable spirits brands
 and to reduce the levels of working capital required to maintain necessary inventory levels of bulk wine and finished goods. The Company intends to continue selling existing finished goods wine inventory through its current sales channels
 but is actively seeking buyers for large lots and for its bulk wine. In connection with this decision
 the Company recognized a loss of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
715
728&lt;/font&gt;
 consisting of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;817
156&lt;/font&gt; on the write-down of net intangible assets and $898
572 in goodwill
 as well as $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;326
869&lt;/font&gt; charged to the provision for obsolete inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the year ended March 31



243













271

271







123

096

058

404

065

692

112

112

178

805






961

409





058

404

 2014 and 2013 totaled $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;654
005&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;732
783&lt;/font&gt;







143


 2014 and 2013
 the Company had&amp;#160;&amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;302
920&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;416
565&lt;/font&gt; (translated at the March 31
 2014 exchange rate) and&amp;#160;&amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;352
255&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;451
346&lt;/font&gt; (translated at the March 31
 2013 exchange rate)
 respectively
 of cash restricted from withdrawal and held by a bank in Ireland as collateral for overdraft coverage
 creditors&amp;#8217; insurance







953

501

015

496

250

125

574

298

714&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;416
280&lt;/font&gt; (translated at the March 31
 2014 exchange rate) with an Irish bank
 including overdraft coverage
 creditors&amp;#8217; insurance
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable on demand
 continue until terminated by either party
 are subject to annual review

693&lt;/font&gt;
 or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;20
205&lt;/font&gt; (translated at the March 31
 2014 exchange rate)
 and &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;69
761&lt;/font&gt;
 or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;89
407&lt;/font&gt;
 (translated at the March 31
 2013 exchange rate)
 at March 31
 2014 and 2013

 GCP issued a promissory note (the &amp;#8220;GCP Note&amp;#8221;) in the aggregate principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;211
580&lt;/font&gt; to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1
 2020
 is payable at maturity
 subject to certain acceleration events
 and calls for annual interest of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5&lt;/font&gt;%
 to be accrued and paid at maturity. At March 31
 2014 and 2013

579&lt;/font&gt;&lt;/font&gt; of accrued interest was converted to amounts due to affiliates. At March 31
 2014 and 2013


 the Company and CB-USA entered into the Keltic Facility (&amp;#8220;Keltic Facility&amp;#8221;)
 a revolving loan agreement with Keltic Financial Partners II
 LP (Keltic)
 providing for availability (subject to certain terms and conditions) of a facility of up to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5
000
000&lt;/font&gt; for the purpose of providing the Company and CB-USA with working capital. In July 2012
 the Keltic Facility was amended to increase availability to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;7
000
000&lt;/font&gt;
 among other changes. In March 2013
 the Keltic Facility was amended to increase availability to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;8
000
000&lt;/font&gt;
 among other changes. In August 2013
 the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below)
 subject to certain conditions set forth in the amendment
 to modify&amp;#160;certain aspects of the EBITDA covenant contained in the loan agreement
 permit the Company to incur indebtedness in an aggregate original principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
125
000&lt;/font&gt; pursuant to the terms of the Note Purchase Agreement and Convertible Notes (as each term is defined below in Note 9F)
 and permit&amp;#160;the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Convertible Notes
 subject to certain conditions set forth in the amendment. In November 2013
 the Keltic Facility was further amended
 to
 among other things

 2016. The Borrower may borrow up to the maximum amount of the Keltic Facility
 provided that the Borrower has a sufficient borrowing base (as defined under the loan agreement). The Keltic Facility &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 3.25%
 (b) the LIBOR Rate plus 5.75% and (c) 6.50%&lt;/font&gt;. For the year ended March 31
 2014
 the Company paid interest at &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 6.5&lt;/font&gt;%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement)

000&lt;/font&gt; commitment fee in connection with the first amendment
&amp;#160;a $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;70
000&lt;/font&gt; closing and commitment fee in connection with the second amendment&amp;#160;and a $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;25
000&lt;/font&gt; closing and commitment fee in connection with the third amendment. Keltic also receives an &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;annual facility fee in an amount equal to 1% per annum of the maximum revolving facility amount and a collateral management fee of $1
000 per month (increased to $2
000 after the occurrence of and during the continuance of an Event of Default)&lt;/font&gt;. The loan agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan agreement includes negative covenants that
 among other things
 restrict the Borrower&amp;#8217;s ability to create additional indebtedness
 dispose of properties
 incur liens and make distributions or cash dividends. At March 31
 2014
 the Company was in compliance
 in all material respects
 with the covenants under the Keltic Facility. At March 31
 2014 and 2013
 $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
953
037&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;6
501
321&lt;/font&gt;
 respectively

 the Company and CB-USA entered into an inventory term loan of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
496
000&lt;/font&gt; (the Bourbon Term Loan) that was used to purchase&amp;#160;bourbon inventory on March 11
 2013. Unless sooner terminated in accordance with its terms
 the Bourbon Term Loan matures on December 31
 2016. &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;The Bourbon Term Loan interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 4.25%
 (b) the LIBOR Rate plus 6.75% and (c) 7.50%&lt;/font&gt;. For the year ended March 31
 2014
 the Company paid interest of 7.5%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement)
 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31

000&lt;/font&gt; of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan

000&lt;/font&gt;&lt;/font&gt;)
 an entity affiliated with Phillip Frost
 M.D.
 a director and principal shareholder of the Company
 Mark E. Andrews

000&lt;/font&gt;&lt;/font&gt;)
 a director of the Company and the Company&amp;#8217;s Chairman

000&lt;/font&gt;&lt;/font&gt;)
 a director of the Company and the Company&amp;#8217;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement
 the junior participants receive interest at the rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 11&lt;/font&gt;% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However
 the Borrower is party to a fee letter (the Fee Letter) with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;45
000&lt;/font&gt; in three equal annual installments of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;15
000&lt;/font&gt;. In August 2013
 the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
500
000&lt;/font&gt; to up to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;4
000
000&lt;/font&gt; to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
015
000&lt;/font&gt; and $2
496
000 at March 31
 2014 and 2013

 the Company entered into a Loan Agreement (the Junior Loan Agreement)
 by and between the Company and the lending parties thereto (the Junior Lenders)
 which provides for an aggregate $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
250
000&lt;/font&gt; unsecured loan (the Junior Loan) to the Company. The Junior Loan bears interest at a rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;11&lt;/font&gt; % per annum
 payable quarterly in arrears commencing November 1
 2013
 and matures on October 15
 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default
 which
 if uncured
 entitle each Junior Lender to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2&lt;/font&gt;% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year)
 payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 Mark E. Andrews
 III ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;50
000&lt;/font&gt;) and an affiliate of Richard J. Lampen ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;50
000&lt;/font&gt;). In connection with the Junior Loan Agreement
 the Junior Lenders entered into a subordination agreement with Keltic; the Company is not a party to the subordination agreement. At March 31
 2014
 $1
250

 the Company entered into a &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5&lt;/font&gt;% Convertible Subordinated Note Purchase Agreement (the Note Purchase Agreement)
 by and among the Company and the purchasers party thereto
&amp;#160;which provided for the issuance of an aggregate initial principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
125
000&lt;/font&gt; unsecured subordinated notes (the Convertible Notes) by the Company. The Convertible Notes bear interest at a rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5&lt;/font&gt;% per annum
 payable quarterly beginning on December 15
 2013 until their maturity date of December 15
 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&amp;#8217;s common stock at a conversion price of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;0.90&lt;/font&gt; per share (the Conversion Price). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium
 but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default
 which
 if uncured
 entitle each note holder to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on

 including an affiliate of Dr. Phillip Frost ($500
000)
 Mark E. Andrews
 III ($50
000)
 an affiliate of Richard J. Lampen ($50
000)
 an affiliate of Glenn Halpryn ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 a director of the Company
 Dennis Scholl ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;100
000&lt;/font&gt;)
 a director of the Company
 and Vector Group Ltd. ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 a more than 5% shareholder of the Company
 of which Richard Lampen is an executive officer and Henry Beinstein
 a director of the Company


 each&amp;#160; purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement
 by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement. At March 31
 2014
 $2
125



250

968

125


574


 the Company entered into an Equity Distribution Agreement (the Distribution Agreement) with Barrington Research Associates
 Inc. (Barrington)
 as sales agent
 under which the Company may issue and sell over time and from time to time
 to or through Barrington

 may be effected by any method permitted by law deemed to be an at-the-market offering as defined in Rule 415 of the Securities Act of 1933
 as amended
 including without limitation directly on the NYSE MKT LLC or any other existing trading market for the common stock or through a market maker
 up to the amount specified
 and otherwise to or through Barrington in accordance with the placement notices delivered by the Company to Barrington. Also
 with the prior consent of the Company
 some or all of the&amp;#160;Shares may be sold in privately negotiated transactions. Under the Distribution Agreement
 Barrington will be entitled to compensation of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 2.0&lt;/font&gt; % of the gross proceeds from the sale of all of the Shares sold through Barrington
 as sales agent
 pursuant to the Distribution Agreement. &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;Also
 the Company will reimburse Barrington for certain expenses incurred in connection with the matters contemplated by the Distribution Agreement
 up to an aggregate of $50
000
 plus up to an additional $7
500 per calendar quarter related to ongoing maintenance; provided
 however

 2014
 the Company sold &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5
394
608&lt;/font&gt; Shares pursuant to the Distribution Agreement
 with total gross proceeds of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;4
531
643&lt;/font&gt;
 before deducting sales agent and offering expenses of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;184

100
000&lt;/font&gt; of newly-designated &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 10&lt;/font&gt;% Series A Convertible Preferred Stock
 par value $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;0.01&lt;/font&gt; per share (&amp;#8220;Series A Preferred Stock&amp;#8221;). As part of the June 2011 Private Placement
 the Company completed a private offering&amp;#160;to third-party&amp;#160;investors of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
155
000&lt;/font&gt; of Series A Preferred Stock for its stated value of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
000&lt;/font&gt; per share and &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;warrants (&amp;#8220;2011 Warrants&amp;#8221;) to purchase 50% of the number of shares of the Company&amp;#8217;s common stock
 issuable upon conversion of such Series A Preferred Stock.&lt;/font&gt; Subject to adjustment (including dilutive issuances)

 whether or not declared by the Company&amp;#8217;s Board of Directors
 which were only payable in shares of the Company&amp;#8217;s common stock upon conversion of the Series A Preferred Stock or upon a liquidation.&amp;#160;For the years ended March 31
 2014 and 2013
 the Company recorded accrued dividends of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;384
599&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;744
468&lt;/font&gt;
 respectively

 or otherwise dispose of or issue (or announce any sale
 grant or option to purchase or other disposition)
 any common stock or common stock equivalents entitling any person to acquire common stock at an effective price per share that was lower than the then conversion price of the Series A Preferred Stock

000 per trading day and the Volume Weighted Average Price (as defined in the articles of designation of the Series A Preferred Stock) for at least 20 trading days during any 30 consecutive trading day period exceeded $0.76 (subject to adjustment)
 the Company could convert all or any portion of the outstanding Series A Preferred Stock into shares of common stock.&lt;/font&gt; The Company&amp;#8217;s common stock exceeded these thresholds
 and on February 11
 2014
 the Company&amp;#8217;s Board of Directors approved the mandatory conversion of all outstanding shares of the Series A Preferred Stock pursuant to their terms
 effective on or about February 24
 2014.&amp;#160;Pursuant to the mandatory conversion
 all &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 6
271&lt;/font&gt; outstanding shares of Series A Preferred Stock
 and accrued dividends thereon
 converted into &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 25
760

 2014 mandatory conversion
 holders of Series A Preferred Stock converted &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 430&lt;/font&gt; shares of Series A Preferred Stock
 and accrued dividends thereon
 into &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 1
704

 2013
 holders of Series A Preferred Stock converted &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 195.132&lt;/font&gt; shares of Series A Preferred Stock
 and accrued dividends thereon
&amp;#160;into &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 720

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  


  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

 and reflects any net gains and losses currently in earnings. At March 31
 2014 and 2013
 the Company had no forward contracts outstanding. Gain or loss on foreign currency forward contracts
 which was de minimis during the periods presented


 the Company implemented the 2003 Stock Incentive Plan (the &amp;#8220;2003 Plan&amp;#8221;)
 which provides for awards of incentive and non-qualified stock options
 restricted stock and stock appreciation rights for its officers
 employees
 consultants and directors to attract and retain such individuals. Stock option grants under the Plan are granted with an exercise price at or above the fair market value of the underlying common stock at the date of grant

 there were 2
000
000 shares of common stock reserved and available for distribution under the Plan. In January&amp;#160;2009
 the Company&amp;#8217;s shareholders approved an amendment to the Plan to increase the number of shares available under the Plan from &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 2
000
000&lt;/font&gt; to &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 12
000
000&lt;/font&gt; and to establish the maximum number of shares issuable to any one individual in any particular year. As of August 2013

 the Company&amp;#8217;s shareholders approved the 2013 Incentive Compensation Plan (&amp;#8220;2013 plan&amp;#8221;) which provides for awards of incentive and non-qualified stock options
 restricted stock and stock appreciation rights for its officers
 employees
 consultants and directors to attract and retain such individuals. As of March 31
 2014
 &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 280
000&lt;/font&gt;&amp;#160;shares&amp;#160;had been issued under the 2013 Plan
 with &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 9
720

 2014 and 2013 amounted to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;393
914&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;282
314&lt;/font&gt;
 respectively
 of which $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;81
567&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;51
075&lt;/font&gt;
 respectively
 is included in selling expense and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;312
347&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;231
239&lt;/font&gt;
 respectively
 is included in general and administrative expense for the years ended March 31
 2014 and 2013
 respectively. At March 31
 2014
 total unrecognized compensation cost amounted to approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;947
916&lt;/font&gt;
 representing &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5
662
560&lt;/font&gt; unvested options. This cost is expected to be recognized over a weighted-average period of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 2.18&lt;/font&gt;&amp;#160;years. There were 80
758 options exercised during the year ended March 31
 2014 and no options exercised during the year ended March 31
 2013. The Company did not recognize any related tax benefit for the years ended March 31
 2014 and 2013


120

330

300

800




174

120

511

248





975

592

992












174

511

601

 2014 were 5
511



593

800


513


871

300


499


662

 risk-free interest rate
 expected dividends
 and expected term. Expected volatility is based on the Company&amp;#8217;s historical volatility and the volatility of a peer group of companies over the expected life of the option. The expected term and vesting of the options represents the estimated period of time until exercise. The expected term was determined using the simplified method available under current guidance. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The Company has not paid dividends on its common stock in the past and does not plan to pay any dividends on its common stock in the near future. Current authoritative guidance also requires the Company to estimate forfeitures at the time of grant and revise these estimates
 if necessary


 subject to adjustment

022&lt;/font&gt; and accounted for the 2011 Warrants issued in October 2011 as a liability&amp;#160;at their initial fair value of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;780
972&lt;/font&gt;. Changes in the fair value of the 2011 Warrants were recognized in earnings for each subsequent reporting period.&lt;/font&gt; &lt;font style=FONT-FAMILY:Times New Roman, Times, Serif&gt;In November 2013
 in accordance with certain terms of the 2011 Warrants
 the down-round provisions included in the terms of the warrant ceased to be in force or effect as a result of the historical volume weighted average price and trading volume of the Company&amp;#8217;s common stock. The Company then reclassed the fair value of the outstanding warrant liability of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;6
187
968&lt;/font&gt; to equity
 resulting in an increase to additional paid-in capital. Further

 2013
 the fair value of the 2011 Warrants was included in the balance sheet under the caption Warrant liability&amp;#160;of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;795
374&lt;/font&gt;. For the year ended March 31
 2014 the Company recorded a loss&amp;#160;on the change in the value of the 2011 Warrants of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5
392
594&lt;/font&gt;; for the year ended March 31
 2013
 the Company recorded a gain for the change in the value of the 2011 Warrants of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;302


 2014
 holders of 2011 Warrants exercised 10
127
123 2011 Warrants and received shares of common stock. The Company received $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;3
848


 2014
 1
543

 March 31

448

543

 March 31

904

127

 March 31

777


 which provides for the production of blended Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least six years prior notice to the Company
 except for breach. Under this agreement
 the Company provides IDL with a forecast of the estimated amount of liters of pure alcohol it requires for the next four fiscal contract years and agrees to purchase &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 90&lt;/font&gt;% of that amount
 subject to certain annual adjustments. For the contract year ending &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;June 30
 2014&lt;/font&gt;
 the Company has contracted to purchase approximately &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;704
900&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;969
351&lt;/font&gt;&amp;#160;(translated at the March 31
 2014 exchange rate) in bulk Irish whiskey
 of which &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;662
351&lt;/font&gt;
&amp;#160;or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;910
838&lt;/font&gt;
&amp;#160;has been purchased as of March 31
 2014. The Company is not obligated to pay IDL for any product not yet received. During the term of this supply agreement

 which provides for the production of single malt Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least thirteen years prior notice to the Company
 except for breach. Under this agreement
 the Company provides IDL with a forecast of the estimated amount of liters of pure alcohol it requires for the next twelve fiscal contract years and agrees to purchase &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 80&lt;/font&gt;% of that amount
 subject to certain annual adjustments. For the contract year ending &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;June 30
 2014&lt;/font&gt;
 the Company has contracted to purchase approximately &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;245
103&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;337
056&lt;/font&gt;&amp;#160;(translated at the March 31
 2014 exchange rate) in bulk Irish whiskey
 of which &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;172
700&lt;/font&gt;
 or&amp;#160;$&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;237
491&lt;/font&gt;
&amp;#160;has been purchased as of March 31
 2014. The Company is not obligated to pay IDL for any product not yet received. During the term of this supply agreement

 Ltd.
 an international supplier
 to be the sole-producer of Celtic Honey
 one of the Company&amp;#8217;s products

 NY
 Dublin
 Ireland and Houston
 TX. The New York
 NY lease began on May 1
 2010 and expires on &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;April 30
 2016&lt;/font&gt; and provides for monthly payments of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;19
975&lt;/font&gt;. The Dublin lease commenced on March 1
 2009 and extends through &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;October 31
 2016&lt;/font&gt; and provides for monthly payments of&amp;#160;&amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
100&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
513&lt;/font&gt; (translated at the March 31
 2014 exchange rate). The Houston
 TX lease commenced on February 24
 2000 and extends through &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; January 31
 2015&lt;/font&gt; and provides for monthly payments of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1






 the Company is obligated to pay its pro-rata share of utility and maintenance expenses on the leased premises. Rent expense under operating leases amounted to approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;356
280&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;325
082&lt;/font&gt; for the years ended March 31
 2014 and 2013
 respectively

 the Company was obligated to pay an earn-out to the sellers based on the financial performance of the acquired business. As of June 30
 2013
 the Company had reached the specified case sale threshold for contingent consideration under the agreement. Accordingly
 no further contingent consideration will be due. For the years ended March 31
 2014 and 2013
 the sellers earned $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5
940&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;145
800&lt;/font&gt;
 respectively

 in August 2011
 the Company and CB-USA entered into the Keltic Facility
 as amended in July 2012
 March 2013


 at times
 may exceed federally and internationally insured limits. The Company exceeded the limits in effect at March 31
 2014 by approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;725
000&lt;/font&gt; and exceeded the limits in effect by approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;300
000&lt;/font&gt; at March 31

 the Southern Wine and Spirits of America
 Inc. family of companies

 2014 and 2013
 respectively

 2014 and 2013


 liqueur
 whiskey
 vodka

 consolidated results from operations
 consolidated net loss attributable to common shareholders


305

444

834

998

140

442


319

375

319

402



753

302

906

448




643

324

521

421

992

803

852

565





626

396

140

442


201

941

320

175

521

117


 2014 and June 25
 2014
 the Company sold an additional&amp;#160;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 1
172
799&lt;/font&gt; Shares pursuant to the Distribution Agreement
 with total gross proceeds of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
169
735&lt;/font&gt;
 before deducting sales agent and offering expenses of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;37

 2014
 the Company called for cancellation all &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 1
657
802&lt;/font&gt; unexercised 2011 Warrants pursuant to the terms of such 2011 Warrants after satisfying applicable conditions. Holders of the Warrants had until 6:30 p.m. New York City time on April 21
 2014 to exercise such Warrants at $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;0.38&lt;/font&gt; per share in cash. Pursuant to the call for cancellation
 holders of all &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 1
657
802&lt;/font&gt; unexercised 2011 Warrants exercised and received &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 1
657
802&lt;/font&gt; shares of common stock. The Company received $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;629




 but instead are tested for impairment annually
 or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives
 generally on a straight-line basis

 &amp;#8220;Intangibles - Goodwill and Other&amp;#8221;
 impairment of goodwill must be tested at least annually by comparing the fair values of the applicable reporting units with the carrying amount of their net assets
 including goodwill. The required two-step approach uses accounting judgments and estimates of future operating results. Changes in estimates or the application of alternative assumptions could produce significantly different results. The estimates that most significantly affect the fair value calculation are related to revenue growth
 cost of sales
 selling and marketing expenses and discount rates. Impairment testing is done at the reporting level. If the carrying amount of the reporting unit&amp;#8217;s net assets exceeds the unit&amp;#8217;s fair value
 an impairment loss is recognized in an amount equal to the excess of the carrying amount of goodwill over its implied fair value. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination with the fair value of the reporting unit deemed to be the purchase price paid. Rights
 trademarks

 2014 and 2013 by weighting a combination of the present value of the Company&amp;#8217;s discounted anticipated future operating cash flows and values based on market multiples of revenue and earnings before interest
 taxes
 depreciation and amortization (&amp;#8220;EBITDA&amp;#8221;) of comparable companies. Other than the write-downs of intangible and goodwill related to the wine brands discussed in Note 7
 the Company did not record any impairment on goodwill or other intangible assets for the years ended March 31


 &amp;#8220;Accounting for the Impairment or Disposal of Long-lived Assets&amp;#8221;
 the Company periodically reviews whether changes have occurred that would require revisions to the carrying amounts of its definite lived
 long-lived assets. When the sum of the expected future cash flows is less than the carrying amount of the asset
 an impairment loss is recognized based on the fair value of the asset. The Company did not record an impairment on long-lived assets for the years ended March 31

 the Company determined to reduce its sales and marketing efforts on its wine brands
 which do not provide a material contribution to the Company&amp;#8217;s results of operations. The Company made this decision to optimize its resources and focus on its faster growing and more profitable spirits brands
 and to reduce the levels of working capital required to maintain necessary inventory levels of bulk wine and finished goods. The Company intends to continue selling existing finished goods wine inventory through its current sales channels
 but is actively seeking buyers for large lots and for its bulk wine. In connection with this decision
 the Company recognized a loss of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
715
728&lt;/font&gt;
 consisting of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;817
156&lt;/font&gt; on the write-down of net intangible assets and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;898
572&lt;/font&gt; in goodwill
 as well as $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;326
869&lt;/font&gt; charged to the provision for obsolete inventory to adjust both bulk wine and finished goods to estimated net realizable value
 for the year ended March 31




 &amp;#8220;Foreign Currency Matters&amp;#8221;


 &amp;#8220;Financial Instruments&amp;#8221;
 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company&amp;#8217;s balance sheets due to the short term maturity of these instruments
 or with respect to the Company&amp;#8217;s debt




 &amp;#8220;Income Taxes&amp;#8221;

 no such provisions for accrued interest and penalties related to uncertain tax positions have been recorded as of March 31


 the FASB issued ASU 2012-02
 &amp;#8220;Intangibles&amp;#151;Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.&amp;#8221; The amended guidance simplifies how entities test indefinite-lived intangible assets other than goodwill for impairment.&amp;#160;After an assessment of certain qualitative factors
 if it is determined to be more likely than not that an indefinite-lived asset is impaired
 entities must perform the quantitative impairment test. &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Otherwise
 the quantitative test is optional. &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2012-04
 &amp;#8220;Technical Corrections and Improvements.&amp;#8221; The amendments in this update cover a wide range of topics in the ASC. These amendments include technical corrections and improvements to the ASC and conforming amendments related to fair value measurements. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2013-01
 &amp;#8220;Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities&amp;#8221;. This update is intended to improve the comparability of statements of financial position prepared in accordance with U.S. GAAP and International Financial Reporting Standards
 requiring both gross and net presentation of offsetting assets and liabilities. The new requirements are effective for fiscal years beginning on or after January 1
 2013
 and for interim periods within those fiscal years. As this guidance only affects disclosures
 the adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued amendments to the accounting guidance for presentation of comprehensive income to improve the reporting of reclassifications out of accumulated other comprehensive income. The amendments do not change the current requirements for reporting net income or other comprehensive income
 but do require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition
 an entity is required to present
 either on the face of the statement where the net income is presented or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income
 an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about these amounts. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations

 the FASB issued ASU 2013-11
 &amp;#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force)&amp;#8221; (&amp;#8220;ASU 2013-11&amp;#8221;)
 which requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward
 or similar tax loss or tax credit carryforward
 rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 does not require new recurring disclosures. This new guidance was effective for the Company as of April 1
 2013. The adoption of this standard did not have a material impact on the Company&amp;#8217;s results of operations


 2014
 the FASB issued final guidance to change the criteria for reporting discontinued operations while enhancing disclosures in this area (Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2014-08). Under the new guidance
 only disposals representing a strategic shift
 such as a major line of business
 a major geographical area or a major equity investment
 should be presented as discontinued operations. The guidance will be applied prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The guidance is effective for annual financial statements with fiscal years beginning on or after December 15
 2014 with early adoption permitted for disposals or classifications as held for sale which have not been reported in financial statements previously issued or available for issuance. The Company will adopt the guidance effective April 1
 2015 and the adoption of this guidance is not expected to have a material impact on the Company&amp;#8217;s results of operations

 2014
 the Emerging Issues Task Force (the &amp;#8220;Task Force&amp;#8221;) reached a final consensus to amend the accounting guidance for stock compensation tied to performance targets (Issue No. 13-D). The objective of this guidance is to clarify the accounting treatment of certain types of performance conditions in stock-based compensation awards
 more specifically
 when performance targets can be achieved after the requisite service period. The Task Force concluded that performance criteria subsequent to a service period vesting requirement should be treated as vesting conditions
 and as a result
 this type of performance condition may delay expense recognition until achievement of the performance target is probable. Issue No. 13-D will be effective for all entities for reporting periods (including interim periods) beginning after December 15
 2015
 and early adoption is permitted. The adoption of this guidance is not expected have a material impact on the Company&amp;#8217;s results of operations



174

120

777

874

879

361

312

874



502

191

147

540

650

731




243














271

271







123

096

058

404

065

692

112

112

178

805







961

409





058

404

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  






953

501

015

496

250

125

574

298

714&lt;/font&gt; or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;416
280&lt;/font&gt; (translated at the March 31
 2014 exchange rate) with an Irish bank
 including overdraft coverage
 creditors&amp;#8217; insurance
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable on demand
 continue until terminated by either party
 are subject to annual review

693&lt;/font&gt;
 or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;20
205&lt;/font&gt; (translated at the March 31
 2014 exchange rate)
 and &amp;#8364;&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;69
761&lt;/font&gt;
 or $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;89
407&lt;/font&gt;
 (translated at the March 31
 2013 exchange rate)
 at March 31
 2014 and 2013

 GCP issued a promissory note (the &amp;#8220;GCP Note&amp;#8221;) in the aggregate principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;211
580&lt;/font&gt; to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1
 2020
 is payable at maturity
 subject to certain acceleration events
 and calls for annual interest of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5&lt;/font&gt;%
 to be accrued and paid at maturity. At March 31
 2014 and 2013

579&lt;/font&gt;&lt;/font&gt; of accrued interest was converted to amounts due to affiliates. At March 31
 2014 and 2013


 the Company and CB-USA entered into the Keltic Facility (&amp;#8220;Keltic Facility&amp;#8221;)
 a revolving loan agreement with Keltic Financial Partners II
 LP (Keltic)
 providing for availability (subject to certain terms and conditions) of a facility of up to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5
000
000&lt;/font&gt; for the purpose of providing the Company and CB-USA with working capital. In July 2012
 the Keltic Facility was amended to increase availability to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;7
000
000&lt;/font&gt;
 among other changes. In March 2013
 the Keltic Facility was amended to increase availability to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;8
000
000&lt;/font&gt;
 among other changes. In August 2013
 the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below)
 subject to certain conditions set forth in the amendment
 to modify&amp;#160;certain aspects of the EBITDA covenant contained in the loan agreement
 permit the Company to incur indebtedness in an aggregate original principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
125
000&lt;/font&gt; pursuant to the terms of the Note Purchase Agreement and Convertible Notes (as each term is defined below in Note 9F)
 and permit&amp;#160;the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Convertible Notes
 subject to certain conditions set forth in the amendment. In November 2013
 the Keltic Facility was further amended
 to
 among other things

 2016. The Borrower may borrow up to the maximum amount of the Keltic Facility
 provided that the Borrower has a sufficient borrowing base (as defined under the loan agreement). The Keltic Facility &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 3.25%
 (b) the LIBOR Rate plus 5.75% and (c) 6.50%&lt;/font&gt;. For the year ended March 31
 2014
 the Company paid interest at &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 6.5&lt;/font&gt;%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement)

000&lt;/font&gt; commitment fee in connection with the first amendment
&amp;#160;a $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;70
000&lt;/font&gt; closing and commitment fee in connection with the second amendment&amp;#160;and a $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;25
000&lt;/font&gt; closing and commitment fee in connection with the third amendment. Keltic also receives an &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;annual facility fee in an amount equal to 1% per annum of the maximum revolving facility amount and a collateral management fee of $1
000 per month (increased to $2
000 after the occurrence of and during the continuance of an Event of Default)&lt;/font&gt;. The loan agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan agreement includes negative covenants that
 among other things
 restrict the Borrower&amp;#8217;s ability to create additional indebtedness
 dispose of properties
 incur liens and make distributions or cash dividends. At March 31
 2014
 the Company was in compliance
 in all material respects
 with the covenants under the Keltic Facility. At March 31
 2014 and 2013
 $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
953
037&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;6
501
321&lt;/font&gt;
 respectively

 the Company and CB-USA entered into an inventory term loan of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
496
000&lt;/font&gt; (the Bourbon Term Loan) that was used to purchase&amp;#160;bourbon inventory on March 11
 2013. Unless sooner terminated in accordance with its terms
 the Bourbon Term Loan matures on December 31
 2016. &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;The Bourbon Term Loan interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 4.25%
 (b) the LIBOR Rate plus 6.75% and (c) 7.50%&lt;/font&gt;. For the year ended March 31
 2014
 the Company paid interest of 7.5%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement)
 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31

000&lt;/font&gt; of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan

000&lt;/font&gt;&lt;/font&gt;)
 an entity affiliated with Phillip Frost
 M.D.
 a director and principal shareholder of the Company
 Mark E. Andrews

000&lt;/font&gt;&lt;/font&gt;)
 a director of the Company and the Company&amp;#8217;s Chairman

000&lt;/font&gt;&lt;/font&gt;)
 a director of the Company and the Company&amp;#8217;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement
 the junior participants receive interest at the rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 11&lt;/font&gt;% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However
 the Borrower is party to a fee letter (the Fee Letter) with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;45
000&lt;/font&gt; in three equal annual installments of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;15
000&lt;/font&gt;. In August 2013
 the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
500
000&lt;/font&gt; to up to $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;4
000
000&lt;/font&gt; to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
015
000&lt;/font&gt; and $2
496
000 at March 31
 2014 and 2013

 the Company entered into a Loan Agreement (the Junior Loan Agreement)
 by and between the Company and the lending parties thereto (the Junior Lenders)
 which provides for an aggregate $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
250
000&lt;/font&gt; unsecured loan (the Junior Loan) to the Company. The Junior Loan bears interest at a rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;11&lt;/font&gt; % per annum
 payable quarterly in arrears commencing November 1
 2013
 and matures on October 15
 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default
 which
 if uncured
 entitle each Junior Lender to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2&lt;/font&gt;% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year)
 payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 Mark E. Andrews
 III ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;50
000&lt;/font&gt;) and an affiliate of Richard J. Lampen ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;50
000&lt;/font&gt;). In connection with the Junior Loan Agreement
 the Junior Lenders entered into a subordination agreement with Keltic; the Company is not a party to the subordination agreement. At March 31
 2014
 $1
250

 the Company entered into a &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;5&lt;/font&gt;% Convertible Subordinated Note Purchase Agreement (the Note Purchase Agreement)
 by and among the Company and the purchasers party thereto
&amp;#160;which provided for the issuance of an aggregate initial principal amount of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
125
000&lt;/font&gt; unsecured subordinated notes (the Convertible Notes) by the Company. The Convertible Notes bear interest at a rate of &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 5&lt;/font&gt;% per annum
 payable quarterly beginning on December 15
 2013 until their maturity date of December 15
 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&amp;#8217;s common stock at a conversion price of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;0.90&lt;/font&gt; per share (the Conversion Price). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium
 but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default
 which
 if uncured
 entitle each note holder to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on

 including an affiliate of Dr. Phillip Frost ($500
000)
 Mark E. Andrews
 III ($50
000)
 an affiliate of Richard J. Lampen ($50
000)
 an affiliate of Glenn Halpryn ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 a director of the Company
 Dennis Scholl ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;100
000&lt;/font&gt;)
 a director of the Company
 and Vector Group Ltd. ($&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt;)
 a more than 5% shareholder of the Company
 of which Richard Lampen is an executive officer and Henry Beinstein
 a director of the Company


 each&amp;#160; purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement
 by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement. At March 31
 2014
 $2
125


 consolidated results from operations
 consolidated net loss attributable to common shareholders


305

444

834

998

140

442


319

375

319

402



753

302

906

448




643

324

521

421

992

803

852

565





626

396

140

442


201

941

320

175

521

117

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

 when annualized
 is the greatest of (a) the Prime Rate plus 3.25%


 when annualized
 is the greatest of (a) the Prime Rate plus 4.25%


 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31

  
  
  
  

000 per month (increased to $2

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

 the Company will reimburse Barrington for certain expenses incurred in connection with the matters contemplated by the Distribution Agreement
 up to an aggregate of $50
000
 plus up to an additional $7
500 per calendar quarter related to ongoing maintenance; provided
 however

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

 a family of premium rums with a 200-year history
 including the award-winning Gosling&amp;#8217;s Black Seal rum
 for which the Company is
 through its export venture GCP
 the exclusive marketer outside of Bermuda
 and Gosling&amp;#8217;s Stormy Ginger Beer

 Jefferson&amp;#8217;s Reserve and Jefferson&amp;#8217;s Presidential Select
 Jefferson&amp;#8217;s Rye
 an aged rye whiskey; the Clontarf Irish whiskeys
 a family of premium Irish whiskeys
 available in single malt and classic pure grain versions; Knappogue Castle Whiskey
 a vintage-dated premium single-malt Irish whiskey; and Knappogue Castle 1951

 a premium Irish cream liqueur; Castello Mio
 a super premium Sambuca
 Celtic Honey
 a premium Irish liqueur; pursuant to an exclusive U.S. marketing arrangement
 Pallini Limoncello
 Raspicello and Peachcello premium Italian liqueurs; and pursuant to a U.S. distribution agreement
 Gozio amaretto

 an ultra-pure

 super-premium tequila
 Tequila Tierras Autenticas de Jalisco or Tierras. The Company is the exclusive U.S. importer and marketer of Tierras
 which is available as blanco

  



 title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination)


 bulk wine
 dry good raw materials (bottles
 labels
 corks and caps)
 packaging and finished goods
 and are valued at the lower of cost or market
 using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company&amp;#8217;s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including
 but not limited to
 historical usage

 2014 and 2013
 the Company recorded allowances for obsolete and slow moving inventory of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;200
000&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;684
830&lt;/font&gt;
 respectively. The Company recorded these allowances on both raw materials and finished goods
 primarily in connection with the disposition of wine brands
 label and packaging changes made to certain brands


 computers and software and furniture and fixtures. When assets are retired or otherwise disposed of
 the cost and related depreciation is removed from the accounts


 &amp;#8220;Income Taxes&amp;#8221;

 2014 and 2013 consists of federal
 state and local taxes attributable to GCP
 which does not file a consolidated income tax return with the Company
 and foreign taxes. As of March 31
 2014
 the Company had federal net operating loss carryforwards of approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;86
800
000&lt;/font&gt; for U.S. tax purposes
 which expire through &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt; 2034&lt;/font&gt;
 and foreign net operating loss carryforwards of approximately $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;19
800
000&lt;/font&gt;

 on a financial statement basis
 from foreign sources totaled $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;168
233&lt;/font&gt; for the year ended March 31
 2014 and the pre-tax loss
 on a financial statement basis
 from foreign sources totaled $412
182 for the year ended March&amp;#160;31





 the Company recorded a deferred tax liability on the ascribed value of the acquired intangible assets of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
222
222&lt;/font&gt;
 increasing the value of the asset. The deferred tax liability is being reversed over the amortization period of the intangible asset (&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;15&lt;/font&gt;&amp;#160;years). For each of the years ended March 31
 2014 and 2013
 the Company recognized $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;590
414&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;118
349&lt;/font&gt; of income tax benefit








125

967



706

623

974

957



394

143

921

143





037

518

666

 2013
 the Company recorded a full valuation allowance against its deferred tax assets as it believed it was more likely than not that such deferred tax assets would not be realized. The Company released its deferred tax asset valuation allowance allocated to GCP as of March 31
 2014 due to management&amp;#8217;s determination that it was &amp;#8220;more likely than not&amp;#8221; that the GCP&amp;#8217;s deferred tax assets would be realized. &amp;#8220;More likely than not&amp;#8221; is defined as greater than 50% probability of occurrence. Management considered the guidance in paragraphs 21-23 of ASC 740-10-30 in forming its conclusion. A determination as to the ultimate realization of the deferred tax assets is dependent upon management&amp;#8217;s judgment and evaluation of both positive and negative evidence
 forecasts of future taxable income
 applicable tax planning strategies
 and an assessment of current and future economic and business conditions. In 2014
 GCP was in a position of cumulative profitability on a pre-tax basis
 considering its operating results for the three years ended March 31
 2014. Management concluded that this record of cumulative profitability in recent years
 in addition to a long range forecast showing continued profitability for GCP
 provided sufficient positive evidence that the net U.S. federal tax benefits more likely than not would be realized. Accordingly
 in the year ended March 31
 2014
 the Company released the valuation allowance against GCP&amp;#8217;s net federal deferred assets
 resulting in a $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;473
330&lt;/font&gt; benefit in provision for income taxes for the year ended March 31
 2014. In addition
 at March 31
 2014
 the Company changed its estimate of the cumulative deferred tax asset allocated to the amortization of intangibles. The Company&amp;#8217;s income tax benefit and effective tax rate for the years ended March 31

 2014 and 2013 was approximately $38
921
000 and $36
143
000
 respectively. The net change in the total valuation allowance for the years ended March 31
 2014 and 2013 was $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
778
000&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
846
000&lt;/font&gt;


 including the shipment of point of sale materials to the Company&amp;#8217;s regional sales managers and customers
 and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
879
881&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;1
171
290&lt;/font&gt; for the years ended March 31
 2014 and 2013


 including product depletions
 product samples for various promotional purposes
 in-store tastings and training where legal
 and local advertising where legal. Such charges are reflected as selling expense as incurred. Also
 the Company has entered into arrangements with certain of its distributors whereby the purchase of a particular product or products by a distributor is accompanied by a percentage of the sale being composed of promotional goods or as a predetermined discount percentage of dollars off invoice. In such cases













125

967



706

623

974

957



394

143

921

143





037

518

666




 which is included in selling expense
 was $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
052
819&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;2
212
774&lt;/font&gt; for the years ended March 31
 2014 and 2013


 and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment tests
 derivative instruments and equity issuances
 warrant valuation
 stock-based compensation
 allowances for doubtful accounts and inventory obsolescence
 depreciation


 including both its own proprietary brands and those it distributes for others. The Company does not have long-term written agreements with all of its suppliers. Also
 if the Company fails to complete purchases of products ordered annually
 certain suppliers have the right to bill it for product not purchased during the period. Suppliers&amp;#8217; failure to perform satisfactorily or handle increased orders
 delays in shipments of products from international suppliers or the loss of existing suppliers
 especially key suppliers
 could have material adverse effects on the Company&amp;#8217;s operating results. The inability to maintain

  
  
  
  
  
  
  
  
  



317

026



327

036

759

519



 2014 and 2013 totaled $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;204
180&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;187
539&lt;/font&gt;



317

026



327

036

759

519



  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  






  
  
  
  
  
  
  
  
  
  
  
  


120

330

300

800




174

120

511

248


 March 31

448

543

 March 31

904

127

 March 31

777






975

592

992












174

511

601




593

800


513


871

300


499


662





  
  
  
  


  
  
  
  

000 per trading day and the Volume Weighted Average Price (as defined in the articles of designation of the Series A Preferred Stock) for at least 20 trading days during any 30 consecutive trading day period exceeded $0.76 (subject to adjustment)

  
  
  
  
  
  







143

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  



250

968

125


574

  
  
  
  
  
  
  
  
  
  
  

 as successor in interest to I.L.A.R. S.p.A.
&amp;#160; is a shareholder in the Company and one of the officers of Pallini is a director of the Company. In January 2011
 CB-USA entered into an agreement (New Agreement) with Pallini regarding the importation and distribution of certain Pallini brand products. The terms of the New Agreement were effective as of April 1

 the Company is permitted to import Pallini Limoncello and its flavor extensions at a set price
 updated annually

 2014 and 2013
 the Company purchased goods from Pallini for $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;3
467
812&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;3
685
192&lt;/font&gt;
 respectively. As of March 31
 2014 and 2013
 Pallini owed the Company $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;115
288&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;34
628&lt;/font&gt;
 respectively
 for its share of marketing expense
 which is included in due from shareholders and affiliates on the consolidated balance sheet. As of March 31
 2014 and 2013
 the Company was indebted to Pallini for $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;229
557&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;967
188&lt;/font&gt;
 respectively

 the Company entered into a management services agreement with Vector Group Ltd.
 a more than 5% shareholder
 under which Vector Group agreed to make available to the Company the services of Richard J. Lampen
 Vector Group&amp;#8217;s executive vice president
 effective October&amp;#160;11
 2008 to serve as the Company&amp;#8217;s president and chief executive officer and to provide certain other financial and accounting services
 including assistance with complying with Section&amp;#160;404 of the Sarbanes-Oxley Act of 2002. In consideration for such services
 the Company agreed to pay Vector Group an annual fee of $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;100
000&lt;/font&gt;
 plus any direct
 out-of-pocket costs
 fees and other expenses incurred by Vector Group or Mr.&amp;#160;Lampen in connection with providing such services
 and to indemnify Vector Group for any liabilities arising out of the provision of the services. The agreement is terminable by either party upon 30&amp;#160;days&amp;#8217; prior written notice. For the years ended March 31
 2014 and 2013
 Vector Group was paid $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;104
746&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;113
406&lt;/font&gt;
 respectively

 the Company entered into an agreement to reimburse Ladenburg Thalmann Financial Services Inc. (&amp;#8220;LTS&amp;#8221;) for its costs in providing certain administrative
 legal and financial services to the Company. For the years ended March 31
 2014 and 2013
 LTS was paid $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;126
000&lt;/font&gt; and $&lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;154
972&lt;/font&gt;
 respectively
 under this agreement. Mr.&amp;#160;Lampen
 the Company&amp;#8217;s president and chief executive officer and a director
 is the president and chief executive officer and a director of LTS and two other directors of the Company serve as directors of LTS
 including Phillip Frost

 in March 2013
 the Company entered into a Participation Agreement with certain related parties. As described in Notes 9E and 9F
 in August and October 2013

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

 its wholly-owned domestic subsidiaries
 Castle Brands (USA) Corp. (&amp;#8220;CB-USA&amp;#8221;) and McLain &amp;amp; Kyne
 Ltd. (&amp;#8220;McLain &amp;amp; Kyne&amp;#8221;)
 the Company&amp;#8217;s wholly-owned foreign subsidiaries
 Castle Brands Spirits Group Limited (&amp;#8220;CB-IRL&amp;#8221;) and Castle Brands Spirits Marketing and Sales Company Limited
 and the Company&amp;#8217;s &lt;font style=FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt&gt;60&lt;/font&gt; % ownership interest in Gosling-Castle Partners
 Inc. (&amp;#8220;GCP&amp;#8221;)


 marketing and sale of premium and super premium brands of rums
 whiskey
 liqueurs
 vodka and tequila in the United States
 Canada

  
  
  
  
  
  
  
  
  
  
  
  




 net and Cost of sales include excise taxes of $6
420
730 and $5
964
374 for the years ended March 31
 2014 and 2013









    





714 or $416
280 (translated at the March 31
 2014 exchange rate) with an Irish bank
 including overdraft coverage
 creditors&#8217; insurance
 customs and excise guaranty
 and a revolving credit facility. These facilities are payable on demand
 continue until terminated by either party
 are subject to annual review
 and call for interest at the lender&#8217;s AA1 Rate minus 1.70 %. The balance on the credit facilities included in notes payable totaled &#8364;14
693
 or $20
205 (translated at the March 31
 2014 exchange rate)
 and &#8364;69
761
 or $89
407
 (translated at the March 31
 2013 exchange rate)
 at March 31
 2014 and 2013




 GCP issued a promissory note (the &#8220;GCP Note&#8221;) in the aggregate principal amount of $211
580 to Gosling&#39;s Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1
 2020
 is payable at maturity
 subject to certain acceleration events
 and calls for annual interest of 5%
 to be accrued and paid at maturity. At March 31
 2014 and 2013
 $10
579 of accrued interest was converted to amounts due to affiliates. At March 31
 2014 and 2013
 $211




 the Company and CB-USA entered into the Keltic Facility (&#8220;Keltic Facility&#8221;)
 a revolving loan agreement with Keltic Financial Partners II
 LP (&#34;Keltic&#34;)
 providing for availability (subject to certain terms and conditions) of a facility of up to $5
000
000 for the purpose of providing the Company and CB-USA with working capital. In July 2012
 the Keltic Facility was amended to increase availability to $7
000
000
 among other changes. In March 2013
 the Keltic Facility was amended to increase availability to $8
000
000
 among other changes. In August 2013
 the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below)
 subject to certain conditions set forth in the amendment to modify certain aspects of the EBITDA covenant contained in the loan agreement
 permit the Company to incur indebtedness in an aggregate original principal amount of $2
125
000 pursuant to the terms of the Note Purchase Agreement and Convertible Notes (as each term is defined below in Note 9F)
 and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Convertible Notes
 subject to certain conditions set forth in the amendment. In November 2013
 the Keltic Facility was further amended
 to
 among other things
 provide for the issuances of letters of credit thereunder. The Company and CB-USA are referred to individually and collectively as the Borrower. The Keltic Facility expires on December 31
 2016. The Borrower may borrow up to the maximum amount of the Keltic Facility
 provided that the Borrower has a sufficient borrowing base (as defined under the loan agreement). The Keltic Facility interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 3.25%
 (b) the LIBOR Rate plus 5.75% and (c) 6.50%. For the year ended March 31
 2014
 the Company paid interest at 6.5%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any &#34;Default&#34; or &#34;Event of Default&#34; (as defined under the loan agreement)
 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. The Company paid a $40
000 commitment fee in connection with the first amendment
 a $70
000 closing and commitment fee in connection with the second amendment and a $25
000 closing and commitment fee in connection with the third amendment. Keltic also receives an annual facility fee in an amount equal to 1% per annum of the maximum revolving facility amount and a collateral management fee of $1
000 per month (increased to $2
000 after the occurrence of and during the continuance of an Event of Default). The loan agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan agreement includes negative covenants that
 among other things
 restrict the Borrower&#8217;s ability to create additional indebtedness
 dispose of properties
 incur liens and make distributions or cash dividends. At March 31
 2014
 the Company was in compliance
 in all material respects
 with the covenants under the Keltic Facility. At March 31
 2014 and 2013
 $1
953
037 and $6
501
321
 respectively




 the Company and CB-USA entered into an inventory term loan of $2
496
000 (the &#34;Bourbon Term Loan&#34;) that was used to purchase bourbon inventory on March 11
 2013. Unless sooner terminated in accordance with its terms
 the Bourbon Term Loan matures on December 31
 2016. The Bourbon Term Loan interest rate is the rate that
 when annualized
 is the greatest of (a) the Prime Rate plus 4.25%
 (b) the LIBOR Rate plus 6.75% and (c) 7.50%. For the year ended March 31
 2014
 the Company paid interest of 7.5%. Interest is payable monthly in arrears
 on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. After the occurrence and during the continuance of any &#34;Default&#34; or &#34;Event of Default&#34; (as defined under the loan agreement)
 the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan
 all accrued and unpaid interest thereon
 all fees
 costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31
 2016. Keltic required as a condition to funding the Bourbon Term Loan that Keltic had entered into a participation agreement (the &#34;Participation Agreement&#34;) providing for an initial aggregate of $750
000 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan
 including Frost Gamma Investments Trust ($500
000)
 an entity affiliated with Phillip Frost
 M.D.
 a director and principal shareholder of the Company
 Mark E. Andrews
 III ($50
000)
 a director of the Company and the Company&#8217;s Chairman
 and an affiliate of Richard J. Lampen ($50
000)
 a director of the Company and the Company&#8217;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement
 the junior participants receive interest at the rate of 11% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However
 the Borrower is party to a fee letter (the &#34;Fee Letter&#34;) with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $45
000 in three equal annual installments of $15
000. In August 2013
 the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $2
500
000 to up to $4
000
000 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $2
015
000 and $2
496
000 at March 31
 2014 and 2013




 the Company entered into a Loan Agreement (the &#34;Junior Loan Agreement&#34;)
 by and between the Company and the lending parties thereto (the &#34;Junior Lenders&#34;)
 which provides for an aggregate $1
250
000 unsecured loan (the &#34;Junior Loan&#34;) to the Company. The Junior Loan bears interest at a rate of 11 % per annum
 payable quarterly in arrears commencing November 1
 2013
 and matures on October 15
 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default
 which
 if uncured
 entitle each Junior Lender to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of 2% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year)
 payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust ($200
000)
 Mark E. Andrews
 III ($50
000) and an affiliate of Richard J. Lampen ($50
000). In connection with the Junior Loan Agreement
 the Junior Lenders entered into a subordination agreement with Keltic; the Company is a party to the subordination agreement. At March 31
 2014
 $1
250




 the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the &#34;Note Purchase Agreement&#34;)
 by and among the Company and the purchasers party thereto
 which provided for the issuance of an aggregate initial principal amount of $2
125
000 unsecured subordinated notes (the &#34;Convertible Notes&#34;) by the Company. The Convertible Notes bear interest at a rate of 5% per annum
 payable quarterly beginning on December 15
 2013 until their maturity date of December 15
 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&#8217;s common stock at a conversion price of $0.90 per share (the &#34;Conversion Price&#34;). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium
 but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default
 which
 if uncured
 entitle each note holder to accelerate the due date of the unpaid principal amount of
 and all accrued and unpaid interest on
 the Convertible Notes. The purchasers of the Convertible Notes include certain related parties of the Company
 including an affiliate of Dr. Phillip Frost ($500
000)
 Mark E. Andrews
 III ($50
000)
 an affiliate of Richard J. Lampen ($50
000)
 an affiliate of Glenn Halpryn ($200
000)
 a director of the Company
 Dennis Scholl ($100
000)
 a director of the Company
 and Vector Group Ltd. ($200
000)
 a more than 5% shareholder of the Company
 of which Richard Lampen is an executive officer and Henry Beinstein
 a director of the Company
 is a director. The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company&#8217;s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50
000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty ( 20 ) trading days during any thirty ( 30 ) consecutive trading day period exceeds 250% of the then-current Conversion Price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder&#8217;s then-current note holdings. In connection with the Note Purchase Agreement
 each purchaser of the Convertible Notes was required to execute a joinder to that certain Subordination Agreement
 dated as of August 7
 2013 (as amended
 the &#34;Subordination Agreement&#34;)
 by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement. At March 31
 2014
 $2
125















    

























        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    


    
    


    


    
    


    


    
    


    








    


    
    


    


    
    
    






    
    


    


    
    


    


    










    


    
    
    




    
    
    



 Net


418 and $70
692





    







473 and $461
660

    



 Net

    




    




    



 Plant and Equipment

    
    


    


    





058
005 and $5
404
000





    
    
    
    




    




    




    




    




    




    




    




    




    




    




    

375 and $600
000 of related-party participation at March 31
 2014 and 2013

    





000 of related party participation at March 31






100
000 of related party participation at March 31





    




    
    






    


    
    


    
    




    



 Value


 $.01 par value
 25
000
000 shares authorized
 0 and 6
701 shares of series A convertible preferred stock issued and outstanding at March 31
 2014 and 2013
 respectively (liquidation value of $0 and $7
876
530 at March 31
 2014 and 2013




 Value


 $.01 par value
 300
000
000 and 225
000
000 shares authorized at March 31
 2014 and 2013
 respectively
 151
841
133 and 108
773
034 shares issued and outstanding at March 31
 2014 and 2013





    


    
    




    


    
    


    
    




    
    
    


    
    


    


    
    












    


    
    


    


    
    


    


    
    


    


    


    


    


    


    
    

























 Plant and Equipment



    
    








    
    


    


    
    
    


    
    










    
    




    


    
    




    
    
    


    
    
    



 Related Parties


 Related Parties



    
    

 excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another
 related security




 Interest Rate































    















 Shares




 Shares





    
    
    


    


    


    
    


    


    


    
    








    


    






    


    


    


    
    


    






    
    




    






    



 Raw Materials

    



 Finished Goods

    


    
    
    


    
    
    


    


    


    


    
    
    


    


    
    
    








    
    


    
    
    






    
    


    



 Goods



    


    
    


    
    
    




    
    


    
    


    
    


    
    




    
    


    
    
    




    








    
    
    
    


    


    






    
    
    


    
    


    
    
    




    




    





 basic and diluted







    






    
    


    


    
    
    
    


    


    




    


    
    
    


    


    


    
    






    


    
    

 often within specific geographical areas or supply channels
 for a specified period of time



    
    
    




    




    










    


    
    


    






    
    


    


    


    
    


    
    


    


    



 Amortization Expense





    


    


    


    










    
    


    
    
    


    
    
    


    
    


    
    


    




    
    


    


    


    


    


    


    


    


    


    


    


    






    
    


    


    


    


    


    


    


    


    






    
    
    


    
    


    
    


    
    


    
    


    






    



























 Debt Default


 Debt Default













    
    
    








    
    


    
    
    


    
    
    


    
    


    
    







 Convertible




 Convertible




 Convertible




 Convertible




 Convertible







    


    
    


    


    


    
    


    
    


    


    



Officers











    


    


    


    
    
    


    


    


    


    


    


    


    


    



 Dividend Rate


 Dividend Rate




 Preferred Stock


 Preferred Stock
















 Dividend Rate



    
    


    
    







 Shares





    
    


    


    


    


    


    


    


    


    


    


    
    


    


    


    


    







 Measurements




 Inputs



    


    










    


    


    


    


    


    















 Options
 Grants in Period





    
    



 Nonvested Awards


 Nonvested Awards



    





 Nonvested Awards
 Total Compensation Cost Not Yet Recognized

    


    



 Net Of Tax

    



 Foreign Currency Transaction and Translation Adjustment

    



 Net Of Tax

    



 Net Of Tax

    



 Future Minimum Payments Due





    


    


    


    


    


    







 2014 To January 31



    






    


    


    
    


    


    


    


    


    


    
    








    


    









 Income Statement


 Income Statement



    
    


    
    
    


    
    


    


    


    


    


    


    



 Goods



    


    


    


    
    


    












    


    


    


    
    


    
    
    


    
    


    
    


    
    


    
    


    
    


    


    


    


    


    


    


    
    


    
    
    



 Goods

    






    


    
    


    
    




    


    










    
    
    


    
    
    


    


    


    


    


    


    


    


    


    


    


    


    


    


    


    














    






    


    


    


    


    


    


    


    


    


    




    




    


    


    


    


    
    


    
    


    
    




    
    



 Value





    
    
    


    
    
    


    
    
    


    
    
    



 Value

    



 Options

    




    
    

 stock



    
    
    



 Share-Based Compensation

    


    










    


    
    


    
    


    
    




    


    
    


    
    




    


    
    


    
    




    
    


    
    




    




    



 Continuing Operations

    




    



 Plant

    


    
    


    
    



 Continuing Operations

    




    


    
    


    
    
    


    
    
    


    
    

 typically the entity&#39;s common stock



    
    


    
    


    
    



 Continuing Operations

    




    




    


    
    




    


    
    


















    
    
    


    
    


    
    


    
    


    














    


    














    
    


    






    






    
    
    



 Plant and Equipment




 Plant and Equipment















    
    
    



 at Federal Statutory Income Tax Rate






 Change in Deferred Tax Assets Valuation Allowance

    



 Net Change in Fair Value of Warrant Liability

    
    




    



 Plant and Equipment


 Plant and Equipment




 Depletion and Amortization
 Property
 Plant

    




    
    



 Foreign Income Tax Rate Differential

    


    
    
    



 Other Adjustments

    


    
    






    
    
    


    
    
    


    
    




    



 Tax Deferred Expense
 Compensation and Benefits

    



 Net

    


    
    
    





 basic and diluted





    



 Operating Loss Carryforwards

    



 Operating Loss Carryforwards

    



 Tax Credit Carryforwards

    



 Gross

    




    



 Net of Valuation Allowance

    


    
    
    


    
    
    



 Net

    


    



 Future Minimum Payments Due

    



 Future Minimum Payments

    



 Future Minimum Payments

    



 Future Minimum Payments Due

    


    
    


    


    
    


    
    


    
    



 Stock Options



    


    



 Stock Options



    
    











 Amortization Expense

    


    
    



 Amortization Expense

    



 Amortization Expense

    



 Amortization Expense

    



 Amortization Expense

    


    
    


    
    

 excluding financial assets and goodwill



    
    


    


    


    







 Deferred Tax Asset




 Options
 Outstanding
 Number










 Options
 Forfeitures and Expirations in Period






 Options
 Exercisable








 Options
 Outstanding
 Weighted Average Exercise Price








 Options
 Grants in Period






 Options
 Exercises in Period






 Options
 Forfeitures and Expirations in Period






 Options
 Exercisable




 Exercisable



    


    


    
    


    
    


    










    


    
    


    



 Options
 Grants in Period

    


    









 Maturities

    












    
    




    



 Maturities

    



 Maturities

    



 Maturities

    



 Maturities

    



 Options
 Outstanding


 Outstanding




 Options
 Exercisable

    


    







 Shares Authorized under Stock Option Plans
 Exercise Price Range






 Shares Authorized under Stock Option Plans
 Exercise Price Range






 Equity Instruments Other than Options
 Nonvested
 Number








 Equity Instruments Other than Options






 Equity Instruments Other than Options






 Equity Instruments Other than Options





    





 Equity Instruments Other than Options
 Nonvested
 Weighted Average Grant Date Fair Value








 Equity Instruments Other than Options
 Grants in Period






 Equity Instruments Other than Options
 Forfeitures






 Equity Instruments Other than Options
 Vested in Period






 Fair Value Assumptions

    



 Fair Value Assumptions

    



 Fair Value Assumptions

    



 Fair Value Assumptions

    


    
    


    

 Outstanding and exercisable


 Outstanding and exercisable

    


    


    


    


    


    


    


    




    


    


    


    


    


    


    


    


    


    







 Options
 Exercisable



    
    


    


    


    


    


    


    


    


    






    


    


    


    


    


    


    


    


    


    
    


    
    






    
    


    


    
    










    


    
    



 Maturities

    



 State and Local Income Taxes






 Percent

    







 Fair Market Value
 Per Warant






 Fair Market Value
 Per Warant


 fair value



    
    





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
  
      

          

        

      










        
        
        


        

312
920

874
659



          

        
        


        
        
        


        

174
007

120
765



          

        
        


        
        
        


        

777
802

874
087



          

        
        


        
        
        


        
        

879
807



          

        
        


        
        
        


        

361
111
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          











Years ending March 31

        
        


        

205
        


        

250
000
        


        

968
037
        


        
        
        


        

125
000
        


        

580
        


        

574
822

298
308




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities redeemable at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of unamortized discount or premium
 excluding amounts to be repaid within one year or the normal operating cycle
 if longer (current maturities). Includes
 but not limited to
 notes payable
 bonds payable
 debentures
 mortgage loans and commercial paper. Excludes capital lease obligations.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          











        
        
        
        
        


        

000
        

000
        


        

947
        

947
        


        

271
555
        

271
555
        


        

959
        

959
        


        

000
        

000
        


        

460
        

480
        


Finite-Lived Intangible Assets
 Gross

123
921
        

096
941
        


        

058
005
        

404
000
        


        

065
916
        

692
941
        


        

112
972
        

112
972
        


Intangible Assets
 Net (Excluding Goodwill)

178
888
        

805
913
        

      
        

      



              
              







        
          

        
          
            

 symbol or other device or style for a specified period of time.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 often within specific geographical areas or supply channels
 for a specified period of time
 including reasonably expected renewal periods.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 excluding financial assets and goodwill
 lacking physical substance with a finite life.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 excluding financial assets and goodwill
 lacking physical substance with a finite life.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 excluding financial assets and goodwill
 lacking physical substance with a finite life.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 or to acquire such rights.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 symbol or other device or style for a specified period of time.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 excluding goodwill
 as of the balance sheet date
 net of accumulated amortization and impairment charges.
              
 -Subparagraph ((a)(1)
(b))
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xlsx




M5:X*E!@%2BR2A19)8JL$D56B2*K1)%5HL@J4625*+)*%%DEBJP*15:%(JM
MD56AR*I09%4HLBH4616*K`I%5H4BJT:15:/(JE%DU2BR:A19-8JL&D56C2*K
M1I%5H\A:H
A:H
A:H
A:H
A:H
A:H
A:H
A:H
A:H
A:H
AJ4&0U*+(:%%D-
MBJP&15:#(JM!D=6@R&I09#4HLLY09)VAR#I[*UECJOD1'S]??Q?C

M-Q0NW`TY'/K2Y(WU5/V

O+G)E;'



M$SO+=N5#9@NIS]NHFD++28


\

$%``&``@`


M`B41V-D)
#MA5DFDKAWCYG


MUV^^!EW]!```__\#`%!+`P04``8`````$`8`:$K5`%``!8%0``#P```'AL




M4!F2@W%KT/B$=GKF)K@X,L%J%QT\27&(E';'B(:=5/!Q%RS&53Q@\FEN?^
M8T6N[S'+&[-P


&1S
M)T`=++



M;8$SM7CJYU9`T$6!10IV$Z`18J=+V-'.


.((1PZA*<,')8%'_/Z'9TG.27*0A`2D
@A.K


R(F)'4E&
MHT+MLT;@!


U_OA2]_0\``/__`P!02P,$%``&``@````A`,*QI1TP!@``
M\A<``!@```!X;]W;W)K<VAE971S+W-H965T-YX;6RL6-N.HT80?8^4?T\
MV]`7;M9X5@-FDTB)%$6Y/#
8VVB-L8#9V?W[5-.-I[J8]=I1]F$];I]3G%-=

WJLMJTY4M3G08=I*N.Q0#Z^T-]
M[J=H37E+N*;H/KV<%V7;G'$<WVLAZ]C4-=IRM4O^U/;%<]'\/V%R:*<8H]?




M9&
V5A@F)4\2:NYZ&
LOU/Q_\JMXQ&]LTTU)!C]E^(
`R)ETQ#KOO%87@H
M1
!F0;(2SUO



2/36F%!Q&G98)*M
M7C7
FPM';8:SW)-$I0:DY2P8+
-8D/G)#`;EWV9)Z7
_)-9SS+)=J(Z)7*@S
MBH!YN;X


-%9-L$ZK5(1
WUI1ND+89(C15KRVPC*::
M$@D/Z#$I

M

Q`\(18I)#Y


)V0@R`T$F;%(DI0S)5IACDNV!]/+;JHN_T]
9*9W4@/3[

M:

'T!4=[EMO[Q7P```/__`P!02P
$
M.
5+TFT3C1T$P\07A+78*
W6-ABQ+3EDNZ5:PUC@1Q1IB('Y=\TX?


MPY#-H06GP8F+I6.F?1

M
FBD492^'N-\NI'C7DG!5
56K&DTHG)KQTD(AP]WATEW'_7#:G@`DZ8C%?M.
M5

Z;_6\

M+?X!``#__P



[DBS
BU/1_A!.;:O,-I\/YZI.7T_`^SM;I)GT+;X8[LLBJZNFVK<S<.=@
MH;GP`D<\/3\MN``9]VJ\[W6_N%;1)O;3O/3V*_B[R]V;PO]4<J_=?ZF+W
MI3CG





)Z.B2R\O=QM+0
M#YDO]#&)A/#D`DJ*%V@XY'4]CV3X'`P9
PC-=]?Z#X6(`:%4^L=$4F$E\:

MZ90D@R':W

D#:/G.36'BCN`1]$6#7L$#
F`82H320AGYRB&R)1%`-8#4


^#&FQQ\B9DPHB5!
M24//F*:91%A^`YF4(#'H^?@J31#S%CT$J&BEX;;T4L$C3[0H[\[S?@X(H.1

I+






../F09&%T7
:-Y)R&]9M)R4^B$








MOX\\T\6*A+-)%'NA#W)GQY1^X




MCBP4M*L'GS[V%A5PO52\5?2PH-?'8QEQ!RMN+7$)

N(


`4$L#!!0`!@`(````
M(0#
%&(OLQ


MW%U=[1Z^KU]6N\O-C_6K_




<_#.NXL^2&N



MFFR\R[
GN^KV


M2D]F



M*NY`Q2VHN`=50A.^;:\1;C*U


M8N4D8]6I)!FK3C7!!#?F]M3.S:UU5_5S4@ANS3(-#]/T
*T$D[6F#&T/T_$P
MW21C/84]#]-/
GGS^1DDF6O3#).

M2]F
H:1F
M/4

R7(0W@9695[.TB,=)23.

M#Y3M@8H]4(T'WJ:I9\E:\S!U#]/P
$T/T_(P;0_3\3!=#]-+
E;[]).
U:H#
M#S/T



1Q*U6
T?%FI7C$=;/C

HQ@:

Q29].%MLO1EVIH.MK!
M&T4'11=%#T4?Q0#%$,4(Q1C%!,44Q0S%',4Q1*%4DRXYU2)JW#7*6X[Q7VG
MN/$4=YYRMIZ1=?(FK)%U[JLX6ML99YT
%D/CRC@49105%%44-13U4!0.\91)


GD;ZQI7BD$R=L6KN:A$A4L44510U&GS6@0:!)HX4:T4710=%'T4/11
M#%`


E
-K_SU
/-
M[(BSWLTI1BAY*PX15F)29E)A4F528U)GTF#29-)BTHY(&!.%0Y-:.=$Q2)@D

F4R83)G
F

M4-W%]RG''I#EHFP\VE%Y]*.L*0WO*SPV;Y*.35EERMOCT9*R\)3KN)O2S$-9
MMF#

]I]0=HSJ9\5I\4(^382R4F9285)E4F-29U)@TF32:M!%+(


F(R9C)A
F4R8S)G
[&-$-1KW,]T69C<)4

ZDPJ3*I
M
:DS:3!I
FE%)#SWR.ES#_/J6)MK=)ATF?28])D
F`R9C)B
F4R83)G
F
R9
8*5ZDRJ3&I,VDP:3)I,6DSZ3#I,NDQZ3,9,!DR&3$9,YDPF3*9
M,9DS63!9,I$4#'O-T4B2@FP\&E)2D.MXM*3,[F.1U/*K)#KN-O23$*]J/L#
ML\)P+;@Q*[RV@JJHOVN)9H5(REREPJ3*I
:DSJ3!I
FD%1&Y6*R_3$.^VBB\
M*!W_/ZC\8;U!W^:B'29=)CTF?28#)D
F(R9C)A
F4R8S)G

PK.WFT


MF8R8C)E
F$R9S)C

`9
ADQ&3
9
)DRF3&9
Y

2[TB_0-Y&2YD
M-_/2FI(5]5=
TUDTDC)7J3I,JDQJ3-I,&DR:44DBK&L?`]^G&'/\]CK
U%
M.TRZ3'I
^DP&3(9
1DS&39,IDQF3.9,%DR630@L:\D(-F4/(Q'@\HI-=^7

D?39P:8A##;.$?.UP^)F.DWNQA-F)235*

4(N!X1LM
*DRJ3&I
ZDP:3)I
6DS:3#I
NDQZ
M3/I
!DR&3$9
QDPF3*9
9DSF3!9
EDPD`/GC&W$W.II-OGF=ZWATI
0@U_'H
M28E!KN/1E?+UZZXZ9@Y*I!DYZ'==

&DR:3%I
VDPZ3+I


;S^:9XF#+G*B
F8R83)E
F
R9S)@LF2B20A]IHD(9N2A_'H2$E
MOJ^X)QUS'$EKN/1E9*$KCIF$LKV&$GH.3/4-S-GAK?VTIL@-(X'7&)29E)A

IDQF3.9

JDQJ3.I
&DR:3%I
VDPZ3+I

MSV00D6
.IJVE^T.N
6(R9C)A

MHR
E![F.1T]*#KKJF#FHEVR_(P?#%=YF#EI'=C%P+0./WC5&4N8J%295)C4F

QDPF3*9
9DSF3!
M9

VDP:3)I
M
6DSZ3#I
NDQZ3
9
!DR&3$9
YDPF3*9
9DS63!9

F(R9C)A
F4R



MF728=)GTF/29#)@
F8R8C)E
F$R9S)C
F2R8+)E(&&(/21BR*7D8CV:4R2'?

M$DBA8'V
IIZ`K(?=8-)DTF+29M)ATF728])G
F`R9#)B
F8R83)E
F
R9[)@



VDP:3)I
6DSZ3#I
NDQZ3
9
!DR&3$9
YDPF3*9
9DS63!9




M:3S[+]MVV+CFP]:&M=N&]W

2%!W*Z@0;PN
:VYW-E^


'YM.W2!H\V^+0AH`TA


:KKJ=


\`H3!Q
7
M$P\3'Y

8+O.%+#LB'J<G'D^K5U@9K=
MOC6=3

8W3*LI9-:D]T@

28))BD#;DD%)GX
V4(.3W8M)9?DQX8VSP
MP\BDHI.-JMT@99J(.`KBX@N)AXF/B8!)B$F$28Q)@DF:0^Q=%+GRGK0^SV)

MQB3!)
4D4Q(Y6=A(2A

*K9X8`BES!!('1W$Q\3#Q
0DP3&),(D;
M(FYKC)G)CGT08
$ATDQR91$3A%:E04ITE.


M






M-RYX;6R4EEMOFS`8AN\G[3\@[@
VY*R0JDG7K=(F3=



I!B-KG5+HD/W0Y!2C/TWJ.9ZOP5*:MIK-N0:[



M(GN%PPXO^4#B&[5+'X^'F6]%+?X
P&74GP^+\7)KPY1RWA^#5V]:4<LVF@93



\GNU)B?F8U:2D2UK2BS@L=EYO&X(SM6D
MLO`WX^]$M/*U19FS1`;;+NE&7EBV6M)*J&--*3``OCYGM;\:*W

M6H\R5M9@8D




MP]*Q$
)SV3'P2
YYE)/45%!SR






NOX


MXBUCXO@@._O3/Z[E?P```/__`P!02P

M)`D@0E6HNE7:I&G:Q[-QG






M$G3^6+52D4T#OE_:$'[GYP1B\X55++TGA`YSNAYYYG_LP'IN6BX.#`QHX4
M*W-\%\[7*?:7BSZ?7YSM]-%_I&NY^Z1X\86W#
*&

M







YX;6R455UOFS`4?9^T_V#YO1A#@0*









M`2K(#YCK4TPR(@B(CQF`ZC2#]Y4]&#+$:**\&'F'[*X#9C;%C(@7RD!SOK('
MES@9W8QS4;*(!JVBU
=%9DQ0AXH0EIG:_IP1/-?*0

M&+'S-3UXHOEL(VB&[:


!1CB
`UUJ[X\+?
M@N/':?T/``#__P
`4$L#!!0`!@`(````(06+$6^`




MQLNU36:N;;$RX6E6'M?VKY^/GQ:V)20M4YKSDJWM-R;LSYN/'U9G7C^)$V/2


\Z?
M%/HM57^Q<YH]6/CP'^UE;(#?<[E#W[^AV7'DP2[0\A();9

5$C;2IZ%Y
4?
MA)J





LWE9M6MD]QUT6@3B.B
MZQQ,%K/+'DXL\LMA`_3ET/:*L
(PR]1$[X2XBM318_L7UH?LU)8.3O`KG=G





`
'SE]0^B/#6[#9N=O]

%H^%-

M(B3P5BM=D(P%ONM[WN61A;J9/-2BIM,0@,@5AI%^!X7D`



;#8Z)$*D!+F+5
N/'Z:CE:U\FP9X_(YO46HCJ]1A@.




9]?GY)V-N39V)KO?]D9/%%MH#)QC+Y`FRT

$'P
+-@80OU?I!BB
#$6^N3%TVPZ<(.YH!F?:LX5
MJ_<49]X0<NK-5W*$C?Y^MOREG&(AN1


M3V[COX+@+TQ5Z#H%IH(5-(TE0N_\Q*3('7:'87Y(?0'?[]QR/N18,,!#EG'
M*_C*325;2QHH$1E'&4Z56
:%DYW?:]OM




M8IL&ZGZ.)ZQXS1X&%_&M*)34LC(!Q(5.]++F63@+(6FY*`548-N.%*]R?!?/

MNT(EK]BN
3_D_C

M-PN/W49+MW)


M`.C1W7-+W^-F8=^-DE.NVVN..?0L2V9D

MF7-SC-MK23JELW';/!.T\EIMSHS=V2Z(Z5G6_Z-J:WH-&IX!7L\C)HO'('



(K*8RVNG`1XE@P

G(_(ML`).-





:E@XW7;=OM

:LDYWP(``+T'```9````

!2&[R?M/UB^+]]?B4*J


@


M8AN@/KX'HLAV(_@1P9V!(V5']`UTUV`\!&8PQE#_%2F$J$WNM$N*X;)#$!*J

@/?(
FG314E'1'ZUJB






MOQ$O+\;8_9=9^+HL6L;9H5M`.`N%SCW'5FQ!I












X)I
X7AN+P!\
M8*P;OPBST\5[\Q\```#__P
`4$L#!!0`!@`(````(0!U_;TOU`
``(D-```9

#+Q
Y$36OX


;)F]/W&9



+X$

$



@DG/?^1$@:(O3F\]!U75T1JPH6!C-5H3'B



MF-2U]

M!


'FRVPBR8\#


P-Y99:XP[#'82R^V8$S?:-6UF-E

(X[:=TR;GT=)%

2W&S2R%TE!A%K:@G&(H
8ZBL








J#%H@.AQ&MEJOXEX_'9D
MPEI,'2D:T@XMXQ=NXIU0XZ;#U)$B..C8$MX$NW`&=E1=/&2U0:3WNBUGQ#LW
MY(2`M&7D2)%+$(A[*_T&*#/[;8(<$,E^B[/`=LKA-Q%ZK[M-FUB%-U_M+^R
M%.D%R&PG[`B!;[D$0HW=JV&6[N$T**_SQ7@^-*FW;$?!4.`?
F`A$
'MEE



;
MIHP4`662G8TR



MG.HF9QH*(I@S_ES8TN

M0(AS+


`4$L#!!0`





H7^\W

G1/3_OMNUCM_VV;]]/F.30OFU.









MSU
5'//(TJ@TC:M*UF8\#2L7
*.$Q\MEP)QE50@*-6)4U-.4O8$O]CLP]L88
M6A
TFW-^S9P-6$I
;)C&LN;00O;<\?D;L)R_
M[`_$7%`.ODAF/H;6!,WF7/$YSUM[$R055/)%JA$SIB'\`IR`Y<5Y!!20;!$

#XU]E<Y^#*\IGL_<&-W\F:
MPD(-


KY\YL;RYL\<#9+./#@LU,JYZ(B&'&30D!NY&*1]WF`/,H8WGP/:(^N#X.)!
M.0^].)W&0P8.DT&:!K$ZQ,*;QX]%/9KO0N%U@P5A'Q1)E&5RJVTLA+0!P)'
M3HM**%/3(

M\W45&[0\[XG-L[:@L?W50[RN_
A%
6H/D;T1&V



MZ(8ZYOZ\*KA\0#W!SH81E!K+$:^*($C;M^F#.#5CL(3:1`.A'3.3#`Z+\:1G
M-QXR2&TR2-

AM`Z8&8-4E8(RQ26`
MID&
@_G


M6.R\RN!EDQ9A)\L)PCR[5'F9;^B'9J+)XRDAERT2_\TS!-



M089B-(.F&5C-TJM.`CU:N&APQ+2@




M=8NJAH+H!0P+PF)J#*#CU=I!D['^._\HJ!;\TU:;*)UBJ!183G((PW
B(L





G,P0E^QS9B%?33-P
M=E=9?19:/5R'\.6O+0B6W._3<@OVD*%5,/-(D*9!G,-51I^A`X-F_?1&[&@


8E&1Y%A7B

M1_
-#;YS*;K%@D9$TWB(KY(?&30L2JL]!((XAZO


;P*QC/G


M6-9R!8^TTI\SI[NIO'Q)C



M--D9E6FSPA=4P9
CKLNTA9_U26DN-4H/7:6R4'15M90RS2N9*FSJ1S3P\9AG
M*



ME5GMJ(O`G[5T0



UD=F$'#
OOXH`D
.\
DYUV^?QYEH`?CO.!FA2\D`B$1
MHE(2,1(EDB&!=ANYFZ2!9U`_;PY76)5-K)


]2A#\T1S3
/D#/8I8'8&\_8-SV[ISLF'(OE(*!$+B63:B&'K

M@M
4?&QA[&KQ?M[BU.V#7@\M&2I&`C$2BI%H1
A!7%T9W.H9C\^_S/UD$6$]



\I++E7O:!E[TY^61

$
M%``&``@````A`/MBI6V4!@``IQL``!








ME]]^]N?7'Z

MV'6/^H)+/E'H'D4=3$M-
J0C)Y`6BW9I!'Z9E^D

M2`C




U9^2F-+VWA`UH




M5(;'*`&O2]U


[F3\N>]I!HTW>04\\VI9/G>:W/@G^Y\;#*#4FX=
M-@U-9O]

D```

MR62QXR`!=A8!35$V=WA12&K&WB`O^9Y\5;XD5;QVB2*[235%.4F
[$B46'WJ


HO6EIH7FH^4:X:F_MCSX9.4'





T@LH`J_
M=GT5_JQ\-APX




K`Y+^W9C?L$S);Z)C\WF


#D[/9[/9
M!4SH+BYFD_%P
HE)OD\SVO:6UI.%\U-I-)413`'!;'PQ.QL!D
'D(F[JH`C&

MJK3B

I-7':5M8Q#=O*YXUPCSU
MW@^6L/J1;?@
RE!`\0X:/Q7*XJ(_
&6(^


/9I'ZZ=V4DB\3
QS[MPYK;SO:!EU[;A^02;E]F/N#%7&E20PC8
MI*[#(Q

4S8


MBJ).&)(1XX`T
!#Z4D@F&T9]222+H2^-+$(QZDLB&0A]*20;B;XDDL70ET8R

27+JZ0UNKC-31`NAGAEH6\0VWZQH#Q3C%(

!AP=L53Y*3GZ!!=5


M9TVHX6(2K3:^_Q]

M%
.L
.O



M3QRX+S)!.6M!AU











MM4]37'!*BHMR/Q7D?K(KCCA58GARR*X6%M%'%&V&.[!Y::VBCAX%A;X')3
-+\G@OF=6DB!?88CR;P

Z(P%@8CKEQ#'Q\2V8(*@+6(;S07\C2HV5^


M)NW#$L$QYT/MR3-36PIBJ-/QN!A[V%=-VM'*WPJ+C#*U3_RZ?BX5@Q[Y$!
MCR2





RG2QN
MWKS19X/18/$/H
QUO/#R:3B9JX]1M+[4M-!\M%PC/'5M
_!#?Q6=FO#P4G^U



M/_Z'+_-\D7#O)/_UHYO%8O;+SS_/^S?9.
W7I[-LPB]7T_DX7?#G_/KS?#;/


M7WZN6_RVS:WD[72RN

M;




MD(ZR2?OG;Z9Q#R99_V,BR[1\+5DDBV2Z56ADP_&J78OF0P75XNKI:C)(WW








3


!$_*!^ZAA/KI[


4E__HO/_W7__W3?_N7

K'B(8UE:EAZ:5'8K#JXD4FWYTIX@^
PQO.OJ'


*U5XC=J0S1&3W1&H9G@U




8

(F@


LV)]22%@^%HB7(K$U#G
M2/6&F(^YGQ_YAL#Y1@8CQ=EA+2)(7.9\)R@'_(+S4H0_BQ*WLBU#7MH3FV#-
*&0]IF9$O!3<DO6.:<L
M










/CW;/]G?/]Y







^K:



^L$4)'?Z7N*R6^Q]_8V^L;\R.4
M:I%Q]MY


M




KN%


'W

MU&4DX_WP0H5-'X`'
2S.C5WVMJ'U3#BX)/^:IO64?FTG^U?&;1I;ILG;X507


M5W$



M:[$_I4)1@AECBG

MN?K!G)4$/#;E+

MXJ.+'B?.O@M/8D*&`'BV-1ZM\==DC?P

MR_*

#'5L7T]3
I9D4YQ/N@2
MYPLAZ3+-UR6_JT8A[BL!OR[R)68BP\`FA&)9&V\,OF0'&)5@ZQX6D3BFH`P
M$?6YMHXV]JPJ689U04&6#ENDA2(;72
N3A

21


5USJE






&-I0-0EX7V\*Q9
M$.2&/X$XCR9+4[K

QW]




M
#L8#`Z'H?9QS87E`$!?H-/!)58?1H6RQ;M%3PP70+T4BTB`M:BTL/NAA6
M0M'IN-]9C^Q!T66UXZ&O-):R
P?M*
MU&&7[YSOVM7;SW')])J4:Y+3'5@3O1-93ZFT%DN)T)['4X$2L9+W!,SE)$




MOAIB'PB$X`6]L:R]?F_X2;7`DJ

MF
B--G_

_JHHVA-/Y+#DHKVR(30-2+;ZZ@
?UIW8.C``
U)BX__KP8L^[)AE<P4-J3M8_3NB[7$_,I2'J*+GDV;.X`_K\
MC*J##*'BEH5-M+N4KCG8:!B?*OFB0*=ZP3MEYZ3!%XR`6#(G6'QU9O7]6;
M3LJG@\V&NI@O9GGR/0+XE4[]K?`


MLIN6^#0P8VE@F&N$%6!3OEL+/0[]@;
-`Q)`LA-)T2@BF-N6`YD;*IA4=5




M87T+/QN8'RSN-2X8;KH9(&@B*Z_.)CA4U









HX59L:5ENA-?ORT+1IE#TV948BAAH6BC


M+.GBX&)^A[2PJ7B=O]'YA)Q(8MT5&.[(IEWIQP1JWG)P)
BG

MV67])5(:IB

MZ@&:JO92490(V?_ZS=9)+MG2N+7DH+^GHSEZ&I*;

-R=X+)N676)+APJ9ZV



M
G


6JJ:OI
W
DG8
!T;!(-7M9

M.@_I




M&I;:RX

MACB5[O5V/^];T
J\M&;318:\/?.]


XJZ
M9$;

'3]`=&O%%7#F0



M+LKS6SY6

MKZ4$-DVX!(6:);


M(`AD3S:=5Z$!50P.VW

MG


C&1L&



Y0HP[)R_


MKC-U7
VHU

MZ%;;S








M1M/G8GM_._%7

##







M6TA]PK69:C3&/R).TX0XD&UB8)4C*33`U$A!=@I2Y
JU1JKWB$Q\D-RI_%9E


5RQ`
!
5I%]
7:QK

M:'66!L:NT)H`B?:2#M_3R?AH:MSXW_4TW[W*(\)8R+6[85PX:4POX2-.C$YN
M4#+NFBXR8@MG.6%-[.?
-9[@8QN.;!=!.OP5`Y$H)P!NH\\G.-`RY0E%(Z

S1Z4]!;$X








MN@R3#1F


X:

?)281W]CMLXI%ZDQ6


M++$XA1VKP=M6C^K+S+T4$]YBSG-IZK/=SV!*%)U1Z5&U`U\8V/_R-VN@OL%)
MAA$JD]
H


!'Z(;?JG0BWE<19LMK==%]^#X=C6S:<+NRJ_OFK
M[Z=M/?TO['!:7*\[E-5=U9[[\9/?_SO




;0
E-%







KJW2N9355^
0GP'CM7OPOX:'W%8.
7B

M4
_A?47

M#3`;:7P]


LAPPA10OR6IU(K-B1+'^ID-
YJZ:





MES0+Z2W:1(?K2+G?E@4VK[A%&UO1$_$V7P.E;1KA-::45\W/YC_W?_=$DVOU
M\^




''EGEUNO_N]ZF



9R55)S.ME]
MKN3
YELO4U4#/I#C6=O%C:

G0:C^V



ENOQKN=G*XM73WIVCA2^OC^RW5K\@[


RH&-;VWM9V&1
MXJ'/QU^V&:ZA4DRF0


%UVI%?=EI'5:(#B)
M0!%7XE5K_97
JPBA/

]W:Y





(PMXJJ
C2.FG
MRH!1&ROD)B.K)?Q


!G?@R-SR^ETF*0Y/45A$J5D8%H0

Q_WV9=V%U)*5+93]18SKA`]
MGX(98FBN7G$27A1'=PF=5C!'*XKEJFAV-3=4VI6E7FEP;3+54^@+RW-/`-
MQOM;5W-:C+#5

613
M.:-I%/)?/-?ZPW

M*%.O_D#U1BZJ'O:2ZK[\C3O@DL*R9?J







SOTU3KF13]9Z^D/^JG_/11A^[0RH@$



&%5O
MT'KV3'M2QPQ68*JTT2#[CY&<*]!VI\?#0?S2X
U.Y
Y_/HT.1HL8SRFZ4SF
M`XO&1FUQ&@FW=$BFLS[:5&T;.
&LA!S3+%4HN7%F$)IJ+J:JINS'/R+-R4

M6L=JI76L_0I:!Z?&

!;7PX

%#;!8.




YTA]EQEF!
AMN+KD1PPD
MXDV836=GLNJ
RN?HV\_;YO/K^
^[?+?E00^GGI8:O(#KK!1PDRT/84IVKT


M+%O;C\[(OK`=(+':;68ON!NWM(8Z;M5-1%&N&A[4AEU+O


A?4*
M=PN^W)02`]$19E64!T)





M.-$
CM$?[:Q2UW`V8X&7.`Q#`!T7B_
`N].X5

MET@P&


T*F;MK1)'Y*6V@Q2^*N5.;+S5+;`D9P;D+\P:`6




MN2T/RK





J.-*^F^8[0HZ1&
MS\0BXWF%
GD?WT.[?7Z*L0&UED%RNJP^5)K)-
EV$IZN^!241*4K0:T?[1





72&NGR%100=M[^U?=E_U
MWGQ#EW^:32;URZ5OOD\Y'W2=J1'Z

M?




595=7U$SIL!



.G89Z^53Y
#)!)
F46_
9F1


9=74\*W0^ZL^OKL#?WA^!

MO4





M;FW.Q/Z[)DOM3ZGK\'WG;/VR2JD



M[I^GDTCGU%[0.W

MGJ8V!Y


0CRA2\$FG8(DN/09F#T1X)1IP$N@9?6AV`)4G2_V
M=;+.!

M594
0F+5.C'5U



@;S$0_?'!9UJ03[&65

MLK;$)(%TH35NGOL5G?@(6$YE






G@8A:I([91YZG7HY!_S'UA

M5R8&C
E!#=JI9W?#BR+OJ%C5TAHGYF'6AU;%8@_(PM*B@Z\)VO6:VHQDK^&A

E!'2ALF%2`A'1MVNYS9S7$X
1I#A_8D#T


M%)G3

3JBBR&=GD!A/))'_Y]-]R

MUI?#Q-^4.J.&9#LJ;

MV+RK0@'
\/[R[-3%&/(U)&@YH^GM1XBWVN3(
MMA$NQ.%H:7X%I4%8/]?OKQ.R'NE8NX1A)][!^SU@(KB[
\S$RW0USESD)[*W


M
FTLM=!QRMD%H]&M/`VF_=ZX/%6#8QQEYP*4MP^):MWW(;'6GN-1'R:.T/YV



M6!


MAYO#$]N+Q

_(RKH*^9#*[ED3MVH:YBD1&$A


MLK:T&0/BT$4EXCQ'IAB:-1:JH9A84@\G-)+LDMXT*AV;ZPGXIJO#-;)V5QH=

X1Y+%8C.].-NUE`W1EPA2*#.WLC:8'TI
M82_PU`!D!4:62
TT%GTX-ZE&VI&`-[L@IICUH+$C5=Q?_Q0DT3UH(:F*-`C

7X/?YK+%BFFT

ME
[?QS<*+\:[N;7OW9OO5
MV]VQ[OUNJVA%I.'=L9F0H;[CQ#DSG66#SF0(G%WE-2Z\
-TGUW#-+J
J!@9S
M!-?[!T9ZP$:;@1\3QAA\?C''^\^U#&+P;TII+'5S$\T#?$(I(;'XW%&`G_6?


*D7OA:=:@U:$T/^?
^


BJFT&G2,?P

6^<&-?*L1!US7$ZZM#9LOXM:
M#3WF1H.JF-4^8YWVY0!&ZRD898I@5IN7P#?R1))G-'9S2'N3$9Y`;\-X9^

M/REXR]?2JHU7-)R@Q!*A12*\6'WMZN@$9!(5W-T64&MO
[VC#M12PC5R^Y4=


M346PR^UE;RC











M7%W3C[PTZG5^?16L+C%H8SF@MWE?VT


M=*&WMCI[.4$X3O'U]V;D?D]C(GG._2?9N;]5V$+(%$0H'@*=('.(.*OH-^H`
MB#5HN44?F(24M6&)%5K4I2=?'



6%








M!^$50)C^[J$




.:[H<^E.ZF4A;@'T=^=W<97?`Y)NZN_6N<W0J
M-]ZEH`],N%B!C9B'L',ZL.N]FUF2T++?&5E@.?V*=ZPJ?'#V5'G?IMY=W(S




-%L2[K4(I(KT7)$_K
7TCL[$D][HE6UA]-H6D&H;!




M_CBOPQ1V]-DD;^:#3I3T@C



L_]_-.Y97\'91
MU2V'@Q(:1FN_GUX1Q\]?DT-)RYPN\PM
]7*2)SD__
.^)SQCMJ1GH6DB\*O

6\WGLOU+):CGI]R:$CSERY#/![)8@DSXH`T

W#BB:0P#$W'`?5W$'1)?2^:3J3`3ZYCD$]&`0YE1$0GLV!0E

M'_+'U7D`



MWD033SE9H1B[3I'TPRN6S'2QGEKO0X6I8D?2B!0:`-0+D#OJA%SD6HZE.N-%
MTVD5EVI&Q
#P7A1O6U7\[8B^^C*Z=Y@_WDH5+AUPE_7=K:KDP9#+7]8=2^8&



[MIX^G.K@V2O\2:X)

.^O[

MB9N@A)@4.I?%-M6+@##

MHD.AO&A
5:FD/&



M7602

M3'401!U

MVAVL^ZLD(Y_^PB.[%\F]/+('\XG7V)@V[
\I=1#(16G9_3T.Q!_/;DB1O/U)

MZW-7.%R@0326H+X&RG*MAQVM=H\.^8C!](S-T-EF`^-Q$'KM0XKNJ:6J.9
MLC$.Q

<<NEINQW!QLLT`
:S_1.GX!
M
V_(D]UVZX.#V56YUG?N*RQ_O./4IG6A'T5SRL&'3H'*'TLT*'^V?3
5-(W:





$J1YM;.Q]V#TD.*O:W]L9*SZK6ME'
MME7PU2.?N99N9

KD@HIHIK3_)

M:\ZJGY$.T_
G53\_1EU;T[AIII9(K`
I





LWEC$OHN.N7O/]]R<'Z0KU\+5)(+;-./W1^*2*'$
M-M^Z%5L$!ZSG4O!@2M!&G]2595\RG@D!$4D9[9%YI%5]S]'ZK.=6M0G_;(P

$E3MNY:38O!/6Q%]$5U16T%M$Y"4H3L('PL5/?7+3H



M`
%EA9NV&Q:IIY]D[%*(5EY[&UB]?E4IK_P6PH*3PWP+XCMWIQ8F8Q85\S-L

L&:MT8D




R
')C\=R4#BKG6PX%YGTN=U;Q;P!=?+#&;
MZ



Y$?9W)`(!7A(6*.+F8)N'%(\##Z[#5$*

4TVN3W4
N&BXW!&

IKUV]&$

M1)WR.D?@W^G%)2%C$%
J-

M.K%HY^]MK2%;Z'A7GKN]`[
+[SS$;H-J%[C+(ZT-`B.`G'^\H-)F$!N/1!
M8'_(E+C`

M@3\.GH#9;=%9KZI-ZNPL






M2]E:


P[4\RE/[PA($B6
WWWY=<P

+O@[N;2KUQVZQ-1YEB^
MY@$BBCB#9YYG7HMTYUFO3#[/3#:`%



D)0=RH$[$7`

4Z2EEX),]-AAR0
M5\H!

MPS&0G_T(\5&X(V@O=(ED50!9L%93M1*1LCBE'1*\DHF#&`HAIC_#(%!
L0


ML-*G\;Q!0K!Z_19DY_C7:HD!:_W5^)N8J0GF/.`@J*^/6*I11NPW0\1*-`
M/#'NU
5.KA2J^+O6^F;^6C7^++;8U0W-U3W_X9A8YIM/@I


MTCO6/^[,W1#BZVW?H;YUE!I-F1)+3HS=]41R5/*!/8&H'-M8X2.K#O38

3:8:[F*^/1=$('
M1)LI@N_4V@_1VL5TCE-S3:HQ4*:P1'U%3OY!RTPO4(4SV0ZTU;%?FS@W)I

`HW)^GY4QH6P.N.J'-]_H=(/X;W7QKT[_]
MLNW1-BK7];_;6TPT`JQL28A(&*94*]((^64=B(F#BUITQ`(ER&W8W\-4A=W


UJS

MIY$;^S-TC=+`\?='KB`QX@*DF5W;JEV$1ELK((Q\EE+4;HB3D\/@!+*L4^)
M_8*QZ/HK9FQ]2OV()7Q*TQ:1^2'?25!_ZLM28WZ5?KI0I?NT$KX3A26^/




*-%=J(ENMX^5#U5\)Y'[5D&$J^(J%V+^OJ41N_Y`A


34X^'JGJLY`1:9P4FCSM


Y%#Z4UUJ:@\VMKZ
M`$RH5R[Y'

M(?\HS


MY/W]I9C

H7I@BO7*6OCM3/1\-5.-36?KE

ML+A)A%'O;=U5-V2-[H9)5!







MGDY$LGC-00^8(G5_2-H8^.U)K#II#P:[9%`BA


(%0W3ZG!@_Z

M+Z*9NQ870@6'L3&;7`



M
[
![FK)]:!A5]M:4Z4K&)W4D



M?ED3K3JI'J8$2



R(GFJ??AQ^\7QBX2A28(&R-KG


M1

M];.NN4^C]E0RT`6FL@:E5%5KMD`-%V
^TK;B6R^'?].W/T$]\@OQDAX#`'S0


M

T5K72K2190



[(OHF@;MX^B]W4$+IN@I;`G7$#_$W$W
MDBTCGR
#^W=4









]TZ_+Q.D


M?OAW$`




M-:JK9B\QFV


MH\LIN:U2/MG!K2S89DNF=
[5
=9@M



@;H?PTAAYB;W8
MHF








MV]X
Z#\=5







MP*\BY2LO-@;5]$[P
KS#M8#?Y03S3_.TP2;2MHGDBD=JIRNR\5IU;16-[:




MVO*#.K5&]\8HJ-7Q-%[C
'U:T[)RZW\XDBO4');M

MJ*1:=Y?5

6//)1\MN41WEXB$IW%KV?M\H'CF[&AI/2
M:N;795DIB!R'G=2^O\;G?8ROY1]I@3L71\O]-B



MF7DI:$/*4(%P6A2-Q?H(1Q&JD_&YO?O?/?.'ZWA'+9'T8&MGI!Y9^Z

M'HQV)Z.-)=L;[N







M&-ZA!QD
@4DQ



M-@='U`U+LC:H+)PY(8%3)GEE(\.BN8:#[_=YRAYX^ERR2B))PXI$@GYQS&OQ

M3QLN^%[.@






M@WL$JB!#X%!#Z%4*K_SY:B``PLB_DH

#E`1\DK]MC](Y+./2W7X]PR6-PQB8S`.\YE^\/ZGK27QO7OP``
M`/__`P!02P,$%``&``@````A`--3^XCY!@``9!T``!@```!X;]W;W)K<VAE
M971S+W-H965T

MKA5;3H3:EB&I3?OV.Q1IDS.*3[U(X_C3Z.=P.#\I/7[XOMW


MB+#K%\GK


M/3UV[=L



@B2`GEGB^YQ,I(6P;EH=XJ1QKD1&@#(&))-
M!.E(F

CSV;

M(LXA3EQJI)0$*!V0CC
?OD.:K


)$69@

PGM_IA[E#X.N8KS

M*G`:;W(
/K4




XX(\U^7AY['B
M%:FJ8HQX:'@&VIG
2=LI$9(IJ;D

1

M\

+QT9)#0]:G&6F\L


MYCX

M2P

M[33MO]\Y.+#866G6BS3`ZY?GG-=PLKQ]J2OOF4G%19.2R`^)QYI


M-7E$+*F&@[E+EM9#3O%M55$(?A+*@I;XAQ6
A+/$11\(S=BVQ?LT8;$\DJ




27PTF0#]\7I\J4E@@+KZ[JFFJZ44

GB&EF9'

YOI$X[1M
Z:PV


53A=F]
83'.
M;
;Q/8;B]Y(UFC&V


];9
87%F-B
XZFC^+W4C6:
;4QAL4$\


[EC&U95RLO$
M'F=C#-MM.#O

MFP

`4$L#!!0`




M[XH[T7LG4ZA]7ZX_[&36.X'GX





RLK@%F.(;0]O

MFF:CVAH;[


X%V!`.AG.-+0/]4W0'$]]B
M4%8DXXR@%PY'E*T8)2W'A%#;8V.!@@XL-'C;XV!!@0S@8SM&]RH?H%H
4
MB&\Q2.OD%G/V(T07%G(/1)?1L(2]F
LLPQ0[\XHS(/!IOD/=?4T2-DDX).&2




8(06W8SPIJCW=O1B.5

]8]=!(G-8T8M.(0R

(#;MQ:$1

_)``_%Q$3`
VF





MQ)1L@&(C*F%/'2E&DLU?M[72=%.![V







`4$L#!!0`!@`(````(0`8
M*=B`E`




GWCF@Y


]14(PH6`1D6ZL;X#VP&62;2T40#F@:61H2H+9J^V04^$
MFZ#@$X`TB`=_!:DTX41C*#9O*31&,#$9`VCXM[.&FY8V)&)(4IH$!J/21%UY
M@S3Q4C?1%1M-$65!EF6#0F.$G$T9WV9#L<$6&JVS5IHS6^#BW_#+788W4P6@
MNUX\9EACB]_#AF*#+1E[1]56:13;G?<7-$V0)M&(KH$E[P%#L0D6Z2E9*TT/
M%F:9'YH5U261%\1N.KAH=/BJFQPD;Y<4Q2;=6`Z5-J51=%$<^U$\YD65=*HP
M&U)CRW0V?&S__4C@)I/12,]::;+ND7!G@7FP&,MC8VAT'CR=T]3=AM?M,OA

MA.K@UPG'$^M
J$378WU:SG$\_O]A.K4UPA3XS%8P^#G3H0&CG&P4A;'[M4



MUWB([98G[$DDAYP5VIA(EE$-_&K/2W5RRY-K['(J7P_E72+R$BPV/./ZHS)U
MG3Q9?-L50M)-!G&_AQ.:G+RKBYY]SA

.$6#:


M9M+2=!3QD
)B!)











1N`9
U[.3XG-_&;Q-#^MB=NIY]KQM

M.-G:GP7\D2&PJ4+BR
H9D_V-VK*'OT;K?P```/__`P!02P
$%``&``@````A
76E7.CHZ']<$G`05

).T_[[G6&`8J?-




MU#!=D0P*W`G`&QDA\GC^TD?4%

M%*]M
!\7GONST9?@2!-.-;HBN:;0V

8W[$?$.3
MD



MJ;^C!R6:KDG:05]6??O$?IP#IV%YX!X+X0:'G!L;/?_`(``/__`P!02P
$





MLW7694BD\QM




M%!84-A0.%X4'A0^%`$4(101%#$411I6YC:]5K\?'2S+D.N?/.V(2?20B6D



MZ
9U'.%\A@QJH=@?(281)C$F28I)ADF.2:%DLAIY4/5=`(WT!I8H1;OH
B
MHXW+&BF.S@H3JR:B`S#'
U



M7$P\3'Q
`DQ3)
8DP23%)

DQR3`HED5/+1\:_D%HQHZE5B=A6FH*5
+
MB=51Q=3)F(/=@4B'[&#B8N)AXF
28!)B$F$28Y)@DF*289)C4BB)G%N6JJ_D
MEB]&+FAU
L2QU`12YA82JZ.*J9.1$KL#M7(+7\K%53Q


(DQ23!)


+]FW34(2?(%)

DQR30DFDO.I=

M
$DQR3#)
2F41
XMG?527Q+H';-=!AD77=9(F5=11T&LNHJX?IUJ\YDY);V)

/$QR3`)
0DPB3&)
$DQ23#)


8DPB3%)
$DQR3#)
M
2F41


M5CJ5==LWL?B7[5MAI=

M8N)AXF
28!)B$F$28Y)@DF*289)C4BB)G-BOS6^Q9^2T^UDZ#ELC93\KZBB(

M(-QOH3B(&'6GM=






M


O;05^;ZR


@HR


/O6&7^3`(

MA#_K/F)
WDR$YBW^+]X0'N=M7%EBJ+*

`VM+[06$9C('I66OI
ML;7;1$5-UT&FO!D1+7$
9^3)56WIS\K:049_M`X\1G1_.'-/]T?SO#8A!^%H
5H`9E8
M[4<KR6VZZ`8U0<9LFA#=YV@Y^:3:M`*8=PK,M$QTW6A='^CI61B'FDUT$?-

*VD5_`2[BR%FSHT$$72M3M
MSGTO%!P6VJ\G.!QRV.ZZ
X`/0JCK!;Z@/VYN_@4``/__`P!02P
$%``&``@`


M7A54PF5U]



M'$3\UP[S&.`H7C=
_WT[Y%

8Z?8N9
M2&`:8*Q)







M?M47-?UF*2)V[PS







BYX
M;6R455UOVR`4?9^T_X!XK['SX311G*J)U:W2*DW3/IX)QC&J
1:0IOWWNT#J

MK57#
_S#;Y9?/XTWRG]:K.+0*&QF2XLK:=$6)8Q24UD6IY`T]*I26U
-4;



M!*&GGJ=D2H!I




[ZP@.`
.'9S/WH&/E0_[[UT&



`
M4$L#!!0`!@`(````(0#

M
7)%NFF)2Y[\\OP0_FZAF95AT^:5%]




IS4#=!B89@%UA

M


;:/B?$L(9+:B+5\PZ^5$I+


[@8U2SP[Z6+H0;8GNQ_\7S7J.05W;;VA]I]Y:)N+!SW'!PY
0,5#`EU66Q$OR`J;9'G,7,/`<,,F`(`Z*(/:=&4'=LJN*BZ5NQ`XEDG/




2^
MA0%*Z^6N@@A(VK6VW*_T;U:0V:9NK)=#@OZNRM=.^+_6'9O7I*UVOU7G$K(-
M\T1FX+%IGHAIMB

M[`K(*
C


F8#R
M_1\R051()G@

MOHD3[!72?
_EL#;4QH+GCD6AE
1V-!E#1R1)$8D021%)!.)E`#82]0$DWT
MDRN`J

T3K6@Y(29G0K):/)F!)$(D1B1!)$4D0RD4@I@?#%E-RN!6(\
M1
Y'O*&$[

M%)%
)%*@I(T5#J_;=4J


M(NZ/5?&T:6!5P2%V)5H'CEYZ(!

MXC
?(Y(@DB*244(')
5OP?'SGQ
PB
@98$A
`48A0^YB:&-LTW+ERH\F@S$!

OL
.=+Y9*
&C#HZTX86





M?4$E6U.
'1.&!

P&XLBF'`^\BU'XNPBJXA;L1W%

M
V
VM#[E7)'F2LC5!ZN!MF)24BB2JH6A:8Y#BR)O0A%'BS'!
4/)I)PJ\DQ
MY6ARS1'.3[24PGQ_5PMT
9

(HQ2C!*


`4$L#




_SP^3DZOQ^WZOAVT?YZ$



@&UW@./A+XR[=Z


%Y
)BB&%0&7




M0*-H*B9K9]0%JDBA2*E(I4BM2.
3%F@`V]+P2%MK'BHB?[YJE&M4:%1J5&E4
M:]0PQ.
SRL1K6:O%VGE[?MIMOJP.

2LO(&-B$JUBR*K0W


MKNU-%!Q^A!:)4L8R0K3R2VE1XE`1()K9NL7)?K6L1)-;$_P`(U&\`+LF61^
MK:RB@'S1-%@9S6BJP&N5R$C0RA4FQX%0*U?DGJ:T`[%\\6(:SH6:+ND.6M\\
M.




MKFG@V[X;



MCX19B%:NMCDA5]L$7;)`E2Q7EZ4HTH[JM]WU-HGAYY1VP.VZ&UU@PMXDM




I%I[21=@S07S!S),BA*<Y;#*[[?C]DB+441BIQ#A963EZIDC\G<*


MZ3


MY!H5&I4:51K5&C4
L9#A%)^5^G+(K377C8B\8F4:Y1H5&I4:51K5&C4
\?B$




M^=I?HURC0J-2HTJC6J.&(1ZW4+R7%UN8[W*F((+XW+2/8J$)






.JF86Q:88-LWV
M9QKL-_#WV^/C-ML^/Y]&F\-7\Q


&O


.?=+7)O#-OJ7Y
MWEY/




M5=TJ;=(T[?+L&`-6







M\CQ8\%C*6^9NF[AF]SO%CYQ@JF&?6-?IB



Z'NTWR^KMT!S7


]$HYF9'+=Q!



M0

M9_UJ3QF1C&2
Y(P4C)2



M188X`C9TUQ$#`8=%:B*NA*G%2`2M:?[NI87L&I!(XJ[)[4S*D$38K*K4R=FH
M@HTJV:C*'44
#6#'NM[23IJ:JE'BEF8Q\UR?:BEAMW=I$1C7^SA=?[9$;*



M:%

&_A%'!6U%NJ

I/:I



\SR)V+
QRW
B&&KG39$@2*3H!U38X$U`N
MBZ:+*UR&_0:9BT;N7'IDG1'Z[;H
!Z1$8ILU.F.U@3LSON`RW.[)-!&%MIJG






:P16
M
2E'DJ.






A%KRW
MB1#96/AMC1%P8]&/L58@2B'^W:8O6[+B2YJQTT-BUJDWBV31LG,1,/?K[4`
M62JHQD&947/N!2311*UPVQ*(*SX4O;6H\8X$OEO2\9Z5\R]VI0:*3=2.!`_


BT%JT25@N&7FT0Y
M-=KM&`:
ON[](Z0*LQI1I#R/5\1?2.#GZOOZ^%:G]6[7CC;-I_KU`]PT/-[W

O.+.!
]\C./Q--809=
M1K$S\+L1J+\#

7`?OCGQM`JX#C^T&Q@CP`3P^&CH3P9G.P4Q;


;A*
)4!_2L!+AV@#]%

MC`TD!M*0E[1







MSHB

MPQ+


M-D!IL;E

/-E!*R;!U97:!TTVR


MK4P=G#Y\]!ZC*HRA4


_AI0F&W&V)5MYRKZ@&0O?K'SNH_````__\#`%!+`P04``8`````$`
M2:'WA*0``#`!@``&0```'AL+W=O<FMS:&5E='

]L(-&\I1;\FT;TYL0FV3ETDNJ[?7_!
ME.R!8B=:81\]*4:2Y9_K3FFZ:R'OAWA.V8G;+Y[12\&T,JJR$=18/1YSAG)
X<]'/I0K9/-M]ZP_@FT8EK^B^M=_5X1

LK+Q]ON&%04*)
MDH5C8JH%`_!$4KC.@(+0AP(G(Q*VQ0X74:+U2R-`8YVW-A;X2@Q8GMCE?P=

I
/0IZ!LH


[*=0B
99*7


H5(G-_+7W?AXD1KJ7DNN8?

$[M
0'0;5-G'[G\;G^=9?!3)\@`'2TYI_I;H6G4$MKX!RYDND

M=#$S+GAM;)1576^;


MIL1YWN2\-HW

7BMA


:N.5$8S*6!5
Y38$3F4F
MEV72H0P6/876O6T4#P'NQ$0:SWK^D$'`3$\P\QXQ
`J0\481#+T82O\C#M(!







TA?$WQ^+2R&AE
M]DBX
JU?7B^?LJJ\0(CGXE2TW[J@QJC
%LGA7-7I\PET?V5NFLG8W1\D?%ED
M==54^W8




</V^
M



MDJ@$902VF)^0$1X%%A4\95!KSUVL=]
;W4O)8#*DA)`D)0B)8D$0E*6P

V`&W?*Y8@W@O`=7LF%AW.Q'8RDFT](0$A(2$1(3$BB$B04-OW'



U
DH8@T&K&?NAI=
%P9GL
MD0



MA^]%(76
J&-
'1/DB/7Q'DK1]V/%(!HQ)%L@5`S
T9V*^G`GGF796JF%-'K4H_O18RVZ,W78?*+U_@F*CG/*V[`[.?U2
M76#EW#R;E*V*MUG:7M4C]2RFR*<HHBD**(HIBA!.OFO9:B^X.UTG=FUX6Q
M80*!ONO<.Y:E[R#E5PK_M51HHBD**(HIBB!$LF7==CTL6/1ID4`YSP]]S
MPRC*27(IU8!12%%$44Q10E6!_OOQ[7)[HUI&]HX-0I);^2!RN9&)\1%%`4


MK'KE;ZHA^^OE@



M+NDA_SVM#\6Y&9WR/4P^?'R`W;06'S+$'VW?\CU7+7R`Z+J_(WQPRJ&KM_C6
MNZ^J5OX!F3'3UCK?P$``/__`P!02P,$%``&``@````A`;MXXT[!@``.!@`

NI;JJL@Z_-V6KO


MLOVVJ=\-6`P@97O/Z-(B'@3C$\:2':?P6S


Q#A(=I!)0TH;5\@/2IE%@L2H%H$VOSVP(/
A8
M)2M-BM%DU`*1$)$(D1B1!)%4)HHBL&_\`$5H%%A4

J8[7P]5_/U!Z./)!E-


2()(BD
E&R@C/[\:RHL9H5(]KT+;7I&XW&
MZ4

48)1JB`U/]J7
M2/7).K%^D7:7





N*-X
MB)@C$2OAL0A;I
NUNUGK)9@J?JI$M%/2)++[]UK6;NER,606D\;[3WH0$8K
M(1=#CMA`PL'*H9L[O$XO5K#0M$@1CA1S-Q$IX0AJ]MOISS61$'1EDI2ZU\V


ML5`.K!UGM=26=
J?:J(::(?V@5J?Z_NW^A1YKV%]GB(70_TLLM7*KAG9=555

&#
V]^Q<_)8UY_+6&M?B
M!)-B]YMHPVY^V9=N*(CGNH

M`/__`P!02P




M]PE


7^&@]1'SDVW


L`0\MK^'GBJBP0%


MLS+Z4O]6*91H2.X-2X(@[%$@NZ\K+&/5]X+6$J/F,T[F%BVR%

M/]?XONF=%`

\-L5B

_5GTOKKP7]09

3P7)T_.GIC
7#M*YCU)[?F;J\A
M!LY!S
^=



MC[KYTN[*LIN!A6/[

OZ5!ZA9%LWAZ*#K\W[JCTU9;'I
M*QWV*VI9[NI05





MJ#;=[F5NNTO'LVP^.RM;+NTXB;GL_77MJL/_PF(2%/")5&XF-$/*P$5L:

M)RO#\]SRXY

IS+1%..K
M3#S%!J33#VI3+I%$-4)IMBJ

ML=OK'@K&$XI[CD]=BKH7#1'7#UQ'-1$/RXGE6PY%0B4*P8AK!Y2B24F'S()0





Q*Y
MCE`T)!!_WR]B3V

36]


HM\*
M(XD
1


M.\]\D46HJJ)S(R2Z5$/ZJ!&)I14Q-T)5'%TDYI92
Y*9D5R+*+K2A[*GGL;'



2*Y%5%%AW3Z^YBFOA7S4
MQM=



MX`!N%DB`PIE(89!6DD#O$90?43A'C
J)4B6#GA
IDH/&&L)[/*;
\X)


`
J^FJAOVWM6W#Q^NSJ+UT&_JP7V^(I?]VU?U5O_RO*YY<6


M7

=9]E^!FRAIR;2

D#F`^(P


MI6;(;(CAR`D)V.=A+PCNS`.H2.MAK9.2]#V[OGLL-,3=N%9BA&$]U:)2LXS
M[-D+)6'H.R87[RC';9XRFX8M]



MB)60&ESB3$T8&
33R4
V$HKW*2#LTZ8#B





@)!LG-N4SA#:0*_N%X]40-O2O78XDR4:`9W/
3)[

.ZH^JZXV?0P\W!(ZN91X9C0SB8X8#I^]J4+0B6@L

MM!.LP-NTS@HC!H8=)3^5C


DG8JTT6P9E

'F69HF__5OJ+1



9MXA-F(O4MB:A#D]`NCB*^!,H+06LI@6.12
M=LQBWF$W8BU\[9+V0S[/`6_0X;'(/QAGCV\


MH3_E\_!_````__\#`%!+`P04``8`````$`3
_U7B8``A!```&````'AL



M(8:U7%(3J8'W\*566E(+1]T0
VA.*Q\D.S*)XSF15/0X$#)]#T/5M6!\I=A.





MIB

M.%?J6Y$;U#':[`01X_0?QUV+!RL&GRW

$%``&``@````A

M_%N]7%RNN]/S[KT[M8_+7^UE^?O3G__T\*


L#E/


?]E.&.N_/7;Q^_[;OC!PSQ





!PFR6)Z9$]UFB,&2H4'2JM_.38`HCHAKK^6U4:@*O'5,)^PF61#
M=.H1+D'12V,CH*D3FY?ZX)%
SI0NEHR9$@GE
AI`0D:`MLY72-0.J']:]
MVZN6&$,'I[#[9FLAIIB#N&25)YF-DIK5?92DC#[-*(_0-*XN:!I(:!9`FT9


+



MI68#!X
4S951'M'
6+'0C+LS:19`2E_&*BLU0T-E!+1F!4QTA`GY

(Y8
M#W'!_%,!VF'H60.G`MA,@N\(S=#3]0!6A(L]'01)05#A_4%FW0J@'.N;^H6
MXII1%'!B%N6.`)JRLAU%DJ4#=3!%`V:41S0S=BV2C#LX:19`2E_&*BLUB_A\

VJ!CI:5@
+
9HA
MI`@3E#'A(B95PUNKZ*.]@B8PL#+$44Q2`E($O#\75O%/8`SES`+G9\@S"V
M$EXU:ER4K?%*0)*M5PQ&Y`H+0&8@IDT30DI`DH!G[5JNM!K_A)J%+F\AYA,.
MXI*YTFQ2W$9)GW`E2S)&(Y[L$QG9-BL!!`G)3!2#E(B2!#QS1\G2I)Q0P+/0
MZW$-:


MVWH;5O7X-M0=Y5I9B'$)(64AJ8^KX&+Y\EFNKJ


/?S957%0EP@BA);+//.\IVE$GE2J2DC`[+*(]H1G[
:1+$


7N`(*Y7`G;$5J<




MOL\DQ!G4ZPEEN
2.WAXF2$[55.:1PJG$0LJA@H/J57?'`2DYQ3=_0F0:5)
M3L+;Q(WM**+243'&K#_TBM@(QLL+%QZ`%L;26L3)9*90S(5(O4GF?2$2TE%
M@^^LOH[8.\V-C1*:%:ZTF.9C0+I8!7-8Y5I




M()9AC1Y3F)L2D%0

S)+
0UHRB9BUZ-4+:CU&S`_:M9[J^C

MW+XVUBX$(K=GJ4]13#

G)&/B
MMB-8$]MRSE8EXUDF#B^Z^CY)D-[R9F3S*JMY[_+8GE_;IGU_ORSVW3=\316^
M8GUZZ&'S#NUV?0\OT6I7UIR:-&#^RU5N<&/`N`T?DL-H\'A+=:20DL:;8'K
M0'&.]8'K0




(&%B(VU1^
@5MI@L$?Q3OOEDWOQ?

M@[^QT
N39=06F48P1[TI5B6Y?X%\_'V\6&!G+NHJUJN
%?N4&
#PTI/\5!U+4K^H,J#Y)T-)IJWS`*_:41OWMQD.<5.,OUTZ&]*
M)7NPV(E6V%=OBI$L5U_VG=)LUT+<+S1EY9NW'US92U%J951M([`C`?0ZYB59
M$G#:KL!$;BT(\WK`M_1U3;#9+/V^?DM^-$
(IW

M1W5V24XN

M+SJ#6E[[QL[!0X?6CR
;:K_^MMN\GER0P^9E
M=8+K/SYOWXX^VFY]2;C=ZO#UV]NG]7[W!B&^;%^VIS_;H
/!;KTP3Z_[P^K+
^_6E/S











M\:$%L8+L\AYQ\HWTB$
SN&NZ'DG&K--+N\


NTL_*)5!Z%D:T188-
1W*=$6&4#*-IF'PT9U=CB`\MQZ_0I:G4




\$[XQ8(`GA5L8T=77DI4251+U$BD)-(2&8)H?E8*1?GQ
O7&AW!RCLV$BF)M$0&D;L(6@DK
MIOYR)9PB(PV`(BVD7<+CDJT7J81#/]]Y0A\P$7`
$$
J6#UDYVG8.##&'(U




@5T3N+

`N%DCB$'9+[\BE49&4AZ%2!H11DKF

M
X&


N1I:):L3HRJ]
_

M5(0VJCVR;S'`ISG9;)XF8@)H9SE'4,L[9&/U5\O$HO6ZRH):U^/9,^\B*-

M@O4#VSPMT8KT@W


M!)2QN[A$1])
SA'N[]!
#L$36UN[&?R/;T(T

MZQ?M)V;B2`I'V@6;'TFRA?VB3\]YDAR.M.D)GP*.M$]/X@CD`]_!Z(LVA2.M
MC!0^




RYX;6RLE]V.XC@0





\_BY/
M?XELMZ]AN4.8$4XLVKQSH5)P%-(
@A`SI3('`/CK%!F6!CB2O#6?IVQ3[Q?N






3$ES&

MNZ#V-6XK!&?\.S@83'&T$HR[VEQ?*-Q6R-@3.G:SI=EH@)WFMBWX(N4PBL71
M*;U1@3^D1O$K02'K=SNAQ=]9JP'=)L1@2F@4B_!X;9QI[1L77S@ZJ]#8%O


M/'K7

M;O07

ZVZ9XKA





-ZK\DMO^

MA
.AKC..PM1C282]*43LMC\E%`\.9))$_934%U
N22BG'2R=@FF53*MB6K6M





$G
Z:*D520E(Q
K60*ZDH

M3`93C4Q'R!2*#

?+^9$5*+`!M54A;*.
HY

G`^)HPK9C@[(J@K/F?8R?T1*Q.9'
ETO

XZU@'[K)?

@.
MF3/G9/Z(E$A




MP@/W5DJ&CS1P]+0WJ4C



]&Y

9


M*=V=


M38V


MC0])0CXJ*938-Z!%Y-[34%+6:PN90N0M#2'



M_I!S?H$K9

@


ML`)X;#1V!58`SU#&KL`*X.G#V!7X'CDKNBL((#]P]Y?K9-$2WC\=X?$27NGD
MO(R7\)HFYS!Z+7.8HO@5^*.4IS&^@E2.9Q*6.F)GA2D9X4_A\DF^5N0Z#7&2



`4$L#!!0`!@`(````(0!N

T+GAM;*Q;6V_B


5
:\FJZF




RLOUQ-P[APON'R_/=.%I
YLM9


MP[AB#VSM8.'372=
YL'\O2LMT!


X]M663;R_;^]M1\'\%:@YDZOV[UR@W6P&7KP62UJYW@0J0Y-\

*&1?@;


.LNALK/1^RIP1)1#==];C@HYVIDA
MB8`=WD]$SX2#!+,SKHUIQ`;Q(Q9(9I`$:M&M]6!&AYQW1G;(A2`J.YLK1*HS
MLD253T1B#T`L#P^^M:;1(Q3Y+3T.VZ7.BL[I
QKBWD"U-842L+`KK$;DJ
ML)`C4==)*N)!4Z$UD*?ZKM=!8!03;&4VH@U$:PX;Y:YL'%6UC&SD!-(.4+)


M*[9!5\2)YD

+H+TFO#VNC#!SW_M).(*NFLK&-F'5WAY`C93A+!P03=

83
M3O@16&5Y9!V$3)SR//W9O((8[;U%\Q1[RT)%*T+M_)&99D&-%>TYZF#3_Y:
MFO:2;B(6`9,9&VOE:P$^6
M+72&$#TCX1(L=U:V'@H)E1)2$JH0ZCDHT0]@_GHFC#@BF4]Y&=0%E[];OQ

P[9*K;
6J&<3
M_Y8Z680VCIW^8&7(VD:.6?(5C(*;<<H84Y89J+.`KKXX1^:2%'H]ZCJ:R/
MU'ZAEEK#R\@(,U)&!B)E%RXR&\O0T\0+.1T?XX0UDPTBWL28B[GU6
IB10E


ML'MCCE98)U&\[$T*^OF%(J@4HPH684^#):
B&Y



GXJF16M
;]I_

@_]8&N5;N;J=`R'

-!JY5Y(!@OY1HH
M)'<YB%M9;MBMO1%P34OH24ICIFEY2H<=7;8LM

H16SBJW


2WB@08OL-


M)!TKXDCC8Z*4M\Y!!\\P1K&V#




D



/][=/C\^.7

SSW=?
M;G[__G)X_+.\N__Z[87\/:(FN9;-/_\[O7N^I2XE
Q?]D;-T^_B=*D#_?_9P


M/QTEH]?Z
J'0:8IT_SBMC8D$@?L'JT[?5-V$_.4+U?AYF^L3B1GWC[:ZP_YH
M




IA9D%N06




B`Y
&8G]X<E


J6:ZZ0X'

M*-2DDEMFAKIU)A%YK]X%ZE


.SZTWO=H%'O?.''!BH-!Z\14T+!%F27
M.[DCJV34,[-&+B)JJ!DADI&LUYC:$CGX_%\6(F.FJD%J9FEH+^NSTI$=.NS
M9A3U2']F5I8-2PV];3KL-X-[BY9W;[*\%T6N=6\RGIH8.8A(4^LX(-Q^_82`

M&39-ZUT
S(2Y%1TULQ.D9O:
II/&S&`VZX\'9MT[B%IC*?:V.Q$XP=O^`('L
MR=1R[8[TR=LTL$-OFV!?J)0HIH)TX&2

6
[YZD
M9T_T#Z+3

Q6-Z8E:/A;L;:L<T(PWF
M3*3\*$JFPPYG@Z%M-10R8@'=7(Q-FM))3HZ;&I!:F8IZ*_KLQ(1U5H+4ML;

F741#PT4T\X
T*

V2
MT5_69B5FM.BU(+6\833TP]U

M0N^_LDWSASN1F_F\1T-RD0!*&=&*'#C5BXW4SSEJ%H)T%)2



MO*TH&#SB8!A

3@8#NLD9^PL0ZT42X6@<$Y@2[*<P/
0HM
Q

M[$I&NJ#`
`C-Q$'RM^2D`\Q)&44#N&-!P9R4%:
YQ$NU\J0GA6QSZ[D4F`8
M/&]9*DC
P;K8/0SBG!TXC'2@CBD\)BP6B5!3#!859.&.(I@94(4CMEXS
M&4.D&L4H&&APQBU\UX+26#$-YU2U1VM9,&QL8LJ:%#/2/ZD8X[G
V9R/#^F
MUY7M([JYF`JB05`XF^&2PE+426[[0\F96?8J
=
1(#9;M=WWM@/T(6:QC/``










M+EF(6

%M\


M(]U#Y=T9

D%:239



MH\9.\UGG=J6A6W)Q!U^SD/M\@TK%
GX%%&&
M*$=4(H158AJ1$M$*T1K1!M$6T0[1'M$APC%[G&)_MM3T#'OW1AN&9$[I&.
M7R!*$66(<D0%HA)1A:A&M$2T0K1&M$&T1;1#M$=TB%#LB]-V5F/<63$*[FDM
M$*6(,D0YHH)1=/=P:!]5*U5*`J**;,5M=KN%$^+/;R[+=8]QO!C4]$*:(,
M48ZH8&3:;(Y\2Y72-H?UBMKL/LUV0IL;\7BWPBCT,Z(4488H1U0P,FTVV4^I
M4FV;(UMQFT_;?$QP\\$H:K.7E*4AFB'%'!R+39[&U*E=(VAY6(VVSWN\Z

R51*6I2CK4*E0EOF)*E4*;%51;;BWK&;




#JQ`4





+@$D,CNEI6DC;EKH$[]X2H#5A17#

O5I:IB$
M


TBH&
^1-C\]?7F98L[*B#RM/ASUS('U


PH-D1FCZ"Y;[\
MG*F4C+


M$M$*T9K1\4IL5$HJL15;^$KFS.U_3NAXOUV*.IYW4-K`16
T_K0CH@Q1CJA@
B%$4
M\;RQ4U^D*)4ARA$5C$R;S4%HJ5+2Y@IMU8B6B%:(UHR.5V*C4E*);60K[OC7



M&%*M0I#&32F&VN\DF;.$G5J06IYJ68T_.&^`H5UX*T2ANUU01-/#RWHM`4

MBM^


M^M59MA6

H1PY@72V7'



T19GWT@BIS1BDG'DS

YCXWK2D+N\RRH*;F/F:_IL#^<SFP1/YD8UI3\J=GQVM*+O9B;4UG

+LY\=O][6]O'6O.CEW5/`M6
'(O
'*O9_%88Q:--=;5


M




M*_O.*VF2S+.D*W(*NE)V7JGIRK+SRIJN;#JO[.C*OO-*2AW=U?Z:IH(N7E#W





$L1*2&C0#/S0\94XAH@+]64[&M`1DI7OOGK3K0\]H.HEFX<`
/S*T](C2O



DF2*XBFC@0HHI[7!]FW&N0






&Y\SY^405B-.4_9T0B;

!W86&MTDH#E+


X;NB+\$9OB
17$?=&9P_1XRI?&$+
M#%^FF_\```#__P



M%$GQHVKKUMS=9\56$M78ELM2)C/_?M$$P.X&2%G.SCR

#-(@&T``IZN
_


MOWP]O#YM3_#/UV_7QY?7W?:A$WIZO`YGL_GUTW;_/$$--Z^7Z#A\_;J_WV6'

+J/BR?]R?_NJ4






M!&
2A)\D&-O%S\B!ULYJ^



LF&&2S*C-)+6
M0Z!0@*E!#82J102Z10.L`U^#)WIVPA7^'.XT:XTYVQ!T#UK^A\!TS623
MP%HN00*902V$B@DD`M@48K0-XOH/H^SM\9]1`#79
8D6OK/ND&
RS\:K

M==YEK]PA$L)1Z_A;)GY/8K%



BV
MDQE#D!_]R1*F2S]ULS4%U$LR0)1



&_#.)9
MO!2%

MH0)S9[)F99#8C.6LS89R

ZZ%
J,!LX&$ADKN]V\LN'5;9)4!V773W_$
-#H(6\SU83R3&H\0U*TZGP




MT?J@Z05'.R.ZLC$KO80(Y<`N]_BRSJA3XU<S@MS.B$;D!D+NIU1CSF=D18M







M/3-3NN?_&U6

M:Q9T4X$$;4O5





M%]V!''Z](1(=$UJ6-5C:T9Z4KL4\


M
\L*%II5


1'26+C(4L;9`RIV+%
MF$-A'*JW`VK6[:80*H*YQ]R^T@]%663

MN7Q[HV:*-:?QS8%WMOP2T++(F#G^_@#+VQ]Y]^*BD='TS/)P0DBDE3AE5R0(
M)G
.902Y=V(9PAD-WHD#/XFKSK6F@B!^9AW(2E.RS%@DT\;AE3@&5;Y!493.

M(=GS(4)^U


MUW(LP7H4U8`
0X5FE;R^?:ZWL:R1=W
L@377&FHTU!(TY%^H$%YY/S^VQ88N


M6O6-9K7
ZM3[\6DF-/=X?

@HF.M
MF6
-;`@:&]5;%ADST=]%


M-4'T(0O81=A+]7E4K:H@*.`/68C52Q9Q$WA@



MKYU74*99:PWE&BHT5&IHHZ%*0[6&&@VU'N0[T4Q8[Z@J-)#9_N

MX7Z
?P=J95GV7.\%&5IK5JZA0D.EAC8:JC14:ZC14.M!GO^@[7J/_SJZ7U$(
'X]7]X<?YGNXX6&3Q][&+\D##;AQA@)CA1_
M@:\/^]RUW@*_@Z\5ZT8B8<W\`TU6L]==`/?KZ+QS_'-9VP]I:(8+!H0N$O@

MN_X:AVGSQHQQ0W\);\RTH_\TPW(='^Y[LV+TQ[V7[;M=O7;_OGX]7C[BML



L/SZ7A?7$&LE%
ME=CN9&I;K



4?HE

9I`HV$R\&3IE
MH@``^+9*CDL#$DF?V]\3S]4AL?UP



MGF:$M(:

MA`-_@B1-
-1H@E:QN:8P&



/



)6OV;
.*0EJ9..)FR8-'3)_5&[D[#U^_

M!]A)

`4$L#!!0`!@`(````(0`/D(M.
MR@




MS[[SDD&VH4Y8@8

M


MMR!9@?$M
=Q"!#/5),%OA+[?!
MC0@70<%[`'&XZ/PUI-:$?8VIV(\I#$8PL1GGL.''LX:+-BXDHDM2'Y-@IW6
M1$UY201;=QGXIF3?EX31(@GCZ-W%H(2L]2G'Z5!LT476HW=:`P#O$5AP8PJ#
M+3;9[JLR+IJJLM:

8XI#

9O=)_(HMBU
MHK%\CDI
3FSY%N=TU8D^*



ME%S1$_M!ZQ
OI9.S(UCZLP3R5NLY6U\H437#ZD$HF(^;CV?X?XC!A.?/0'P4
M0MTN\`'=?UC;GP```/__`P!02P

@``!D`


K_Y






M=/J282840/Z4$DG3Q0N[R_&32`]R+8)!Y+[QX76=9/$=U@Z







M(L7S+$=4(H158AJ1`VB':(648=H'YWA#:^RZG_]\8/F7EL?(^4\0&E;J_9

EVB%I$


I!



M]'PG.I'B3NR5+FUX56O_[-5VBB5X0


9Z6
;
MT/-][(+4T




2SV(QMAPU;


]EA%F0FJ_ZF9`D

MK$GZV`;T?!^[(+7A/MJD9J\TZQGC:G;KWB3:'OOO^^\_VAZC%93W#&@#'Q:[


_':1FD)$Y-'RO6'
VE@*(^-HQ\'^?3^7ICDY8=:Y(^M@$]

6(D098%1


M



MZX\3-WFV1\IC'D7]3%T:3@WI0LAFR!#EB(J`GK\!68H4JZ]8EX1-S4@ZT2#:
M(6H1=8CVC.2
=2W(D]ZCH@.B(Z*:0]IK8.:)!G/(9;
M!#./E
?KH%$5AJD(B=FB')$!:NG1GE*&9[NQ0I-E:%NFI$#:(=HC:@Y\.F
M$RGNQ!YU'40J'I#9KCV*%.LZ*5W*B7.U*7'6B;VXGG8!D1.C3BW-COTV2$5.





-6]7:E29?

V1U7CS)).I


MD6AI&/VP-SN6D$8M(U'=!10FM-F/V7
#T7%@)#J.HD.L/-V`GV.3:C_;K:GG

N@)TWEZ99^K
MJ[`[-2/I3G.V.SMLU#**I[/O(67:;IE:7MGO
Z3G],I</;:AH9K3H:$$<\92?A8E:WK@P@1-SB(2
M[P4C450&%9U<F6O)16W$34U(U'3


M*.LBNZU[UE*&AX6@@Z



CR
K;!:`4488H
M1U0@*A%5B&I$#:(=HA91AVB/Z(#HB.BDD/:%*]XO\(6O]94O0ODOJ=Z6ZHJ^
M%!.4(LH0Y8B*@
PM2W

L`MU7`P9D`9
M2N6(BH#
F

N;XC'K
KG[8,R^SE-C#J5?/&9`*54LQ@P9HAQ1$9`9
ML[DK5(J4C#D^HQZS+4E_:D.2CRX.H1*-38%H#0T=(7UL'N&[W6+%(\H#RBZ


M8$O_@MYLL:'[1R9+REF5%%)%0*X(&FP/)5H9I&A+VS\8;C_
72G-VGJVB'I^

]AZRP











MOSU_Y78/59@;#`%%5MXB2A%EB')$!:(2486H1M0@VB%J$76(]H@.B(Z(3@II




I(7
MG;*`Z'VI*&=?FP'FW%!R]@)1R4C45^/JS59HS0U[]=I8EY5C:U][Q5
K(*J]


Y$
M%I9PZY'J:;XV.WE;D1)CA892B65!RDV$R%BFT


M48FH0E0C:A#M$+6(.D1[1`=$1T0GA;0O7
9_@2]\@:!\$=$4MC(][;RHS=7
M^TR/Q'B12D=8-L+R$5:,L'*$52.L'F'--N-L':$=2-L/\(.(^PXPDZ::7^Y


M
I3*$16(2D05HAI1@VB'J$74(=HC.B`Z(CHII-US65F\P;(XH
C*6T0IH@Q1

M2
E4\;HB)V8HE2
J$)6(*D0UH@;1#E&+J$.T1W1`=$1T4DB[Y[(]`/JR/;@G
M%/QQ[HPO_X6&D2]21!FB'%&!J$14(:H1-8AVB%I$':(]H@.B(Z*30MH]EVT+



N!R0DK9L


M03;U$NZY2VY6
(QF`%D0U)




M(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X\!(X_%3'LL
MN;!.[N5-G1Q8Y(IM@BP=8=D(RT=8


M?LHE23S3$PH832A@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@Y!Y@




M@='@/3.#-QMU-/A!+!I\K
X




`W)D&-!'(0-M::1Q6SW2:5P]D-B9D?;B9@H%YCY7
M$%WI8$





M_04JV4SF&WN[F&(C:)
EBTPTG$$Z
G*!F)\J_'*_O`FV3!6;FSH4L/(AN?


`49(^7J*-HB-49$[DD
M\`(3^9Q1F\BSL]<D+Z:O28&)W\E$@0W?@2-:X).NLA$T)1

M)'PU





MOU+8(_2HBAOQJ+XUM:)WID=ZMU[1D7XR6WUK
BYE2V-MR+3TFN+(D0T9EEZ:



Q6A[OZ)@H




M;O1(

F5^R;H
&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;*Q<6V_CR@U^+]#_8/A]8^OJY(<
MQ+H#+5`4I^VSUW$28^
XL+VW?U^.AM0
226Q]NQYJ+N?2%J\#/G-R
KU'S_V


K#X;A?



M


M#;Q\1^&
N[6R


MY`HI%%(JI%)(K9#&1YA7
(9\KVQ/OS)3\_RTVWQ9'2`MT`5[TAI![[8=W=C@
MSEHDLM/=M.=
(;E%8G\01)%H\T4G1%$K?4/
$S#TESTQ-K@G%HG\M1I%LBNC
MD




I^*1E4R0]Q!0R4\\M2SH+PL!99X
MP(B@NE\A)/*42$^L8N32DJ
B9

N[

`0
[D04)%.-O15*P%KH(BN!D3H;63JZA0D.EABH-U1IJ
M&
2#8Z:S%YP/NIR=Y:S+64CP0;%=R().RKFLH$)+E1JJ-%1KJ&$0=]F
Z
M=

M&$L
%V()%$Z*ZJ'44*6A6D


I+S9




JE





M(N.U

MY1HJ-%1JJ-)0K:&&03RBADI=3
]

M51JJ-=0PB+L\B+$!I54N6ZBG6'IYT.!3ZJAC0BZD:2`V2RN2@L'0!5XU?[3D
MCJ)RIT8-LM!0J:%*0[6&&@:QL




M(S

M6D


%5GI
M6$7_[`&E3$/LVE48BP.?4MNJ$/)LU1?9:I@MMJ;

MO2`$'U3X!4+0`PDJM6*E%6NMV#!%[I]@I+_$4Q)-5!$2]2!G-4FY%I`C]
&1
M!$K!TC?

.(_H!QSXLB
)J&&YQ!#2N\S$
#=ORVYS




C5@B!+
M*]
HC%(1H))$-*]
!(GZP`G-EEH#[:\?T`D1P(P$_.0@PW)
L$`I.(]IIV!D
MWM`4^PYFB%58.HC9M-(\$PBY3

D$092*(U6-8$M&92'\'?6F-

X`NQM:;A2WY48KO3K)'E


+T&E+3EZ)ITMSJ-[S/3&\
MCP_M3U_)DW19V*4HK


[Z)\/ISA
M#R!`VX=7Z.$/7FSAYV#3*^##X?#F?X!7SWI_H3&[?\!``#__P,`4$L#!!0`
M!@`(````(0#7A

P
GI?K]6_AE
MKBI-FU:'M`57JION%&_KG[_;7$G]4MSQKA5@*%JENJY;2^^IC79&9=I
R
7
M7

M-2[2%M;?G/-+
[5V3-T95J_7]?



MYX?VO%1-9V:[NHG`7-GCI@US2JDJV;5I2?DO
^H\&DF
G@3&G@2Y
\NPW?E'

M8S'J0KY-VW2UJ




8X:8TZ(P/)=W:=
;.:




.)9Y(



M^D8N(-;_'E;91VYB$;`KA.T;2R*

M1-FM;&O[L*/`?!%W?&C2

R%[:'O=

OPBL_@
``/__`P!02P
$%``&``@`


M3YS=&8_`G\UH5^[SEU/W5_WV:UD=CAV$.P2+T+#E[EM2M@5X%-2
68B:BOH$



MO8O[*%6)1)IJCVA_LVE`LR@9$`J9KG5%@\N1@N]S1%*4.!L+EFZ)@Z0.



M&Y(*V:R7HHQQGAB,WW&9F#Z$IH`85&??D5A@#9$8QP?D`T@I^Q(72ETH(Q!E
MCO/#8,X/(PL?CXGOU#W.!LY%:3YQ1HR#/-UYLE#A]1EFA\RG<24
DX%@_([
MSI8SQ
P)`1ENC'T'2EPH=:&









M.K:'3
=:@SQ1NB`P1OKK1PC*^$/S%]_CVC0%-

M[:BH7_#%


M\6(9#RXDBR4^3[L[$G^^Q!.GNP*?)!Z'0.K`?DM6#@H#Y$:M3C#/3S(6[[

MG4IX;SW%%U7[NN[4#[!XTG_&VOP'``#__P
`4$L#!!0`!@`(````(0#0HW%D
M40

!A]




H[P;5

E[S


M-V^1W



\
MDW$_

G.#3RK7\!3V2#OX3[
5R?YSI)$*?!!7P;QEOUH39.`GCMMH




2YX;6RLF%N/




PW++ZNLS:JM^@6_HG\YXJZM
M!OC9G:S^UJ'J
`YJ+Y9KVZ'55LW5I`I1]Q$-?#PV-4IP_=BBZT!%.G2I!IA_

2(9N
?X@9B6!X)@L*6-SL8
_-$9!W2L'B_#
MG_BY0
WI/$Z`_(.!8=7A/4UQ!1D%FX`5&J\04F`/\:;4-*`R)2O8S/Y^8P


M%1()[D/
P1P:5W&;6_`AB0I2%60JR%50J*`4@.2VI[OMP:;Q]G+G^2:#8&$+

M*]G?F!F]%Y+)9`J)1E*-9!K)-5)HI!2)%!+8Z\20O%\+Q'CTG
\XIL0-A5AX


4-#Q9HYC^SC5*44

MF!)/W-
(ZR0V2:<OX1Y4)6

J0




*.V'$_2N;T3SV_X


=Z&[?P$``/__
M`P!02P





M'%ASH.)`S8&&`ZT%7(


MR022Z002F0M4`J@=0:032VHCC6M@K?H5KE1HH%'9WFU1L&2^1=(YW_:4



M

M:VA2D*UA!H)M0CI[^BZ5;70?]^MNA%WW*HAQZT2E7?#


HU$=1*M9S$NP.R3I6
M(5DEL8Q=:X0L]944K$G0J&\DJR56I]Z-3]4LO\-_V%L;.^\\#2T@:OK
C4*V
M]`FR`C



FCK&Q08AL#*9L-VY)9LQ&=R55$V^OY
\5

!0BMZI\U8(_86;(*R0)
AR$D0+1B9G




MCZF'@M`O4QW

:P9H+=$&LD7-1[8K



M*EP97D](P+ZNW$R'6+(W(I:N76!=X+.=LB:*L:]!%NCV91]I99$QBQT5_7
MC+:^'&T18OL%*Y8)LNS]`B&[
R)(=T8?O
+(]$9254%0CFJ\[($WL#B8R5

K\T9+
F$7NVJEA]/+J




MFR04Q#;$BX+08WU(3II




4&0*5(90G9[1P33(5DE<0RNM82JJ1@




^D:R6F(-




:DA




!BRG:])MIY!6A'N1
MOE*(F/F..L#6MZS/AW=K7((L0QBWR-!%L0.+49*D(G8C#*H'`Y8PN=$\4H

RR+*.6W,I6$A622R3H6MBF7BO#*GN34)&E8C






MJ:I`R*.'+-C52Q(9ZQ5P
85!%0KB(Q9PZ+2(HHB-+35I-XG?($2/6(3\M+(E
MF3&+G+6#!'?7[GP%Z^AN!4/([N81LM
-(;N;)\A4^EP*%I)5$LOJYHEE0KPB

MQ;[92;UX8^0,5VK*&_@D\N'-BEV[SK5%
M`7S2]8;L$W@9XZ=!7A)8S=X

M5_!.G8$OO5C!FV








M61ZFL*]@^!D*X??'LFKN9[^#=EL7T\8Q&8]8^P@ME)ZV(\`
^`;2D&I)6LM^

?X8=T!&`

)X9AQ#M`D*U*X
L



OHHKF

M-]DXG(





M_.\3
@9GQC67W$$:I6+ZI4QQ*



W9[
M



MI1]B

MG7IKX2#**8(Z
M%L4)I(Q_40]_OUS$/N\ARL5%(=1A%



M7.NC@%_8$;+6

K:


MW9862NB8



X+=0(*S4CN:][

MM.*C'@Q8N/
].:9YB#)V42S!


(NUY!


8YZ!]7O3O$5;DN@




M*8NV
B!EW$SJT!.09@1U+(H3$&U5__(G,4MHW80V;`QU%$$X35P?F)EC&0


M?K@MU
[*25OP$-4L9?@5?G)U=6ZC]


M+;*Y;0/D0W`;
$;2Q2$&)`.&)
L&C4^0%'UE*'LZ7&;/8O%6R.8)V_]$T[+S


MW)UTBFSN


MNS8A9DIQU&

D(`Y(!HR31LT7V1`

2)+F%*KYZ/25ZB8;W@(UWK[
8

-4)Y-L?P-&%@?F%



976KC2J12#53Y?KN#EN
08N-+!&X/QE54.^N2IV5JX

M^%V]Q_\#``#__P






:V-M



M1Y-1P6)%16D$1!4@7)YHB@B/
IBE`6V%3PEE:TQ'C#0:C]R09349)%12

5!PRQ5C
M+&\I:K$?C;A;J1


(44#0I_UM$
(N8YI2CRQPI
H/*G`XR'+=%=26\D&


R`-MY1QEW*CW$U6AXY$T$%HK.AB_

M#)!4+VM9(.8(5MPQY(Y3'XT&R(&D36*OI1$CYHX35\*AB2OE7(CMRJ7GKCVY
M_#+!3Y2(CE*21&CYB^V4CD'2[AH@L9[6RI#
'
%JDHM!SM0SHH'+H?T;FH:]
M@DTF




`4$L#!!0`!@`(````(0!*I*('P@(``+('```9

!1]G[3_8/F]&$@@
M#0JITE7=*FW2-.WCV0$#5C%&MM.T_W[7-D6AZ3KZ0L+-\3GW7-LGFZM'T:('
MIC2778ZC(

M@*'3.6Z




%W`1($FB!/+5

M#9@(?72?1UZ:)L?Q.H@ODRA)`8_V3)M;;CDQ*@[:2/''HZ*!R[/$`PM\#BR+
M-$A6X2+Z/PGQ'3F#-]30[4;)(X)3`Y*ZI_8

M#0_;)%ULR`.
KA@PUQX#SQ$3C0@HJ,RJ,U7MFK;&=K6[GVA5.9^'69Q7MD
M+#C'\!R;3]+ER.N5/69Y@DE'Q
0@0.8;M&#8@ZET
A)[:0^:(0V':KZT!3OI



M-I26+AO=U?4)Z0-$

MOYQ;C+Y8




5X68F(\B=KX;O_YAQ56Y594,A/U%(4]<182[F]



MG+X7XY2;=T`4

$5(S3%+`BFM]Y\WM#W_)CX




MX+(]6_(MW==L/@!'*]=#WKW'P3*X6D.;7%L62DT/P:GI




MQ!Q/J(OV3?MO@GUZ?C+^/(8[=&?

@__&]C_`0``__\#`%!+`0(M`!0`!@`(
&UL4$L!`BT`%``&``@````A`+55,/U````3`(```L`````````
M````````C`0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A``LABONU`@``

`8``/(7





3``!


X```9````


M971S+W-H965T-#






M:&5E='

YX;6Q02P$+0`4``8`````$`@I%1[U`'``!`)@``

M`0(M`!0`!@`(````(0`X.8=.30P```D_```9`````````````````
YV``!X











M````(0=#MEL@
``.L







M``!







M+W-H965T-BYX;6Q02P$+0`4``8`````$`9:IO;J0'``R)@``&```````
&UL4$L!`BT`%``&
M``@````A`


M`#@&```9`````````````````


M:&5E=#(S+GAM;%!+`0(M`!0`!@`(````(0!M#E7Y7`L```TU```9````````

U+GAM;%!+
M`0(M`!0`!@`(````(0!;#M/&?P0``-X.```9`````````````````.\R`@!X


M-RYX;6Q02P$+0`4``8`````$`79POS+4#``#@P``&0``````````````

X+GAM;%!+`0(M`!0`!@`(````
M(0`/D(M.R@
``*8-```9`````````````````
Q








M=#(U+GAM;%!+`0(M`!0`!@`(````(0!I:RP`I@4``%`5```9````````````

M='





M;6Q02P$+0`4``8`````$`ECH[C$!``!``@``$0`````````````````:


 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashUninsuredAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateAtPeriodEnd'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermLineOfCredit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AnnualFacilityFeeReceivableDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LinesOfCreditCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_LineOfCreditFacilityAdditionalInterestRateDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_TermLoan'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_CommitmentFeePayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_CommitmentFeeAnnualInstallmentAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UnsecuredDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PercentageOfFundingFee'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubordinatedBorrowingInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertibleLongTermNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Depreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ScheduleOfNotesPayableAndCreditFacilityTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate) with an Irish bank, including overdraft coverage, creditors&#8217; insurance, customs and excise guaranty, and a revolving credit facility. These facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender&#8217;s AA1 Rate minus <font style=FONT-FAMILY: 'Times New Roman'
 %. The balance on the credit facilities included in notes payable totaled &#8364;<font style=FONT-FAMILY: 'Times New Roman'
, or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate), and &#8364;<font style=FONT-FAMILY: 'Times New Roman'
, or $<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of <font style=FONT-FAMILY: 'Times New Roman'
%, to be accrued and paid at maturity. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'

 of accrued interest was converted to amounts due to affiliates. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'

<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 for the purpose of providing the Company and CB-USA with working capital. In July 2012, the Keltic Facility was amended to increase availability to $<font style=FONT-FAMILY: 'Times New Roman'
, among other changes. In March 2013, the Keltic Facility was amended to increase availability to $<font style=FONT-FAMILY: 'Times New Roman'
, among other changes. In August 2013, the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below), subject to certain conditions set forth in the amendment, to modify&#160;certain aspects of the EBITDA covenant contained in the loan agreement, permit the Company to incur indebtedness in an aggregate original principal amount of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

. For the year ended March 31, 2014, the Company paid interest at <font style=FONT-FAMILY: 'Times New Roman'
%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is <font style=FONT-FAMILY: 'Times New Roman'
% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. The Company paid a $<font style=FONT-FAMILY: 'Times New Roman'
 commitment fee in connection with the first amendment,&#160;a $<font style=FONT-FAMILY: 'Times New Roman'
 closing and commitment fee in connection with the second amendment&#160;and a $<font style=FONT-FAMILY: 'Times New Roman'
 closing and commitment fee in connection with the third amendment. Keltic also receives an <font style=FONT-FAMILY: 'Times New Roman'
. The loan agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan agreement includes negative covenants that, among other things, restrict the Borrower&#8217;s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. At March 31, 2014, the Company was in compliance, in all material respects, with the covenants under the Keltic Facility. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 (the Bourbon Term Loan) that was used to purchase&#160;bourbon inventory on March 11, 2013. Unless sooner terminated in accordance with its terms, the Bourbon Term Loan matures on December 31, 2016. <font style=FONT-FAMILY: 'Times New Roman'
. For the year ended March 31, 2014, the Company paid interest of 7.5%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.7in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan, including Frost Gamma Investments Trust ($<font style=FONT-FAMILY: 'Times New Roman'

), an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III ($<font style=FONT-FAMILY: 'Times New Roman'

), a director of the Company and the Company&#8217;s Chairman, and an affiliate of Richard J. Lampen ($<font style=FONT-FAMILY: 'Times New Roman'

), a director of the Company and the Company&#8217;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement, the junior participants receive interest at the rate of <font style=FONT-FAMILY: 'Times New Roman'
% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However, the Borrower is party to a fee letter (the Fee Letter) with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $<font style=FONT-FAMILY: 'Times New Roman'
 in three equal annual installments of $<font style=FONT-FAMILY: 'Times New Roman'
. In August 2013, the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $<font style=FONT-FAMILY: 'Times New Roman'
 to up to $<font style=FONT-FAMILY: 'Times New Roman'
 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 unsecured loan (the Junior Loan) to the Company. The Junior Loan bears interest at a rate of <font style=FONT-FAMILY: 'Times New Roman'
 % per annum, payable quarterly in arrears commencing November 1, 2013, and matures on October 15, 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default, which, if uncured, entitle each Junior Lender to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of <font style=FONT-FAMILY: 'Times New Roman'
% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year), payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust ($<font style=FONT-FAMILY: 'Times New Roman'
), Mark E. Andrews, III ($<font style=FONT-FAMILY: 'Times New Roman'
) and an affiliate of Richard J. Lampen ($<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

% Convertible Subordinated Note Purchase Agreement (the Note Purchase Agreement), by and among the Company and the purchasers party thereto,&#160;which provided for the issuance of an aggregate initial principal amount of $<font style=FONT-FAMILY: 'Times New Roman'
 unsecured subordinated notes (the Convertible Notes) by the Company. The Convertible Notes bear interest at a rate of <font style=FONT-FAMILY: 'Times New Roman'
% per annum, payable quarterly beginning on December 15, 2013 until their maturity date of December 15, 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&#8217;s common stock at a conversion price of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

), a director of the Company, Dennis Scholl ($<font style=FONT-FAMILY: 'Times New Roman'
), a director of the Company, and Vector Group Ltd. ($<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 consecutive trading day period exceeds <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProvisionForIncomeTaxesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EffectiveIncomeTaxRateReconciliationNetChangeInFairValueOfWarrantLiabilityPercent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EffectiveIncomeTaxRateReconciliationGainLossOnAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EffectiveIncomeTaxRateReconciliationTaxesIncludedInMinorityInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_OperatingIncomeLossPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NetIncomeLossAttributableToControllingInterestPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_IncomeTaxExpenseBenefitsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_IncomeTaxExpenseBenefitPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AssetsPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_OperatingIncomeLossPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NetIncomeLossAttributableToControllingInterestPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AssetsPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_OperatingIncomeLossPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NetIncomeLossAttributableToControllingInterestPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AssetsPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RisksAndUncertaintiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; The Company maintains its cash and cash equivalents balances at various large financial institutions that, at times, may exceed federally and internationally insured limits. The Company exceeded the limits in effect at March 31, 2014 by approximately $<font style=FONT-FAMILY: 'Times New Roman'
 and exceeded the limits in effect by approximately $<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; Sales to one customer, the Southern Wine and Spirits of America, Inc. family of companies, accounted for approximately <font style=FONT-FAMILY: 'Times New Roman'
% and <font style=FONT-FAMILY: 'Times New Roman'
% of the Company&#8217;s revenues for the years ended March 31, 2014 and 2013, respectively, and approximately <font style=FONT-FAMILY: 'Times New Roman'
 % &#160;and <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_FiniteLivedIntangibleAssetsAmortizationExpenseTotal'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PercentageOfRawMaterialsLocatedOutsideUnitedStates'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PercentageOfFinishedGoodsLocatedOutsideUnitedStates'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentsToAcquireInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueFromRelatedParties'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueFromRelatedParties'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AnnualFeesForServicesRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillImpairmentLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_GoodwillPaymentUnderContingentConsiderationAgreementDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue'


@9&]C=6UE;G0@:7
@82!3:6YG;&4@1FEL92!7



3)F7S0P-S9?.#1C
E\W
M-#)A
39E96%D







T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@



T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M(`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?;V9?3W!E
3PO



O4VAE970P-BYH=&UL(B\^
&-E;%=O<FMS:&5E






3`N
M:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC96Q7

551%1%].151?




&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*(`@(#QX.DYA;64^04-154E3251)3TY3/]X.DYA;64^#0H@(`@




O


7T%.1%])

&-E;%=O<FMS:&5E=#X-B`@


O4VAE970Q-RYH=&UL
&-E;%=O<FMS


O4VAE970Q.YH=&UL(B\^#0H@(`\+W@Z17AC96Q7;W)K







T0B
#I7;W)K<VAE



#I.86UE/D-/34U)5$U%3E13
M7T%.1%]#3TY424Y'14Y#2453/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(T+FAT;6PB+SX-B`@



T0B5V]R:W-H
&-E;%=O<FMS:&5E=#X-
MB`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^4U54T51545.
M5%]%5D5.5%








&-E;%=O<FMS:&5E=#X-B`@(`\

&-E;%=O<FMS

T0B5V]R:W-H965T


M(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^1T]/1%=)3$Q?04Y$
M7TE.5$%.1TE3$5?05-31513
#I.86UE/DY/5$537U!!64%3$5?04Y$7T-!4$E404Q?3$5!4S$\





M97





#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1)7;W)K<VAE971S+U-H965T
S@N
M:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC96Q7

551%1%].151?

M968]

#I.86UE/@T*
M(`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E='
O4VAE
M970T





T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@
#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1)7;W)K<VAE971S+U-H965T-#8N:'1M;(O/@T*(`@

M(`@/'@Z3F%M93Y'3T]$5TE,3%]!3D1?24Y404Y'24),15]!4U-%5%,R/]X

MB`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^1T]/1%=)3$Q?





O4VAE970U





M3F%M93Y.3U1%4U]005E!0DQ%7T%.1%]#05!)5$%
7TQ%05





#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1)7;W)K<VAE971S+U-H965T
M-38N:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@(`@/'@Z3F%M93Y04D]625-)3TY?1D]27TE.0T]-














T0B5V]R
&-E;%=O<FMS:&5E
M=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^4U1/0TM
M05-%1%]#3TU014Y3051)3TY?1&5T86EL









M(`@(#QX.DYA;64^1T5/1U)!4$A)0U])3D9/4DU!5$E/3E]$971A:6QS/]X









]



]

]

]


]
T1T:#Y*=6XN(#(U+`R,#$T/&)R/CPO=&@^#0H@(`@(`@(#QT:!C


]




]


]




]

#`Q
S$Q-3


]

]

M+3



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]

]
T1T97AT



]



M=&5X=#XG



]




]

\+W1D/@T*

]


M)S(P



]




T1T;W`^16YT:71Y(%9O


]
T1T





]



M:6

M
RPP
#`L



3)F7S0P-S9?.#1C
E\W-#)A
39E96%D




S$L(#(P
30\8G(^/]T
M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q



]


]


]
T1N=6UP/B0@.3`X+#4P



T1T;W`^06-C
M;W5N='

#0L-#$X(&%N9`D-S`L-CDR+!R97-P96-T

]
T1N=6UP

#(U+#


]


34L
C@X/'-P

S`S

]



]
T1N=6UP/C$T+#8U




L
S
P

M

]

]



]


]
T1N=6UP/C(R+#0X
RPW
#



Y-3QS


]


]
T1N=6UP
M/C$Q-BPW


M:6=N/3-$=&]P/DEN=&%N9VEB;&4@87-S971S(T@;F5T(&]F(&%C8W5M=6QA
M=&5D(&%M;W)T:7IA=&EO;B!O9B`D-BPP-3@L,#`U(&%N9`D-2PT
#0L
#`P

]
T1N=6UP
M/C@L



]


M





]
T1P;!V86QI9VX],T1T;W`^5&]T86P@07-S971S/]T9#X-B`@(`@



T1T;W`^/'-T





M


]


]




2PP-S
L
M

M;7`^-SDS+#(T


]

2PY
S8L
C0Q/'-P

BPS

]



S8L
3
Q/'-P86X^




]






M-C`P+#`P


]
T1N=6UP/C(L
#$U+#`P



T1T;W`^3F]T
M97

#`@

M


T1T
M;W`^3F]T97

M;VX@870@36%R8V@@
S$L(#(P
30I/]T9#X-B`@(`@(`@/'1D(&-L87-S




]
T1N=6UP/C(Q


3$L-3@P


]
M


]
T1N=6UP/C$L-3$X+#




T1T;W`^0V]M;6ET;65N='
@86YD($-O
M;G1I;F=E;F-I97
@*$YO=&4@
34I/]T9#X-B`@(`@(`@/'1D(&-L87-S



]

]
T1T97AT



#`L
M

2!S:&%R97
@;V8@

M-BPU
S`@870@36%R8V@@
S$L(#(P
30@86YD(#(P
3


]
M

2!P87(@=F%L=64L(#
P
PP,#`L,#`P(&%N9`R
M
C4L
#`P+#`P
!S:&%R97,@875T:&]R:7IE9!A=!-87)C:`S
2P@
C`Q

R!A;F0@
3`X

RPP


2PU


P/'-P86X^



T1T;W`^06-C=6UU;&%T960@

C


]
T1N=6T^*#$L





M;7`^


]

BPR


M


]


]
T1N=6UP/B0@
S
L






]

#$T/&)R/CPO=&@^#0H@(`@(`@


]

]
T1N=6UP/B0@







M;7`^-#8Q+#8V


]







]
T1N=6UP/C
P








#`L

C4L
#`P+#`P


]






]
M


]
T1N=6UP/B0@-RPX-S8L
M-3



#$\

M(#`N



#`L

C(U+#`P


]



]
M

]







3)F7S0P-S9?.#1C
E\W-#)A
39E
M96%D


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q





T0Q(')O=W-P86X]



M;'-P86X]


M
CY-87(N(#

M1'1H(&-O;'-P86X]

S$L(#(P
3


]
T1N=6UP/B0@-#@L
30P+#0X




]
M




#`\





#


]

]
T1P



3$L


M9VX]

S
L-S$Q/'-P86X^





]
T1N=6UP/CDR


]

]



M(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@




]

M(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@







]
T1R;SX-

M
2PP-C(L

]
T1N=6T^*#4X-RPS
M



M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@

#(L-S




]

M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]


]
T1N=6T^*#0L
M.#



M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-
MB`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@V









]



]

]


]

M.3
L


T1T;W`^3F5T(&QO


@86YD(&1I;'5T960L(&%T=')I

]
T1N=6T^)`H,XP

]
T1N=6UP/C$Q-BPU
3$L-#0T




T1T;W`^6S%=/]T
M9#X-B`@(`@(`@/'1D(&-O;'-P86X]



C`Q



M0SHO964W
#1E9&9?
#$R9E\T

M:&5E='
O4VAE970P-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\

T1T97AT+VIA

@

]

M;G









M871I;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970P-BYH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]

M;65N='





\+W1D



M9VX]



M


L


3$V+#0S


]


L


3$V+#0S


]



#1E9&9?
#$R
M9E\T

M:6QE.B\O+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X-&

F$Q-F5E860P



^+RH@1&\@3F]T(%)E;6]V



2!R



]

M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^0V]M;6]N(%-T;V-K(%M-


]
T1P
M;!V86QI9VX],T1T;W`^0D%,04Y#12!A=!-87(N(#
Q+`R,#$R/]T9#X-

]
T1N=6UP
M/B0@


]

M




]







T1T;W`^3F5T(AL;W-S*2!I;F-O;64\+W1D/@T*(`@

]
T1N=6T^*#0L.#















]


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]

I/]T9#X-B`@(`@(`@/'1D(&-L









]





]

C@R+#


]



]
T1P;!V86QI9VX],T1T;W`^0D%,04Y#12!A
M=!-87(N(#




I

S$L(#(P
3


]


]




]
T1P;!V86QI9VX],T1T;W`^3F5T(AL;W-S*2!I;F-O;64\

]





]

M


]


L



]
T1P;!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M+!N970@;V8@:7-S=6%N8V4@8V]S='

]





]
T1R

M;B!S:&%R97
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
M




]



]
T1N=6T^*#8W+#`Q


C`W+#8T

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
M



]




]




]

#$L





]

3`L
3(W+#$R


]



C4L








]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P

S@T



]



]
T1N=6UP/C8L





T1T;W`^4W1O8VLM8F%S960@8V]M

L



]



]
T1N=6UP/B0@
3DL.3
U+#$Y


]
T1N=6UP/B0@
M
2PU



]
T1N=6T^)`H,3,Y+#4V,2PY-CDI/'-P86X^/]S



M
2P@

]


M.#0Q+#$S


]


F9?-#`W-E\X-&

F$Q-F5E860P-@T*



]

M:60]






M05-(($9
3U=3($923TT@3U!%4D%424Y'($%#5$E6251)15




\



M86QI9VX]



]
T1T97AT



]
T1N=6UP/CDR

]
T1R93X-


]





M=6P@86-C;W5N='


]



]

M86QI9VX]


3$X+#


@



M9VX]
T1T;W`^169F96-T(&]F(&-H86YG97


]
T1N=6UP/C(T-RPT
M




C@R+#


]

C`P+#`P




]
T1R

]
T1N=6T^
M*#$L.34Y+#4Y

M87-S/3-$;G5M/B@X-C$L
S



]

3DS+#8X


T1T;W`^
M26YV96YT;W)Y/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q+#(T
M-BPU-3




]
T1N=6T^*#4Y
2PQ.#@I/'-P

C`P



T1T;W`^06-C;W5N='










T1T;W`^1'5E('1O(')E


]
M
T1P;!V86QI9VX],T1T;W`^5&]T86P@861J=7-T;65N=',\+W1D/@T*(`@

]
T1N=6UP/C(L



]

]
T1N=6T^*#0L.3@V+#0S

]
M


]



C8L



]


]
T1R93X-


M86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q-#4L.#`P*3QS


]

CDS+#DV




]
M

@;VXI('!R;V-E961S(&9R;VT@2V5L=&EC(&9A8VEL:71Y


]
T1N=6T^*#0X
2PP
M

M;7`^
BPT.38L








]
T1N=6UP/C@Y+#@V

]

]
T1N=6UP/C0L-3
Q+#8T


]
T1R

3@T+#
T





T1T;W`^4')O8V5E9'
@9G)O;2!E



M($)9($9)3D%.0TE.1R!!0U1)5DE42453/]T9#X-B`@(`@(`@/'1D(&-L

RPU

@3T8@1D]2

]
T1R974^#0H@(`@(`@(#QT


#


]
T1P;!V86QI9VX],T1T;W`^0T%32!!3D0@

Y+#
R

M15%5259!3$5.5%



SDL




]
M




]
M
T1N=6UP/C@L

]

@02!C;VYV97)T





]

]
T1N=6UP/B0@
30L.#0X



3)F7S0P-S9?
M.#1C
E\W-#)A
39E96%D

T1#;VYT

]
T13:&]W+FIS


M(&-O;'-P86X]
T0Q(')O=W-P86X]

M(%-T871E;65N='

S$L(#(P
30\



]



#1E9&9?
#$R9E\T
M

O4VAE970Q







M1'1H(&-O;'-P86X]


#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L


]
M






M04Y$(%-534U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@



3$%04T4Z

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L





M;BP@5&EM97

\



M($MY;F4L($QT9X@*8C.#(R

3LI



M;F0@=&AE($-O;7!A;GDF(S@R




@:&%V92!B965N


M86YC97

M15(M0T]

'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97



M
T0G9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M








M
'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



38P.SPO9&EV/B`\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@

3`P)3L@0D]21$52+4-/
M3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@






M.T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

M/'4^0G)A;F1S/]U/B`F(S$U,3L@/'4^4G5M/]U/B`F(S$U
3L@1V]S;&EN
M9R8C.#(Q-SMS(')U;7

M(&$@



M)B
X
C$W.W
@=')A9&5M87)K960@1&%R:R`F(S@R
38[;B!3=&]R;7DF(S$W

63I4




R4G
M/CPO=&0^(#QT9!S='EL93TS1=724142#H@
R4G/B`\9&EV/B8C
38P.SPO


M;&4]


M=3X@)B

Z



[($MN87!P;V=U92!#87-T


3DU
2P@


T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)
M3CH@


M.B!N;W)M86PG/B`F(S$V

M.B`Q

M
T0P(&-E;&QP861D:6YG/3-$

+4%

T0G5TE$5$@Z(#
E)SX\+W1D/B`\=&0@

T0G5TE$5$@Z(#
E)SX@/&1I=CXF(S$V

14%2

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97


3L@
M0G)A9'DF(S@R

:6UO;F-E;&QO+!287-P:6-E;&QO(&%N9!0



'!T.U1%

'!X.R!&3TY4.B`Q
'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97


38P.SPO9&EV

T0G5TE$5$@Z(#$P



T0P/B`\





34Q.R!;W)U('9O9&MA+!A;B!U;'1R82UP=7)E



M.B`Q

'!X.R!&
M3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97


M

T0G5TE$5$@Z(#$P





M97%U:6QA(%1I97)R87

M87


@879A:6QA8FQE



05!313H@8V]L;&%P


M
R4G/CPO=&0^(#QT9!S='EL93TS1=724142#H@
R4G/B`\9&EV/CQF;VYT

M:#H@;F]R;6%L.T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97
L



63I4





@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M4
M15A4+4E.1$5.5#H@


3$%0

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97







M5&EM97




M=&UE;G0@87




M($)/4D1%4BU#3TQ

@

R4G/B`\9&EV/B8C
38P.SPO9&EV

T0G5TE$5$@Z(#



T0G5TE$




M86YC92!F;W(@97-T:6UA=&5D('5N8V]L;&5C=&EB;&4@86-C;W5N='
@=&\@

@;VX@=&AE('1R861E(&%C8V]U
M;G1S(')E8V5I=F%B;&4@8F%L86YC97
N(%1H92!#;VUP86YY(&-A;&-U;&%T
M97


@


T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[
M($U!4D=)3CH@


M=')E=&-H.B!N;W)M86PG/B`F(S$V

M)U=)1%1(.B`Q


T0P(&-E;&QP861D:6YG/3-$

M0T%
+4%

T0G5TE$5$@Z(#
E)SX@/&1I
M=CXF(S$V

M9F]N=US=')E=&-H.B!N;W)M86P[1D].5U&04U)3%DZ5&EM97
@3F5W(%)O








M:7



M/3-$)T-
14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&


M.B`G5&EM97



T0P(&-E;&QP861D:6YG
M/3-$

+4%
24=..B!T;W`G/B`\=&0@

T0G5TE$5$@Z(#

T0G5TE$5$@Z
M(#




M



T0G9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H


Q-3$[($EN=F5N=&]R:65S

L(&)U;&L@=VEN







M4V5E($YO=&4@

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@

M(%1I;65S+!397)I9CL@9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US
M=')E=&-H.B!N;W)M86PG/B`F(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1=#
M3$5!4CIB;W1H.R!&3TY4+49!34E



@96YD960@36%R8V@@
S$L(#(P
30@86YD(#(P
3
L('1H92!#
M;VUP86YY(')E8V]R9&5D(&%L;&]W86YC97

#`@86YD(0V.#0L.#,P
M+!R97-P96-T:79E;'DN(%1H92!#;VUP86YY(')E8V]R9&5D('1H97-E(&%L
M;&]W86YC97







M3E0M1D%-24Q9.B`G5&EM97


63H@



14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2




Q


M34E








'!T.U1%

'!X.R!&3TY4.B`Q
'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97


38P.SPO9&EV

T0G5TE$5$@Z(#$P



T0P/B`\





\+W4^(8C,34Q.R!';V]D=VEL;!R97!R97-E;G1S('1H92!E


M='





M=6P@;&EV97





#L\

38P.SPO9&EV/B`\
M+W1D/B`\=&0^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9#X@/&1I=B!S
M='EL93TS1=#3$5!4CIB;W1H.TU!4D=)3CH@

3!P

M;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9'

M)B
X
C(Q.RD@06-C;W5N=&EN9R!3=&%N9&%R9'
@0V]D:69I8V%T:6]N(@F
M(S@R,C`[05-#)B,X,C(Q.RD@,S4P+`F(S@R
C`[26YT86YG:6)L97
@+2!'
M;V]D=VEL;!A;F0@3W1H97(F(S@R,C$[+!I;7!A:7)M96YT(&]F(&=O;V1W




@;V8@9G5T=7)E(&]P97)A=&EN9R!R97-U;'1S+B!#:&%N

M871I=F4@87-S=6UP=&EO;G




@
M:7






M
T1J=7-T:69Y/B8C

14%2.F)O

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97



M:6]N(&%N9!A;6]R=&EZ871I;VX@*8C.#(R
#M%0DE41$$F(S@R
C$[*2!O

M9&]W;G



M9!-87)C:`S
2P@
C`Q-!A;F0@,C`Q,RX\+V1I=CX@)B,Q-C`[/]T9#X@


T0G
M9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M86P[




M;VUA;BP@5&EM97


X


X
C(Q


M:&%N9V5S(&AA=F4@;V-C=7)R960@=&AA=!W;W5L9!R97%U:7)E(')E=FES

@9&5F:6YI=&4@


@=&AA;B!T:&4@

M;W-S(&ES(')E8V]G;FEZ960@8F%S960@;VX@=&AE(&9A:7(@=F%L=64@;V8@



38P.SPO
M9&EV/B`\+W1D/B`\=&0^(#QD:78^)B



63I4:6UE

M92!L979E;'


M;F0@9FEN:7-H960@9V]O9'
N(%1H92!#;VUP86YY(&EN=&5N9'
@=&\@8V]N

M=70@:7


@

@8G5L:R!W:6YE+B!);B!C;VYN96-T:6]N('=I=&@@=&AI



@=&\@97-T:6UA
M=&5D(&YE=!R96%L:7IA8FQE('9A;'5E+!F;W(@=&AE('EE87(@96YD960@
M36%R8V@@
S$L(#(P
3




3$%04T4Z

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L




+CPO9F]N=#X\


M971C:#H@;F]R;6%L.T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM
M97


@;6%R:V5T
M:6YG(&%C=&EV:71I97


@=&\@=&AE($-O;7!A;GDF(S@R






C`Q
M


+4%
24=..B!T;W`G/B`\=&0^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9#X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@


M=R!2;VUA;BP@5&EM97


M(#QT9#X@/&1I=CXF(S$V






X
C(P.V)O;F0N)B
X

@


M(S@R
C`[97@@=V%R96AO=7-E)B
X
C(Q.RP@=&AE('-A;&5S('!R:6-E(')E



T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)
M3CH@


M.B!N;W)M86PG/B`F(S$V

M.B`Q

M
T0P(&-E;&QP861D:6YG/3-$

+4%

T0G5TE$5$@Z(#
E)SX@/&1I=CXF(S$V
M




M5&EM97

M;6]T:6]N86P@9V]O9'







@:7
@8VAA


M3TY4+49!34E

M3TQ

@3F5W(%)O;6%N

R4G/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5TE$5$@Z(#
E)SX@/&1I=CX\9F]N=!S='EL93TS1=F

M3TY4+49!34E




M9V1O;2X@56YD97(@05-#(#@S






@


14%2.F)O=&@[($9/3E0M1D%-

@




M)U=)1%1(.B`Q


T0P(&-E;&QP861D:6YG/3-$

M0T%
+4%

T0G5TE$5$@Z(#
E)SX@/&1I
M=CXF(S$V

M9F]N=US=')E=&-H.B!N;W)M86P[1D].5U&04U)3%DZ5&EM97
@3F5W(%)O


34Q
M.R!!4T











@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M4
M15A4+4E.1$5.5#H@


3$%0

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97





Q-C`[/]D:78^(#QT86)L92!S
M='EL93TS1=724142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S
M93L@1D].5#H@

M9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M86PG




M.E1I;65S($YE=R!2;VUA;BP@5&EM97



M:#H@;F]R;6%L.T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97
L



M+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M86P[1D].5U&04U)
M3%DZ5&EM97




X
C(P.W9A;'5A=&EO;B!H
M:65R87)C:'DF(S@R

[




M=R!2;VUA;BP@5&EM97



@=VAE


M;&4]
T0G9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N


6QE/3-$)U=)1%1(.B`Q,#`E.R!3U)$15(M0T]

'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97




M;V8@86X@87-S970@;W(@;&EA8FEL:71Y(&%S(&]F('1H92!M96%S=7)E;65N

X
C$W.W
@8V%T96=O



'!T)SX@)B
Q-C`[/]D:78^(#QT86)L
M92!S='EL93TS1=724142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL
M87!S93L@1D].5#H@

M9CL@9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M


38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C

T0G
M5TE$5$@Z(#


63I4





M1=615)424-!3U!3$E'3CH@=&]P)SX@/'1D/B`\9&EV/B`F(S$V
#LF(S$V
M
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF
M(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
M
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF
M(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V



M($YE=R!2;VUA;BP@5&EM97

B`F(S$U
3L@:6YP
M=71S('1O('1H92!V86QU871I;VX@;65T:&]D;VQO9WD@:6YC;'5D92!Q=6]T

@






38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^/&9O

T0G9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E
M=&-H.B!N;W)M86P[1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N+!4:6UE



'!T)SX\+V9O



M4CIB;W1H.R!&3TY4+49!34E

'!T)SX\+V9O;G0^




Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL





#M);F-O;64@5&%X97
F(S@R







'!T.U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE.

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L



T0G5TE$5$@Z
M(#$P




T0G5D525$E#04PM04Q)








2P@




Q-C`[/]D:78^(#QT
M86)L92!S='EL93TS1=724142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C
M;VQL87!S93L@1D].5#H@

M97)I9CL@9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N


M


M=R!2;VUA;BP@5&EM97



M5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@
M


T1J=7-T
M:69Y/B8C

T0G5TE$5$@Z(#$P




T0G5D525$E#04PM04Q)1TXZ('1O


BPX

C`Q





M5&EM97

R4G/B`\9&EV/B8C
38P

T0G5TE$5$@Z(#
E)SX@/&1I=CX\





M87-S=6UP=&EO;G


@870@=&AE(&1A=&4@

M(&%M;W5N='









T0G5D525$E#04PM04Q)

M9&EV/B8C

M
T0G1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/]D:78^(#PO=&0^

M/B`\9&EV/B8C

M;&4]
T0G1D].5U325I%.B`Q,'!T)SY5+CPO9F]N=#X\+V1I=CX@/]T9#X@


@













L(&-O=6QD(&AA=F4@;6%T
M97)I86P@861V97)S92!E9F9E8W1S(&]N('1H92!#;VUP86YY)B
X
C$W.W
@

N(%1H92!I;F%B:6QI='D@=&\@;6%I;G1A:6XL
M(')E;F5W(&]N(&%C8V5P=&%B;&4@=&5R;7



@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P
M=#M415A4+4E.1$5.5#H@



'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97



T0G1D].


\

P@,C`Q-P@=&AE($9!4T(@:7-S=65D
M(&9I;F%L(&=U:61A;F-E('1O(&-H86YG92!T:&4@8W)I=&5R:6$@9F]R(')E



#M!4U4F(S@R
C$[*2!.;RX@
C`Q-TP.DN






@8F5G:6YN:6YG(&]N(&]R(&%F



M97-U;'1S(&]F(&]P97)A=&EO;G

@;W(@9FEN86YC:6%L

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@

38P.SPO9&EV/B`\=&%B

T0G5TE$5$@Z(#$P




M;&4]

R4G/CPO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!724142#H@
R4G/CPO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!724142#H@.30E)SX@/&1I=CY/;B!-







@82!R97-U;'0L('1H:7
@='EP92!O9B!P97)F;W)M



M5&AE(&%D;W!T:6]N(&]F('1H:7
@9W5I9&%N8V4@:7



'!T)SX@)B
Q-C`[/]D:78^(#QT86)L92!S
M='EL93TS1=724142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S
M93L@1D].5#H@

M9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M86PG


M2#H@
R4[($9/3E0M4TE:13H@



'!T)SX\=3Y!8V-O=6YT:6YG('-T


3(M

@
S4P*3H@5&5S=&EN9R!)

M96YT+B8C.#(R




L(&EF(&ET(&ES(&1E=&5R;6EN960@=&\@8F4@;6]R92!L:6ME



T0G0TQ%05(Z8F]T:#L@1D].5U&
M04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.
M1$5.5#H@,XU:6X[($U!4D=)3CH@



M4F]M86XL(%1I;65S+!397)I9CL@9F]N=US:7IE+6%D:G5S=#H@;F]N93L@



M.B`Y-4G/B`\9&EV/DEN($]C=&]B97(@,C`Q,BP@=&AE($9!4T(@:7-S=65D
M($%352`R,#$R+3`T+`F(S@R


M:6YG(&%M96YD;65N='

M(&]N('1H92!#;VUP86YY)B
X
C$W.W


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-

05!313H@8V]L;&%P




3LN(%1H:7
@






M86YC92!O;FQY(&%F9F5C='

L('1H92!A9&]P=&EO;B!O




#L\+V1I=CX@/'1A8FQE


T0P(&-E;&QP861D:6YG/3-$

M/3-$)U9%4E1)0T%
+4%

T0G5TE$5$@Z
M(#
E)SX@/&1I=CXF(S$V










M(&%D9&ET:6]N86P@9&5T86EL(&%B;W5T('1H97-E(&%M;W5N='
N(%1H:7
@


3
N(%1H92!A9&]P=&EO;B!O9B!T:&ES('-T86YD




#L\+V1I


T0G5D525$E#04PM04Q)

M9&EV/B8C

M
T0G9F]N=US:7IE+6%D:G5S=#H@;F]N93L@9F]N=US=')E=&-H.B!N;W)M

M/B!);B!*=6QY(#(P
3

C`Q
RTQ
2P@
M)B
X
C(P.U!R97-E;G1A=&EO;B!O9B!A;B!5;G)E8V]G;FEZ960@5&%X($)E


#M!4U4@
C`Q
RTQ
M
28C.#(R




C`Q
RTQ
2!D


M3TY4+49!34E

M4F]M86XL(%1I;65S+!397)I9CL@9F]N=US:7IE+6%D:G5S=#H@;F]N93L@






M8FQE/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
M



M(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970Q
2YH=&UL#0I#;VYT96YT+51R86YS9F5R


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A

M

M;W9E(%1H:7



]


3(@36]N=&AS($5N9&5D/]T
M:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C;&%S

S$L(#(P


@4&5R(%-H87)E(%M!8G-T


]


]

M



14%2.F)O=&@[($9/3E0M1D%-24Q9

M
'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



M3TY4+49!34E

T0G0TQ%05(Z8F]T:#L@1D].









@
M96YD960@36%R8V@@
S$L(#(P
30@86YD(#(P
3
L(&YO(&%D:G5S=&UE;G0@


M(&]U='-T86YD:6YG(&]P=&EO;G


14%2.F)O=&@[($9/3E0M1D%-


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-


63H@)U1I


@

'!T.U1%6%0M

'!X.R!&3TY4.B`Q
'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97


@3F5W
M(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4%
24=..DQE9G0[(%1%6%0M
M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q

M4D=)3CH@
&EN.R!724142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL
M87!S93L@3U9%4D9


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS


13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B`C
#`P



3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0R


F(S$V

24=..B!C96YT97([


M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'

M=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+51/4#H@(S`P
#`P


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.

24=..B!C96YT


M13H@



T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4


M5T5)1TA4.B`T
#`G('=I9'1H/3-$


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($)/4D1%4BU43U`Z

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#$R


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O


M='


M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\


T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,2PX-S0L,#@W
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/D-O;G9E

\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%

M

T0Q
4^(#QD:78^)B,Q-3$[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M25I%.B`Q

3!P=#L@5D525$E#

T0W
M-24^(#QD:78^-24@0V]N=F5R=&EB;&4@;F]T97

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+#
V
2PQ
3$\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G0D]2
M1$52+4)/5%1/33H@(S`P
#`P

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$U
3L\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!3U)$15(M
M5$]0.B`C
#`P


M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

#`G
M('=I9'1H/3-$
3`E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4


M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P


'!T

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


P
#`P
#`@
W!X(&1O=6)L93L@


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E
M/B`\9&EV/C$U+#
Q
BPY

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I


63H@5&EM97
@

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

M;&4]



3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
M







]
T1T:#Y-87(N
M(#



]
T1R


'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@

M;VYG/DY/5$4@
R`F(S$U

M3U))15

T0G0TQ%05(Z
M8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@

M5#H@

'!T)SX\+V9O;G0^/&9O


969T.R!415A4+4E.1$5.5#H@
&EN
M.R!724142#H@


Y96(V8V4@
'!X
M('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P

!S;VQI9<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,!A;&EG



M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\


M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

T0G5$58


M+4%

'!T.R!615)424-!


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(

CX@/&1I=CXR


T0Q)3X@/&1I=CXF(S$V



T0Q

M(#QD:78^
C`Q




+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T

@
M)B

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[

M.B`T
#`G('=I9'1H/3-$

M;&4]

#`P
#L@1D].

M=&@]
T0Q
4^(#QD:78^-PU
#(L
C
T/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I



T0Q)3X@/&1I=CXD/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E


#`G('=I9'1H
M/3-$
3`E/B`\9&EV/C4L

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



'!T


3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U



M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#4T,PX

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P


M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

#`G('=I9'1H/3-$
3`E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M


M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M




24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ-PV-3`L
#(Y

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

3
L
M-S
Q+#DV

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@




M;&4]
T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@
M



T1J=7-T:69Y/B8C
38P.SPO9&EV/B`\9F]N=!S='EL
M93TS1=&3TY4+49!34E


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M

M
C`Q





M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97


T0G


'!T.U1%6%0M

'!X.R!&3TY4.B`Q
'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97

M)B

M04U)3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-05)'24XZ


M13H@

M)T9/3E0M1D%-24Q9.B`G5&EM97






#L\+V1I=CX@/&1I=B!S='EL

'!T.TU!4D=)3CH@




M3TY4+49!34E

T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ
M5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M-05)'24XZ(#!P=`P


M;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T86)L92UL87EO

T0P/CQT



M
#1E9&9?
#$R9E\T

O
M4VAE970Q
RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T

M=#TB=7
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H


T1T97AT+VIA=F%S8W)I

@0V]M;65N

]




#$T/&)R/CPO=&@^#0H@(`@(`\+W1R

]







34Q.SPO8CX@/&(^/'4^15%5

M(S$V

'!T.TU!4D=)3CH@
M



T0G0TQ%05(Z8F]T:#L@1D].5U&
M04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.
M1$5.5#H@,XU:6X[($U!4D=)3CH@


#M$4$-0)B
X



M='D@9F5E('1O($1R:6YK(%!I92P@3$Q#('5N9&5R(&$@;&EC96YS:6YG(&%G






M(&%M;W5N='


2P@


M


'!T





'!T)SXR

M8W1I=F4F(S$V
#M$4$-0+B!#0BU54T$@86QS;R!E87)N960@82!D969I;F5D


C`Q
RP@0T(M


#`\


#`\

M97%U:71Y(&UE=&AO9!O9B!A8V-O=6YT:6YG+B!4:&4@:6YV97-T;65N=!B

T0G1D].5U&04U)3%DZ(=4:6UE


M
#PO9F]N=#X@870F(S$V




M(&]F9G

@

Y.2PV
3@\

M=64@9G)O;2!$4$-0+CPO9&EV/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S
M='EL93TS1=W:61T:#HQ
#`E.R!T86)L92UL87EO=70Z9FEX960[)R!C96QL


M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T










3XQ
B!-;VYT:'

2P@
M

]






M.B`Q
'!T.TU!4D=)3CH@


3L\+V(^(#QB

@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M
3!P=#M415A4+4E.1$5.5#H@




C`Q
RP@=&AE($-O;7!A;GD@



@3F5W(%)O;6%N)RPG

M96-T:79E;'DL('5N9&5R('1H:7
@86=R965M96YT+B!4:&4@96%R;BUO=70@

@:&%V92!B965N(')E8V]R9&5D(&%S(&%N(&EN8W)E87-E('1O
M(&=O;V1W:6QL+CPO9&EV/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL
M93TS1=W:61T:#HQ



M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970Q-2YH=&UL#0I#;VYT


M87-C:6DB#0H-CQH
M=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N



M*B!$;R!.;W0@4F5M;W9E(%1H:7

]


]
T1T:#Y-87(N(#



]
M

M
'!T.TU!4D=)3CH@



#L\+V1I=CX@/&1I=B!S='EL93TS

'!T.U1%6%0M24Y$14Y4.B`P+C(U:6X[($U!4D=)3CH@
'!T



@3F5W(%)O


@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@


14%2.F)O=&@[




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0W-24^(#QD:78^)B

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$
C
E(&-O;'-P86X]

Q-C`[
S$L

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.



#`G
M('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/C(P

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P



M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

M14E'2%0Z(#0P

M9!S='EL93TS1=415A4+4%

3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;#L@4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W

P
#`P
#`@
M
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXR+#`R-BPP

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$P+#
R-3PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$P+#
R-3PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M
M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

M

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%

M13H@

T0Q

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T

M1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T



'!T.R!615)4


'!T





M


M25I%.B`Q

M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

'!T.R!615)424-!



3!P=#L@5D52

M
T0W-24^(#QD:78^)B

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/
M4#H@(S`P
#`P

M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&

+4%
24=..B!B;W1T;VT[($)/4D1%


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q

3!P

M=VED=&@]

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97




P
#`P
M
#`@


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/C4V.PS.34\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q

24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXU,38L-C0Q/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M3$5!4CIB;W1H.R!&3TY4+49!34E

T0G0TQ%

@3F5W





T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$
#X\='(^/'1D/CPO



#1E9&9?
#$R9E\T

M9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
M
F9?-#`W-E\X-&


38N



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C


12!!4U-%5%




]


]

'!T.TU!
M4D=)3CH@



'!T.U1%6%0M

'!X.R!&3TY4.B`Q
'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97

M)B

M04U)3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-05)'24XZ













@=VEN92!I;G9E;G1O


M=!S='EL93TS1=&3TY4+49!34E



'!T)SXX

34V

M9F]N=!S='EL93TS1=&3TY4+49!34E







M3TY4+49!34E


2P@
C`Q-!A;F0@,C`Q,R!W97)E(&%S(&9O;&QO=W,Z/]D:78^(#QD

T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W
M(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!
M4D=)3CH@


969T.R!415A4+4E.1$5.5#H@
&EN.R!72414
M2#H@



T0P(&%L:6=N



24=..B!C96YT97([



M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


'!T.R!6


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M



+4%
24=..B!B;W1T;VT[($)/4D1%4BU4


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q

3!P

M=VED=&@]
T0X-R4^(#QD:78^5W)I=&4M9&]W;B!O9B!G;V]D=VEL;!R96QA
M=&5D('1O('=I;F4@8G)A;F1S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$


T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!R:6=H

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

#$S/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXD/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E


#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C0Y



3!P=#L@5D52

M
T0X-R4^(#QD:78^)B

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C


M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97


M9#L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
3`E/B`\9&EV/C4L.30P/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


'!T.R!615)4

24=..B!L


#`G('=I9'1H/3-$
24^(#QD

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

M5%E


#`G('=I9'1H
M/3-$
3`E/B`\9&EV/C0Y-BPR

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G1D].

#L\+V1I=CX@

'!T.TU!4D=)3CH@

M5#H@




M='



#L\+V1I=CX@/&1I=B!S='EL93TS


T0G34%21TE..B`P:6X[
M(%=)1%1(.B`Q


M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V


M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4


M3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M



M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6


P
#`P
#`@
7!X('-O;&ED.R!&3TY4

CX@/&1I=CXR
M

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q)3X@/&1I=CXF(S$V

T0Q

M;CTS1#(^(#QD:78^
C`Q

T0G5$58



+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/D1E9FEN:71E

M13H@

T0Q)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
3`E/B`\9&EV
M/C$W


M


+4%
24=..B!B;W1T;VT[

M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P



M+#`P

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W




24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97



M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



'!T


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M.PR-S$L-34U/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&


M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/CDV+#DU.3PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



'!T.R!6



3!P=#L@

M=&@]

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXY
M.30L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M63H@5&EM97


M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





'!T.R!615)424-!


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


'!T.R!615)424-!


'!T.R!6



'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR.PT

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&



#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

P
#`P
#`@
M
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R



3`L
#DV+#DT
3PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q


M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXU+#0P-PP

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P



M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
3`E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!6

M1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT+#8Y
BPY

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

34Q.R!I;F1E

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97



M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
3`E/B`\9&EV/C0L
3$R+#DW

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/C0L
3$R+#DW
CPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


M25I%.B`Q





M(%9%4E1)0T%
+4%


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

3!P=#L@5D52

M
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M
M0D]45$]-.B`C
#`P

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&


'!T.R!615)4

24=..B!L







'!T



14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S

@3F5W(%)O;6%N



M.7!T.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97





63I4




&EN.R!724142#H@
M
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@3U9%4D9




3!P=#L@5D52

M
T0W-24^(#QD:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G0D]2
M1$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
C
E(&-O;'-P86X]
M

Q-C`[
S$L/]D:78^(#PO=&0^(#QT9!S='EL

M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q





#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
M
T0R/B`\9&EV/C(P

13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS

CX@/&1I=CXR
#$S/]D:78^(#PO=&0^(#QT9!S

M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%


P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\

M965F9CL@0T]

M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$W


'!T.R!6

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0W-24^(#QD:78^5')A

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR-C(L,#DX/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





M-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$
M.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!6


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4



+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
3`E/B`\9&EV/C(P+#
U

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P





'!T

3!P=#L@5D525$E#04PM04Q)1TXZ

T0W-24^(#QD:78^

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV-#0L,S@W/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P




M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXM/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


P
#`P
M
#`@
7!X('-O;&ED.R!415A4+4%

M

T0Q


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W


M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO




T0Q
4^(#QD:78^)B,Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q


M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

M

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV


M

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXU+#0P-PP

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

14%2.F)O=&@[($9/3E0M






#L\+V1I=CX@/&1I

'!T.TU!4D=)3CH@

M








M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)



M4CIB;W1H.R!&3TY4+49!34E





'!T)SXW



M
'!T.U1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@

M

T1J

@3F5W

M:6UA=&5D(&%G9W)E9V%T92!A;6]R=&EZ871I;VX@97AP96YS92!F;W(@96%C


#L\+V1I=CX@/&1I=B!S='EL


T0G34%21TE..B`P
M:6X[(%=)1%1(.B`Q

P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T.R!&

M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@


F(S$V
M



M

T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$Q


13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


T0X-R4^(#QD:78^
C`Q-3PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

#`G('=I9'1H/3-$
24^



+4%
24=..B!B;W1T
M;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV,S0L-S4W/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T


M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


3!P=#L@5D525$E#

T0Q
M


+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#@W)3X@/&1I=CXR

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C8S
2PU-C(\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXV
S$L-#`U/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q




M25I%.B`Q

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T

38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L


#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M25I%.B`Q

M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4




T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$
#X\='(^/'1D/CPO



#1E9&9?
#$R9E\T

M9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
M
F9?-#`W-E\X-&






^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C



3(@36]N=&AS($5N9&5D/]T:#X-B`@


S$L(#(P



]

M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS

@3F5W(%)O;6%N

M3TY4+49!34E


3L\+V(^(#QB/CQU/E)%4U12

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M
3!P=#M415A4+4E.1$5.5#H@

38P.R8C.#
V-#L\9F]N=!S='EL93TS1=&
M3TY4+49!34E

T0G


Q+`R,#$T(&5X8VAA;F=E(')A=&4I(&%N98C
38P.R8C.#
V
M-#L\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@)U1I;65S($YE=R!2;VUA




T-CPO9F]N=#X@


@9&5S8W)I8F5D(&EN




F9?-#`W-E\X-&

F$Q-F5E860P-@T*



]

M:60]


3XQ
B!-;VYT:'
@16YD

M(&-L87-S/3-$=&@^36%R+B`S
2P@

]
M



]

M

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-





14%2.F)O=&@[($9/


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97


M+49!34E



M
3!P=#L@3U9%4D9


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS


13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B`C
#`P



3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0R

M1#4^(#QD:78^36%R8V@F(S$V
#LS

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I
M9'1H/3-$
24^(#QD:78^)B

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`W
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\





P
#`P
#`@
7!X('-O;&ED.R!4
M15A4+4%

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


M3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


#`G('=I9'1H/3-$
M
3$E(&-O;'-P86X]
T0R/B`\9&EV/C(P
3

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'



M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@4$%$1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXD/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E


M2%0Z(#0P

C`L

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXX.2PT

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4


M25I%.B`Q

M13H@

T0Q)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(Q
2PU.#`\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%

3!P

M=VED=&@]
T0Q


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/DME;'1I

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q
4^(#QD:78^,2PY-3,L,#,W
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




63H@5&EM
M97


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR
M+#`Q-2PP

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@

T0Q
4^(#QD:78^,BPT.38L,#`P/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#

T0W
M-24^(#QD:78^2G5N:6]R(&QO86X@*$4I/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C



+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV
M/C$L
C4P+#`P

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[





'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS




T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(L
3(U+#`P
#PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


'!T.R!6


+4%
24=..B!B;W1T;VT[($)/4D1%

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!
M3U)$15(M5$]0.B`C
#`P

M

Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\



T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T9#X@/'1D('-T

P
#`P
#`@
W!X(&1O=6)L93L@5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\


T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97



'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T9#X@

P
#`P
#`@
W!X(&1O=6)L

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/CDL
CDX+#

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97


14%2
M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97



M4E1)0T%
+4%
24=..B!T;W`[($)/4D1%4BU

M9&EV/B8C

T0G0D]21$52+4)/



M8VEL:71I97

X

M3E0M1D%-24Q9.B`G5&EM97


P
BPW

M25I%.B`Q
'!T)SXT
38L



M9&5R)B
X
C$W.W
@04$Q(%)A=&4@;6EN=7

T0G1D].

M=&%L960@)B
X

M97

M

'!T)SXR


M.B`Q

M13H@


Q+`R,#$S(&5X8VAA;F=E(')A=&4I+!A=!-87)C:`S
2P@
C`Q


#L\+V1I

M(S$V

M3TY4+49!34E



C$Q+#4X





T0G

M9F]N=!S='EL93TS1=&3TY4+49!34E


M.B`Q
'!T)SXQ
PU-SD\+V9O;G0^/]F;VYT/B!O9B!A8V-R=65D(&EN=&5R


S$L(#(P
30@86YD(#(P
3
L(0\9F]N=!S='EL93TS

'!T)SX\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@)U1I

M($YO=&4@:7
@:6YC;'5D960@:6X@;&]N9RUT97)M(&QI86)I;&ET:65S+CPO

M+4%
24=..B!T;W`G/B`\=&0^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9#X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D/B`\9&EV/B8C
38P.SPO

T0G5D525$E#04PM04Q)1TXZ


M5&EM97

3$L('1H92!#;VUP86YY(&%N
M9!#0BU54T$@96YT97)E9!I;G1O('1H92!+96QT:6







M3E0M4TE:13H@


C`Q

M87





@3F5W(%)O;6%N)RPG

3(U+#`P



Q-C`[=&AE






'!I<F5S(&]N($1E8V5M8F5R(#,Q+`R





@3F5W(%)O;6%N)RPG

@=&AE


@
RXR-24L(AB*2!T:&4@3$E
M3U(@4F%T92!P;'5S(#4N-S4E(&%N9`H8RD@-BXU,4\+V9O;G0^+B!&;W(@
M=&AE('EE87(@96YD960@36%R8V@@
S$L(#(P
30L('1H92!#;VUP86YY('!A

T0G1D].5U&04U)3%DZ(=4






M(&AA=F4@8F5E;B!N;R!%=F5N='



M;&]S:6YG(&%N9!C;VUM:71M96YT(&9E92!I;B!C;VYN96-T:6]N('=I=&@@
M=&AE('-E8V]N9!A;65N9&UE;G0F(S$V

M

C4L
#`P/]F;VYT/B!C;&]S:6YG(&%N9!C;VUM
M:71M96YT(&9E92!I;B!C;VYN96-T:6]N('=I=&@@=&AE('1H:7)D(&%M96YD

M4TE:13H@

M(&9E92!O9B`D
2PP


@

@=&AA


2P@

M9&5R('1H92!+96QT:6

Q+`R,#$T(&%N
M9`R


M97

M+#
R

@
M1F%C:6QI='D@:7
@:6YC;'5D960@:6X@;&]N9RUT97)M(&QI86)I;&ET:65S

14%2.F)O=&@[($9/3E0M1D%-24Q9

'!T(#`N-6EN.R!&3TY4.B`Q
'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97





+4%
24=..B!T;W`[($)/4D1%4BU
1494+5=)


M

'!X

@3F5W


M4TE:13H@

M;G0^+B!&;W(@=&AE('EE87(@96YD960@36%R8V@@
S$L(#(P
30L('1H92!#




;V%N+B`\9F]N=!S
M='EL93TS1=&3TY4+49!34E






M3&]A;B!W:71H:6X@
34@8F%N:VEN9R!D87ES(&9R;VT@=&AE(&-O;7!L971I


M(&1A=&4@;V8@=&AE($)O=7)B;VX@5&5R;2!



S$L(#(P
38\+V9O







'!T)SXW-3`L


M3&]A;BP@:6YC;'5D:6YG($9R;W-T($=A;6UA($EN=F5S=&UE;G1S(%1R=7-T


M4TE:13H@








3!P





3!P








M13H@

3







M960@:6X@;F]T97

M25I%.B`Q
'!T)SXR+#`Q-2PP


@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@


M.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



T0G5D525$E#




M1$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$
M15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS1=&3TY4
M+49!34E


T0G1D].


;V%N($%G


@




;V%N(BD@=&\@=&AE($-O;7!A;GDN(%1H92!*=6YI;W(@3&]A;B!B96%R




2P@
C`Q
RP@86YD
M(&UA='5R97


;V%N


M;G0N(%1H92!*=6YI;W(@3&]A;B!!9W)E96UE;G0@8V]N=&%I;G
@8W5S=&]M



M5&EM97






96YD97)S(&]N('1H92!D871E(&]F('1H92!*=6YI;W(@






@3F5W(%)O

#PO9F]N=#XI



#$T+`D,2PR-3`L,#`P(&]F('!R:6YC:7!A;!D=64@



@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@

M

M


<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52


M(#PO=&0^(#QT9#X@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E
63I4

M3TY4+49!34E










M5&EM97





M:P@:68@=6YC=7)E9P@96YT:71L92!E86-H(&YO=&4@:&]L9&5R('1O(&%C



T0G0TQ%05(Z8F]T:#L@
M1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M4
M15A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@

3!P



M-3`L

M=!S='EL93TS1=&3TY4+49!34E




'!T)SXQ
#`L
#`P/]F;VYT/BDL(&$@9&ER96-T
M;W(@;V8@=&AE($-O;7!A;GDL(&%N9!696-T;W(@1W)O=7`@3'1D+B`H)#QF

@3F5W(%)O;6%N)RPG


T0G0TQ%05(Z8F]T
M:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P
M=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@



M+49!34E





'!T)SXU

6QE/3-$
M)T9/3E0M1D%-24Q9.B`G5&EM97





T0G1D].





14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE

'!T(#`N-6EN.R!&3TY4.B`Q
'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97


@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@

&EN(#`N-6EN.R!&
M3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97




@86YD

@=&\@=&AE($-O;7!A;GD[

S$L(#(P


T0G
M0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@
'!T(#!P




63I4

M
!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1(.B`Q
#`E


P
#`P
#`@
7!X('-O;&ED
M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

3!P=#L@5D52

M

F(S$V




3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q)3X@/&1I=CXF(S$V
M

M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%

CX@/&1I=CY!;6]U

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[


T0X
M-R4^(#QD:78^

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M


M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@
M,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXR,PR

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#(U


'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0X-R4^(#QD:78^
C`Q-SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXS+#DV.PP

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF
M(S$U

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N





+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U



+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#@W)3X@/&1I=CY4:&5R96%F=&5R/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E



'!T

3!P=#L@5D525$E#04PM04Q)1TXZ

T0X-R4^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


T0Q)3X@/&1I=CXF(S$V

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I=CY4;W1A;#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97



P
#`P
#`@


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$

CPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&4]


'!T)SX\+V9O;G0^(#PO9&EV/CQT86)L92!B;W)D97(]
T0P





3)F7S0P
M-S9?.#1C
E\W-#)A
39E96%D



M@T*/&AT;6P^#0H@(#QH96%D/@T*(`@(#Q-151!(&AT='`M97%U:78]
T1#

]
T13:&]W

M1'1L(&-O;'-P86X]
T0Q(')O=W-P86X]



]
T1T:#Y-87(N(#




MB`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1=-05)'


'!T.TU!4D=)3CH@
M



3`@)B

14%2.F)O=&@[($9/3E0M1D%-

@



3
L('1H92!#;VUP



L($EN8RX@*)87)R:6YG=&]N


@*'1H92`B

38P.VAA=FEN9R!A(&=R

M.B`Q

@3F5W(%)O;6%N.T9/
M3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@


M3TY4+49!34E


3$
@;W(@86YY(&]T






M=&ET;&5D('1O(&-O;7!E;G-A=&EO;B!O9B`\9F]N=!S='EL93TS1=&3TY4
M+49!34E



M
PP,#`L('!L=7,@=7`@=&\@86X@861D:71I;VYA;`D-RPU







63I4:6UE

M:6X@


M


'!T)SXT+#4S
2PV
M-#



3@T+#
T

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M
3!P=#M415A4+4E.1$5.5#H@


'!X.R!&3TY4
M.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97


M+49!34E






@3F5W(%)O;6%N)RPG


M92`H)B
X

#MT

M3E0M4TE:13H@

@02!0





M
C`[
C`Q



M;6UO;B!S=&]C:RP@:7-S=6%B;&4@=7!O;B!C;VYV97)S:6]N(&]F('-U8V@@


M=!S='EL93TS1=&3TY4+49!34E


C`Q


@3F5W(%)O

S@\+V9O;G0^('!E


'!T
M.U1%6%0M24Y$14Y4.B`P+C(U:6X[($U!4D=)3CH@

M

M

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97




#$T(&%N9`R,#$S+!T



M9F]N=!S='EL93TS1=&3TY4+49!34E



M=6UU;&%T960@9&5F:6-I=!A;F0@:6X@861D:71I;VYA;!P86ED+6EN(&-A

M92!S:&5E='

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@

M5&EM97




M;W5N8V4@86YY('-A;&4L(&=R86YT(&]R(&]P=&EO;B!T;R!P=7)C:&%S92!O





C`Q

M


M25I%.B`Q

'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

M)B

M04U)3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.
M1$5.5#H@


3`P+#`P

@;V8@9&5S:6=N871I





3$L(#(P
30L
M('1H92!#;VUP86YY)B
X
C$W.W






C`Q-XF(S$V,#M0=7)S=6%N=!T;R!T:&4@;6%N9&%T

'!T

@


63I4



M/3-$)T-
14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&

M






T0G1D].5U&04U)3%DZ(=4



'!T.U1%6%0M24Y$14Y4.B`P+C(U:6X[
M($U!4D=)3CH@



'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97


2P@
C`Q

M97

M)T9/3E0M1D%-24Q9.B`G5&EM97


3

@;V8@8V]M;6]N('-T;V-K+CPO9&EV/B`\
M+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T




M+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970R


T0G




M/3-$



S$L
M(#(P





'!T.TU!4D=)3CH@

M5#H@

M5$4@
3$@)B

M.B`Q

'!X.R!&
M3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M

@:6YT;R!F






2P@




M-&5D9E\P
3)F7S0P-S9?.#1C
E\W-#)A
39E96%D


M(&-O;G1E;G0]


M/3-$



]
T1T:#Y-87(N
M(#




'!T.TU!4D=)3CH@

M1D].5#H@


B`F(S$U



'!T.U1%6%0M24Y$14Y4.B`P+C5I;CL@34%2

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97


@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@


@:6X@86-C;W)D86YC92!W:71H($%30R`W

@86YD(&QI86)I;&ET:65S(&%R

@97AP96-T
M960@=&\@87!P;'D@=&\@=&%X86)L92!I;F-O;64@:6X@=&AE('EE87)S(&EN

M.B`Q

'!X.R!&
M3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

Q

M3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-05)'24XZ(#!P


@


M



M;W(@=VAI8V@@=&%X('EE87)S(#(P

M3TY4+49!34E

T0G0TQ%05(Z8F]T:#L@1D].


Q+`R,#$T(&%N9`R
M


M=&AE($-O;7!A;GD@:&%D(&9E9&5R86P@;F5T(&]P97)A=&EN9R!L;W-S(&-A


T0G

#PO9F]N=#X@9F]R(%4N4RX@=&%X('!U

M25I%.B`Q
'!T)SX@



@3F5W(%)O;6%N)RPG

PP,#`\+V9O;G0^+!W
2!T:&4@)B
X

C$[(')U
M;&5S(&%S('-E=!F;W)T:!I;B!S96-T:6]N(#
X
B!O9B!T:&4@26YT97)N

14%2.F)O
M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P



M.R!&3TY4+49!34E



'!T)SXQ-C@L
C


@=&]T86QE9`D-#$R+#$X,B!F;W(@
M=&AE('EE87(@96YD960@36%R8V@F(S$V,#LS,2P@,C`Q,RX\+V1I=CX@/&1I
M=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4+49!34E






M
C`Q

'!T.TU!4D=)3CH@
M




M;V8@

14%2.F)O=&@[($9/3E0M


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P
M=#M415A4+4%
24=..DQE9G0[(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q
M

Y96(V8V4@
M

'!T.R!/5D521DQ/5SH@=FES:6)L93L@0D]2



M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'

M=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0R


F(S$V

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19


M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

#L\

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


M13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@
M(S`P
#`P


P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M


M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

T0Q






P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T

CX@/&1I=CXE/]D:78^(#PO=&0^(#QT9!S

M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].
M5U714E'2%0Z(#0P

S0N
#`\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


#`P
#`P.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97




+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P
M,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH,C@N-3$I/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M25I%.B`Q


P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@

M=&@]
T0Q


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].
M5U714E'2%0Z(#0P

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM

T0Q

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M

M9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M(#QD:78^

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97



P
#`P
#`[($9/3E0M4TE:13H@
M



T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



P
#`P
#`[
M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q
4^(#QD:78^)B,Q-3$[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M.B`Q

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D52

M
T0Q


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T


T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3$]2.B`C
#`P

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@





T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M




+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

#`P
#`P

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@S+C@Q*3PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].
M5U714E'2%0Z(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



P
#`P
#`[($9/
M3E0M4TE:13H@

T0Q
4^(#QD:78^-XY
SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97



M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
M3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M-BXP

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97



+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/C8N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!3U)$15(M5$]0.B`C
#`P

M(#0P




M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L


#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P

#`P
#`P.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@V+C8S*3PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97



24=..B!R:6=H=#L@
M1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P
#`P
#L@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

M/3-$)T-
14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&

T0G

T0G0TQ%

@3F5W


M($9/3E0M4TE:13H@





C`Q
M

M13H@

M3TY4+49!34E

M:70L(&YE=X\+V1I=CX@/&1I=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4
M+49!34E









@3F5W(%)O;6%N.T9/3E0M4TE:
M13H@

#L\+V1I=CX@/&1I=B!S='EL


T0G0D]21$52+4)/

1494.B`C.65B-F-E

M0T]



T0P
M(&-E;&QP861D:6YG/3-$

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I
M9'1H/3-$-S4E/B`\9&EV/B8C

M


M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=.


38P.S
Q+#PO9&EV/B`\+W1D/B`\=&0@


M


M3E0M4TE:13H@

T0W-24^(#QD:78^)B

M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%

M15A4+4%

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


P
M
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([($9/3E0M4U19

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M
M5$]0.B`C
#`P



M13H@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@/]T9#X@/]T

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M

24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%


M25I%.B`Q


+4%
24=..B!B


'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P



3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$

M

#`P
#L@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXW
BPP

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+
M1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXQ,#,L,#`P/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0W-24^(#QD:78^06-C
M;W5N='

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#

T0Q
M


M25I%.B`Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E


M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P

M4TE:13H@


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

#`P
#L@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS
#0L

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

#`P
#L@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR.#`L

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!6

M1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!
M04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%
M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+#$R-2PP,#`\+V1I=CX@/]T9#X@




M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$



+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

P
#`P
#`[($9/3E0M4TE:
M13H@

T0Q


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:
M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z
M(#0P

C`V+#`P
#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


1494
M.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




63H@5&EM
M97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
M,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-PW
#8L
M

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\


M(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS
2PV
M
C
L

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@


M


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4



+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


#`P/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+4Q%1E0Z(#$S

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!6


M



P
#`P
#`[($9/3E0M4TE:13H@
3!P

M=VED=&@]
T0Q


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


P
M
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV


M0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]

#`G('=I9'1H/3-$
M
3`E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+
M1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@/]T9#X@/]T

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E


M2%0Z(#0P

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




63H@5&EM
M97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
M,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS.2PS.30L
M,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




63H@
M5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@
M(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-BPQ
M-#,L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



M



T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z
M(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

X
M+#DR
2PP

M

T0Q)3X@/&1I=CXF(S$V

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F
M.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&





M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%


P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M

24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%


M25I%.B`Q

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%


M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

M

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q

P
#`P
#`@
M


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
3`E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97



M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O
M=6)L93L@1D].5U714E'2%0Z(#0P


M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,`S

M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

P
#`P
#`@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P




M3E0M4TE:13H@

T0W-24^(#QD:78^1&5F97)R960@:6YC;VUE

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





'!T


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV


M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)424-!

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


'!T.R!6

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXH.#@X+#@V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P

3!P=#L@5D525$E#

T0Q
M



M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&

#L\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@4$%$1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M25I%.B`Q


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C
#`P

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS



'!T.R!6


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M


M3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-05)'24XZ(#!P


#L\+V1I=CX@/&1I=B!S='EL93TS


'!T(#!P


M86QI9VX]

S$L(#(P
3
L('1H92!#

@87
@:70@8F5L:65V960@




X
C$W.W

M9!B92!R96%L:7IE9X@)B
X

X
M



3`M
S`@
M:6X@9F]R;6EN9R!I='

M('1O('1H92!U;'1I;6%T92!R96%L:7IA=&EO;B!O9B!T:&4@9&5F97)R960@

X
C$W
M.W







M9!-87)C:`S
2P@





'!T)SXT-S
L
S



C`Q
M







Q+`R,#$T
M(&%N9`R

C$L

M:&4@=&]T86P@=F%L=6%T:6]N(&%L;&]W86YC92!F;W(@=&AE('EE87)S(&5N

Q+`R,#$T(&%N9`R

M

BPW-S@L

T0P





3)F7S0P
M-S9?.#1C
E\W-#)A
39E96%D



M@T*/&AT;6P^#0H@(#QH96%D/@T*(`@(#Q-151!(&AT='`M97%U:78]
T1#

]
T13:&]W

M1'1L(&-O;'-P86X]
T0Q(')O=W-P86X]



]
M
T1T:#Y-87(N(#
Q+`R,#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@


M(%)E;&%T960@0V]S='



]


M
'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)
M3CH@



M5&EM97


'!X.R!724142#H@
R4[($)/4D1%4BU43U`M5TE$


M97

M;65S($YE=R!2;VUA;BP@5&EM97


M('-T;V-K(&]P=&EO;G




T0G5D525$E#


M)3L@0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P
M.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
#L\+V1I=CX@



+4%
24=..B!T;W`[($)/4D1%4BU

M24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97




M


M(%=)1%1(.B`T)3L@0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!
M3$E'3CH@=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
M


+4%
24=..B!T;W`[
M($)/4D1%4BU

M)T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

M)B




#LR


@879A:6QA8FQE('5N9&5R('1H92!0



#`P+#`P
M

T0G1D].5U&04U)3%DZ(=4:6UE

M



@;V8@075G=7-T(#(P
3
L(&YO
M(&YE=R!A=V%R9'

'!X.R!724142#H@
<^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N

M+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M
M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!
M34E

38P.SPO


M/3-$)U9%4E1)0T%
+4%

T0G0D]21$52


'!X.R!615)424-!3U!3$E'3CH@=&]P
M.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=CX\9F]N=!S='EL93TS

M(8C,38P.SPO9F]N=#X\+V1I=CX@/]T9#X@/'1D/B`\9&EV/CQF;VYT('-T



#LR
#$S('!L86XF(S@R
C$[*2!W


L



@;V8@36%R8V@@
M
S$L(#(P

@

#`P

M24Q9.B`G5&EM97




T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ
M5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@
M,XU:6X[($U!4D=)3CH@


T1J=7-T:69Y/B8C
38P.SPO

14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I

'!X



Q+`R,#$T(&%N9`R
#$S(&%M;W5N

'!T)SXS.3


'!T)SXX

M3E0M4TE:13H@


'!T)SXS
3(L



2P@



M5&EM97

M-RPY

M13H@

38P.WEE87)S+B!4:&5R92!W97)E

M960@36%R8V@@
S$L(#(P
30@86YD(&YO(&]P=&EO;G


2P@
C`Q
RX@5&AE($-O;7!A

C`Q
RP@
M87

@=V5R92!D92!M:6YI;6ES+CPO9&EV

14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S

'!T(#`N-6EN.R!&3TY4.B`Q
'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97


@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@



38P.SQU/E-T;V-K($]P=&EO;G



T0G0TQ%05(Z

M

T0P(&-E;&QP
M861D:6YG/3-$

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M-3$E/B`\9&EV/B8C

T0G5$58


M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT



Q-C`[
S$L

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.



#`G
M('=I9'1H/3-$
C
E(&-O;'-P86X]
T0U/B`\9&EV/C(P

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($)/4D1%4BU4


P
#`P
#`@
7!X('-O;&ED.R!&3TY4

M

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P
M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%



24=.

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%

M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

24=..B!C




3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P





T0Q)3X@/&1I=CXF(S$V
M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T


M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\



24=.


M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
M







M3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

3!P=#L@5D525$E#04PM04Q)

T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.


M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q


T0G



M

T0U
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]




3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
3$E(&-O;'-P86X]

M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\






M

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$
3$E(&-O;'-P86X]

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT





24=..B!C96YT97([


M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@









M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$-3$E/B`\9&EV/D]U='-T86YD:6YG(&%T(&)E9VEN;FEN9R!O9B!Y96%R

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q)3X@/&1I=CXF(S$V



T0Q
4^(#QD:78^.PQ
C`L

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@

M=VED=&@]
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'


M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C`N-C0\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58


+4%
M24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV+#,S,PU.3D\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


T0Q
4^(#QD:78^,XW-#PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97



M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q

M;#L@4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$L.#`P+#$V-CPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXP+C,P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P





M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$U
3L\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%

3!P

M=VED=&@]
T0Q
4^(#QD:78^,XP

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#4Q)3X@/&1I=CY&;W)F96ET960\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q




M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^*#$V-BPP

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C4N-SD\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G0D]21$52
M+4)/5%1/33H@(S`P
#`P

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

M

T0Q

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%

3!P=#L@5D525$E#04PM

T0Q

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97





M.B`Q


+4%
24=..B!M:61D


'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

M14E'2%0Z(#0P


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@

M=VED=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@



M.B`C
#`P

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-3$E/B`\9&EV/D]U


'!T.R!6

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


P
#`P
#`@
W!X(&1O=6)L93L@5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\


M25I%.B`Q

M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXP+C4Q/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
W!X(&1O=6)L
M93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



'!T

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXD
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C8T/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P
#`P


'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P
M
#`P


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

M8VES86)L92!A=!P97)I;V0@96YD/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
W!X
M(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q




24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C8S/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT+#(T.PY-3@\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G0D]2
M1$52+4)/5%1/33H@(S`P
#`P

3!P

M=VED=&@]
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+CDT

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D]21$52
M+51/4#H@(S`P
#`P

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!
M3U)$15(M5$]0.B`C
#`P


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L
M93L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
M
#`P


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@




M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$

T0G5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/C`N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^,XQ-CPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&4]



T0G0TQ%05(Z8F]T
M:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P
M=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@

M


M
2P@

'!T.TU!4D=)
M3CH@


969T.R!415A4+4E.1$5.5#H@
&EN.R!724142#H@
M


3!P
M=#L@3U9%4D9







M

T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#(S

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\






M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
SDE/B`\9&EV/B8C
38P.SPO9&EV



P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M


#`G('=I9'1H/3-$
3`E/B`\9&EV
M/B8C


M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B


M=&@]
T0Q

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

M
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\


#`G('=I9'1H/3-$
M
24^(#QD:78^)B



T0Q
4^(#QD:78^)B,Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([



M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV





M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

CX@/&1I=CY!

M($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M





M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\

M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C




M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
SDE
M/B`\9&EV/B8C




24=.



24=..B!C



M15A4+4%

'!T.R!615)4


3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%

'!T.R!615)424-!

M3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

3!P=#L@5D525$E#04PM

T0Q
24@

M;&4]




M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
SDE/B`\9&EV/E)A;F=E)B
Q

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



Q-C`[

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



M+4%

'!T.R!615)424-!

M3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/B8C





M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6


3!P=#L@5D52

M
T0Q

M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
SDE/B`\9&EV/D5X97)C:7-E)B

M;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]




P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M


M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V


CX@/&1I=CY3:&%R97

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


3!P=#L@

M=&@]
T0Q

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


3!P=#L@5D52

M
T0Q

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
24^(#QD:78^)B

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0S.24^(#QD:78^)#`N
#$@)B
Q
M-3$[(0P+C(U/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!3U)$15(M5$]0.B`C
#`P

M(#0P



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P


M:78^-C(Q+#4P

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[

M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXT+C4W/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I



T0Q)3X@/&1I=CXF(S$V
#L\

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@

M=VED=&@]
T0Q


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@


#`G('=I9'1H/3-$
3`E

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4


34Q.R`D
2XP
#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'



M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^-PU.3(L-#0W/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97



M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L



M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#
Y)3X@/&1I=CXD
2XP
2`F(S$U
M
3L@)#(N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@

T0Q


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M

T0Q)3X@/&1I=CXF(S$V

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[($9/
M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U7
M14E'2%0Z(#0P


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E



2XX
CPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#
Y)3X@/&1I=CXD-2XP
2`F(S$U
3L@)#8N
#`\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


3!P=#L@

M=&@]
T0Q
4^(#QD:78^,C$L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





M-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$
M.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXP+C0P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





M.R!&3TY4+49!34E
63H@5&EM97


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV+C`P/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97





M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M


3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV


M4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$W+#`P
#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXV+C,V/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#
Y)3X@/&1I=CXD-RXP
2`F(S$U
M
3L@)#@N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@

T0Q


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M

T0Q)3X@/&1I=CXF(S$V

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/
M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U7
M14E'2%0Z(#0P

2XV.#PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L



M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXQ.#0L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





M.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@


M

Q-3$[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

34Q.R`D.2XP
#PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$


3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

M

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%

M13H@

T0Q


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M63H@5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#
Y)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



T0Q
M
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





P
#`P
#`[
M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!3U)$15(M5$]0.B`C
M
#`P


M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

#`G('=I9'1H
M/3-$
3`E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\



T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#
Y)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

#`P

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$


M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I


63H@5&EM97
@


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/
M54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXT+#8P,2PS,S8\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


3!P

14%2.F)O=&@[($9/3E0M1D%-


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-



3$L-#0W+B!4:&4@=V5I



38P.WEE87)S

14%2.F)O=&@[($9/3E0M1D%-24Q9

@3F5W



@96YD960@36%R
M8V@@
S$L(#(P
30@86YD(#(P
3

@3F5W(%)O;6%N.T9/3E0M4TE:
M13H@

#L\+V1I=CX@/&1I=B!S='EL


T0G34%21TE..B`P
M:6X[(%=)1%1(.B`Q


M

T0W-24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]




3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
3$E(&-O;'-P86X]

M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/



M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M



M3E0M4TE:13H@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19



M4TE:13H@

T0Q




M3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD
M:78^)B

M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C






3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q)3X@/&1I=CXF(S$V
M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL
M93TS1=415A4+4%

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6


M15A4+4%

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^56YV97-T
M960@870@36%R8V@@
S$L(#(P

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'


M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C
L-3DS+#DY

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

#`G('=I
M9'1H/3-$

T0G5$58


+4%
M24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C,T/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!6

M1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97


M.B`Q


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^,XS

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


'!T.R!6


M

M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV




T0Q
4^(#QD:78^)B,Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P






M

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD
M:78^56YV97-T960@870@36%R8V@@
S$L(#(P
3

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS+#@W
2PX


M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

M1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M25I%.B`Q

3!P=#L@5D525$E#

T0W
M-24^(#QD:78^)B

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^)B,Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/D=R

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%

M4TE:13H@

T0Q
4^(#QD:78^,RPS,#`L,#`P/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O



3!P=#L@5D52

M
T0W-24^(#QD:78^0V%N8V5L960@;W(@97AP:7)E9#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M




'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R





+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

3!P=#L@5D525$E#04PM04Q)

T0Q


M25I%.B`Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E





M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&

#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q

M
#`P

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/E5N=F5S

Q+`R,#$T/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
W!X
M(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXU+#8V,BPU-C`\+V1I=CX@/]T9#X@




M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$

T0G5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/C`N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\

14%2.F)O=&@[($9/3E0M1D%-24Q9





M4V5R:68G/B`F(S$V

'!T
M.TU!4D=)3CH@


M=6YD97(@=&AE(%!L86X@:7





M97AP96-T960@=&5R;2!W87



@;VX@:71S


@=&AE($-O;7!A;GD@=&\@97-T:6UA=&4@9F]R9F5I
M='5R97
@870@=&AE('1I;64@;V8@9W)A;G0@86YD(')E=FES92!T:&5S92!E


M;6%T97


63I4:6UE

M

14%2.F)O=&@[($9/3E0M1D%-


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E





#L\+V1I

'!T.U1%6%0M04Q)1TXZ3&5F=#L@

M



3!P
M=#L@3U9%4D9


M4TE:13H@

T0W
B4^(#QD:78^)B

M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\




M
#LS

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-S(E
M/B`\9&EV/B8C



P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([


24=.


M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V


M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

CX@/&1I=CXR
M

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P
M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


'!T.R!6


+4%
24=..B!M:61D;&4[($)/4D1%

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4


M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N
M.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U3
M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P



M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M
6QE/3-$)U1%6%0M04Q)1TXZ(&QE

'!T


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q
4^(#QD:78^-2XU(T@-BXR

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
M3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M-C4E(T@-S8E/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





M.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)424-!


M


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E


M14E'2%0Z(#0P

#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


3!P

14%2.F)O=&@[($9/3E0M1D%-

@

M0T]

'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97

M


M='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))

M
'!X)SX@/&1I=CXF(S$V

M0T%
+4%
24=..B!T;W`[($)/4D1%4BU


M5&EM97

M93TS1=415A4+4%,24=..B!J=7-T:69Y)SX@/&1I=CX\9F]N=!S='EL93TS



T0G0TQ%05(Z
M8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@

M5#H@

M
T1J=7-T:69Y/B8C

14%2.F)O
M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P



T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)
M3CH@


'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E


@:7-S=65D(&EN(&-O;FYE8W1I;VX@


T0G1D].5U&04U)3%DZ(=4





C=P=#L@
M1D].5#H@

'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97



M(&$@;&EA8FEL:71Y)B
Q-C`[870@=&AE:7(@:6YI=&EA;!F86ER('9A;'5E
M(&]F(0\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@)U1I;65S($YE=R!2


C`Q


#$Q(&%S(&$@;&EA8FEL:71Y)B
Q-C`[870@=&AE:7(@
M:6YI=&EA;!F86ER('9A;'5E(&]F(0\9F]N=!S='EL93TS1=&3TY4+49!
M34E

M92!O9B!T:&4@
C`Q

M;FEN9W

@3F5W(%)O




M+49!34E



14%2.F)O=&@[($9/3E0M1D%-



T0G0TQ%


M5&EM97




T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W
M(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!
M4D=)3CH@



M/3-$)T-
14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&









@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@

C=P=#L@1D].5#H@

M14Y4.B`P:6X[(%=)1%1(.B`Q


Y96(V8V4@


M3E0M4TE:13H@
3!P=#L@3U9%4D9


M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4T)3X@/&1I=CXF(S$V
M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M


M4TE:13H@

T0Q

M

M(%1I;65S($YE=R!2;VUA;CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@
M,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P
M



M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/

P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M
M5$]0.B`C
#`P


M+4%

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


P
#`P
#`[($9/3E0M4TE:13H@
M

T0Q)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

P
#`P
#`@
7!X('-O
M;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q
4^(#QD:78^,XS

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#
M3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q

M3E0M4TE:13H@



M


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E


M14E'2%0Z(#0P


M54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q
4^(#QD:78^,XS-CPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N
M.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U3
M25I%.B`Q


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-30E/B`\

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C(N-C

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z
M(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!6


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E


M(#0P

RXR-3PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C
M8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O



+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W
M(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@
M1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@/]T9#X@




M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P
M,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@1D].5U714E'2%0Z(#0P



'!T


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M3$]2.B`C
#`P

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M4TE:13H@

14%2.F)O=&@[





M34E

C=P=#L@1D].5#H@



T0G1D].

RPX-#@L
S





M;W1H.R!&3TY4+49!34E

C=P=#L@1D].5#H@

T1J=7-T:69Y/B8C
M

14%2.F)O=&@[($9/3E0M1D%-



M



'!T.TU!4D=)3CH@

'!T


'!T)SY&;W(@=&AE('EE
M87(@96YD960@36%R8V@@
S$L(#(P


M.B`Q

M

'!T)SX\+V9O;G0^)B

@3F5W(%)O;6%N.T9/
M3E0M4TE:13H@


'!T.TU!4D=)3CH@

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
M
3!P=#M415A4+4%
24=..DQE9G0[(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(
M.B`Q

Y96(V
M8V4@

'!T.R!/5D521DQ/5SH@=FES:6)L93L@



M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!

M/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C



M)B

M($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M






3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M:#TS1#$P)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS


M-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M


M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19



M4TE:13H@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q


M13H@

T0Q


13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-S4E/B`\9&EV
M/B8C




24=..B!C96YT



24=..B!C96YT97([


M3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

T0G


M15A4+4%

'!T.R!615)4


M15A4+4%

'!T.R!615)4







M

T0Q)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]

#`G
M('=I9'1H/3-$
3`E/B`\9&EV/C$S+#0T.PQ,SD\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P



M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



'!T


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#

T0W

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@


M

Q-3$[/]D:78^(#PO=&0^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+4Q%1E0Z(#$S

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M63H@5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXF(S$U

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&




'!T.R!615)424-!


'!T.R!6

M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M





M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97



'!T.R!615)424-!


M25I%.B`Q


+4%
24=..B!M


'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P



3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
M

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+
M1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXQ,2PY,#0L.3(U/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!6



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXP+C0V/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N




+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E



Q-3$[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


1494.B`Q
M
W!X.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^*#$P+#$R-RPQ,C,I/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





M-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T.R!6

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$U

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^)B,Q-3$[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-S4E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R
M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W





3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:
M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z
M(#0P


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@

M

T0Q)3X@/&1I=CXF(S$V

M/]T86)L93X@/&1I=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4+49!34E

M:78^(#PO9&EV/CQT86)L92!B;W)D97(]

M



;V-A=&EO;CH@

3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
M



]


T0Q(')O
M=W-P86X]




S$L(#(P
M



]




3L\+V(^(#QB/CQU/E)%3$%4
M140@4$%25%D@5%)!3E-!0U1)3TY3/]U/CPO8CX\+V1I=CX@/&1I=B!S='EL
M93TS1=#3$5!4CIB;W1H.R!&3TY4+49!34E




M+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M
M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V


+4%
24=..B!T;W`[($)/4D1%4BU
1494+5=)1%1(

M($YE=R!2;VUA;BP@5&EM97



@;V8@4&%L

M(#(P


M86YD('!R;V1U8W1S+B!4:&4@=&5R;7
@;V8@=&AE($YE=R!!9W)E96UE;G0@
M=V5R92!E9F9E8W1I=F4@87
@;V8@07!R:6P@
2P@
C`Q
X\+V9O;G0^/]D





M2#H@

M.E1I;65S($YE=R!2;VUA;BP@5&EM97



+4%
24=..B!T;W`[($)/
M4D1%4BU

38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[($)/


#L\+V9O;G0^






M)T)/4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$




@3F5W(%)O;6%N
M)SL@1D].5U325I%.B`Q,'!T)SX@/]F;VYT/B8C
38P.SPO9&EV/B`\+W1D



M24142#H@
'!X.R!724142#H@


@3F5W(%)O

M(#QT9#X@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@)U1I;65S


M

Q+`R,#$T(&%N9`R
M



@

L-C@U+#$Y
M

@;V8@36%R8V@@
S$L(#(P
30@
M86YD(#(P
3

M($9/3E0M4TE:13H@


M)SL@1D].5U325I%.B`Q,'!T)SXS-PV


@

M1D%-24Q9.B`G5&EM97


M13H@




@3F5W(%)O;6%N

3$%04T4Z(&-O

'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E


M;&4]

M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4+5=)1%1(.B`P

'!X.R!72414
M2#H@


M
38P.S(P
#@L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(&UA;F%G96UE







M

3`P+#`P
#PO9F]N=#XL('!L=7


M97
@:6YC=7)R960@8GD@5F5C=&]R($=R;W5P(&]R($UR+B8C
38P.TQA;7!E

L


F(S@R


Q+`R,#$T(&%N
M9`R

M3E0M4TE:13H@

T0G

05!313H@8V]L;&%P





'!X.R!615)424-!3U!3$E'3CH@=&]P
M.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=CX\9F]N=!S='EL93TS

M($



@96YD960@
M36%R8V@@
S$L(#(P
30@86YD(#(P
3
L($Q44R!W87



M=!S='EL93TS1=&3TY4+49!34E









'!T.U1%6%0M24Y$

'!X.R!&3TY4.B`Q
'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97

Q
M-C`[/]D:78^(#QT86)L92!S='EL93TS1=724142#H@
3`P)3L@0D]21$52
M+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@

T0P(&-E;&QP861D:6YG
M/3-$

+4%
24=..B!T;W`G/B`\=&0@

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[(%1%6%0M04Q)







C`Q
RP@=&AE


M


M961F7S`Q
F9?-#`W-E\X-&







]

T1)1#!%344^




S$L(#(P


@86YD($-O;G1I;F=E;F-I97
@1&ES




'!X.R!&
M3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

@3F5W
M(%)O;6%N.T9/3E0M4TE:13H@

M/DY/5$4@
34@)B

@3F5W(%)O
M;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@


3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL
M87!S93L@1D].5#H@


T0P(&-E;&QP861D:6YG/3-$

M/3-$)U9%4E1)0T%
+4%

T0G0D]21$52
<^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M

M)3L@0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P
M.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS
M1=&3TY4+49!34E

M






M

M8FIE8W0@=&\@8V5R=&%I;B!A;FYU86P@861J=7-T;65N='





'!T)SXY-CDL

2P@

V-#L\9F]N
M=!S='EL93TS1=&3TY4+49!34E


#MO



M)B



M97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@



M
'!X.R!724142#H@


'!X.R!615)424-!3U!3$E'3CH@
M=&]P.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=CX\9F]N=!S='EL


@






M3E0M4TE:13H@


3!P



X
S8T.SQF;VYT



#

'!T)SXS


2P@

V-#L\9F]N
M=!S='EL93TS1=&3TY4+49!34E


M



C
W+#0Y
3PO9F]N=#XL
M)B




38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@


M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97





'!T.U1%6%0M



05!3



M)T)/4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$


'!X.R!7
M24142#H@




L

@;V9F:6-E('-P86-E(&EN($YE

2P@
C`Q


M;`S,P@


'!T)SXQ.2PY-S4\
M+V9O;G0^+B!4:&4@1'5B;&EN(&QE87-E(&-O;6UE;F-E9!O;B!-87)C:`Q

T0G1D].

2P@
C`Q-CPO9F]N=#X@86YD('!R;W9I9&5S

Q-C`[)B
X
S8T.SQF;VYT('-T




M($9/3E0M4TE:13H@



C`P


M3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.

#L\+V1I=CX@/&1I=B!S='EL


'!T



@3F5W(%)O






'!T


3!P

969T.R!4
M15A4+4E.1$5.5#H@
&EN.R!724142#H@

M1=-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,4[($)/4D1%4BU#3TQ
05!313H@

3!P=#L@3U9%4D9



#`P
#`P(#%P
6QE/3-$)U1%6%0M04Q)


24=.


M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+51/4#H@(S`P
#`P




+4%
M24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97



'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#@W)3X@/&1I=CXR,#$V/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





M3TY4+49!34E
63H@5&EM97


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0X-R4^(#QD:78^
C`Q-SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C
P
M+#DV

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W





'!T


+4%
24=..B!B;W1T;VT[($)/

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!3U)$15(M5$]0.B`C
#`P

M(#0P


3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P

P
M
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M4TE:13H@

T0Q


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B


T0G
M0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@
'!T(#!P


M86QI9VX]
T1J=7-T:69Y/B8C

M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)

'!X(#!I;B`P+C1I;CL@1D].5#H@
3!P






M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97



@
M96YD960@36%R8V@@
S$L(#(P
30@86YD(#(P
3



@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@


M


M

M4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$5$@Z


@;V8@=&AE

M36-





M;&4]

M($9/3E0M4TE:13H@


14%2.F)O=&@[($9/3E0M

'!T(#`N
C5I;CL@1D].
M5#H@

M3TQ

@3F5W(%)O;6%N





M
'!X.R!724142#H@




M5&EM97

M=7-T(#(P
3$L('1H92!#;VUP86YY(&%N9!#0BU54T$@96YT97)E9!I;G1O
M('1H92!+96QT:6

#$R
M+!-87)C:`R

M86YD($YO=F5M8F5R(#(P
3

M
T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$


M964W
#1E9&9?
#$R9E\T

M+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X-&
R


C4N:'1M;`T*0V]N=&5N



^+RH@


M

]






]

'!T



14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I

'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

M/&(^3D]412`Q-B`F(S$U
3L\+V(^(#QB/CQU/D-/3D-%3E12051)3TY3/]U
M/CPO8CX\+V1I=CX@/&1I=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4+49!
M34E


'!X
M.R!724142#H@


'!X.R!615)424-!3U!3$E'3CH@=&]P
M.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=CX\9F]N=!S='EL93TS



M870@=&EM97

N(%1H92!#;VUP86YY(&5X8V5E9&5D('1H
M92!L:6UI='

2!A

'!T)SXS
#`L
M
#`P/]F;VYT/B!A=!-87)C:`S,2P@,C`Q,RX\+V9O;G0^/]D:78^(#PO


^(#QD:78^)B



3L@4V%L97


M;F


'!T)SX@
S$N.3PO9F]N

'!T)SX@
S`N
CPO9F]N
M=#XE(&]F('1H92!#;VUP86YY)B
X
C$W.W

@9F]R('1H92!Y

2P@

M34E

M4TE:13H@

#$T(&%N9`R,#$S+!R97-P96-T:79E;'DN

3)F7S0P-S9?.#1C
E\W
M-#)A
39E96%D






M;VYG/D=%3T=205!(24




]


M86QI9VX]

]




14%2
M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@






'!T

'!X.R!&3TY4.B`Q
M
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97



@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M-



M96EG;B!C;W5N=')I97

M5&EM97






M5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@



M25I%.B`Q

T0G0D]21$52+4)/5%1/33H@


3$%0




M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#4S)3X@/&1I=CXF(S$V
#L\

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


M13H@


F(S$V
M


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M

M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-S`P)R!W:61T:#TS1#4S)3X@/&1I=CXF(S$V

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


P
#`P
#`@
7!X('-O
M;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($)/4D1%4BU4

M9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q

3!P=#L@5D525$E#04PM

T0U
R4^


M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\



T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M+4%


'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R




+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^-RPS

M13H@

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXQ-2XR/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXD
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E



3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXQ

3!P

M=VED=&@]

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$-3
E/B`\9&EV/E5N:71E9!3=&%T97,\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q




'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT,PX

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M3U143TTZ(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E




T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-2PY.3@L,3DV/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!R:6=H

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M
3`E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@
M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/

+4%
24=.



M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P



M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-3
E/B`\9&EV/E1O=&%L($-O;G-O;&ED871E9!2979E;G5E/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B`C
#`P

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ
#`N
#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT,2PT-#(L.3DT
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M4D1%4BU3U143TTZ(
P
#`P
#`@


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$P
XP
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z
M(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M:61T:#TS1#$P)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV



M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M:61T:#TS1#$E/B`\9&EV/B8C

M


M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X
M(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M




Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3E0M4TE:13H@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#04PM

T0U
R4^

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!R:6=H

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
3`E/B`\9&EV/B@R-C8I/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E

M

T0Q
4^(#QD:78^*#(V+#,R.2D\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%

M5#H@

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I
M=CY5;FET960@4W1A=&5S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
7!X('-O;&ED
M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@Q+#
Q

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))1TA4

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@
M(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH-PS
M-S4L-S

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+51/4#H@(S`P
#`P

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F

+4%
24=..B!B;W1T;VT[($)/
M4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M0D]21$52+51/4#H@(S`P
#`P


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#4S)3X@/&1I=CY4;W1A;!#;VYS;VQI9&%T960@4F5S=6QT


M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXD/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q


'!T


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q


'!T

M4D1%4BU3U143TTZ(
P
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
M
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ
M
#`N

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0U
R4^(#QD:78^)B
Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].

#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[




M9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@

T0Q)3X@/&1I=CXF(S$V

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P





'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@



M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
3`E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

Q-C`[/]D:78^(#PO=&0^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

3!P=#L@5D52

M
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0U
R4^(#QD:78^26YT97)N871I;VYA

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P

M9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R
M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@Q
M-3

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


#`P
#`P.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$N-SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M


M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH





M3TY4+49!34E
63H@5&EM97


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=4
M15A4+4%

M3$5&5#H@

'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@
M/&1I=CY5;FET960@4W1A=&5S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P


P
#`P
#`@
7!X('-O
M;&ED.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


P
#`P
#`@
M
7!X('-O;&ED.R!415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R
M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$
M.B`C8V-E969F.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


63H@5&EM97
@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P
M,#L@1D].5U325I%.B`Q

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXE/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M
M0D]45$]-.B`C
#`P


'!T.R!6


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


63H@5&EM97
@


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@/]T


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0U
R4^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V


T0Q
M)3X@/&1I=CXF(S$V

M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/
M4#H@(S`P
#`P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M




M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M4$%$1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N
M.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U3
M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH.PY
#8L-S0W*3PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P

3!P=#L@5D525$E#

T0Q
M



M9&]U8FQE.R!415A4+4%

3!P=#L@

M=&@]
T0Q


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@/]T9#X@


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-3
E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\


M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!

M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4

+4%
24=..B!B;W1T;VT[($)/4D1%4BU4
M3U`Z(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!

M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

P
#`P
#`@
W!X(&1O

T0Q
4^(#QD:78^)B,Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P






M

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$-3
E/B`\9&EV/E5N:71E9!3=&%T97,\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q

24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

P
#`P
#`@

M4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXU

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

3!P

M=VED=&@]
T0Q)3X@/&1I=CXE/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^
3$X+#

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97




M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!
M3U)$15(M5$]0.B`C
#`P

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C

+4%
24=..B!B;W1T
M;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'
M2%0Z(#0P


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M


M.B`Q


+4%
24=..B!B;W1T
M;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'
M2%0Z(#0P




M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



#`G('=I9'1H/3-$
M
3`E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97



'!T.R!615)4


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q
4^(#QD:78^
M)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ-BPV-#,L-C0P/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




3!P

M=VED=&@]

M3E0M4TE:13H@

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R



34L
S(T+#DP-#PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%

M5#H@

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I
M=CY7:&ES:V5Y/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97


'!T.R!615)424-!


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T




63H@5&EM
M97


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E



C(N.#PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@
M/&1I=CY

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


'!T.R!615)4

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M




63H@
M5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E



C$N
CPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


'!T.R!615)4

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%

M13H@

T0Q

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)424-!

3!P=#L@5D525$E#04PM

T0U
R4^

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR,3@L-34R/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P





'!T




63H@5&EM
M97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%

M5#H@

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I
M=CY7:6YE/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M63H@5&EM97


M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C



+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C`N-CPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%

M4TE:13H@

T0Q
4^(#QD:78^,2XW/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P



1494.B`Q
W!X
M.R!&3TY4+49!34E
63H@5&EM97


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M
M0D]45$]-.B`C
#`P


M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P


M.R!&3TY4+49!34E
63H@5&EM97


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P


M-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T.R!6

M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^,RPS
M.38L-38W/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



M/3-$)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q

3!P=#L@

M=&@]

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$-3
E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%


M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&

+4%
24=..B!B;W1T;VT[($)/4D1%


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@

M;#L@4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

13H@


M


M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)#PO9&EV

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R




T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV

14%2.F)O
M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P

'!T.U1%

'!X.R!&3TY4.B`Q
'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97


@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4%
24=..DQE9G0[(%1%
M6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q

M)T)/4D1%4BU3U143TTZ(
Y96(V8V4@

Y96(V8V4@
'!X('-O;&ED.R!3U)$15(M4DE'
M2%0Z(
Y96(V8V4@



T0G5$58


M+4%

'!T.R!615)424-!


38P.S
Q+#PO9&EV/B`\






M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0U
R4^(#QD:78^)B
Q-C`[

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!3U)$15(M5$]0.B`C
#`P




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V


T0Q)3X@
M/&1I=CXF(S$V

M13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@
M(S`P
#`P


+4%
24=..B!M:61D;&4[($)/4D1%4BU4

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I



T0Q)3X@/&1I=CXF(S$V
#L\

3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M(%9%4E1)0T%
+4%


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@/]T9#X@/]T

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E


M2%0Z(#0P


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

BPR
#$L
S0S/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z
M(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P


3!P=#L@5D52

M

M13H@

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

2PY-#$L-3
W/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E



M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=3U)$15(M0D]45$]-.B`C
#`P

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!
M04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%
M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-PS
C`L

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E



'!T.R!6

M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=3U)$15(M0D]45$]-.B`C
#`P


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T

3!P=#L@

M=&@]
T0U
R4^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO




T0Q
4^(#QD:78^)B,Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

#`G
M('=I9'1H/3-$
3`E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97



1494.B`Q
W!X
M.R!&3TY4+49!34E
63H@5&EM97


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXD/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P(#-P

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].
M5U714E'2%0Z(#0P

S8L-3(Q+#4Q
#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

3!P=#L@5D52

M
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M
M0D]45$]-.B`C
#`P

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS
RPQ

#DU

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V


M.R!&3TY4+49!34E
63H@5&EM97


3!P=#L@5D52

M


#L\+V1I=CX@

'!T.TU!4D=)3CH@

M5#H@

T0G=VED=&@Z
M

T0P(&-E
M;&QP861D:6YG/3-$

#1E9&9?
M
#$R9E\T

M.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X-&

F$Q-F5E



^+RH@1&\@3F]T(%)E



]





]




14%2
M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97


M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97


@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@

M($)E='=E96X@07!R:6P@
2P@
C`Q-!A;F0@2G5N92`R-2P@,C`Q-P@=&AE

M3E0M4TE:13H@


'!T
M)SXQ+#$V.2PW

T0G


CDU/]F;VYT/BX\+V1I=CX@/&1I=B!S='EL93TS
M1=#3$5!4CIB;W1H.R!&3TY4+49!34E


T0G0TQ%05(Z8F]T:#L@1D].
M5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M415A4
M+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@



M='


T0G1D].


C`Q
2!7

#$Q(%=A



2P@

M34E


63H@)U1I;65S($YE=R!2


M+CPO9&EV/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T
M:#HQ



M;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T



M;G1E;G0]



24-)15
@*%!O;&EC

3XQ
B!-;VYT:'

M
2P@

]

]



M0FQO8VM=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S

@3F5W

@3F5W

'!X.R!72414
M2#H@




+4%
24=..B!T;W`[($)/
M4D1%4BU

M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

M+V9O;G0^/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-



M04U)3%DZ5&EM97



X

X
C(P.TUC3&%I

X
C(Q.RDL('1H92!#;VUP86YY)B
X
C$W.W
@=VAO

X
C(P.T-+4E238C.#(R
3LI
M(&%N9!#87-T;&4@0G)A;F1S(%-P:7)I=',@36%R:V5T:6YG(&%N9!386QE


M)B
X



M($9/3E0M4TE:13H@

M
T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$


M
T1T;W`^3F%T=7)E(&]F($]P97)A=&EO;G



'!X.R!724142#H@
R4[($)/4D1%




+4%
24=..B!T;W`[($)/4D1%4BU
1494+5=)

M;65S($YE=R!2;VUA;BP@5&EM97


Q-3$[(%1H92!#;VUP86YY(&ES('!R




M

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97


#`E.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97

M:6YG/3-$



+4%
24=..B!T;W`[
M($)/4D1%4BU

38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[

'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M



M/B`F(S$U

M(S@R



M;BUA;&-O:&]L:6

'!X.R!72414
M2#H@




+4%
24=..B!T;W`[($)/
M4D1%4BU

M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

Q



M/3-$)U9%4E1)0T%
+4%

T0G0D]21$52
<^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M

M

T0G0D]2

+4%
24=..B!T
M;W`[($)/4D1%4BU

M14%2.F)O=&@[34%21TE..B`P:6X@


'!T)SX@)B









M($MN87!P;V=U92!#87-T;&4@
3DU
2P@82!P=7)E('!O=US=&EL;!W:&ES


T0G5D525$E#04PM04Q)1TXZ


M+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M
M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
<^(#QD:78^/&9O;G0@<W1Y;&4]

#L\+V9O;G0^/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@



M97

M

T0G5D525$E#04PM


M0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!
M3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
<^(#QD:78^/&9O;G0@<W1Y;&4]

#L\+V9O
M;G0^/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M



T0G1D].




M92!5+E


M+4%
24=..B!T;W`[($)/4D1%4BU

M

T0G0D]21$52+4)/5%1/33H@

'!X.R!615)424-!3U!3$E'3CH@
M=&]P.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=CX\9F]N=!S='EL


M4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$5$@Z

M=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL
M93TS1=&3TY4+49!34E


M)T)/4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$


'!X.R!7

M3$E'3CH@=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N
M=!S='EL93TS1=&3TY4+49!34E



'!X.R!615)424-!3U!
M3$E'3CH@=&]P.R!3U)$15(M3$5&5U724142#H@,'!X)SX@/&1I=B!S='EL
M93TS1=#3$5!4CIB;W1H.TU!4D=)3CH@




3L@0F]R=2!V



'!X.R!6




M;&4]
T0G0TQ%05(Z8F]T:#M-05)'24XZ(#!I;B`P:6X@
'!T)SX\=3X\9F]N

Q-C`[



+4%
24=..B!T;W`[($)/4D1%
M4BU

38P.SPO9&EV/B`\+W1D/B`\

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[($)/4D1%

M24142#H@

M24142#H@
6QE/3-$)T9/3E0M4TE:
M13H@

34Q.R!A(%531$$@8V5R=&EF:65D(&]R9V%N:6
L('-U

M87


M87




]
T1P;!V86QI9VX],T1T;W`^0V%S:!A

]

M/3-$)TU!4D=)3CH@


T0G=VED=&@Z
3`P

T0P(&-E;&QP
M861D:6YG/3-$

+4%
24=..B!T;W`G

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[($)/


'!X.R!724142#H@-3!P

M.R!3U)$15(M3$5&5U724142#H@

M.B`Q

T0G0D]21$52+4)/
M5%1/33H@;65D:75M(&YO;F4[($)/4D1%4BU224=(5U724142#H@,'!X.R!

+4%
24=..B!T;W`[($)/
M4D1%4BU

14%2.F)O
M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P

@3F5W(%)O
M;6%N)SL@1D].5U325I%.B`Q,'!T)SX\=3Y#87-H(&%N9!C87-H(&5Q=6EV




M86)L92!B;W)D97(]




]



M5$@Z(#$P


T0P(&-E
M;&QP861D:6YG/3-$

+4%
24=..B!T

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[
<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))


M=&0^(#QT9#X@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E
63I4:6UE



@:6X@=F%L
M=64@:7

@








M5TE$5$@Z(#

'!X.R!724142#H@-3!P

M.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS
M1=&3TY4+49!34E

M



M=&EB;&4@86-C;W5N='

@
M;VX@=&AE('1R861E(&%C8V]U;G1S(')E8V5I=F%B;&4@8F%L86YC97
N(%1H
M92!#;VUP86YY(&-A;&-U;&%T97



M=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/CQT86)L92!B;W)D97(]
T0P('-T



]

M)TU!4D=)3BU43U`Z(#!P=#L@5TE$5$@Z(#$P

T0P(&-E;&QP861D:6YG/3-$

M/3-$)U9%4E1)0T%
+4%

T0G0D]21$52
<^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M

M


34Q.R!2979E;G5E






]
T1P;!V86QI9VX],T1T;W`^26YV96YT;W)Y+!0






M

'!X)SX@/&1I
M=CX\9F]N=!S='EL93TS1=&3TY4+49!34E




Q-3$[($EN

L







RX\9F]N=!S='EL93TS1=&3TY4+49!34E


14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE

#L\+V1I=CX@/&1I=B!S

'!T.TU!4D=)3BU
1494.B`P+C0U:6XG/B`\9F]N
M=!S='EL93TS1=&3TY4+49!34E



@96YD960@36%R8V@@
S$L(#(P
30@86YD(#(P
3
L('1H92!#;VUP86YY
M(')E8V]R9&5D(&%L;&]W86YC97



3!P



L
M(&%S('=E;&P@87


@:&%V92!B965N(')E8V]R9&5D(&%S(&EN

M87)S+CPO9&EV/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W
M:61T:#HQ




#L@1D].5#H@,3!P=!4


'!X.R!615)424-!





L(%-E


M86-C;W5N='





M/B`\+W1A8FQE/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W
M:61T:#HQ







M5&EM97

M5&EM97


M
'!X.R!724142#H@


#L@5TE$5$@Z(#4P<'@[($)/



M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97





M;&EV97

L(&%N

'!X.R!724142#H@
R4[($)/




+4%
24=..B!T;W`[($)/4D1%4BU
1494

M.E1I;65S($YE=R!2;VUA;BP@5&EM97


M04U)3%DZ5&EM97


T0G


M1%1(.B`S)3L@0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'
M3CH@=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
#L\


T0G

M(S$V
#L\+V9O;G0^/]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1=#
M3$5!4CIB;W1H.TU!4D=)3CH@

M)T9/3E0M4TE:13H@

C`[1D%30B8C.#(R
3LI($%C8V]U;G1I

X
C(P.T%30R8C.#(R
3LI
M(#
U
P@)B,X,C(P.TEN=&%N9VEB;&5S(T@1V]O9'=I;&P@86YD($]T:&5R
M)B
X





M=64N(%1H92!I;7!L:65D(&9A:7(@=F%L=64@;V8@9V]O9'=I;&P@:7
@9&5T



L('1R
M861E;6%R:W







M2#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E
63I4:6UE

38P.SPO9F]N=#X\+V1I

M=#XF(S$V

M0T%
+4%

T0G0D]21$52+4)/5%1/33H@
<^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N


T0G0TQ%05(Z
M8F]T:#M-05)'24XZ(#!I;B`P:6X@
'!T)SX\9F]N=!S='EL93TS1=&3TY4

M('5N:70@=V%S(&1E=&5R;6EN960@870@36%R8V@@
S$L(#(P
30@86YD(#(P
M
3
@8GD@=V5I9VAT:6YG(&$@8V]M8FEN871I;VX@;V8@=&AE('!R97-E;G0@
M=F%L=64@;V8@=&AE($-O;7!A;GDF(S@R



M;FEN9W




M:`S,2P@,C`Q-!A;F0@
C`Q
RX\9F]N=!S='EL93TS1=&3TY4+49!34E

M+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T








M4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$5$@Z


'!X.R!72414

M3CH@=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S
M='EL93TS1=&3TY4+49!34E

M


Q-3$[(%5N
M9&5R)B
Q-C`[05-#)B
Q-C`[

M='
F(S@R



N(%=H96X@=&AE('-U

@:7



C`Q
RX\+V1I=CX@/&1I

T0G0TQ%05(Z


















'!T)SXX


63H@)U1I;65S($YE


T0G




]



M5$@Z(#$P


T0P(&-E
M;&QP861D:6YG/3-$

+4%
24=..B!T

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[
<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))


M(&AA;F1L:6YG(&-H87)G97


@86YD(&9I;FES:&5D(&=O;V1S+B!4:&5S92!C;W-T



@:6X@8V]N;F5C=&EO;B!W:71H(&ET


M;7
@86YD('!R;VUO=&EO;G
N(%1H97-E('-H:7!P:6YG(&-H87)G97
@87)E




C`Q


T0G=VED=&@Z
3`P)3L@

T0P(&-E;&QP861D
M:6YG/3-$


T1T;W`^17AC:7-E(%1A

]

'!T



T0G34%21TE.+51/4#H@
'!T.R!724142#H@
M
3`P)3L@1D].5#H@

M9CL@34%21TE.+4)/5%1/33H@





M24142#H@


M;&4]

&5S(&%N9!D=71Y(&%R92!C;VUP=71E9!A=!S=&%N9&%R9!R
M871E<R!B87-E9!O;B!A;&-O:&]L('!R;V]F('!E<B!G86QL;VXO;&ET97(@


M(&]U=!O9B`F(S@R,C`[8F]N9XF(S@R





M=&%X97



]

T0G

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97


#`E.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97

M/3-$



+4%
24=..B!T;W`[($)/
M4D1%4BU

38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[($)/

'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M3$5&

M3%DZ5&EM97



@


M97)E(&QE9V%L+B!3=6-H(&-H87)G97

@86YD






M97

M97


'!X
M.R!724142#H@


+4%
24=..B!T
M;W`[($)/4D1%4BU

M/3-$)T9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

M)SX@3RX\+V9O;G0^/]D:78^(#PO=&0^(#QT9#X@/&1I=CX\9F]N=!S='EL



M(&]P97)A=&EO;G
@:7

@
M.#



M1V%I;G








M;&4]

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97


#`E.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97





+4%
24=..B!T
M;W`[($)/4D1%4BU

38P.SPO9&EV

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO

'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$


Q-3$[
M($%30R`X

M=6UE;G0@87
@=&AE(&%M;W5N=!A=!W:&EC:!T:&4@:6YS=')U;65N=!C






M;G1S(&EN('1H92!#;VUP86YY)B
X
C$W.W
@8F%L86YC92!S:&5E='
@9'5E



'!T)SX\







M)T)/4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M5TE$




M3E0M1D%-24Q9.B`G5&EM97


#L\9F]N=!S='EL93TS1=&3TY4+49!
M34E

T0G0D]21$52

'!X.R!615)424-!


14%2.F)O=&@[34%21TE..B`P:6X@



M(&EN(&%C8V]R9&%N8V4@=VET:!A=71H;W)I=&%T:79E(&=U:61A;F-E+!W

M;&4]
T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@,3!P=#M415A4+4E.1$5.5#H@,XU:6X[($U!4D=)3CH@
M







Q




M3CH@=&]P)SX@/'1D/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD


@3F5W(%)O;6%N




L(%-E

M1=615)424-!3U!3$E'3CH@=&]P)SX@/'1D/B`\9&EV/B8C
38P.SPO9&EV


M5&EM97

'!T)SX\+V9O;G0^+CPO9F]N=#X\

M13H@

14%2.F)O=&@[($9/


M5&EM97



'!T)SX\+V9O;G0^(#QT86)L92!S='EL93TS1=72414
M2#H@,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5U325I%
M.B`Q
'!T)R!B;W)D97(]


M0D]45$]-.B`C9#1D
&

&EN(#!I;B`P


M($9/3E0M4TE:13H@

M9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52
M+4Q%1E0Z(-D-&0P8S@@
'!X.R!0041$24Y'+4)/5%1/33H@
&EN.R!0041$


M.TU!4D=)3CH@

M13H@

M

&


M3CH@

3!P




@9F]L

63H@)U1I;65S($YE=R!2



T0G0TQ%05(Z

M86)L92!S='EL93TS1=724142#H@,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C
M;VQL87!S93L@1D].5U325I%.B`Q
'!T)R!B;W)D97(]

M:6YG/3-$

&

M.TU!4D=)3CH@

M13H@

M


M('=I9'1H/3-$

T0G0TQ%05(Z8F]T:#M-05)'24XZ
M(#!I;B`P:6X@

M/BT\+V9O;G0^/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C9#1D
&
X.R!3U)$15(M3$5&5#H@(V0T9#!C.#L@4$%$1$E.1RU



14%2.F)O=&@[34%21TE..B`P:6X@
&EN(#!P

'!T)SY
979E;`Q(8C
M
34Q.R!I;G!U='


M='
@;W(@;&EA8FEL:71I97

N/]F;VYT/CPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C9#1D
&
X.R!3U)$15(M3$5&5#H@(V0T9#!C.#L@4$%$1$E.1RU





T0G0D]21$52+4)/5%1/33H@(V0T



M;&4]
T0G0TQ%05(Z8F]T:#M-05)'24XZ(#!I;B`P:6X@

&
X.R!3U)$15(M
M3$5&5#H@(V0T9#!C.#L@4$%$1$E.1RU3U143TTZ(#!I;CL@0D%#2T=23U5.



14%2
M.F)O=&@[34%21TE..B`P:6X@

'!T)SY
979E;`R(8C
34Q.R!I;G!U='
@=&\@=&AE('9A



M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C9#1D,&,X.R!3U)$15(M3$5&
M5#H@(V0T9#!C.#L@4$%$1$E.1RU3U143TTZ(#!I;CL@0D%#2T=23U5.1U#

&EN.R!724142#H@

M0D]21$52+5))1TA4.B`C9#1D
&
X.R!0041$24Y'+51/4#H@
&EN)R!V86QI
M9VX]
T1T;W`@=VED=&@]



3U(Z('1R

E.R!0041$


&EN.R!724142#H@.#@E.R!0041$24Y'+5))1TA4.B`P


63H@)U1I

M=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T86)L92UL

T0P






M/3-$)T)/4D1%4BU3U143TTZ(&UE9&EU;2!N;VYE.R!3U)$15(M4DE'2%0M


'!X

'!X)SX@/&1I=CX\
M9F]N=!S='EL93TS1=&3TY4+49!34E



T0G1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N+!4



X
C(Q.RP@9&5F97)R

@87)E(')E8V]G;FEZ960@

M=&\@9&EF9F5R96YC97
@8F5T=V5E;B!T:&4@9FEN86YC:6%L('-T871E;65N


M5$@Z(#


M0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!
M3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS1=&
M3TY4+49!34E

M



+4%

T0G
<^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4

M1%1(.B`U


T0G0TQ%05(Z8F]T:#M-05)'24XZ(#!I;B`P:6X@
'!T)SX\9F]N




@:6X@


@;V8@36%R8V@@
S$L(#(P



]

M



T0G34%21TE.+51/4#H@
'!T.R!72414
M2#H@
3`P)3L@1D].5#H@

M97)I9CL@34%21TE.+4)/5%1/33H@



T0G5D525$E#04PM04Q)1TXZ('1O


M4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M3$5&
M5U724142#H@
'!X)SX@/&1I=CXF(S$V
<^(#QD:78^/&9O;G0@<W1Y;&4]




T0G=VED=&@Z
3`P)3L@=&%B

T0P(&-E;&QP861D:6YG
M/3-$


M0V]S='
'0@0FQO8VM=/]T9#X-B`@(`@
M(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1=-05)'24XZ(#!P
M=`P<'@[($9/3E0Z(#$P<'0@5&EM97


'!X.R!724142#H@
R4[($)/4D1%4BU43U`M



+4%
24=..B!T;W`[($)/4D1%4BU
1494+5=)1%1(.B`P

M=R!2;VUA;BP@5&EM97

T0G1D].


C`Q



T0G=VED=&@Z
3`P)3L@=&%B;&4M;&%Y;W5T

T0P(&-E;&QP861D:6YG/3-$
#X\='(^




'!X


'!X.R!724142#H@

M=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL
M93TS1=&3TY4+49!34E

T0G




M87-S=6UP=&EO;G


@870@=&AE(&1A=&4@

M(&%M;W5N='








M(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/CQT86)L92!B;W)D97(]
T0P




]

M

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97


#`E.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97

M:6YG/3-$



+4%
24=..B!T;W`[
M($)/4D1%4BU

38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[

'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M

@9F]R('1H92!S;W5R8VEN9R!O

@;W=N

@









L(&-O=6QD(&AA=F4@;6%T97)I86P@861V97)S92!E9F9E
M8W1S(&]N('1H92!#;VUP86YY)B
X
C$W.W

N
M(%1H92!I;F%B:6QI='D@=&\@;6%I;G1A:6XL(')E;F5W(&]N(&%C8V5P=&%B
M;&4@=&5R;7

@8V]U


63H@)U1I

M;W)D97(]




]

@3F5W




T0P(&-E;&QP861D:6YG/3-$
M

+4%

M;&4]
T0G0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[($)/4D1%4BU224=(
<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4+5=)1%1(.B`P




14%2.F)O=&@[34%21TE..B`P
M:6X@

'!T





X
M
C(P.T%3528C.#(R
3LI($YO+B`R
#$T+3`X*2X@56YD97(@=&AE(&YE=R!G








34L
M(#(P





+4%

T0G0D]21$52+4)/5%1/33H@;65D:75M
<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2



T0G0TQ%05(Z8F]T:#M-
M05)'24XZ(#!I;B`P:6X@
'!T)SX\9F]N=!S='EL93TS1=&3TY4+49!34E



M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4+5=)1%1(

'!X)SX@/&1I
M=CXF(S$V

<^(#QD:78^/&9O;G0@


M4V5R:68G/B`F(S$V


M;VYS96YS=7


M='

RU$*2X@5&AE(&]B:F5C=&EV92!O9B!T:&ES(&=U








M;G

M(&-O;F1I=&EO;B!M87D@9&5L87D@97AP96YS92!R96-O9VYI=&EO;B!U;G1I


3




M92!B;W)D97(]



]


]

M



T0G34%21TE.+51/4#H@
'!T.R!72414
M2#H@
3`P)3L@1D].5#H@

M97)I9CL@34%21TE.+4)/5%1/33H@



T0G5D525$E#04PM04Q)1TXZ('1O


M4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M3$5&
M5U724142#H@
'!X)SX@/&1I=CXF(S$V
<^(#QD:78@<W1Y;&4]
T0G0TQ%05(Z8F]T:#M-05)'24XZ(#!I;B`P
M:6X@

34Q
M.R!);B!*=6QY(#(P

C`Q
BTP
BP@
M)B
X
C(P.TEN=&%N9VEB;&5S)B



@;W1H97(@=&AA;B!G;V]D=VEL
M;!F;W(@:6UP86ER;65N=XF(S$V


@9&5T97)M

M:6YI=&4M;&EV960@87-S970@:7






M+4%

T0G0D]21$52+4)/5%1/33H@;65D
<^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@



T0G0TQ%05(Z8F]T
M:#M-05)'24XZ(#!I;B`P:6X@
'!T)SX\9F]N=!S='EL93TS1=&3TY4+49!
M34E



M1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4+5=)

'!X)SX@
M/&1I=CXF(S$V

<^(#QD:78^/&9O

T0G1D].5U&04U)3%DZ5&EM97,@3F5W(%)O;6%N+!4:6UE


C`[5&5C


M879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY)B
X
C$W.W
@

'!X.R!6




M=CXF(S$V

T0G1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(8C

M


M(%=)1%1(.B`S)3L@0D]21$52+51/4U724142#H@,'!X.R!615)424-!3U!
M3$E'3CH@=&]P.R!3U)$15(M3$5&5U724142#H@
'!X)SX@/&1I=CXF(S$V
M


M

M/B`F(S$V
#L\+V9O;G0^/]D:78^(#PO=&0^(#QT9#X@/&1I=CX\9F]N=!S




M='
@86YD($QI86)I;&ET:65S)B
X

@:6YT




M;&EA8FEL:71I97



M86YY)B
X
C$W.W

E


M+51/4U724142#H@,'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M
M3$5&5U724142#H@
'!X)SX@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!
M34E

38P.SPO


'!T)SXF(S$V

'!X.R!615)424-!3U!3$E'3CH@=&]P.R!3U)$15(M
M3$5&5U724142#H@,'!X)SX@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D




M97

M:78^(#PO=&0^(#QT9#X@/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E





M+!E:71H97(@;VX@=&AE(&9A8V4@;V8@=&AE('-T871E;65N=!W:&5R92!T





N
M(%1H:7


3
N(%1H92!A9&]P=&EO;B!O9B!T:&ES





'!X.R!724142#H@
R4[($)/4D1%4BU43U`M



+4%
24=..B!T;W`[($)/4D1%4BU
1494+5=)1%1(.B`P

M=R!2;VUA;BP@5&EM97


'!T
M)SXF(S$V





M

'!X)SX@/&1I
M=CX\9F]N=!S='EL93TS1=&3TY4+49!34E






3L@*8C.#(R,#M!4U4@,C`Q,RTQ,28C.#(R,3LI+!W

M;FEZ960@=&%X(&)E;F5F:70@87

M9!T87@@87-S970@9F]R(&$@;F5T(&]P97)A=&EN9R!L;W-S(A.3TPI(&-A

@82!L:6%B:6QI='D@=VAE
M;B`H





N(%1H:7
@;F5W(&=U:61A

M(#$L(#(P
3



M='(^(#PO=&%B;&4^(#PO9&EV/CQT86)L92!B;W)D97(]

M)W=I9'1H.C$P


]

M3U`Z(#!P=#L@5TE$5$@Z(#$P


T0P(&-E;&QP861D:6YG/3-$

M0T%
+4%

T0G0D]21$52+4)/5%1/33H@
<^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N





M)T9/3E0M1D%-24Q9.B`G5&EM97



M+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T




M+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970R.2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D



T1T97AT

M:7

]

3(@36]N=&AS($5N9&5D
M/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C

S$L(#(P








M.B`Q

T0G34%21TE..B`P:6X[(%=)1%1(
M.B`Q




M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\


M
38P.V5N9&5D)B
Q-C`[36%R8V@F(S$V
#LS

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
24^(#QD:78^)B

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
38P.SPO9&EV/B`\





P
#`P
#`@
7!X('-O
M;&ED.R!415A4+4%

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P



3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

#`G('=I
M9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/C(P
3

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXF(S$V
#L\+V1I

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P
#`P

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+51/4#H@(S`P
#`P


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M25I%.B`Q


63H@5&EM97
@

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P
M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P





M.B`Q


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E





T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P(#%P


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M


63H@5&EM
M97


+4%
24=..B!M:61D
M;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!3U)$15(M5$]0.B`C
#`P

M(#0P




M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G0D]21$52
M+4)/5%1/33H@(S`P
#`P




34L
S$R+#DR
M

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M

M+4%

3!P=#L@5D525$E#04PM04Q)

T0Q

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\+V1I=CX\=&%B;&4@8F]R9&5R/3-$,!S




3)F7S0P-S9?.#1C
E\W-#)A
39E96%D



M87-C:6DB#0H-
MCQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N





]
T1T



]
T1T:#Y-
M87(N(#



]
M



969T.R!415A4+4E.1$5.5#H@
&EN.R!724142#H@
3`P


Y96(V8V4@
'!X('-O;&ED.R!-05)'
M24XZ(#!I;CL@5TE$5$@Z(#$P

!S;VQI9<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,!A;&EG;CTS1&QE9G0^(#QT


M4TE:13H@

T0Q)3X@/&1I=CXF(S$V



M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@



24=..B!C96YT


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T

CX@/&1I=CXR

T0Q
M)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q

C`Q
SPO



M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G

@)B
Q-3`[(&YE=#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

#`G('=I9'1H
M/3-$


M54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
#`P

T0Q
4^(#QD
M:78^-PU
#(L
C

M13H@

T0Q)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
3`E/B`\9&EV
M/C4L

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97





3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M3TTZ(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E



M.B`Q



M:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXX+#4T,PX

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q

24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ-PV-3`L

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^

T0G0D]21$52+4)/5%1/
M33H@(S`P
#`P



M14E'2%0Z(#0P

3
L-S
Q+#DV
CPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97



3)F7S0P-S9?.#1C
E\W
M-#)A
39E96%D






M;VYG/D5154E0345.5P@3D54(A486)L97


]
T1T:#Y-87(N(#
Q+`R,#$T/&)R/CPO=&@^#0H@(`@


]


'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@

@3F5W(%)O;6%N

M+49!34E




T1L969T/B`\='(^(#QT9!S='EL93TS1=4
M15A4+4%

'!T.R!615)4






M13H@

T0Q)3X@/&1I=CXF(S$V



T0Q

M1#(^(#QD:78^



P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!3U)$15(M5$]0.B`C
#`P




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


24=..B!R

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%


3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^
3`L

M13H@

T0Q)3X@/&1I=CXF(S$V

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

3`L

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($)/4D1%4BU4

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXR+#
R-RPV

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^,BPP,S8L,S4S/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T

Z(&%C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$L-S4Y+#(T
#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$

CPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M
M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=3U)$15(M0D]45$]-.B`C
#`P

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M.B`Q

M;&4]
T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$

M+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?3F5X=%!A

#1E9&9?
#$R9E\T

M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X
M-&


S(N:'1M;`T*0V]N



^


M1$E$



($%.

]






]

'!T



14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I

'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P
M=#M415A4+4E.1$5.5#H@



#L\+V1I=CX@

'!T.U1%6%0M04Q)1TXZ3&5F=#L@5$58

T0G
M34%21TE..B`P:6X[(%=)1%1(.B`Q



3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

M/3-$

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

#$R/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


2PR-#
L

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXH.#DX+#4W

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97



M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C$T-2PX

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

2P@
C`Q
SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M



+4%
24=..B!B
M;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT.3`L,C@V/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T

38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M




Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97





'!T.R!615)424-!


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&


M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V


+4%
24=..B!B;W1T;VT[

M/3-$)T)/4D1%4BU3U143TTZ(
P
#`P
#`@


+4%
24=.
M.B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT.38L,C(V/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P




M(&]F($9I;FET92U

]




14%2
M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z



63I4:6UE

63I4:6UE




T1L969T/B`\='(^(#QT9!S='EL93TS
M1=415A4+4%

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6






M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0Q

M;CTS1#(^(#QD:78^

T0G5$58

M:60[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M


M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/
M4#H@(S`P
#`P






+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXQ-S`L
#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q)3X@/&1I=CXD/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E


#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C$W



3!P=#L@5D52

M

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXU
M,S4L.30W/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M63H@5&EM97




M3E0M4TE:13H@


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
3`E/B`\9&EV/C@L

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P





M

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXY

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%

M4TE:13H@

T0Q
4^(#QD:78^.38L.34Y/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/E!A=&5N='

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


3!P=#L@5D52

M
T0Q


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXY.30L
M

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


P
#`P
#`@
7!X('-O;&ED.R!415A4
M+4%

3!P=#L@5D525$E#04PM04Q)

T0Q
4^(#QD
M:78^-34L-#8P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


P
#`P
#`@
7!X('-O;&ED.R!415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
7!X('-O;&ED
M.R!415A4+4%

3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^,C@L-#@P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-S4E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$-S4E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ
M,PQ
C

M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$P+#`Y-BPY-#$\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


P
#`P
M
#`@
7!X('-O;&ED.R!415A4+4%

M

T0Q
4^(#QD:78^-BPP-3@L,#`U/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P

P
M
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@

T0Q
4^(#QD:78^-2PT,#0L,#`P/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV




T0Q
4^(#QD:78^)B,Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV/DYE=#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXT+#`V-2PY,38\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^-PV.3(L.30Q/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$


3L@:6YD969I;FET92!L:79E9H\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q




M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT+#$Q,BPY-S(\+V1I=CX@/]T




'!T.R!615)424-!


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^)B
Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q)3X@/&1I=CXF(S$V

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+51/4#H@(S`P
#`P


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

24=..B!R:6=H=#L@

M4E1)0T%
+4%


'!T

3!P=#L@5D525$E#04PM04Q)1TXZ

T0W-24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$

M;&4]
T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^.PQ-S@L.#@X/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


P
#`P
#`@
W!X(&1O=6)L93L@
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M.R!415A4+4%

3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^.PX

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M









]

T0G34%21TE.

'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L

M3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.
M5#H@



@;V8@=&AE

'!T.U1%

'!X.R!&3TY4.B`Q
'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97

M9GD^)B

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4%
24=..DQE9G0[(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q
#`E)SX@

Y96(V8V4@
'!X('-O

Y96(V8V4@
'!X('-O
M;&ED.R!3U)$15(M4DE'2%0Z(
Y96(V8V4@


T0P(&%L:6=N/3-$;&5F=#X@/'1R/B`\


M(#0P

M9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q


M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19


M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

#L\

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


M13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@
M(S`P
#`P


P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M


3!P=#L@

M=&@]


M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\

M965F9CL@0T]

M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$W


'!T.R!6


+4%
24=..B!B;W1T;VT[($)/4D1%



P
#`P
#`[($9/3E0M4TE:13H@
M
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
M
#`P


M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR-C(L
M

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(S
PS-SD\+V1I=CX@/]T9#X@



M4TE:13H@


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

#`P
#L@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT+#DV

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


#`P
#`P.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C0L-#`Y+#(R
#PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97



24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M63H@5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV-#0L
M

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C4W.PQ,C$\+V1I=CX@/]T9#X@



M4TE:13H@


M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V


3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M3U143TTZ(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E




T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97






M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&



M25I%.B`Q

M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXV+#`U.PP

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXD/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P(#-P

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXU+#0P-PP,#`\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$

M86QI9VX]
T1T;W`^4V-H961U;&4@;V8@1FEN:71E+4QI=F5D($EN=&%N9VEB

M25I%.B`Q

'!X
M.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97


@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P
M=#M415A4+4E.1$5.5#H@

'!E;G-E

M(&9O;&QO=W

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@


38P.SPO9&EV/B`\

14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE

M05)'24XZ(#!I;CL@5TE$5$@Z(#$P



M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19




M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

P
#`P
#`@
7!X('-O
M;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I=CXR
#$U

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

M=&@]
T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))


M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$


'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0X-R4^(#QD:78^
C`Q-CPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXV,S(L,S8U/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G


M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I
M=CXR

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C8S
2PT

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M
M0D]45$]-.B`C
#`P


M+49!34E
63H@5&EM97


'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0X-R4^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V


M
T0Q)3X@/&1I=CXF(S$V

M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+51/4#H@(S`P
#`P


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q

P
#`P
#`@
M


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
3`E/B`\9&EV/C
L
30S+#$V
3PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97






F9?-#`W-E\X-&

F$Q-F5E860P



]
T1R97!O

T1)1#!%



3XQ
M
B!-;VYT:'

2P@


]



]
T1R;SX-B`@(`@



969T.R!415A4+4E.1$5.5#H@
&EN.R!724142#H@
M


M
T0P(&-E;&QP861D:6YG/3-$

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$-S4E/B`\9&EV/B8C

M;&4]


M/3-$)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%


38P.S
Q+#PO9&EV/B`\+W1D/B`\





M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0W-24^(#QD:78^)B

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P(#%P


P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([($9/3E0M

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P



M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

M13H@


M9&ET(&9A8VEL:71I97

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$

M;&4]

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97



1494.B`Q
W!X.R!&3TY4
M+49!34E
63H@5&EM97




+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

C$Q
M+#4X

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR,3$L-3@P/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ
M+#DU
RPP

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@

T0Q
4^(#QD:78^-BPU,#$L,S(Q/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#

T0W

3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E
M/B`\9&EV/C(L
#$U+#`P

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


'!T.R!6

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^,2PR-3`L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





M.R!&3TY4+49!34E
63H@5&EM97


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V


3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V




BPQ
C4L
M

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^)B

M

T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P

M9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R
M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$

+4%
24=..B!B
M;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T



M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
W!X(&1O=6)L
M93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M8FQE.R!415A4+4%

3!P=#L@5D52

M
T0Q
4^(#QD:78^-RPU-S0L.#(R/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
W!X
M(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97



3!P

M=VED=&@]
T0Q
4^(#QD:78^.2PR.3@L,S`X/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


@3F5W(%)O;6%N.T9/
M3E0M4TE:13H@

#L\+V1I=CX@/'1A



Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4+5=)1%1(


M/&1I=CX\9F]N=!S='EL93TS1=&3TY4+49!34E


M($9/3E0M4TE:13H@


M($ER:7-H(&)A;FLL(&EN8VQU9&EN9R!O=F5R9')A9G0@8V]V97)A9V4L(&-R




'!T)SX@
2XW
#PO9F]N=#X@)2X@5&AE(&)A;&%N8V4@






S$L(#(P
3

M(#
Q+`R,#$T(&%N9`R
#$S+!R97-P96-T:79E;'DN/]F;VYT/CPO9&EV

T0G5D525$E#04PM04Q)1TXZ('1O

M
38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B



X
C(Q.RD@:6X@=&AE(&%G

M25I%.B`Q
'!T)SXR

N(%1H92!'0U`@


M;6%T=7)I='DL('-U8FIE8W0@=&\@8V5R=&%I;B!A8V-E;&5R871I;VX@979E


'!T)SX@-3PO9F]N=#XE+!T;R!B92!A8V-R=65D
M(&%N9!P86ED(&%T(&UA='5R:71Y+B!!=!-87)C:`S
2P@

M9F9I;&EA=&5S+B!!=!-87)C:`S
2P@


T0G

38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^
M)B


@3F5W


M=R!2;VUA;BP@5&EM97

C`Q
2P@=&AE($-O



M=!S='EL93TS1=&3TY4+49!34E





#`L



M('1H92!%0DE41$$@8V]V96YA;G0@8V]N=&%I;F5D(&EN('1H92!L;V%N(&%G



BPQ
C4L
#`P/]F
M;VYT/B!P=7)S=6%N=!T;R!T:&4@=&5R;7
@;V8@=&AE($YO=&4@4'5R8VAA



M;65N9&UE;G0N($EN($YO=F5M8F5R(#(P
3
L('1H92!+96QT:6
@1F%C:6QI


T0G0TQ%05(Z8F]T:#L@1D].

'!T(#`N-6EN.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97


@3F5W(%)O;6%N.T9/
M3E0M4TE:13H@

&EN(#`N-6EN.R!&3TY4
M.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97




@;VX@1&5C96UB97(@
S$L(#(P






2P@

M34E


M(&]F('1H92!+96QT:6





T0G

N
C4\+V9O;G0^)2!P97(@86YN=6T@86)O=F4@=&AE
M('1H96X@87!P;&EC86)L92!+96QT:6


M('1H92!+96QT:6
@1F%C:6QI='DN(%1H92!#;VUP86YY('!A:60@82`D/&9O




'!T)SXW

'!T)SXR-2PP



'!T)SYA;FYU86P@9F%C:6QI='D@9F5E(&EN(&%N


!P97(@;6]N=&@@*&EN8W)E87-E9!T
M;R`D
BPP









M;F%N='

S$L
M(#(P
30@86YD(#(P
3

'!T)SXQ
M+#DU
RPP


3!P

M8FEL:71I97

@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4
M+4E.1$5.5#H@


M

M


<^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52


C`Q
RP@




#MB;W5R8F]N(&EN=F5N=&]R

@=&5R;7

#$V+B`\9F]N=!S
M='EL93TS1=&3TY4+49!34E




2P@
C`Q



@3F5W(%)O;6%N

M96YC92!A;F0@9'5R:6YG('1H92!C;VYT:6YU86YC92!O9B!A;GD@(D1E9F%U
M;'0B(&]R()%=F5N=!O9B!$969A=6QT(B`H87



N




M;VX@5&5R;2!

@9G)O;2!T:&4@




M=7)B;VX@5&5R;2!



M86)L92!I;B!C;VYN96-T:6]N('=I=&@@=&AE($)O=7)B;VX@5&5R;2!
;V%N


14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S

'!T(#`N-VEN.R!&3TY4.B`Q
'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97

Q-C`[)B

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@

&EN
M(#`N-6EN.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E





M='

'!T)SX\9F]N=!S
M='EL93TS1=&3TY4+49!34E





'!T)SXU
PP
M,#`\+V9O;G0^/]F;VYT/BDL(&$@9&ER96-T;W(@;V8@=&AE($-O;7!A;GD@
M86YD('1H92!#;VUP86YY)B
X
C$W.W
@0VAA:7)M86XL(&%N9!A;B!A9F9I
M;&EA=&4@;V8@4FEC:&%R9!*+B!

M25I%.B`Q
'!T)SX\9F]N=!S='EL93TS1=&3TY4+49!34E
63H@)U1I;65S

#`\




M3TY4+49!34E








'!T)SXQ-2PP

C`Q
M
RP@=&AE($)O=7)B;VX@5&5R;2!




BPU
#`L

M

M92!P=7)C:&%S92!O9B!A9V5D('=H:7-K:65S(&9O;&QO=VEN9R!T:&4@:61E






#$U+#`P





M96%R.F)O=&@[5TE$5$@Z(#$P



<^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B!M

M





'!T)SXQ










M97




#`\+V9O;G0^*2P@36%R
M:R!%+B!!;F1R97=S+!)24D@*0\9F]N=!S='EL93TS1=&3TY4+49!34E





[('1H92!#;VUP

S$L(#(P
30L(0Q+#(U,PP


@:6YC;'5D960@:6X@;&]N

M/]T86)L93X@/&1I=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4+49!34E


T0G8VQE87(Z8F]T:#M7
M24142#H@
3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@
M


T0P(&-E;&QP861D:6YG/3-$

M+4%

T0G0D]21$52+4)/5%1/33H@;65D




M04U)3%DZ5&EM97

M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97

M8F5R(#(P
3
L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(#QF;VYT('-T




M=7)C:&%S92!!9W)E96UE;G0B*2P@8GD@86YD(&%M;VYG('1H92!#;VUP86YY

38P.W=H:6-H


M13H@


'!T)SX@-3PO9F]N





X
C$W.W
@8V]M;6]N('-T;V-K(&%T





M=&EB;&4@3F]T97





M4CIB;W1H.R!&3TY4+49!34E



M97
@;V8@=&AE($-O;7!A;GDL(&EN8VQU9&EN9R!A;B!A9F9I;&EA=&4@;V8@

#`I+!A;B!A9F9I;&EA=&4@;V8@4FEC:&%R9!*+B!
M86UP96X@*0U,PP

#`\+V9O;G0^

#`\+V9O;G0^*2P@



C`P+#`P
#PO9F]N

86UP96X@:7
@86X@97AE8W5T:79E(&]F



M25I%.B`Q

'!X



14%2.F)O
M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P

'!X(#!I;B`P+C5I;CL@1D].5#H@


M=&EB;&4@3F]T97
@86YD(&%L;!A8V-R=65D(&)U=!U;G!A:60@:6YT97)E

M('1H92!#;VUP86YY)B
X
C$W.W







C`\+V9O;G0^/&9O;G0@




63H@)U1I;65S($YE



'!T)SXS
#PO9F]N=#X\9F]N=!S='EL93TS1=&3TY4
M+49!34E




M8V@@:&]L9&5R)B
X
C$W.W
@=&AE;BUC=7)R96YT(&YO=&4@:&]L9&EN9W
N

M5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.5#H@
M


#L\+V1I=CX@

'!T.TU!4D=)3CH@



M;&4@3F]T97


M
3(U+#`P




M=6QE(&]F($UA='5R:71I97
@;V8@3&]N9RUT97)M($1E8G0@6U1A8FQE(%1E


@

M4CIB;W1H.R!&3TY4+49!34E


M(S$V

'!T.U1%6%0M04Q)
M1TXZ3&5F=#L@5$585U)3D1%3E0Z(#!I;CL@5TE$5$@Z(#$P,4G/B`\=&%B


M($)/4D1%4BU



T0P(&-E;&QP861D:6YG/3-$



38P.S

T0G5$58


M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!
M3U)$15(M5$]0.B`C
#`P

M


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXR



3!P=#L@

M=&@]
T0X-R4^(#QD:78^

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#(U
M,PP

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(




M3E0M4TE:13H@

T0X-R4^(#QD:78^
C`Q.#PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L



M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4



#`P
#`P.R!&3TY4

+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T


M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


#`P
#`P.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(L
3(U+#`P
#PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I=CY4:&5R96%F=&5R/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!R

M9F9F9F8[($-/3$]2.B`C
#`P

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C(Q

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P




M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B`C
#`P

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W


M.R!&3TY4+49!34E
63H@5&EM97


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B

M97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@

M+V1I=CX\=&%B;&4@8F]R9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T




M+R\O0SHO964W
#1E9&9?
#$R9E\T




T0G




M/3-$

M(&-O;'-P86X]


#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S





'!X.R!&3TY4.B`Q
M
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97

@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@

M('1A8FQE(')E8V]N8VEL97




&EN.R!724142#H@
M

T1L969T/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U19






M

Q-C`[

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S
M='EL93TS1=415A4+4%

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M


M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\
M9&EV/C(P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.


P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$Q)2!C

CX@/&1I=CXR
#$S/]D:78^(#PO=&0^(#QT9!S='EL93TS

M:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q



M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M



3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%

24=.


M3E0M4TE:13H@


M960@=&%X(&)E;F5F:70L(&%T(#

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P



P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@

M=&@]
T0Q




+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U


M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$-S4E/B`\9&EV/DEN8W)E87-E(&EN('9A;'5A=&EO;B!A;&QO=V%N8V4\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@
M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/
M54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXH
C@N-3$I/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C


M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z
M(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P

Q

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W



P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@

M=&@]
T0W-24^(#QD:78^3F5T(&-H86YG92!I;B!F86ER('9A;'5E(&]F('=A

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M


M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].
M5U714E'2%0Z(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



P
#`P
#`[
M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

Q-3$[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C


M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P
M,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L
M93L@1D].5U714E'2%0Z(#0P


T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M($-/3$]2.B`C
#`P

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/B@Q+C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[





+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

#`P
M

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@S+C4W*3PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P



P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@

M=&@]
T0Q


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS



M.B`Q



M:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

P
#`P
#`[($9/3E0M
M4TE:13H@

T0Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
M
#`P


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C
#`P


M34E
63H@5&EM97




M3E0M4TE:13H@

T0W-24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V


T0Q)3X@
M/&1I=CXF(S$V

M13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@
M(S`P
#`P


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@0D]21$52+51/4#H@(S`P
#`P

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,
M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+

+4%


'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0W-24^(#QD:78^26YC;VUE('1A

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


P
#`P
#`@
W!X(&1O=6)L93L@5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97


M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C
M9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)4



T0G
M=VED=&@Z

M
T0P(&-E;&QP861D:6YG/3-$


T1T

M:71I97








@3F5W(%)O;6%N
M.T9/3E0M4TE:13H@

#L\+V1I=CX@

'!T.U1%6%0M04Q)1TXZ3&5F=#L@5$58

T0G

1494





T0P(&-E;&QP861D:6YG/3-$

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`W
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\





P
#`P
#`@
7!X('-O;&ED.R!4
M15A4+4%

'!T.R!615)4

38P.S
Q+#PO9&EV/B`\






M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^)B
Q-C`[

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
M


P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!3U)$15(M5$]0.B`C
#`P




M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/
M4#H@(S`P
#`P

M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&

+4%
24=..B!B;W1T;VT[($)/4D1%


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%


'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R




'!T.R!6


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)#PO9&EV/B`\+W1D/B`\


#`P
M
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXW
BPP
#`\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O
M;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].
M5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,#,L,#`P/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#04PM

T0W-24^
M(#QD:78^06-C;W5N='

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



P
#`P
#`[($9/3E0M4TE:13H@
3!P

M=VED=&@]
T0Q


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))1TA4


24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0W-24^(#QD:78^26YV96YT;W)Y

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS
#0L
#`P

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR.#`L
#`P

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M.B`Q

M;#L@4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W
M(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@
M1D].5U325I%.B`Q


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R



M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



P
#`P
#`[
M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M13H@

T0Q)3X@/&1I=CXF(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].
M5U714E'2%0Z(#0P

C`V+#`P
#PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#
M3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXS-PW
#8L

M13H@

T0Q)3X@/&1I=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P


M.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXS
2PV
C
L

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E


M14E'2%0Z(#0P





M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$



+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M
M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'
M2%0Z(#0P



3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q



M:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

P
#`P
#`[($9/3E0M
M4TE:13H@

T0Q
4^(#QD:78^,BPP,#`\+V1I=CX@/]T9#X@






P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)

T0Q


M

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M


M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]

#`G
M('=I9'1H/3-$
3`E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4


M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O
M;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].
M5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M
M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E



24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#
M3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXS.2PS.30L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F
M.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXS-BPQ-#,L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M3E0M4TE:13H@



T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97



M9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^*#
X+#DR
2PP

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$
M.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!6

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.

3-P



'!T.R!6


+4%
24=..B!B;W1T;VT[($)/4D1%

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/
M4#H@(S`P
#`P

M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&

+4%
24=..B!B;W1T;VT[($)/4D1%


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M


M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M3E0M4TE:13H@

T0Q)3X@/&1I=CXD/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M0D%#2T=23U5.1#H@(V9F9F9F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:
M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z
M(#0P

#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97



P
#`P
#`@


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97






M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P
M,#`@,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M1#$P)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
W!X(&1O=6)L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^1&5F97)R

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@




M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


'!T

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M.B`Q

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%

M5#H@



T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH.#@X+#@V
RD\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G0D]21$52+4)/
M5%1/33H@(S`P
#`P

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G0D]2
M1$52+4)/5%1/33H@(S`P
#`P

3!P

M=VED=&@]
T0Q
4^(#QD:78^*#$L,#,W+#`Q,BD\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P
#`P(#%P




#`G('=I9'1H/3-$
3`E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97



1494.B`Q
W!X.R!&3TY4+49!34E
63H@
M5&EM97

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P


M.B`Q


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

@3F5W(%)O;6%N.T9/
M3E0M4TE:13H@

M9&5R/3-$
!S='EL93TS1=W:61T:#HQ
#`E.R!T86)L92UL87EO=70Z9FEX




#1E9&9?
M
#$R9E\T

O4VAE970S


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q





T0Q(')O=W-P86X]


T0Q/C$R


#$T/&)R/CPO=&@^


]

M3CH@


14%2.F)O=&@[($9/3E0M1D%-


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E



S$L(#(P

@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@

#L\+V1I=CX@/&1I=B!S


T0G34%21TE.
M.B`P:6X[(%=)1%1(.B`Q


M

T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#(S



13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P


M13H@

T0R





24=..B!C






24=.

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%

M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

24=..B!C




3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P





T0Q)3X@/&1I=CXF(S$V
M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T


M13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@
M(S`P
#`P


3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD
M:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#
Y)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C



M(#QD:78^)B

M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C




3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$Q

CX@/&1I=CY796EG:'1E9#PO9&EV/B`\+W1D/B`\=&0@


M



M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T




M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-S`P)R!W:61T:#TS1#,Y)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M


3!P

M=VED=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T


3!P=#L@

M=&@]
T0Q

M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D






M13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/D%V97)A9V4\+V1I

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

CX@/&1I=CY!

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#
Y
M)3X@/&1I=CY286YG928C
38P.V]F/]D:78^(#PO=&0^(#QT9!S='EL93TS

M:#TS1#$E/B`\9&EV/B8C

T0G




3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E
M(&-O;'-P86X]
T0R/B`\9&EV/DQI9F4F(S$V
#MI;CPO9&EV/B`\+W1D/B`\






M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D('-T


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T


M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/DEN=')I





M3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V


M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

CX@
M/&1I=CY3:&%R97

13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C
#`P


M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q



13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q


M($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/E!R

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/E9A;'5E

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

#`G('=I9'1H/3-$
SDE

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4


M:60[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@
M1D].5U35%E


#`G
M('=I9'1H/3-$
3`E/B`\9&EV/C8R
2PU

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

P
#`P
#`@
7!X('-O
M;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P


M.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!


T0Q
4^(#QD:78^-XU-SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))


M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C8R
2PU
#`\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@

T0Q
4^(#QD:78^,XR
CPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L


#`G('=I9'1H/3-$
24^(#QD



+4%
24=..B!B;W1T;VT[

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@
M(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#
Y)3X@/&1I=CXD


M25I%.B`Q


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E



#`W

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
3`E/B`\9&EV/C0L-3DR+#0T-SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXP+C,S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


M34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#
M3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q


M.B`Q

3!P=#L@5D525$E#04PM

T0S.24^
M(#QD:78^)#$N
#$@)B
Q-3$[(0R+C`P/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3$]2.B`C
#`P

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%

M4TE:13H@

T0Q
4^(#QD:78^-C@L,#`P/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T

M1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M25I%.B`Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E



2PP
C`\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(Q+#`P
#PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



P
#`P
#`[($9/
M3E0M4TE:13H@

T0Q
4^(#QD:78^,XT
#PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L



M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E



#PO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$U,3L\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q

M

T0S.24^(#QD:78^)#8N
#$@)B
Q-3$[(0W+C`P/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q

M;#L@4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P





'!T.R!6


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E


M(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P





M.B`Q

3!P=#L@5D525$E#04PM

T0S.24^

#$@)B
Q-3$[(0X+C`P/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].

M3$]2.B`C
#`P

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%

M4TE:13H@

T0Q


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,Y)3X@/&1I=CXD.XP
2`F
M(S$U
3L@)#DN

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXW+#4P

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#

T0Q
M

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P





M.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)4


'!T





'!T

3!P=#L@5D525$E#04PM04Q)1TXZ

T0S.24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


T0Q)3X@/&1I=CXF(S$V

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M($-/3$]2.B`C
#`P

+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[

M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


P
#`P
#`@
M
W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,2PQ-S0L,#`W/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O
M;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].
M5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXW+C$Y/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

P
#`P
#`@
W!X(&1O=6)L93L@5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
3`E/B`\9&EV/C`N-C

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXD/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P(#-P

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
3U(Z(,P,#`P,#`[
M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].
M5U714E'2%0Z(#0P

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P







]

M3CH@


14%2.F)O=&@[($9/3E0M1D%-


'!X.R!&3TY4.B`Q
'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97
L(%-E



T0G0TQ%05(Z8F]T:#L@1D].5U&04U)3%DZ
M5&EM97,@3F5W(%)O;6%N.T9/3E0M4TE:13H@,3!P=#M-05)'24XZ(#!P=`P


M+49!34E


M15(M0T]


T0P



24=..B!C




3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q)3X@/&1I=CXF(S$V
M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P





'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS



13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58



M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C




3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V





M(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q


M13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M


M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M


M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

M

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
M


M4TE:13H@

T0Q


M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]

M;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




'!T.R!615)4


'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!3U)$15(M5$]0.B`C
#`P
#`P


P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!R:6=H=#L@1D].

M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+51/4#H@(S`P
#`P


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXP+C

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P
#`P

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


M

T0Q)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$L.#`P+#$V-CPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXP+C,P/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$



'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@


M



+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

3!P=#L@5D525$E#04PM

T0Q

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R

M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q
4^(#QD:78^,XS
SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)4


+4%
24=..B!M:61D;&4[($)/4D1%4BU4

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C


M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


M


M25I%.B`Q

M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

'!T.R!615)424-!




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^



+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C`N
S(\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!3U)$15(M5$]0.B`C
M
#`P


M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

#`G('=I9'1H
M/3-$
3`E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M

Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^
RPS
#`L

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C`N-#
\+V1I

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

3!P=#L@5D52

M
T0Q

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^,XS
M

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


'!T.R!6


M

M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


3!P=#L@

M=&@]
T0Q
4^(#QD:78^,XS

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97



'!T.R!6




+4%


'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%


#$T

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=3U)$15(M0D]45$]-.B`C
#`P

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXU+#8V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M63H@5&EM97





T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$
#X\='(^/'1D/CPO











14%2.F)O=&@[($9/3E0M

M97


M4F]M86X[1D].5U325I%.B`Q,'!T.U1%6%0M04Q)1TXZ3&5F=#L@5$585U)
M3D1%3E0Z(#!I;CL@5TE$5$@Z(#$P

Y96(V8V4@
'!X('-O;&ED
M.R!3U)$15(M4DE'2%0Z(
Y96(V8V4@


T0P(&%L:6=N/3-$;&5F=#X@/'1R/B`\=&0@


M


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M


3!P

M=VED=&@]




M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V


M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

CX@/&1I=CXR
M

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



P
#`P
M
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z

M25I%.B`Q

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/


3!P

M=VED=&@]
T0W


M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]

M5T5)1TA4.B`T
#`G('=I9'1H/3-$


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@0D]21$52+51/4#H@(S`P
#`P

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,
M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+
M1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
#`P

T0Q



3!P=#L@

M=&@]
T0W

\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@
M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV
M/C4N-2`M(#8N

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





P
M
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q
4^(#QD:78^-C4E(T@

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T


M13H@

T0Q)3X@/&1I=CXF(S$V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%

M13H@

T0Q


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\

14%2.F)O=&@[



]

'!T.TU!
M4D=)3CH@





'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97

Q-C`[)B

@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@
3!P=#M415A4+4%

M


M.B`Q
'!T.R!/5D521DQ/5SH@=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C



13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-30E/B`\9&EV/B8C
38P.SPO9&EV



P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M

38P.T-O;G9E

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@
M3F5W(%)O;6%N.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G


M4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!C


38P.S

3

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!#3TQ/
M4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q
4^(#QD:78^,XY
CPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$
M.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q
'!T.R!6


+4%
24=..B!M:61D;&4[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXP+C

M
#`P

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C8Q/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q)3X@/&1I=CXF(S$V
#L\

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C

#`P
#`P.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@1D].5U714E'2%0Z(#0P



M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%

3!P=#L@5D525$E#04PM04Q)

T0Q

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
#`P
M
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P



'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXS+C(U/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M




M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C



+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$

#`P
#`P.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P




M=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P
#`P
#L@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T

M1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


P
M
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O


3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T]
M3U(Z(,P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

T0G0TQ%







'!X.R!&3TY4.B`Q
'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97

@3F5W(%)O;6%N.T9/3E0M4TE:
M13H@

28C.#(Q-SMS(&]U='-T86YD

@
M3F5W(%)O;6%N.T9/3E0M4TE:13H@

M:68G/B`F(S$V

'!T.U1%
M6%0M04Q)1TXZ3&5F=#L@5$585U)3D1%3E0Z(#!I;CL@5TE$5$@Z(#$P,4G







T0P(&-E;&QP861D:6YG/3-$

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-S4E/B`\9&EV/B8C
M




24=..B!C96YT97([



M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/


M3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

T0G


M15A4+4%

'!T.R!615)4


3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3`E
M/B`\9&EV/B8C







M13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL









M4F]M86X[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^)B
Q-C`[

M;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO





M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/E!R

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P
M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%







3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

S$L(#(P
M

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

#`P

M
T0Q


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


63H@
M5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

3!P

M=VED=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@



M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'


M

T0Q)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO



+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q.SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



'!T.R!6



M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&


M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

M(#QT9!S='EL93TS1=415A4+4%

M

T0Q
4^(#QD:78^)B,Q-3$[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4

M24=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXH
2PU-#
L

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXV+C4S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-S4E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U



M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0W-24^(#QD:78^)B
Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].

M=&@]
T0Q)3X@/&1I=CXF(S$V

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+51/4#H@(S`P
#`P


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M4TE:13H@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&UI9&1L93L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[






M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

Q-3$[/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E



24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P






M25I%.B`Q


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E





M+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^
M(#QD:78^)B

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97


M;VQI9#L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
3`E/B`\9&EV/B8C

M;&4]
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P





M

3!P=#L@5D525$E#04PM04Q)

T0W-24^(#QD
M:78^)B

M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+51/4#H@(S`P
#`P


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q
4^(#QD:78^)B,Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T



'!T.R!615)4

24=..B!L



M/3-$)T)/4D1%4BU3U143TTZ(
P
#`P
#`@

M54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P
#`P
#L@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W


M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


M-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T.R!6



M)T9/3E0M1D%-24Q9.B`G5&EM97



M



M86QI9VX]




M/B`F(S$V

'!T.U1%6%0M
M04Q)1TXZ3&5F=#L@5$585U)3D1%3E0Z(#!I;CL@5TE$5$@Z(#$P,4G/B`\

T0G34%21TE..B`P:6X[(%=)1%1(.B`Q

M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0U
24^(#QD:78^
M)B

M($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W

T0Q
3X@/&1I=CY9

38P.V5N9&5D)B
Q-C`[36%R8V@F(S$V
#LS

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-3$E/B`\9&EV/B8C
38P.SPO



P
#`P
#`@
M
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M

M
#`G('=I9'1H/3-$
C
E(&-O;'-P86X]
T0U/B`\9&EV/C(P
3
\+V1I=CX@

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-3$E/B`\9&EV/B8C
38P




P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@
M-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


#`G('=I9'1H/3-$
3`E
M/B`\9&EV/B8C


M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B


T0Q


13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B


M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

M(%9%4E1)0T%
+4%


P
#`P
#`@
7!X('-O;&ED.R!&3TY4
M+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\


#`G('=I
M9'1H/3-$
3$E(&-O;'-P86X]

M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([



M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/



M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M



M3E0M4TE:13H@

T0Q





24=..B!C96YT97([



M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/


24=.


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS
M1#4Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C



M(#QD:78^)B

M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C





M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!6


3!P=#L@5D52

M
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%

'!T.R!615)4


3!P=#L@5D525$E#

T0Q
M

13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
M
#`G('=I9'1H/3-$
24^(#QD:78^)B

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$-3$E/B`\9&EV/B8C
38P.SPO9&EV/B`\





P
#`P
#`@
7!X('-O
M;&ED.R!415A4+4%

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T









M9!S='EL93TS1=415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q



M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M

3!P=#L@5D525$E#04PM04Q)

T0U
24^(#QD

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



+4%
24=..B!B
M;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#$R,PW-C4\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q
4^(#QD:78^,XV-#PO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E


M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C8L
S
P+#4Y.3PO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L


#`G('=I9'1H/3-$
24^(#QD



+4%
24=..B!B;W1T;VT[

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%

3!P=#L@5D525$E#04PM

T0Q
4^
M(#QD:78^,RPS,#`L,#`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P





M3TY4+49!34E
63H@5&EM97


'!T.R!615)424-!

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R



2PX
#`L
38V/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/C`N

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


'!T.R!6


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP
M+C

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\



+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
34Q.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXP+C`P/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-3$E

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97


M9#L@5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH
38V
M+#`P


'!T


+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E


M2%0Z(#0P


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXH
3`L

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C,T
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-3$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G5$585U!3$E'3CH@;&5F=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N

M+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L


#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=.
M.B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

P
M
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
3`E/B`\9&EV/B8C

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97



P
#`P
#`[
M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0U



T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


'!T.R!615)4

24=..B!R

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=3U)$15(M0D]45$]-.B`C
#`P

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


'!T

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


P
#`P
#`@
W!X(&1O=6)L93L@


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E
M/B`\9&EV/C@L

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97



M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T

P
#`P
#`@
W!X(&1O

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D
M/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!3U)$15(M5$]0.B`C
#`P

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O=6)L
M93L@1D].5U714E'2%0Z(#0P

Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!3U)$15(M5$]0.B`C
#`P

24=..B!R:6=H

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@
M,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M:78^)B

M

T0Q)3X@/&1I=CXF(S$V

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$-3$E/B`\9&EV/D5X97)C:7-A8FQE(&%T


M.B`Q

M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P


P
#`P
#`@
W!X(&1O

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$

M
T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q

P
#`P
#`@
M


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
3`E/B`\9&EV/C`N-C

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

3!P=#L@5D525$E#04PM04Q)1TXZ(&UI

T0Q)3X@/&1I=CXF(S$V
M


63H@
M5&EM97


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E



M34E
63H@5&EM97




M3E0M4TE:13H@

T0U
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V


#`G('=I9'1H/3-$
24^
M(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,
M24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

P
#`P
#`@

M
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@1D].5U3
M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!

M+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O=6)L
M93L@1D].5U714E'2%0Z(#0P

Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].

#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

P
#`P
#`@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

24=..B!R:6=H

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@
M,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M:78^)B

M

T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M25I%.B`Q


+4%
24=..B!M
M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W


+4%
24=..B!M:61D;&4[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E





M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q
4^(#QD:78^
M)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L




M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T


M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C$V/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


M.B`Q




F9?-#`W-E\X-&

F$Q-F5E860P-@T*



]

M:60]

3(@36]N
M=&AS($5N9&5D/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@

S$L(#(P
30\8G(^/]T:#X-B`@


@
M86YD($-O;G1I;F=E;F-I97





M($U!4D=)3CH@







M;W1H.R!&3TY4+49!34E

M(#$P





T0G0D]2
M1$52+4)/5%1/33H@(S`P
#`P

M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#@W)3X@/&1I=CY996%R

38P.V5N9&EN9R8C

Q-C`[

M5#H@-S`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4
M+49!34E
63H@5&EM97

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H
M/3-$
3$E(&-O;'-P86X]
T0R/B`\9&EV/D%M;W5N=#PO9&EV/B`\+W1D/B`\





M+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I=CXR,#$U/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P



3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!3U!
M3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0X-R4^(#QD:78^
C`Q-CPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXR-C(L-C0V/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M



M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I


M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXS
PY-C,\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q

M

T0X-R4^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\



T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#@W)3X@/&1I

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T9#X@/'1D('-T

P
#`P
#`@
W!X(&1O=6)L93L@5$58


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\
M9&EV/C4W


M.B`Q

M;&4]
T0G=VED=&@Z


T0P(&-E;&QP861D:6YG/3-$

M+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?3F5X=%!A

#1E9&9?
#$R9E\T

M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X
M-&






^


M1$E$




]
T1T:#Y-87(N(#




]






2X\+V1I=CX@/&1I=B!S='EL93TS1=#3$5!4CIB;W1H.R!&3TY4
M+49!34E


969T.R!415A4+4E.1$5.
M5#H@
&EN.R!724142#H@


Y96(V
M8V4@
'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P

6QE/3-$)U1%6%0M04Q)1TXZ

M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V


M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4


38P.V5N9&5D)B
Q-C`[36%R8V@F(S$V
#LS

M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$-3
E/B`\9&EV/B8C
38P.SPO



P
#`P
#`@
M
7!X('-O;&ED.R!415A4+4%
24=..B!C96YT97([($9/3E0M4U193$4Z(&YO

M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
M
#`P



3!P
M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P
M

M
#`G('=I9'1H/3-$
C(E(&-O;'-P86X]
T0T/B`\9&EV/C(P
3
\+V1I=CX@

M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^)B

M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



T0Q
M
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO




T0Q
4^(#QD:78^)B,Q
M-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4


M25I%.B`Q

M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


M.B`Q

M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!

'!T.R!615)4




63H@
M5&EM97


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)424-!




M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E


M(#0P


+4%
M24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]4
M5$]-.B`C
#`P


M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$
M15(M0D]45$]-.B`C
#`P


M3TY4+49!34E
63H@5&EM97


M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX-XX
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C
U+#DY


'!T



'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX
M-BXY/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)4


+4%
24=..B!B;W1T;VT[($)/4D1%4BU4

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$
M15(M5$]0.B`C
#`P


Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+51/4#H@(S`P
#`P

24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F

+4%
24=..B!B;W1T;VT[($)/
M4D1%4BU43U`Z(,P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q


'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


Q

3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R




'!T.R!615)4

24=..B!L





'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT.PQ

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

3!P

M=VED=&@]
T0Q)3X@/&1I=CXE/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P


M-7!X.R!&3TY4+49!34E
63H@5&EM97


M

M+4%

3!P=#L@5D525$E#04PM04Q)

T0Q


M


+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$-3
E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@
M,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M:78^)B

M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M

M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO
M=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\
M+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)

T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M




Q-C`[

3!P=#L@5D52

M
T0Q)3X@/&1I=CXF(S$V

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXF(S$V

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$E/B`\9&EV/B8C

M;&4]

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V
#L\

M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


'!T.R!6

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4

M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



+4%
24=..B!B;W1T;VT[($9/
M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C`N
#PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$

T0G5$58

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXH
C8L
S(Y*3PO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^,XV

3!P=#L@5D52

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-3


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V-C965F9CL@1D].5U325I%.B`Q


M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^*#$L

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXQ
#`N

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


M25I%.B`Q

M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
7!X('-O;&ED
M.R!415A4+4%

3!P=#L@5D525$E#

T0Q
M

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M


M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F
M9F9F9CL@1D].5U325I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!3U)$15(M5$]0.B`C
#`P

M(#0P




M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R
M:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%


M.B`Q


+4%
24=..B!B;W1T


'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

M14E'2%0Z(#0P


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
M
#`P

M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$-3
E/B`\9&EV/E1O=&%L($-O;G-O;&ED871E


+4%
24=..B!M:61D;&4[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P
#`P

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\



M3$E'3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4
M.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXQ
#`N

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P

M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P


P
#`P
#`@
W!X(&1O=6)L93L@


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E
M/B`\9&EV/C$P
XP/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

M(#0P





M


+4%
24=..B!B;W1T;VT[
M($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'2%0Z
M(#0P




M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C



#`G('=I9'1H/3-$
3`E
M/B`\9&EV/B8C

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M


M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D


M3U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'

M3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)

+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z
M(,P,#`P,#`@,W!X(&1O=6)L93L@1D].5U714E'2%0Z(#0P


M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O



T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P


3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[



'!T.R!615)4

'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T




M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V,#L\+V1I=CX@/]T9#X@/'1D('-T

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C
M965F9CL@1D].5U325I%.B`Q

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I=CY);G1E

M

T0Q)3X@/&1I=CXF(S$V

M9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@

3!P=#L@5D525$E#04PM

T0Q
4^
M(#QD:78^*#$U,RPT,3DI/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



P
#`P
M
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q
4^(#QD:78^,2XW/]D:78^
M(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-4

M0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

24=..B!L



M15A4+4%
24=..B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@Q-#4L-S@T*3PO9&EV

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U3
M5%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97


3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q
4^(#QD:78^
M,BXW/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M4$%$1$E.1RU
1494.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO

T0G0D]21$52+4)/5%1/33H@(S`P
#`P
M

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G0D]21$52+4)/5%1/33H@
M(S`P
#`P

#`P
#`P.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$

RPS

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E



'!T.R!6

M4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)T)/4D1%4BU3U143TTZ(
P
#`P
#`@
7!X('-O;&ED.R!415A4+4%
24=.
M.B!R:6=H=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$
3`E/B`\9&EV/B@U+#
P
BPY-S

3!P=#L@5D525$E#04PM04Q)1TXZ

T0Q)3X@/&1I=CXF
M(S$V

M(,P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5U3
M5%E


M2%0Z(#0P

SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I=CXF(S$V
M

M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!6
M15)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M


T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[





#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M

#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P



T0Q
4^(#QD:78^
M)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



M

T0U


'!T.R!615)424-!

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P



24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P

M4D1%4BU3U143TTZ(
P
#`P
#`@


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$P
XP
M/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&

M86X[($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


'!T.R!6

M4BU3U143TTZ(
P
#`P
#`@

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$P)3X@/&1I=CXH-2PT-#@L-S4W*3PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97


M.B`Q


+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/



'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P

24=..B!R:6=H=#L@

M4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X
M(&1O=6)L93L@1D].5U714E'2%0Z(#0P

M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M0D]21$52+51/4#H@(S`P
#`P


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M4E1)0T%
+4%
24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(,P,#`P,#`@,W!X
M(&1O=6)L93L@1D].5U714E'2%0Z(#0P



M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

M1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




M


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N


+4%
24=..B!M:61D;&4[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M3D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@


M


+4%
24=.
M.B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P

M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E
M/B`\9&EV/B8C

T0G0D]21$52
M+4)/5%1/33H@(S`P
#`P




M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
#`P

M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$P)3X@/&1I=CXQ
3@L

M3E0M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

M4$%$1$E.1RU224=(5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

M3E0M4TE:13H@


M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@

T0Q)3X@/&1I=CXF(S$V

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!


M25I%.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0
M.B`C
#`P


+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B

3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P


'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!3U)$15(M5$]0.B`C
#`P


M4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=4
M15A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!
M34E
63H@5&EM97

P
#`P
#`@

M=VED=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/


M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$-3

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q)3X@/&1I=CXF(S$V
#L\+V1I

3!P=#L@5D525$E#

T0Q
M
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P



M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M)B

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V

M9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&
M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV


M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!
M3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P
M)3X@/&1I=CXF(S$V

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\


M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF
M(S$V

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N


M


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@1D].5U325I%.B`Q


M+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^



+4%
24=..B!B;W1T
M;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C$V+#8T
M

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
3`E/B`\9&EV/C

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(

M965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M
M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ-2PS

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V

M(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-BXY

3!P=#L@5D52

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-3

M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].
M5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%
M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O

T0Q


M(%9%4E1)0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

C@N

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E


M14E'2%0Z(#0P

C$L

3!P=#L@5D525$E#04PM

T0Q)3X@
M/&1I=CXF(S$V

M1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR
M

3!P=#L@

M=&@]

M4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H
M/3-$-3


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C@L

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


3!P=#L@5D52

M
T0Q


+4%
24=..B!B;W1T;VT[($9/3E0M5T5)
M1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\+W1D/B`\=&0@

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H=#L@

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].

T0Q
4^(#QD:78^.PX
#
L

3!P=#L@5D525$E#

T0Q
M)3X@/&1I=CXF(S$V

M3U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I
M=CXR

3!P

M=VED=&@]

M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$-3
E/B`\9&EV/E9O9&MA/]D:78^(#PO=&0^(#QT9!S='EL93TS

M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].

T0Q)3X@/&1I=CXF(S$V
#L\+V1I=CX@

M2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\
M9&EV/B8C



+4%
24=..B!B
M;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C(L

T0G5$585U!3$E'3CH@
M;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@


3!P=#L@5D52

M
T0Q
4^(#QD:78^-2XY/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P

24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[





'!T.R!615)424-!


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97


M(%9%4E1)0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I
M9'1H/3-$
24^(#QD:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S
M='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[


'!T.R!6
M15)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#4S)3X@/&1I=CY497%U:6QA/]D:78^(#PO=&0^(#QT9!S='EL93TS
M1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M





M-7!X.R!&3TY4+49!34E
63H@5&EM97

M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T
M.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W
M:61T:#TS1#$E/B`\9&EV/B8C

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M

T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97


+4%
24=..B!B;W1T;VT[
M($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D
M:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].
M5U35%E


M14E'2%0Z(#0P

C0R+#4S-SPO9&EV/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
M13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97

24=.

3!P=#L@5D525$E#04PM04Q)1TXZ(&)O

T0Q
4^(#QD:78^,XV

3!P=#L@5D52

M

M0T%
+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M-3

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!R:6=H

M9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@

T0Q


M0T%
+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^
XV/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=..B!L



M15A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-

M14E'2%0Z(#0P



M.B`Q
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV.#DL-C,W/]D:78^(#PO=&0^(#QT
M9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M

M(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI
M9&1L93L@1D].5U714E'2%0Z(#0P


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q



3!P=#L@5D525$E#04PM04Q)

T0U
R4^(#QD


3!P=#L@

M=&@]
T0Q)3X@/&1I=CXF(S$V

M

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'+5))

M4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M:78^-2PV
C8L

M13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$24Y'

M0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P

M(#QD:78^

T0G5$585U!3$E'
M3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97


M.B`Q





M25I%.B`Q

M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)

'!T.R!615)424-!


M.B`Q

M

T0U
R4^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S

M9F9F9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\



T0Q)3X@/&1I=CXF(S$V
M

3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P
#`P

M;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P

+4%
24=..B!M:61D;&4[($9/3E0M5T5)1TA4.B`T
#`G
M('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&
M3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97


1494
M.B`Q
W!X.R!&3TY4+49!34E
63H@5&EM97


M8V5E9F8[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L

T0Q)3X@/&1I=CXF(S$V
#L\


+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P



M(#0P

30P+#0X
SPO9&EV/B`\+W1D

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@
M;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97




+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD:78^

T0G0D]21$52+4)/5%1/33H@(S`P
M
#`P

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXD/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-.B`C
M
#`P

M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U3
M25I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I
M=CXF(S$V



M34E
63H@5&EM97

3!P=#L@5D525$E#04PM04Q)

T0Q)3X@/&1I

@3F5W(%)O;6%N.T9/3E0M
M4TE:13H@

14%2
M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z





M1%1(.B`Q

T1L969T/B`\='(^(#QT9!S='EL
M93TS1=415A4+4%

M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T



24=..B!C96YT97([


M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T:#TS1#4S)3X@/&1I
M=CXF(S$V

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.
M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`W
#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=3U)$15(M0D]45$]-
M.B`C
#`P


M($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+51/4#H@(S`P
#`P


P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-S`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G
M0D]21$52+4)/5%1/33H@(S`P
#`P

13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM
M97

+4%
24=.

24=..B!C96YT


M13H@

T0U


M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)4
M24-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS
M1#$E/B`\9&EV/B8C

T0G5$58
M5U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$E/B`\9&EV/B8C

T0G

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@

M=VED=&@]
T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL
M93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/

M
#`G('=I9'1H/3-$
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S
M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(
M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXF(S$V

M1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@
M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M

T0G5$585U!3$E'3CH@;&5F
M=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W

P
#`P
#`@
M
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV
M/B8C



T0Q
4^
M(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4

#`G('=I9'1H/3-$
M
24^(#QD:78^)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%,24=..B!R:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
M63H@5&EM97

P
#`P
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T
M:#TS1#$P)3X@/&1I=CXF(S$V

M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@
M1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\
M+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F
M9CL@1D].5U325I%.B`Q

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5U714E'2%0Z(#0P


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T9#X@


M
'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P
M)R!W:61T:#TS1#$P)3X@/&1I=CXR+#(P,2PS-#,\+V1I=CX@/]T9#X@/'1D

M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C9F9F9F9F
M.R!#3TQ/4CH@(S`P,#`P,#L@1D].5U325I%.B`Q


M


'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4
M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/]T9#X@


M


M;#L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@
M(V9F9F9F9CL@1D].5U325I%.B`Q


M+49!34E
63H@5&EM97


+4%
M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
#`G('=I9'1H/3-$
24^(#QD
M:78^)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9!S='EL93TS1=415A4
M+4%

M5#H@

'!T.R!615)424-!3U!3$E'
M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4S)3X@/&1I
M=CY5;FET960@4W1A=&5S/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4
M+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9

M2%0Z(#0P


P
#`P
#`@
7!X('-O;&ED
M.R!415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M


P
#`P
#`@
7!X
M('-O;&ED.R!415A4+4%

#`P
#`P.R!&

+4%
24=..B!B;W1T;VT[($9/3E0M
M5T5)1TA4.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/C
T+#
R


'!T.R!615)424-!


M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F
M9CL@0T],3U(Z(
P
#`P
#`[($9/3E0M4TE:13H@
3!P=#L@5D525$E#04PM

T0Q

M3CH@;&5F=#L@1D].5U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z

+4%
24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T
M
#`G('=I9'1H/3-$

M
T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@

T0G0D]21$52+4)/5%1/33H@(S`P
#`P

M2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!
M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXS

M4TE:13H@

T0Q)3X@/&1I=CXF(S$V

13H@;F]R;6%L.R!0041$

M($)!0TM'4D]53D0Z(-C8V5E9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@1D].5U714E'2%0Z(#0P


T0G5$585U!
M3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@
M5&EM97

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#4S)3X@/&1I=CXF(S$V

M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED
M9&QE.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P

T0G5$585U!3$E'3CH@;&5F=#L@
M1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O

P
#`P
#`@
7!X
M('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
M



T0Q
4^(#QD
M:78^)B,Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%
24=.
M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE

M



M.B`T
#`G('=I9'1H/3-$
3`E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\

T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R
M;6%L.R!&3TY4+49!34E
63H@5&EM97

24=..B!L969T

M4F]M86X[($)!0TM'4D]53D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,`Q

#`G('=I9'1H/3-$
24^(#QD:78^
M)B
Q-C`[/]D:78^(#PO=&0^(#QT9!S='EL93TS1=415A4+4%,24=..B!R
M:6=H=#L@1D].5U35%E
13H@;F]R;6%L.R!&3TY4+49!34E
63H@5&EM97
@

P
#`P
M
#`@
7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@
M/&1I=CXF(S$V

M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5U325I%
M.B`Q,'!T.R!615)424-!3U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@
M-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C
38P.SPO9&EV/B`\+W1D/B`\=&0@


M(V9F9F9F9CL@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T

T0Q
4^(#QD:78^)B,Q-C`[/]D:78^(#PO=&0^
M(#QT9!S='EL93TS1=415A4+4%
24=..B!L969T.R!&3TY4+5-464Q%.B!N

M3D0Z(-F9F9F9F8[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@1D].5U714E'2%0Z(#0P

3!P=#L@5D525$E#04PM04Q)

T0U
R4^(#QD


T0G5$585U!3$E'3CH@;&5F=#L@1D].5U35%E
13H@;F]R;6%L
M.R!&3TY4+49!34E
63H@5&EM97



P
M
#`P
#`@

M(S`P
#`P
#L@1D].5U325I%.B`Q,'!T.R!615)424-!3U!3$E'3CH@8F]T
M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-BPU
M

3!P

M=VED=&@]
T0Q)3X@/&1I=CXF(S$V


M5#H@-7!X.R!&3TY4+49!34E
63H@5&EM97

3!P

M=VED=&@]
T0Q)3X@/&1I=CXE/]D:78^(#PO=&0^(#QT9!S='EL93TS1=
M3U)$15(M0D]45$]-.B`C
#`P

M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5U325I%.B`Q
M,'!T.R!615)424-!3U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P


M-7!X.R!&3TY4+49!34E
63H@5&EM97


M

M+4%

3!P=#L@5D525$E#04PM04Q)

T0Q


M


M3%DZ5&EM97
@3F5W(%)O;6%N.T9/3E0M4TE:13H@
3!P=#M415A4+4E.1$5.
M5#H@






3)F7S0P-S9?.#1C
E\W-#)A
39E96%D






M;R!.;W0@4F5M;W9E(%1H:7

24-)15
@
M*$1E=&%I;'


CXQ
B!-;VYT:'
@

M/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^






T1T;W`^4F5V97)S


]
T1N=6UP/B0@-C@T+#@S
#QS

]





M=P@17-T:6UA=&5D(%5S969U;!





]


]





T1T;W`^26YV96YT;W)Y(%=R:71E+61O=VX\




]

]
M
T1N=6UP/B0@


;V-A=&EO;CH@9FEL93HO+R]#

3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
#8O5V]R:W-H



M151!(&AT='`M97%U:78]

]



]


]
T1T:#Y-87(N(#



@4&5R
M(%-H87)E(%M



]


@;F]T(&EN8VQU9&5D


3(L.3(P/'-P86X^


]


]




]




M


]


]
T1R




]


]


]

]



M;V8@16%R;FEN9W
@4&5R(%-H87)E(%M


]



M97
@;F]T(&EN8VQU9&5D(&EN(&-A;&-U;&%T:6YG(&1I;'5T960@;F5T(&QO



M


]

]



M;V8@16%R;FEN9W
@4&5R(%-H87)E(%M


]



M97
@;F]T(&EN8VQU9&5D(&EN(&-A;&-U;&%T:6YG(&1I;'5T960@;F5T(&QO


M+#
V
2PQ




3)F7S0P-S9?.#1C
E\W-#)A
39E96%D



M87-C:6DB#0H-
MCQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N






M+B`S
2P@

]



]




]





M
#1E9&9?
#$R9E\T

O
M4VAE970T
2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T

M=#TB=7
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H


T1T97AT+VIA=F%S8W)I

@0V]M;65N


T0Q(')O=W-P86X]
T0Q/CQS

@*$1E=&%I;'

]
T1T:#Y-87(N(#







]






3)F7S0P
M-S9?.#1C
E\W-#)A
39E96%D



M@T*/&AT;6P^#0H@(#QH96%D/@T*(`@(#Q-151!(&AT='`M97%U:78]
T1#

]
T13:&]W



S$L(#(P
30\8G(^
M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^3V-T+B`S
2P@
C`Q
SQB

#$S


]



]

3DN





M
T1T;W`^4&%Y;65N='



#QS





]




M='D@365T:&]D($EN=F5S=&UE;G1S(%M


]



M;V0@26YV97-T;65N='

]
T1N
M=6UP/B0@


]
T1P


M

]
T1N=6T^*#4P
BPU
3@I

M

]


]




]


M1FEN:7-H960@1V]O9'




L($-U




M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P





]
T1N=6T^*#4P
BPU



]
T1P;!V86QI9VX],T1T;W`^17%U:71Y($UE=&AO9!);G9E

3(P+#DP




#1E9&9?
#$R9E\T
M








T0R/C$R($UO

#$T/&)R/CPO=&@^#0H@


]



]
T1P;!V86QI9VX],T1T;W`^4&%Y;65N=',@=6YD97(@36-,86EN
M(9A;7`[($MY;F4@86=R965M96YT/]T9#X-B`@(`@(`@/'1D(&-L87-S



M
#1E9&9?
#$R9E\T

O
M4VAE970T-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T

M=#TB=7
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H


T1T97AT+VIA=F%S8W)I

@0V]M;65N


T0Q(')O=W-P86X]
T0Q/CQS


2P@
M

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S



]




M92!A;F0@9FEX='5R97

]
M
T1N=6UP/C$P+#



BPS

M-C

M;7`^
BPP
S8L



]
T1N=6UP/C$L-S4Y+#(T



]
T1N=6UP
M/B0@-38X+#


#1E9&9?
#$R9E\T

M965A9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T961F
M7S`Q
F9?-#`W-E\X-&





^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\


M


#$T/&)R

]
T1R93X-


T1T;W`^1&5P





3)F7S0P-S9?.#1C
E\W-#)A
M
39E96%D




^#0H@(`@(`\='(^#0H@(`@(`@

]
T1T:#Y-87(N
M(#


S$L(#(P
3




T1T;W`^0F%L86YC93PO=&0^



]


]


]

30U+#@P
#QS

]



3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
#8-



M87-C:6DB
M#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$






T0Q(')O=W-P86X]

M3$P@04Y$($E.5$%.1TE3$4@05-31513(A$971A:6QS(#$I(A54T0@)D\


]

#$S/&)R/CPO=&@^









U+#DT-SQS


T1T;W`^4FEG:'1S/]T9#X-B`@


M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@




]


]

]

M+#`P

]


]







3`L
#DV+#DT







]


]

]



M970@*$5X8VQU9&EN9R!';V]D=VEL;D\+W1D/@T*(`@(`@(`\=&0@8VQA

]







3)F7S0P-S9?.#1C
E\W-#)A
39E96%D

M/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N=U4





2P@
C`Q

M
#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$




]
T1R:#X-

M86QI9VX]








#QS

]


]



]





]
T1T97AT



]
M














]

]
T1T





]



]



]


]



M9E\P
3)F7S0P-S9?.#1C
E\W-#)A
39E96%D



M87-C:6DB#0H-CQH=&UL/@T*(`\



M4F5M;W9E(%1H:7


M
T0Q(')O=W-P86X]










]


]
T1N=6UP/C8S




]


]
T1N=6UP/C8Q



M(`@(#PO='(^#0H@(`@/]T86)L93X-B`@/]B;V1Y/@T*/]H=&UL/@T*

F9?-#`W-E\X-&

M






]



12!!4U-%5%
@*$1E=&%I;'
@

CXQ
B!-;VYT:'
@16YD960\+W1H

M/3-$=&@^36%R+B`S
2P@

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*



]



]

]


C8L.#8Y



]
T1N=6UP/B0@-S








]


#$T/&)R/E531`H)D\8G(^/]T:#X-B`@
M(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@

]
T1T:#Y-87(N
M(#




]




]
T1N=6UP/B0@

M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T


O4VAE970U
RYH=&UL#0I#;VYT96YT





M;R!.;W0@4F5M;W9E(%1H:7

M;'-P86X]
T0Q(')O=W-P86X]

@4$%904)
12!!


CY-
M87(N(#

M(&-O;'-P86X]

S$L(#(P
3



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@



M)`W+#4W-PX


M
CDX+#


T1T;W`^1F]R96EG





]

M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@



]












T1T;W`^3F]T97

M86)L92!A;F0@8W)E9&ET(&9A8VEL:71Y/]T9#X-B`@(`@(`@/'1D(&-L






]

]

:6YE($ET96US

]
T1F;CX\+W1D

M9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^

]


M+#4P
2PS



]


]

M(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S








]
T1N=6UP/C(L
#$U+#`P


BPT.38L
#`P/'-P86X^


]
T1R





T1T;W`^3F]T97

M8W)E9&ET(&9A8VEL:71Y/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M



]



]


]



]


]
T1N=6UP/B0@
M



M=7

&%C.S
P
BPW
30@;W(@


M9&ET(&9A8VEL:71Y+B!4:&5S92!F86-I;&ET:65S(&%R92!P87EA8FQE(&]N




L(&]R(0R,PR

Q
M+`R,#$T(&5X8VAA;F=E(')A=&4I+!A;F0@)B-X
C!A8SLV.2PW-C$L(&]R




@17AP;W)T
M(A97)M=61A*2!





#$T(&%N9`R,#$S+`D
C$Q+#4X




M
T1T;W`^26X@075G=7-T(#(P
3$L('1H92!#;VUP86YY(&%N9!#0BU54T$@
M96YT97)E9!I;G1O('1H92!+96QT:6
@1F%C:6QI='D@*.*`G$ME;'1I8R!&


B*2P@



#`L


#`L





@
M;V8@=&AE($5251$02!C;W9E;F%N=!C;VYT86EN960@:6X@=&AE(&QO86X@


M97






'!I
M<F5S(&]N($1E8V5M8F5R(#,Q+`R



M;&]A;B!A9W)E96UE;G0I+B!4:&4@2V5L=&EC($9A8VEL:71Y(&EN=&5R97-T
M(')A=&4@:7


@
RXR-24L
M(AB*2!T:&4@3$E3U(@4F%T92!P;'5S(#4N-S4E(&%N9`H8RD@-BXU,4N

2P@





PP,#`@8V]M;6ET;65N=!F964@:6X@8V]N;F5C

M:6YG(&%N9!C;VUM:71M96YT(&9E92!I;B!C;VYN96-T:6]N('=I=&@@=&AE
M('-E8V]N9!A;65N9&UE;G0@86YD(&$@)#(U+#`P
!C;&]S:6YG(&%N9!C
M;VUM:71M96YT(&9E92!I;B!C;VYN96-T:6]N('=I=&@@=&AE('1H:7)D(&%M

2PP


M9F%U;'0I+B!4:&4@;&]A;B!A9W)E96UE;G0@8V]N=&%I;G





M;&EE;G


S$L(#(P


C`Q
RP@)#$L.34S+#`S-R!A;F0@)#8L-3`Q+#
R
2P@



T1T;W`^26X@36%R8V@@
C`Q
RP@=&AE($-O

;V%N
M(BD@=&AA=!W87,@=7-E9!T;R!P=7)C:&%S92!B;W5R8F]N(&EN=F5N=&]R

@=&5R;7

#$V+B!4:&4@0F]U



24)/4B!2871E('!L
M=7

2!I;B!A<G)E87)S+!O







M:7!A=&EO;B!A9W)E96UE;G0@*'1H92`B4&%R=&EC:7!A=&EO;B!!9W)E96UE





@:6X@=&AE($)O=7)B;VX@5&5R
M;2!

#`L




M968@17AE8W5T:79E($]F9FEC97(@*&%M;W5N='







M92!












M;W1A;&5D(0R+#`Q-2PP,#`@86YD(0R+#0Y-BPP
#`@870@36%R8V@@
S$L
M(#(P
30@86YD(#(P
3

T1T;W`^6S5=/]T9#X-B`@(`@(`@/'1D(&-O;'-P
M86X]

C`Q
RP@=&AE($-O;7!A
M;GD@96YT97)E9!I;G1O(&$@3&]A;B!!9W)E96UE;G0@*'1H92`B2G5N:6]R
M($QO86X@06=R965M96YT(BDL(&)Y(&%N9!B971W965N('1H92!#;VUP86YY


#$U+B!4:&4@2G5N:6]R($QO









#`P
M*2X@26X@8V]N;F5C=&EO;B!W:71H('1H92!*=6YI;W(@3&]A;B!!9W)E96UE


#$T+`D,2PR-3`L,#`P(&]F('!R:6YC:7!A;!D=64@;VX@



T1T;W`^6S9=
M/]T9#X-B`@(`@(`@/'1D(&-O;'-P86X]

M;B!/8W1O8F5R(#(P
3
L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(#4E

BPQ
C4L
M

#$S('5N=&EL('1H96ER(&UA='5R:71Y(&1A=&4@;V8@1&5C96UB97(@
M
34L(#(P








@;V8@=&AE($-O;7!A;GDL(&EN8VQU9&EN9R!A;B!A

#`I+!A;B!A9F9I;&EA=&4@;V8@
M4FEC:&%R9!*+B!
86UP96X@*0U,PP


@4V-H;VQL(@D,3`P+#`P,DL(&$@9&ER96-T;W(@
M;V8@=&AE($-O;7!A;GDL(&%N9!696-T;W(@1W)O=7`@3'1D+B`H)#(P,PP
M

86UP96X@:7
@86X@97AE8W5T:79E(&]F











@
C4P)2!O9B!T:&4@=&AE;BUC=7)R96YT($-O


M=&EB;&4@3F]T97


@=&AE;BUC
M=7)R96YT(&YO=&4@:&]L9&EN9W


C`Q
R`H87









]

M*$1E=&%I;'
@

]
T1T:#Y-87(N(#
Q+`R,#$T/&)R/CPO=&@^#0H@(`@

S$L(#(P
3
\8G(^/]T:#X-B`@


@96YD:6YG


]
M


M:6=N/3-$=&]P/C(P

M86QI9VX]
T1T;W`^


T1T;W`^



T1T;W`^


]

M=F%L:6=N/3-$=&]P/C(P


]






;V-A=&EO;CH@

3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
M



]




T0Q

T0R/C$R($UO

M

T0Q/C$R

M86X]

M1'1H(&-O;'-P86X]
T0Q

3XQ
B!-;VYT:'


3XQ
B!-;VYT:'
@16YD960\+W1H/@T*


3XQ
B!-;VYT:'
@16YD

M(&-L87-S/3-$=&@^36%R+B`S
2P@

S$L(#(P
30\8G(^1552


&%C.RD\
M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q

#$S/&)R/D=#4!.;W1E(%M-96UB97)=/&)R/E531`H)D\8G(^/]T





S$L(#(P


M
S$L(#(P

]
T1T:#Y-87(N(#
Q
M+`R,#$T/&)R/D)O=7)B;VX@5&5R;2!,;V%N(%M-96UB97)=/&)R/E531`H



#$T/&)R/DUA

S$L(#(P
30\8G(^4FEC:&%R

#$T/&)R/D=L96YN($AA


]
T1T:#Y-87(N(#







S$L(#(P
30\8G(^36%R:R!%($%N9')E=W
@26EI(%M-96UB

;V%N(%M-96UB97)=/&)R/E531`H)D\8G(^/]T
M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@



#$T/&)R/E-E


]
T1T
M:#Y-87(N(#





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]





]





]







]




]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





M



]





]





]





]





]








]


C$Q+#4X


]





]
T1N=6UP/C4P+#`P


]
T1N=6UP/C(P



]




]
T1T



M86QI9VX]





]






]
T1N=6UP/C
P
BPW
M



]
M




]







]




]


M=&4@:7


@

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


@=&AE(&=R96%T97-T(&]F
M(AA*2!T:&4@4')I;64@4F%T92!P;'5S(#0N,C4E+`H8BD@=&AE($Q)0D]2




]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M


M8V]N=&EN=6%N8V4@;V8@86YY(8C,S0[1&5F875L=8C
S0[(&]R(8C,S0[
M179E;G0@;V8@1&5F875L=8C


@













]
T1T97AT




M06UO=6YT/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]








]



]



]



]


C4L
#`P/'-P


]


2PS

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]



]



]




]





]





]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T



]


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



M:&4@;V-C=7)R96YC92!O9B!A;F0@9'5R:6YG('1H92!C;VYT:6YU86YC92!O


]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



T1T

]
T1N=6UP/C$T+#8Y


]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]



]



]




]





]

2XW

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]






]





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]




]


BPP
34L


]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T


#`L


C`P+#`P


]
T1N=6UP/C4P+#`P


]
T1N=6UP/C4P+#`P
#QS

]
T1N=6UP


M86QI9VX]
T1T;W`^0V]M;6ET;65N=!&964@4&%Y86)L93PO=&0^#0H@(`@





]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]




]
M




]



]



]




]




]



]



M
BPQ
C4L



]



]
T1N=6UP/C$L
C4P+#`P




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]


]



]
M




]




]





]



]



]



]





]







]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





]



]






]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1N
M=6UP/C0L
#`P+#`P


]


]
M




]





]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P





]




]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T



]
T1T




]





]





]





]



]



]
T1P;!V86QI9VX],T1T;W`^1&5B=!)


]
T1T

M=&5X=#XG



]





]





]



]



]






]






]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M





]



]
T1T97AT



]
M




]



]



]


]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




3)F7S0P-S9?.#1C
E\W-#)A
39E96%D





]


T0Q/C$@36]N=&AS($5N9&5D/]T:#X-B`@

3`@36]N=&AS($5N

M
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@@

^
2!-;VYT:'

2P@
M



]
T1T:#Y-87(N(#

C`Q



#$Q/&)R

]



]
T1T
M:#Y-87(N(#


S`L(#(P
M


3$@6TUE;6)E








]





]




]

M9!2871E+!097)C96YT86=E/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$



]





]








]





]



]




]



]


M(#`N







]










]




]
M




]


]
M




]


]



]





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^








]




]

]
M





M)#4P+#`P




M(&=R;W-S('!R;V-E961S(')E8V5I=F5D(&)Y('1H92!#;VUP86YY('5N9&5R




]




]




\+W1D



]




]
T1T97AT



]

]


]


3@T+#
T
3QS

]
T1T97AT




]


]
T1T97AT



]
M



]



M(&]F(%!R:79A=&4@4&QA8V5M96YT/]T9#X-B`@(`@(`@/'1D(&-L87-S



]



]

34U+#`P



]

]




]
T1T




]




]



]




]




]
T1T




M92`U

]


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT




M92!397)I97

2`S,!C;VYS96-U=&EV92!T<F%D:6YG


]




T1T;W`^0V]N


]



]

C4L-S8P+#@X



T1T;W`^4VAA


]
M




]


F9?-#`W-E\X-&

F$Q


]
M



M1#(^

S$L(#(P
30\8G(^
M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q
SQB

]

]






]
T1R93X-B`@(`@

]
T1N

M87-S/3-$;G5M/B@S
2XU



]
M




]


M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q


2XS





T1T;W`^4W1A=&4@86YD(&QO8V%L('1A






;V-A

3)F7S0P-S9?.#1C
E\W-#)A
M
39E96%D



]
T13:&]W+FIS/B\J($1O($YO



S$L(#(P
30\8G(^/]T
M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q



]




]

]
T1N=6UP/C4L



]
T1N=6UP/C(X

]
M


BPQ
C4L



M:6YT86YG:6)L97


]
T1N=6UP/C

M-BPP


2PV
C
L





]
T1N=6UP/C$L.34W+#`P



]
T1P;!V86QI9VX],T1T;W`^3W1H97(\+W1D/@T*(`@(`@(`\=&0@

]
T1N=6UP/C(L

BPP


]
T1N=6UP/C
Y+#


M(`@/'1D(&-L87-S/3-$;G5M/B@S.PY
C$L



T1T;W`^


L



]
T1P



M=&EO;B!O9B!S=6)S:61I87)Y/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$
M;G5M/B@V




M(&EN8V]M92!T87@@;&EA8FEL:71Y/]T9#X-B`@(`@(`@/'1D(&-L87-S
M/3-$;G5M/B0@*#$L-3$X+#


F9?-#`W
M-E\X-&







]

T1)1#!%
DY!13X-B`@(`@(#QT


]
T1T:#Y-87(N(#

S$L(#(P
3


M;64@5&%X97


T1T;W`^1&5F97)R960@5&%X($QI86)I;&ET:65S




]



]
T1R;SX-B`@(`@



3@L



]
T1N=6UP/C$L.#0V+#`P
#QS

]

L
S



]



]



]



]
T1R;SX-

]

#



]


M9VX]





T1T;W`^26YC;VUE




M
#1E9&9?
#$R9E\T

O
M4VAE970V




M(&-O;'-P86X]




]




]


2PQ
M-S0L


]




M-C






]

]
T1N=6UP/C@L
3(P





]
T1R93X-


M;7`^

]





C`L-S8U




]



T1T;W`^5V5I


]
M





M+C



]
T1N=6UP/B0@-2XW.3QS

]






]


]
T1N=6UP/B0@


]
T1N=6UP/B0@


#1E9&9?
#$R9E\T

M83$V965A9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V5E-S`T
M961F7S`Q
F9?-#`W-E\X-&



M(G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@:'1T


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@


]

]
T1T:#Y-87(N(#
Q





T1T;W`^3W!T:6]N


2PQ-S0L


]


]

]



]

]




]




]



]




]
T1N=6UP/C8R
2PU
#`\

M/D]P=&EO;G
L($5X97)C:7-A8FQE+!796EG:'1E9!!=F5R86=E($5X97)C

M

M=&]P/D%G9W)E9V%T92!);G1R:6YS:6

]


]


]




]


]
T1R93X-

@
M-2!M;VYT:'


]


]

]
T1N=6UP/B0@


T1T;W`^








]



\


]




M86QI9VX]



T1T;W`^




M;W5R(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG



:6YE($ET96US73PO


T1T;W`^3W!T


2PP




]
T1R;SX-

M1&YU;7`^
C$L












]





\+W1D




M87)S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG

M
2!M;VYT:'
@

]
M

]
T1R

]
M


]


L($QO=V5R

#$\



@
M4VEX(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG



:6YE($ET96US73PO


T1T;W`^3W!T




]





L($5X97)C:7-A8FQE+!7
M96EG:'1E9!!=F5R86=E($5X97)C:7-E(%!R:6-E/]T9#X-B`@(`@(`@



@

]
T1R



]


]

]










]






]

]


;V-A=&EO;CH@

3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
M



]



M*$1E=&%I;'
@

]


]
T1T:#Y-87(N(#



M(%M


]



M
2PX








]
M
T1N=6T^*#$P+#`P



2PU
3
L-C`X*3QS

]

]
T1N=6UP/C


]


]

]
T1N=6UP
M/B0@

]
M
T1N=6UP/B0@













]
T1N=6UP/B0@

]
T1N=6UP/B0@

#1E9&9?
#$R9E\T

M7S@T8S)?-S0R83$V965A9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T
Z+V5E-S`T961F7S`Q
F9?-#`W-E\X-&

F$Q-F5E860P-B]7;W)K


M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES

$5634%%/@T*(`@(`@/'1R


M/3-$



CXQ
B!-;VYT
M:'

2P@

#$S/&)R/CPO=&@^#0H@




]

]


M


]

]
T1N=6UP/C`N



]








M



]

]


]
T1R

]





:6YE($ET96US73PO

]




]


@
M
R!M;VYT:'




]

M-S8N




]
T1T





T1T;W`^5V%R


]
M



]

]
T1N=6UP/B0@

]
T1N=6UP/B0@
M


M


M:69E(&EN('EE87)S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG
M


@
R!M;VYT:'




]


]

]
T1N=6UP/C`N
#`E

M

M7V5E-S`T961F7S`Q
F9?-#`W-E\X-&

F$Q-F5E860P-@T*0V]N=&5N





]

T1)

CXQ
B!-;VYT:'

M
2P@

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L


M9VX]

]
T1T97AT




2PY

3


]

]



M


]


]

RPR





2PY
#0L







]




]
T1N=6UP/B0@-BXU



]

M97)C:7-A8FQE(&%T(&5N9!O9B!P97)I;V0\+W1D/@T*(`@(`@(`\=&0@

]
T1N=6UP/B0@


3)F7S0P-S9?.#1C
E\W
M-#)A
39E96%D





]

]

M;'-P86X]


S$L(#(P
3$\8G(^/]T:#X-B`@(`@(`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S


]
T1T:#Y-87(N(#

S$L(#(P
3
\8G(^/]T:#X-B`@(`@
M(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@


M=&@^36%R+B`S
2P@
C`Q

M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q

S$L
M(#(P
3

]
T1T:#Y-87(N
M(#


M
S$L(#(P


S$L(#(P
M
#
\8G(^4W1O8VL@26YC96YT:79E(%!L86X@
C`P


#$T/&)R
M/E-T;V-K($EN8V5N=&EV92!0;&%N(#(P
#

2P@
C`P

M:R!);F-E;G1I=F4@4&QA;B`R
#`S(%M-96UB97)=/&)R/DUI;FEM=6T@6TUE

M
2P@
C`P

#`S(%M-96UB97)=

M87-S/3-$=&@^2F%N+B`S
2P@

M;B`R

2P@

#$S




]
T1T97AT



]
M




]


]
M




]





]


]


BPP
M
#`L


]

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT




]



]
M




]




]


]


]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1T



]







]
M
T1N=6UP/B0@
C


]



T1T;W`^16UP;&]Y964@4V5R=FEC92!3

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
M




]





]





]





T1T;W`^16UP;&]Y964@4V5R=FEC92!3:&%R



]



]



]





]






]



]



]

]



]





]





]



]




]




]
T1T



]

]
M
T1N=6UP/C4L


]




]






]
M




]
T1N=6UP/B0@

]





M;&4@4&5R:6]D/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT




]


]




]





]







]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M







]
T1T




]



]
T1P


]





]




T1T;W`^5V5I9VAT960@

]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
M




]





]




]
T1T






]



]
T1T97AT



]
M







]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




3)F7S0P-S9?.#1C
E\W-#)A
39E96%D





M62!44D%.4T%#5$E/3E
@*$1E=&%I;'


M/3-$
CXQ
B!-;VYT:'

2P@
C`Q-#QB

#$S



T1T;W`^

:6YE($ET96US

]






]
T1N=6UP/CDV-RPQ



]
T1R



]
M



]


]




]




3`P+#`P

]



M86YS86-T:6]N(%M


]



3(V+#`P
#QS




]








3)F7S0P-S9?
M.#1C
E\W-#)A
39E96%D

T1#;VYT

]
T13:&]W+FIS




]
T1T:#Y-87(N(#



]




T1T;W`^
C`Q-CPO=&0^#0H@(`@(`@

T1T;W`^
C`Q-SPO=&0^#0H@(`@(`@


T1T;W`^5&]T86P\+W1D/@T*(`@(`@

#1E9&9?
#$R9E\T

M8S)?-S0R83$V965A9#`V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z
M+V5E-S`T961F7S`Q
F9?-#`W-E\X-&



M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O

$5'14)'/@T*(`@(`@/'1R/@T*


M




#$T/&)R
M/DYE=R!9;W)K(%M-96UB97)=/&)R/E531`H)D\8G(^/]T:#X-B`@(`@
M(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@


]
M
T1T:#Y-87(N(#


#$T/&)R/DAO=7-T;VXL(%1X(%M-96UB97)=/&)R/E531`H
M)D\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
M

2P@


#$T/&)R/DER:7-H(%=H:7-K97D@


]
T1T:#Y-87(N(#

#$T/&)R/DER:7-H(%=H:7-K97D@6TUE;6)E


]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT


]



]



]
T1N=6UP/B0@
S


]
M


]
M
T1N=6UP/C$L







]




]


S`L#0H)







]




]


]
T1T97AT/DIU
M;B`S
P-@D)

]
T1T97AT/DIU;B`S
P-@D)
C`Q-#QS

]

]
T1T97AT



]
M

]


]



]




]
T1N=6UP/C8V







]



S(U+#`X


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT






]



]



'0O:'1M;#L@


]




T1T;W`^/'-T







S`P+#`P

]
M
T1P;!V86QI9VX],T1T;W`^0W5S=&]M97(@0V]N8V5N=')A=&EO;B!2:7-K
M(%M-96UB97)=('P@4V%L97,@4F5V96YU92P@1V]O9',L($YE=!;365M8F5R

]


M0V]N8V5N=')A=&EO;B!2:7-K(%M


]




]



]
T1P;!V86QI9VX],T1T;W`^0V]N8V5N=')A=&EO;B!2:7-K+!0

M


M87)T7V5E-S`T961F7S`Q
F9?-#`W-E\X-&

F$Q-F5E860P-@T*0V]N





]

M





]

#$T


]



]

]

]
T1N=6UP/B0@-#@L
30P+#0X


M;&5S(%)E=F5N=64@1V]O9'
@4&5R8V5N=&%G92!.970\+W1D/@T*(`@(`@





]
T1T97AT







]
M
T1N=6UP/C$P




]
M

]






;W-S*2!!='1R:6)U=&%B;&4@5&\@0V]M;6]N(%-H87)E:&]L9&5R

]
T1F;CX\+W1D/@T*



]




]
T1F;CX\+W1D/@T*(`@(`@


]


]


]









]
T1F;CX\+W1D/@T*

MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]

\+W1D/@T*





]


M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]



]






T1T;W`^5&]T

]


]

]


34N



]
T1T97AT






M1&YU;7`^













M1&YU;7`^
BXW

]
M


]

M(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S




2PS-#

M/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M

2PU




]
T1N=6UP/C4N.3`E/'-P








T+#DV-SQS

]
T1N=6UP/C

]

]
T1N=6UP

]
T1N=6UP/C@V+CDP)3QS









T1T;W`^








M

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@





]

]
M

;W-S

\+W1D/@T*

M86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@
M(`@/'1D(&-L87-S/3-$;G5M/B@U+#
P
BPY-S


;W-S*2!!='1R:6)U=&%B










T1T;W`^5&]T86P@


]

]
M




]
T1R:#X-B`@(`@



]






T1T





MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]


]

M/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X





]

]




M
RPQ


M=F5N=64@1V]O9'

]


]

]
'0^

]










]

]
T1N=6UP/C(X

]









]




]

]



M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]


]

M87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P




]


]

3@L


]
T1F;CX\+W1D/@T*


]

M;7`^




T1T;W`^5VEN92!;365M8F5R73PO

]


]



]

]


]






]



]



M86QI9VX]




L
SDV+#4V



2XV


]
T1N=6UP/C@N



S`@86YD(0U+#DV-PS-S0@9F]R('1H92!Y

2P@

ET\+W1D


;V-A=&EO;CH@9FEL93HO+R]#

3)F7S0P-S9?.#1C
E\W-#)A
39E96%D
#8O5V]R:W-H


M151!(&AT='`M97%U:78]

]





]


T0Q/C


S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^
M36%R+B`S
2P@
C`Q



M
2P@



#(L(#(P





]






]




]
T1N=6UP/C$L


]

]
T1N=6UP/B0@-PU,S$L-C0S/'-P86X^/]S




Q+#8T









]





]
M
T1N=6UP/C$L-C4W+#@P


]




]
T1N=6UP/C`N



]


]






]

]



T1T;W`^
M4')O8V5E9'




]
T1N=6UP/B0@-C(Y+#DV-3QS

M871I;VXZ(&9I;&4Z+R\O0SHO964W
#1E9&9?
#$R9E\T






M8V4B/@T*(#QO.DUA:6Y&:6QE($A2968]
T0B+BXO5V]R:V)O;VLN:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`Q+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970P,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#,N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`T+FAT;6PB
M+SX-B`\;SI&:6QE($A2968]
T0B4VAE970P-2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T
#8N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#`W+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970P.YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
#DN:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#$P+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B
M4VAE970Q,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3(N:'1M
M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$S+FAT;6PB+SX-B`\;SI&
M:6QE($A2968]
T0B4VAE970Q-YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,34N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$V+FAT
M;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970Q-RYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T
3@N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS
M1)3:&5E=#$Y+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970R,YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C$N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#(R+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M,T0B4VAE970R,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C0N
M:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(U+FAT;6PB+SX-B`\
M;SI&:6QE($A2968]
T0B4VAE970R-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T

M+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970R.2YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,S`N:'1M;(O/@T*(#QO.D9I;&4@2%)E
M9CTS1)3:&5E=#,Q+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970S
M
BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
S
N:'1M;(O/@T*
M(#QO.D9I;&4@2%)E9CTS1)3:&5E=#
T+FAT;6PB+SX-B`\;SI&:6QE($A2
M968],T0B4VAE970S-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,S8N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#,W+FAT;6PB+SX-
MB`\;SI&:6QE($A2968]
T0B4VAE970S.YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,SDN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E
M=#0P+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970T
2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#(N:'1M;(O/@T*(#QO.D9I;&4@
M2%)E9CTS1)3:&5E=#0S+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE
M970T-YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#4N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#0V+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970T-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T-#@N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#0Y+FAT;6PB
M+SX-B`\;SI&:6QE($A2968]
T0B4VAE970U
YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T-3$N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#4R+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970U
RYH=&UL

M:6QE($A2968]
T0B4VAE970U.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T-C`N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#8Q+FAT
M;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970V,BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T-C,N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS
M1)3:&5E=#8T+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970V-2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-C8N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#8W+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M,T0B4VAE970V.YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-CDN

 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueFromRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentToAcquireFinishedGoods'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueFromRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_InterestOnCapitalContribution'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EquityMethodInvestmentWriteOffOnDiscontinuationOfOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; The consolidated financial statements include the accounts of Castle Brands Inc.(the &#8220;Company&#8221;), its wholly-owned domestic subsidiaries, Castle Brands (USA) Corp. (&#8220;CB-USA&#8221;) and McLain &amp; Kyne, Ltd. (&#8220;McLain &amp; Kyne&#8221;), the Company&#8217;s wholly-owned foreign subsidiaries, Castle Brands Spirits Group Limited (&#8220;CB-IRL&#8221;) and Castle Brands Spirits Marketing and Sales Company Limited, and the Company&#8217;s <font style=FONT-FAMILY: 'Times New Roman'
 % ownership interest in Gosling-Castle Partners, Inc. (&#8220;GCP&#8221;), with adjustments for income or loss allocated based upon percentage of ownership. The accounts of the subsidiaries have been included as of the date of acquisition. All significant intercompany transactions and balances have been eliminated.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NatureOfOperations'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; The Company is principally engaged in the importation, marketing and sale of premium and super premium brands of rums, whiskey, liqueurs, vodka and tequila in the United States, Canada, Europe and Asia.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_BrandsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentsPolicy'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenueRecognitionPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; Inventories are comprised of distilled spirits, bulk wine, dry good raw materials (bottles, labels, corks and caps), packaging and finished goods, and are valued at the lower of cost or market, using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company&#8217;s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements. A change to the carrying value of inventories is recorded in cost of goods sold. See Note 3.<font style=FONT-FAMILY: 'Times New Roman'
 <font style=FONT-FAMILY: 'Times New Roman'
During the years ended March 31, 2014 and 2013, the Company recorded allowances for obsolete and slow moving inventory of $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; Equipment consists of office equipment, computers and software and furniture and fixtures. When assets are retired or otherwise disposed of, the cost and related depreciation is removed from the accounts, and any resulting gain or loss is recognized in the statement of operations. Equipment is depreciated using the <font style=FONT-FAMILY: 'Times New Roman'
 over the estimated useful lives of the assets ranging from <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
&#160;<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
The fair value of each reporting unit was determined at March 31, 2014 and 2013 by weighting a combination of the present value of the Company&#8217;s discounted anticipated future operating cash flows and values based on market multiples of revenue and earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) of comparable companies. Other than the write-downs of intangible and goodwill related to the wine brands discussed in Note 7, the Company did not record any impairment on goodwill or other intangible assets for the years ended March 31, 2014 and 2013.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

, consisting of $<font style=FONT-FAMILY: 'Times New Roman'
 on the write-down of net intangible assets and $<font style=FONT-FAMILY: 'Times New Roman'
 in goodwill, as well as $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; The Company reflects as inventory costs freight-in and related external handling charges relating to the purchase of raw materials and finished goods. These costs are charged to cost of sales at the time the underlying product is sold. The Company also incurs shipping costs in connection with its various marketing activities, including the shipment of point of sale materials to the Company&#8217;s regional sales managers and customers, and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ExciseTaxesAndDutyPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DistributorChargesAndPromotionalGoodsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; ASC 825, &#8220;Financial Instruments&#8221;, defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company&#8217;s balance sheets due to the short term maturity of these instruments, or with respect to the Company&#8217;s debt, as compared to the current borrowing rates available to the Company.<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
&#160;<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 <font style=FONT-FAMILY: 'Times New Roman'
The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument&#8217;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of the valuation hierarchy are as follows:<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 1.1in; FONT: 10pt Times New Roman
 Times
Level 3 &#151; inputs to the valuation methodology are unobservable and significant to the fair value measurement.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdvertisingCostsPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; Advertising costs are expensed when the advertising first appears in its respective medium. Advertising expense, which is included in selling expense, was $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UseOfEstimates'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
&#160;<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_UncertaintiesPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; The Company depends on a limited number of third-party suppliers for the sourcing of all of its products, including both its own proprietary brands and those it distributes for others. The Company does not have long-term written agreements with all of its suppliers. Also, if the Company fails to complete purchases of products ordered annually, certain suppliers have the right to bill it for product not purchased during the period. Suppliers&#8217; failure to perform satisfactorily or handle increased orders, delays in shipments of products from international suppliers or the loss of existing suppliers, especially key suppliers, could have material adverse effects on the Company&#8217;s operating results. The inability to maintain, renew on acceptable terms or find suitable alternatives to the Company&#8217;s contracts with suppliers could have a material adverse effect on its operating results.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <table style=MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
On March 13, 2014, the Emerging Issues Task Force (the &#8220;Task Force&#8221;) reached a final consensus to amend the accounting guidance for stock compensation tied to performance targets (Issue No. 13-D). The objective of this guidance is to clarify the accounting treatment of certain types of performance conditions in stock-based compensation awards, more specifically, when performance targets can be achieved after the requisite service period. The Task Force concluded that performance criteria subsequent to a service period vesting requirement should be treated as vesting conditions, and as a result, this type of performance condition may delay expense recognition until achievement of the performance target is probable. Issue No. 13-D will be effective for all entities for reporting periods (including interim periods) beginning after December 15, 2015, and early adoption is permitted. The adoption of this guidance is not expected have a material impact on the Company&#8217;s results of operations, cash flows or financial condition.<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AccountingStandardsAdoptedPolicyPolicyTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 &#151; Certain prior year balances have been reclassified to conform to the current year presentation.<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfStockLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockDividendRatePercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPreferredStockStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConversionOfStockSharesConverted1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockDividendRatePerDollarAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_CompensationPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntercompanyAgreementsDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsOfStockIssuanceCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_SharesIssuedDuringPeriodValuePrivatePlacement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PreferredStockConvertibleInToCommonStockOnConversionBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsToPurchaseCommonStockIssuableDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertiblePreferredStockConvertibleTermsOfConversionFeature'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConversionOfStockSharesIssued1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentsUnderContingentConsiderationAgreements'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProvisionForDoubtfulAccounts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AmortizationOfFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NetChangeInFairValueOfWarrantLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ReversalOfProvisionForObsoleteInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInDueFromAffiliatesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInInventories'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_IncreaseDecreasePrepaidExpensesAndOtherCurrentAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquireIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInRestrictedCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentsUnderContingentConsiderationAgreements'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentForTermLoan'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProceedsFromOtherNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProceedsFromConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromLinesOfCredit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsOfStockIssuanceCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromWarrantExercises'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SupplementalCashFlowInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConversionOfStockAmountIssued1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_IssuanceOfWarrantLiabilityInConnectionWithConvertiblePreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxesPaidNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfGoodwillTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AccumulatedAmortizationTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsOfStockIssuanceCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NumberOfWarrantsForfeited'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NumberOfSecuritiesCalledByWarrantsForForfeiture'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConversionOfWarrantsSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromWarrantExercises'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueFromRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LinesOfCreditCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueToRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesNoncurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermLineOfCredit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_TermLoan'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherLongTermNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertibleLongTermNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdditionalPaidInCapitalCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MinorityInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesAndStockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EquipmentAndSoftwareGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FurnitureAndFixturesGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ComprehensiveIncomeNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProvisionForIncomeTaxesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredIncomeTaxExpenseBenefitPeriodOfRecognition'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProvisionForIncomeTaxesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_OperatingLossCarryforwardsExpirationPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ProvisionForIncomeTaxesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsLiabilitiesTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsOutstandingAndExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsGrantedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsExercisedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsForfeitedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsOutstandingAndExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantOutstandingAndExercisable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantGranted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantForfeited'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantOutstandingAndExercisable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 As established, there were 2,000,000 shares of common stock reserved and available for distribution under the Plan. In January&#160;2009, the Company&#8217;s shareholders approved an amendment to the Plan to increase the number of shares available under the Plan from <font style=FONT-FAMILY: 'Times New Roman'
 to <font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 In October 2012, the Company&#8217;s shareholders approved the 2013 Incentive Compensation Plan (&#8220;2013 plan&#8221;) which provides for awards of incentive and non-qualified stock options, restricted stock and stock appreciation rights for its officers, employees, consultants and directors to attract and retain such individuals. As of March 31, 2014, <font style=FONT-FAMILY: 'Times New Roman'
&#160;shares&#160;had been issued under the 2013 Plan, with <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, of which $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, is included in selling expense and $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, is included in general and administrative expense for the years ended March 31, 2014 and 2013, respectively. At March 31, 2014, total unrecognized compensation cost amounted to approximately $<font style=FONT-FAMILY: 'Times New Roman'
, representing <font style=FONT-FAMILY: 'Times New Roman'
 unvested options. This cost is expected to be recognized over a weighted-average period of <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times

 per share, subject to adjustment, and&#160;were exercisable for a period of <font style=FONT-FAMILY: 'Times New Roman'
.&#160;&#160;<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times

 Times

 and accounted for the 2011 Warrants issued in October 2011 as a liability&#160;at their initial fair value of $<font style=FONT-FAMILY: 'Times New Roman'
 <font style=FONT-FAMILY:Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times

. For the year ended March 31, 2014 the Company recorded a loss&#160;on the change in the value of the 2011 Warrants of $<font style=FONT-FAMILY: 'Times New Roman'
; for the year ended March 31, 2013, the Company recorded a gain for the change in the value of the 2011 Warrants of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 &#150; In the year ended March 31, 2014, holders of 2011 Warrants exercised 10,127,123 2011 Warrants and received shares of common stock. The Company received $<font style=FONT-FAMILY: 'Times New Roman'
 in cash upon the exercise of these warrants. These exercised warrants had a weighted average fair market value of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0in 0in 0.4in; FONT: 10pt Times New Roman
 Times
For the year ended March 31, 2014, 1,543,214 warrant shares expired unexercised with a weighted average fair market value of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0in 0in 0.4in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 27pt; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

% of that amount, subject to certain annual adjustments. For the contract year ending <font style=FONT-FAMILY: 'Times New Roman'
, the Company has contracted to purchase approximately &#8364;<font style=FONT-FAMILY: 'Times New Roman'
 or $<font style=FONT-FAMILY: 'Times New Roman'
&#160;(translated at the March 31, 2014 exchange rate) in bulk Irish whiskey, of which &#8364;<font style=FONT-FAMILY: 'Times New Roman'
,&#160;or $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

% of that amount, subject to certain annual adjustments. For the contract year ending <font style=FONT-FAMILY: 'Times New Roman'
, the Company has contracted to purchase approximately &#8364;<font style=FONT-FAMILY: 'Times New Roman'
 or $<font style=FONT-FAMILY: 'Times New Roman'
&#160;(translated at the March 31, 2014 exchange rate) in bulk Irish whiskey, of which &#8364;<font style=FONT-FAMILY: 'Times New Roman'
, or&#160;$<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 and provides for monthly payments of $<font style=FONT-FAMILY: 'Times New Roman'
. The Dublin lease commenced on March 1, 2009 and extends through <font style=FONT-FAMILY: 'Times New Roman'
 and provides for monthly payments of&#160;&#8364;<font style=FONT-FAMILY: 'Times New Roman'
 or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate). The Houston, TX lease commenced on February 24, 2000 and extends through <font style=FONT-FAMILY: 'Times New Roman'
 and provides for monthly payments of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.4in; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertiblePreferredStockAccruedDividends'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertiblePreferredStockAccruedDividendsShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PreferredStockDividendAccrued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertiblePreferredStockAccruedDividends'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertiblePreferredStockAccruedDividendsShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_StockIssuedDuringPeriodValueStockSeriesPreferredStockWarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_StockIssuedDuringPeriodSharesStockSeriesPreferredStockWarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PreferredStockDividendAccrued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilityIntoEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryAdjustments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_TermLoanRelatedPartyParticipation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ConvertibleNotesPayableRelatedPartiesClassifiedNonCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TemporaryEquityLiquidationPreference'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_RestrictedCashDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_RestrictedCashDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate) and&#160;&#8364;<font style=FONT-FAMILY: 'Times New Roman'
 or $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentInformationLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityRegistrantName'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCentralIndexKey'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_CurrentFiscalYearEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityFilerCategory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_TradingSymbol'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentType'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_AmendmentFlag'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentPeriodEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalPeriodFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalYearFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityWellKnownSeasonedIssuer'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityVoluntaryFilers'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCurrentReportingStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityPublicFloat'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate) with an Irish bank, including overdraft coverage, creditors&#8217; insurance, customs and excise guaranty, and a revolving credit facility. These facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender&#8217;s AA1 Rate minus <font style=FONT-FAMILY: 'Times New Roman'
 %. The balance on the credit facilities included in notes payable totaled &#8364;<font style=FONT-FAMILY: 'Times New Roman'
, or $<font style=FONT-FAMILY: 'Times New Roman'
 (translated at the March 31, 2014 exchange rate), and &#8364;<font style=FONT-FAMILY: 'Times New Roman'
, or $<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of <font style=FONT-FAMILY: 'Times New Roman'
%, to be accrued and paid at maturity. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'

 of accrued interest was converted to amounts due to affiliates. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'

<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 for the purpose of providing the Company and CB-USA with working capital. In July 2012, the Keltic Facility was amended to increase availability to $<font style=FONT-FAMILY: 'Times New Roman'
, among other changes. In March 2013, the Keltic Facility was amended to increase availability to $<font style=FONT-FAMILY: 'Times New Roman'
, among other changes. In August 2013, the Keltic Facility was amended to modify the borrowing base calculation and covenants with respect to the Keltic Facility and permit the Company to make regularly scheduled payments of principal and interest and voluntary prepayments on the Junior Loan (as defined below), subject to certain conditions set forth in the amendment, to modify&#160;certain aspects of the EBITDA covenant contained in the loan agreement, permit the Company to incur indebtedness in an aggregate original principal amount of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

. For the year ended March 31, 2014, the Company paid interest at <font style=FONT-FAMILY: 'Times New Roman'
%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any Default or Event of Default (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is <font style=FONT-FAMILY: 'Times New Roman'
% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. The Company paid a $<font style=FONT-FAMILY: 'Times New Roman'
 commitment fee in connection with the first amendment,&#160;a $<font style=FONT-FAMILY: 'Times New Roman'
 closing and commitment fee in connection with the second amendment&#160;and a $<font style=FONT-FAMILY: 'Times New Roman'
 closing and commitment fee in connection with the third amendment. Keltic also receives an <font style=FONT-FAMILY: 'Times New Roman'
. The loan agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The loan agreement includes negative covenants that, among other things, restrict the Borrower&#8217;s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. At March 31, 2014, the Company was in compliance, in all material respects, with the covenants under the Keltic Facility. At March 31, 2014 and 2013, $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 (the Bourbon Term Loan) that was used to purchase&#160;bourbon inventory on March 11, 2013. Unless sooner terminated in accordance with its terms, the Bourbon Term Loan matures on December 31, 2016. <font style=FONT-FAMILY: 'Times New Roman'
. For the year ended March 31, 2014, the Company paid interest of 7.5%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.7in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan, including Frost Gamma Investments Trust ($<font style=FONT-FAMILY: 'Times New Roman'

), an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III ($<font style=FONT-FAMILY: 'Times New Roman'

), a director of the Company and the Company&#8217;s Chairman, and an affiliate of Richard J. Lampen ($<font style=FONT-FAMILY: 'Times New Roman'

), a director of the Company and the Company&#8217;s President and Chief Executive Officer (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement, the junior participants receive interest at the rate of <font style=FONT-FAMILY: 'Times New Roman'
% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However, the Borrower is party to a fee letter (the Fee Letter) with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $<font style=FONT-FAMILY: 'Times New Roman'
 in three equal annual installments of $<font style=FONT-FAMILY: 'Times New Roman'
. In August 2013, the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $<font style=FONT-FAMILY: 'Times New Roman'
 to up to $<font style=FONT-FAMILY: 'Times New Roman'
 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 unsecured loan (the Junior Loan) to the Company. The Junior Loan bears interest at a rate of <font style=FONT-FAMILY: 'Times New Roman'
 % per annum, payable quarterly in arrears commencing November 1, 2013, and matures on October 15, 2015. The Junior Loan may be prepaid in whole or in part at any time without penalty or premium but with payment of accrued interest to the date of prepayment. The Junior Loan Agreement contains customary events of default, which, if uncured, entitle each Junior Lender to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the portion of the Junior Loan made by such Junior Lender. The Junior Loan Agreement provides for a funding fee of <font style=FONT-FAMILY: 'Times New Roman'
% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year), payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders include Frost Gamma Investments Trust ($<font style=FONT-FAMILY: 'Times New Roman'
), Mark E. Andrews, III ($<font style=FONT-FAMILY: 'Times New Roman'
) and an affiliate of Richard J. Lampen ($<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=clear:both;WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

% Convertible Subordinated Note Purchase Agreement (the Note Purchase Agreement), by and among the Company and the purchasers party thereto,&#160;which provided for the issuance of an aggregate initial principal amount of $<font style=FONT-FAMILY: 'Times New Roman'
 unsecured subordinated notes (the Convertible Notes) by the Company. The Convertible Notes bear interest at a rate of <font style=FONT-FAMILY: 'Times New Roman'
% per annum, payable quarterly beginning on December 15, 2013 until their maturity date of December 15, 2018. The Convertible Notes and accrued but unpaid interest thereon are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company&#8217;s common stock at a conversion price of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

), a director of the Company, Dennis Scholl ($<font style=FONT-FAMILY: 'Times New Roman'
), a director of the Company, and Vector Group Ltd. ($<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times

<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 consecutive trading day period exceeds <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.5in; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ReversalOfProvisionForObsoleteInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SellingAndMarketingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GeneralAndAdministrativeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestIncomeExpenseNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_NetChangeInFairValueOfWarrantLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

% and <font style=FONT-FAMILY: 'Times New Roman'
%, respectively, of raw materials and <font style=FONT-FAMILY: 'Times New Roman'
% and <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
For the years ended March 31, 2014 and 2013, the Company purchased goods from Pallini for $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively. As of March 31, 2014 and 2013, Pallini owed the Company $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, for its share of marketing expense, which is included in due from shareholders and affiliates on the consolidated balance sheet. As of March 31, 2014 and 2013, the Company was indebted to Pallini for $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
In November&#160;2008, the Company entered into a management services agreement with Vector Group Ltd., a more than 5% shareholder, under which Vector Group agreed to make available to the Company the services of Richard J. Lampen, Vector Group&#8217;s executive vice president, effective October&#160;11, 2008 to serve as the Company&#8217;s president and chief executive officer and to provide certain other financial and accounting services, including assistance with complying with Section&#160;404 of the Sarbanes-Oxley Act of 2002. In consideration for such services, the Company agreed to pay Vector Group an annual fee of $<font style=FONT-FAMILY: 'Times New Roman'
, plus any direct, out-of-pocket costs, fees and other expenses incurred by Vector Group or Mr.&#160;Lampen in connection with providing such services, and to indemnify Vector Group for any liabilities arising out of the provision of the services. The agreement is terminable by either party upon 30&#160;days&#8217; prior written notice. For the years ended March 31, 2014 and 2013, Vector Group was paid $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<font style=FONT-FAMILY:Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 - In November 2013, the Company entered into an Equity Distribution Agreement (the Distribution Agreement) with Barrington Research Associates, Inc. (Barrington), as sales agent, under which the Company may issue and sell over time and from time to time, to or through Barrington, shares (the Shares) of its common stock&#160;having a gross sales price of up to $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 % of the gross proceeds from the sale of all of the Shares sold through Barrington, as sales agent, pursuant to the Distribution Agreement. <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.27in; FONT: 10pt Times New Roman
 Times

 Shares pursuant to the Distribution Agreement, with total gross proceeds of $<font style=FONT-FAMILY: 'Times New Roman'
, before deducting sales agent and offering expenses of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 &#150; In June 2011 the Company entered&#160;into agreements relating to a private placement (the &#8220;June 2011 Private Placement&#8221;) of&#160;an aggregate of approximately $<font style=FONT-FAMILY: 'Times New Roman'
 of newly-designated <font style=FONT-FAMILY: 'Times New Roman'
% Series A Convertible Preferred Stock, par value $<font style=FONT-FAMILY: 'Times New Roman'
 per share (&#8220;Series A Preferred Stock&#8221;). As part of the June 2011 Private Placement, the Company completed a private offering&#160;to third-party&#160;investors of $<font style=FONT-FAMILY: 'Times New Roman'
 of Series A Preferred Stock for its stated value of $<font style=FONT-FAMILY: 'Times New Roman'
 per share and <font style=FONT-FAMILY: 'Times New Roman'
 Subject to adjustment (including dilutive issuances), the Series A Preferred Stock was convertible into common stock at a conversion price of $<font style=FONT-FAMILY: 'Times New Roman'
 per share and the 2011 Warrants had an exercise price of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 The Company&#8217;s common stock exceeded these thresholds, and on February 11, 2014, the Company&#8217;s Board of Directors approved the mandatory conversion of all outstanding shares of the Series A Preferred Stock pursuant to their terms, effective on or about February 24, 2014.&#160;Pursuant to the mandatory conversion, all <font style=FONT-FAMILY: 'Times New Roman'
 outstanding shares of Series A Preferred Stock, and accrued dividends thereon, converted into <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 &#150; In the current year period prior to the February 11, 2014 mandatory conversion, holders of Series A Preferred Stock converted <font style=FONT-FAMILY: 'Times New Roman'
 shares of Series A Preferred Stock, and accrued dividends thereon, into <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 shares of Series A Preferred Stock, and accrued dividends thereon,&#160;into <font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, in finished goods from DPCP under the distribution agreement. As of&#160;March 31, 2013, DPCP was indebted to CB-USA in the amount of $<font style=FONT-FAMILY: 'Times New Roman'
, which is included in due to shareholders and affiliates on the accompanying condensed consolidated balance sheet. At March 31, 2014, CB-USA owned <font style=FONT-FAMILY: 'Times New Roman'
 % of now inactive&#160;DPCP. CB-USA also earned a defined rate of interest on its capital contribution to DPCP, based on its ownership in DPCP. For the years ended March 31, 2014 and 2013, CB-USA earned $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
, respectively, in interest income on its capital contribution to DPCP. The Company&#160;accounted for this investment under the equity method of accounting. The investment balance was $<font style=FONT-FAMILY: 'Times New Roman'
 at&#160;March 31, 2013. In December 2013, CB-USA determined to cease marketing and selling these brands and returned the remaining inventory to Drink Pie, LLC. In connection with the discontinuation of marketing and sales efforts, the Company recognized a loss of $502,518 from its investment in DPCP, including a $120,900 loss on investment and write offs of $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

, consisting of $<font style=FONT-FAMILY: 'Times New Roman'
 on the write-down of net intangible assets and $898,572 in goodwill, as well as $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_EmployeeServiceNumberOfShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsIssuedAtFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ChangeInUnrealizedGainLossOnFairValueWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantsExercisablePeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WarrantLiabilityOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromWarrantExercises'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantForfeited'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExercisePricePerWarrantExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExecrcisePriceFairMarketValuePerWarantExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_WeightedAverageExecrcisePriceFairMarketValuePerWarantUnexercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWriteDown'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AmortizationOfIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 for U.S. tax purposes, which expire through <font style=FONT-FAMILY: 'Times New Roman'
, and foreign net operating loss carryforwards of approximately $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

, increasing the value of the asset. The deferred tax liability is being reversed over the amortization period of the intangible asset (<font style=FONT-FAMILY: 'Times New Roman'
&#160;years). For each of the years ended March 31, 2014 and 2013, the Company recognized $<font style=FONT-FAMILY: 'Times New Roman'
 and $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 and $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

begin 644 0001144204-14-040167-xbrl.zip
M4$L#!!0````(`$PWD2@PR:P$*$!`*/5&0`0`!P`<F]X+3(P
30P
S
Q+GAM






MI%1]OZWNX^

N7J^9/
]4-^'(J+CAG$\K=
8E71@;'?0@I9E38;&#2&\NF\I;

M

X^]W;4N_[TP52'X.
MZ@]$&/FO_Y`8*RS0J=7U[F(78*(_$Z$``B+@T=`8$0C`0V?`;T5=$B%H(;;
MN(H#RPLJ0'S6PR?.(:F#!@QF.C:;47!X',%L1N7%HVXZ!C4NA35I6I.I8Q-E
MS#O#R(XXR-Y2T5W3`1MS*
SR#F*VU1*QIRC7&`=&.Q#GVJ7B&1MV#(:$?2I

IFTVI`UWK;:?C
O%O1DU6AQ*



MK?75
JR()7)%J'WE2CP3?[]K^U=JVDPO:G-7%1ZE@?VN\Q:?01$M




ZP/A*4JM_SR8FB(%(0=2-2


X_N
JHK
ID0
)2:]:UOZ_6(9I&!4^C1_*^@0NEYJN&DF=B0O<K9/1#$






M^9

M8C.STKOL-H77V)'UA*_=+^9*_!M=][H.:


WR


MLB







Q&
W8TYOX[^<;T-3*Z

:.^


-AK1A$!





MTH*H%1D


MUD
%`T4$93U0










MM?\\#65UYM[KMOYUX;WJ[
W%.-.&H(.29/^F)6+\Y4C[5.
6I\O?;4%M?:Q^


M+'

3+H4\/?6


8_'W4Z'%LL2_7=SUH'[;I7H;ZOI4LZVI+YD1$JSV]T7%/55.H+VX`
3K
MZL@VOC%ON%22+Q]]C7;.$H@+:MU[;?W0+;+**I+K1&$^'F=
FE5S/Z=2%\S]




9E0;


M?82W2P8.FF=\P;I:C@U.HFMZ&U1
'&46E3V
*DP79)C
M2OX'9YL4I46@U



M]][X)YO-P+8
?/F\FM5_-KXR$/1W7(^JO@)=Y#RL5SBBGEL&J]\V`,CKD)Z
M8_C`4CWO`^=X'@!OAS/C+'2CV_2W%:QXZ9H[8!QT)(`?14!W'C)+Z:%3S%M
M'+@61@V

M@)H!:@:8

ZA04.
L4_IV;F!SJQ@+K`^
4-
M\.*BF7IESR?)%+2H$^:AP_9G6/+#\C.SI\&!CQ+TK\4!*5.9BO9KZZHE&\D8


0(&Z
W


M

W(.$YB-#ZF\-%AQC]!5D73`$-MXH)6







M#=+/2:0W9[=CU4UH3^

M%X/*]R)P47L









KX'/I6SO?I8'22
M3/]J'3W[F2=!1+R+03;N5


M62
@K&8EB:152\U@]X_!_G

M
V0B92++?Q6V_(!P


US^

S+(



(7P3D


]!/S.6(A;G[WQ6E*FA0=\



EN#\1*%%-SY







QT
M=_S2M8J*NV0&I/0I+0#^\DEZ_WG^_F/^?EFMEP\

MYSA([!#4)%Y4F'*9%2HD/7X#U2_CJ6M$?S'4O

MW9[D70A@H:A#@$;B
S0.L1(O3U[)'Y&E]54DFY3Z/X!ZANJ.R%%V48U+S7!R
MU9(4*#R`/SA_K=R-D_BVGR:&B\3D2#B;T1'$VC@%8Q@G0/&.!$+N5A7@EP
ML#BSW^B)&2CH

M@Y0?YQID7E]8UMXH0V@T'IG]80?5Q%3C*Z37_*7;&9BCP5ADSF3*)E$TD5HA

M`#;K4

M+OLDC/*:'_Z^BB1+E#68ZA@DD=R)$`66&]/TEF(_Z[2\AV+&O)!(%!GE8*]5

__3[%!/YR*'*'4))O*(!=N6E66E0(H*J
BDQ$=Y,C@(N
M047=H^!Q/A^T-&/D^0D28JB25VH28#O'W+FT!K0\(S^0I-QRUY`L^5%\EB1+
M65IEKJ)EZ<.AI/I,:;GLNX'IFCAQFVYQ#C3YR&M323D-@^'X*UI^7R*`L

M9R;/=_X*[EJQ21UD






)
XD\%TT@O7MNH



M5]B':5\9QG




JHR
#4H0[UL6('#:)*96`

MX2BZ

J/0#RT;?ZT.B#\EX+?$W

M7U


M=[F\+F?5





8(Y:Q::DHS73J`IS:NB9K5
V]IUWOK*/

M;MZI9X[

F


X;#WZCVXM'&E64@M








M-KFV:&0#95-@Q_$8YS??A$QN-26M+P
D[5KE%NH+


.Z*3(U:ZLTOWN%4]0.Y2A\H


M(S1?#
+C778SL`0!I`WALR!'=H5ID!+
\UVP*E3ZA4L*VIFL!IVT?906)#:C



K





=4O\XZ#9C8Q$/4

MNA=-?:16_;?
X_%_:O7(.RU3Y)P8


M28SKI@W--B_?.7$D=I^9HEFH')5,RIL.ZX[FR,&J_+530$N3Q]TLPB4QY&




U




MHAK%MP



I9GA(85;-W
AZL9%3*J?]I^@C'J
M?#Q[!:/J'K6M`J

3-Q


Y


XZK5$BYQN*_LJMBF_4KP.H_LTFXAM=+BIK0YE8YW
N
K6K\3IEE



MI6E9%4U&^(QDY

M:#UY?SV*_+^UWM'F53=`$/



VI1C]\C]:$?NE+1!TNT6W+\Q#[#<S.8S
M2-'?D:#[8X*5V!RIYXGND




?#E*']@R+A]_
M#37RBV(^66/*77B8RL]_I1Q]9
TTCH-]9^'4Y47W/!LX6.2!:E$.S8L*`A\K
MU3+'I4_--/!!BS#57L43).#XX%KNQTH;E1$V40





MIM5IF\-!OS$$L06
*R+.9_2_;8GSWU+W


MVS5O^S\8LNCU@W2


J.$L'6.==+Y[?K*)[
M.,TJND]O5F&<??GWZ9?KBZ]GIU=T2S.[4?5K3ZR6SE^VSW7JE0ME\79F$T&
M4T:]DH4Y**[@S9

M0'


/9?)U?2-*%HL@
MY-


B!-

L^9Q
MN,L$(HEI=*'GSHDUQ8%I`*G`@]RI[1E)9-\PTV#?D6;@YUD2)R&.LY_3,Y$T
M[/`;R\;4T_CD!M`'7UE.$J31EJ@YR(F0RP5XE-#8R(/(`$^#W=IY.DTP!FQ

E*:4\NXKD2Q7
YX`E`?^\XID&/\\`N+;P
';^?#8J

%/

M1OG]Z=(XL:



AV3PL=I







MY1;#L^F3]3JU%VY




E#


M54*XLDEB+^P'@XO.&Y14J$R[P.&Y&

\TM@
MCCB*+'9A65?



/21B-!(M1'0
U(

!Y9P
M@VW-CJ.(U1

MX_CJZO2ZR:T/FR1%UR9$+(N/HJD*\B\!TQI-.R[4BNYG82JF#H%[]!ESVS7U
M8SD!Q94788#3-T&TI3E`2UZ#N.PO$-(23G?BQ23U@H60*5%17


MI
467)]%R-$S@YX]IPTYYEK@3VW8T(2^7
)'RPY#^X#8/DYI9[=)(P1`'.
'=@&4&L_]'QW#.]M+FE<AUR'K%(ANUO)

MW5OAEGFG//+WG]-M5R.\3$-Q/&PGPLGH:








\X




Z_543MR9N3=Q[+J1U?%H!*V2KTTBW:H8T
M;MSH=LV/D6D-1^9H--+DKLG]$
A]U
9HT7

72VME?X=+^(G
MK+EV/!D%1!VO2

9L
IHSH1M@SXHKST\_7E;_7
Z&W



SV6$=1-;TVA%Z[;;
[U$.6=B]*]03@QK*E0ZZ-?+9!
%9&CK]'ZIU)=U5Y\ZZAQI:M?4KJG]$*A=$0FN

8V010LV



M5*DHVK*V977-]NYFTJM`\XHPMNUJ6PU22@Y$Y]JOTHO7`U_)T@L5B%L1/K9=




/^8KOCO


M?_Z38?P]#+Z__\JB.'2G
7-.[.BVXF)

M]_

*I*1/\-.7B^M38R2E

MUI-@OK#]!^/6=B0XZ-.H.^C5FH+;;7?
L6CAG.5R!V&]J=P]:V#V!Z6$\;=Q



M+!Y6]B6(F3$^-B;



MZ6=\5G=G6=)54OUS$#+WQE_ITW9A96^/W^V*-E1(TE$!O&WF9NQ#LG^G;78.

:[6M_
'XZN00`8O;VX\YD


MMH%6@J)\:[OF@F6.^UVSW3UHBT$%\#3%;CQGI-^VS.[NQA:K0+$*R]KMVK@?

MM7?Y=`83;&:8I](L;WQX-`I5F%I


M:];V?S!.`O^.A3&-L/

MJ6[:KC7=(+W]0
R2_:KQT

M&JX_]1(\JG7WZ#4?:]+;

XY)'6M=/V%&`O]ZE-;J
M^@3VY
%@`!0+X;:0W@E/B)+)'VP*&Q+`$OS$]G`-+KOG*YK:'N])[&*'*Q;%



MRN83X
6==GML4D6]&T4)$JNQ(,Y?`G!V)90
JW:?D]V-;M#WCQ%_@A^Y/U

M\=B%QS!\991+P(C6*

MHE9DURH:VV9_.%X^?KE&.
O`SK;[G@8E4$83_!G5%:+JR'`21E]G
Y#Y0/A1

M;L8P1-E%6?GX#D[^7CTZ]6Q04UQ^0D.Z!I1U?XYJVJ71%KI-UFRF06[BH'




-%`!8A


I)$(;4Q1B
80`+%)9IXG%%AI
M:#
VDJB`F'(&O.)&D9Z#*(



$ED=%N=/ICJ;R?\Y_.SCQ=?I9_[K6'_!\+OV^D[8]#JMW\H',R6\5D<
M\0=FAP87[T73M:A?DP=`=L;7ZH*`!1:=$,CFQ+LD9PJPKO@6R!3E&AT'<(1









O9Q-T7RY$I7C?DJRW


9V6




%(4O/8X@U

M6^#

[0&4XPVZ!
F+[B^1)G#KLIEQ^IU-

M5

2@36J@9;14^5I%BVX&N\&#FF^K#:H7IZD99#RDM0*4%O&SZ!A@O*_

?WKS+%9VJ'7N;\U#:*(E[5S+Z=X6
DOM;=WJ[
MM#+A*\Z5X54O+Z3*E.(/=4N]7D7X@R0+[+309;.T[R@&?3++0:G7F[J\C.JL
ML`KSH)@7EF:.%/S-*:HE?WB6!5?(!%A;.U#]?C(K:O:F5
D_7/06DBQ[U4F6


MSV7-.FM)934DG=7





0^Y
M7XCOV%)Q'%@HDX=EV6Y!!#ME%<P4\H-

M+7/#K)M&IKJ5+Q^M@ISH2.C=:'.LR$2@0
=4NKO*M.'Y&6C8H/#&?T68(EC(
M.CL/U66J(3^%,0K1U4+\1FTU.`A/-.#4,37$^&CL_2,6DFQW1J7RTYA2VFI
M!9*C)5SB$MZ\6[71M9F&9BVVX?(A5WX
K
0CZ-`\L:A4O`**.V;9KLL=5

MY#'?-WZVO47X4+?AML)V71GN-D$
@`)C*LI'$FOYM583UX-'N%_\Y]^H-D
]<-TKQ+I#N4ER791D!@<@(0*A^9C[PRX\



R):N[\4Q%/0-U)O)4RPBE9W17;)3;HGF$C
M=13W8OLRQ6X)


M#&HGG&DQ1_[Q'I0::JF(*?WP$_KSD:L);3\UK=`@@`N7F9GH3EGNGK/*$S%)
!BTRBSP10@&DS<)#EP5WG^\/CB0^956


9L




ML\[KV)H5?&I\R
+H(









MC46%8XT36+$VV8^7VD5$P9R:!%&_`OHMIW1!-((8(M!-J)=0Z-X!#X1=]MD-
M+(U/+`AM/[*I9C22YU*L(C`)_K3F6#3Z(3+D5T,'ICV=:J3%1F=,B_*:J8Y
M-UR$`2_4S@:(7]


'[Z0CB7(5Y?F(*O=^PKQ;/#37Y
MM
'\FGP:\5^&./6`NCQ

W3-H0
&'K`V=:=SF


M[24USW]HM]JE^0E2FTL)F=DB2PN3

4Q:4I^\J)
M@UBR&SI'U`A$)E3L&Q^$]3.XCFGU*_K1PFM6[0?I:FC;1S&1#D=9[8RWNL
6
M1QOR_CI?=@^**)^K)M$#8?4W\4OA.



'L

RN'N$3%H


O&'W)GK
MN-$BX-

Y;NM4/$L0NO1&




M.CT.B
34+DNNYZJ5FK3.6OU1`[








5/)Z71

&I9





MA.YL\-ZO#/-9L6ZD6L7]$OC3)W+W[B/&0-_JROK@YBO8RMJ+N]I=+Q5ZUJ`_



FS=YZ\/^MY=+_;!ANKMVRB%E_WXD65

M.AH]8VE@4E\'+W

V1IW!P539_/%O83.










ZX^^K(%JQ^

M7S(+PGNLFR



S@QG?_1PT
J:RG4'
/AYO:_U#[B6PM=FS








.T/]EM)F]%0J]?E5FEV+
KZ[WBO$M)0



MY7W)FL]2BS



52D\U2)*;I
=B4#
M6?8EFNYV/B\BT,/I;RGAK*7(J5Q[/4JPR





_

MK^J#V!



QCS!S
7.W:5#M



MP7MU1KT]GE4C2BN84M?L2MUG-4H/YT`VE6+;K=YSBH/W')M[?A:;2JR6.0+V





]:S
M+9.GT-C`=PKS@W'0


MMRRSU]-!


M^Y6_!1]6X_(_$

#O\)\@97Y]&=TF_X-I





)16%Y1%_X




']^K6#C4*



M!3H[-


M4SV
PT8T`VZFX:

MW0B'71=.DA



MK^E;[N'1?T&QL^+^D



[=/\'C[.GL7OGQ@_&@H6QH

)Y&M)04B&&_9K-O%T4[?)JF&I9:Z8W@:,37!`L`@7P1&![RLLP38
M;T)):QI8.XRI:F:^<R1J6#0S/T3$/,+,C[FAW32H-_?`]+4L*@)B^;EBL+R

M

O3J09


M=_\4VO[S\D44`TY)-J2MJB\:?`DUF29HW;;M`8'70RB`G@J4ZE*1:LU8-N

W:X!\-8R^U;7'+1'.Y.[
M:J%XSX_PGABM!]UM1A&YJT.LAV6KZAK#K'N'7&K)'25,6P;A+_]%[,[2FU6
M7\/2)F^C3%ZE38JN.1IB]%9W6FW@H6YX]O%3;5_UBT[V7RAKVU?;OMKVU;9O
MH\'3MJ\F3[7%K$XO;JZ,54%;W_=OVMVVVT39*]&Z8$=R*92;+O54]^/N/]B


M^-M_
337&YYGSV9LBH^;/!AV%5S


_F`X?YS!TD

&SXZ-$+;%S*\&;+L.



MWN%]!B/:1;T?+R50`1^(-+)]D4X*G938-2X!1#](#86MBL1J[#A?T#/
WA


MK%R6

\I
MG6DF`A4+A=80^JR0$E^KO2C*^]:;F7[4J`&QV\OJ?794O]Z9F*/!#\:18;5&


^S(GI+C9G2%7I+%FD3'ER*=+F^

-H5]M5-P-R;_


6W5






M9


MW%:@6&H/=_B(.


MFL'P`B#W

MQ:47NQD6J!J)-\1K0+X$420M5LC;C)RI!\WJO:H;.`!MW#'[XR)X'S*YN0J\


EK:H$7T5Y
!8O]?P4O;=SH+9*;2/E+(?QSGP)YG/

)7[\N@$NDJDJ587YYFE=2YRFL9=I5OHFY2
M\6[P5V





V\!P64IW?BB?#$DVK
X3_NJ5+^/CS*7/OT)N$/4#H

(@Y+<:=82^UY




22%7=.


SB^DY.^_B^/*=


%

9NUXK]'(0SYFH[
M]EE9&WNC8CYW`^IQTVW7B'B;M1%YISR--U
HJW6$]\'P';3Z.Y\MLJ_B6!GS





L+1-CFG)D@SPCA8


M
&PC2A8+[\&P;T+&D`6#'(UOC;/0C6X-X+ZQZWDLC(QS=XX13^
MQ^:HTVE_

##A7O@-/XJ^`
M6Z)O[&_.%UJ`E+`H[\@OP^!E1MN9,#2YZZ/0L:8/!@,ELI8V&'\0/`8]C3
M*4A






M4P$$(&_R2=2YXG\F/C.Z;






C%Q[_J!X-_
6]\7]\@ZE]54KU
M8TGMKU

:&VKD
\918]VY@

MZ20'HG+I!D.ZP=`^\K'MZF?706Q[ARRM&M*299O=*I3KQ+(=S:P_;)N=PW;V
MKHG7%^ZI*^I


J7E?'\

M%SJE^C_'F21Z[,(^/PQ02$7M'7+-6R.026+N!9\*_`X=^;MRDFGD6VA]48

55J8C4H
$T_






8NNR=F



W_:
M

MNQ\[V*@&&R1?#R$)LXB2Z#!66TJM\2Z
TQNPE%Q7E$%Z9S$U0`/^;L0T

HO

T




WH=.0#W:LJ?GW.N%N%(=;H?QKZGU
(VLSC


G[H
M!GEI#\0)O5\Q-MT]7%'BUNA5BC=KWJ6)NZG8U[QKK]%[F.D?VW60T[`+HRJ)
M6WE#2T_`T!




M)G]KF5UK;/8'PYU)JB;3N
[44^U

[K!O#KN6


=)J?DB7PKT
&XU%+_1&3NMM'




M?O\KK0_9]70(^#U@O[EF7_M/WII][3=^&^HZ5\9-?N9/@SDS8ON[
6$^F[FQ

MQ#E5

M_*=^Q;)*$D9IG'9[K8'RV&S49!?-;NIB-WVSV^F9X_;.
L`TNZF=W0Q:.TMX
MV=-V%TJG




OL!GM5M^%[?WE^.M/9[!A\#O\






MK&[/[';:IJ4[%QPR%8Q[!YF2J;F?LG2_)6YGF=:P;_;[.YN6K;G=ZV
=N)OZ




N/TW_#_5X2C)
/6)/NDUO%XA59)-?=V2G?\]+^)&S\8CAO%
MH3M)L




M@OI*?C([/Y;VX&5Q+!)@_?=MK%HS5L$V7^\)MQ@IPN!FB-(-O*E(_!VM+U
M\W7E2XKK/5[M5G=4W+H%@HR

M-YFCG987XY/[XD@`0SLE/G=_D`..A2LJWE[HJRE=7+O'YDDP].G+-J!8PS`V

C-T;%S1X.+`1
MZ*(..B^$QB$I(H41RZ`^DQ$-BG_,A(P3(IN_B+%(N@'^/R;F0:8VZC9HAR1
M+9.HR-%MO`BOXQ(R#$ECN+.]A-[BHDQ:ANK^%HP8

M+;)#L









-1B

]!J


M7NS8:#%^#.`?XVUJY';:'SX?7WW


MPJ@'H)9BQ/?!$2QT@:\
`WMZBQ(8M9AL7_](G!OATX!]24U+766Q`EZ)18@
M!F.N9T6)A];V22YAI3M&3C#CG?18.^.U(GDOFW!6P28GGB*0(
+5`12.D

5T@S2
MU[N1X0!_


M9Q.1M@


83#
:<5/#0P^\E(P1V$FR!KZBV`KV``NLP))3TL^';<T$HH+?.!15RK;ED3@5
M%@/JHE$R^8.(.DCU;$')_EKCH







M


M(I1KLN2T(Y\ATI

MQ=E_T_KWX0M%REZ0J_)%*%4&N74K#FZ/Z);\F5-:73@0\






]



'U*3)&0
&*9HR
'V!]*`DEPVP2
M^$Y+LJ_6@


M=Z&$J!


XPIN3G
MG/@C&&D@%(S+(/&S;!DAR_X%Y\`)YBWN:S2.KTZ

QE



8I*S%9TK
9NGQ%&H


$

CR-

MV[I@D

F



UH5/MR/@E;2#I8PMKA$28ID9`W7.!-$$GCBBYPQ?%9J*4^0)E641



M.'S[!P

X57;Q
&UZ
98
M4N(Q3

MF

`@S+D)HZ

FB]JOJCYHAH;OV]\L?-4

U-8LJT(!'D:%1A6;PNMTXBQQASEZ[I'F#[JX



#N_E@Z/V0/N/D$D?7_U*OQRU.ZOF


M^ZJB74W



MI`1RL]R7=1G\FA`U(=8G#?]I^PD.X
E'(%5(P^Y1VRI(PQ//AN4^I
UJKZ;`



?NJ([!<.J*$%5T3\[9!12D[@VV&

F
M[P
_&WE?J-SGA-





\X70

MH.L!D9-(E@^733:(\OF$_%)\
.I'[DSNKUUXN;P9-#Z)JYT\8E.X$OXDP\Q'
M=.*6AHSWG^/#D^8R^:8C(SYG1)/N0%9RPZ?&;K0_@XWS-]:6-,:'$]1SX*



M&-?

MH:2]18%1E(19*I`=

W/*V6`@):5;\1U0&2
-(IY^8.`E-#%[(_7=VM&K_N*#/
M%05


MFRE'867X.^Y+L4*





M:#[IP4*K?+`_G_+^E59'U@5S'56U4'&@M3=GC]G_-3'+X#`LLK[E\90TL






F


X\%Q8'SBL9A1#%_M
'R@





SM`R^_V=M2G7%*LI5E-L

MX-Y!DZPB`G6[5N\YBZ+WACV=)O.$#\JQYT$8N_^S8S?P#UF?TA
DE//S;3=H
M-\`Q86:[?=`)I9KJ#XSJ^V:OK8/5:HAZ;3L?EB&R7S[`UP-?21^@)FY-W)JX










_R*W^]^O3&<-C4
M!=J+$-9_#-N#<2=O&/:D16P+@G*[L.Y:#KM7L\:U03F7\'?PWAV
'.T9A
6#[7QE==FF'\0/^
MGSMU%T]%P^B1A;<)QN]M:XEEO=VO/ZDC7K=8?^)2TSQ\6(671I/R;D&YR



1V+?8-6P?([RO6
M\PN;3UB81/BJJULX4$@D^

MQ





M.10MMM+]
(+0^$N=+^E9`[



^<QWV&A!&AD'!];!@YB



_!9$'(NROD7'Z?1&$L?'V



M)6!$:Q3B


*


M$8!%2$PA!6D%*FB7[H/P&UF6]L(%RZ=E`![_F7@/B
6.68DAY+GV'$T]XKC`

P#QYT]
MT)63(`RIBS$8PP`6*Q3G&:*B@PG6]!F;!241`7D#%6G$G2
M!E$!=H=]H
M?P-+B=W`LT,@FD@,4D&EY(%/SBV()WQ0[C2`+W`05S;J
B%++^'2S!1%G1.




7I3YS(!T;1

M=3`!9R*T?R3.#LBDIY9)BWU?N


#LTN'@O

WA&L=

%5_
S$B]^@Y_G-*7IW\*?LKQO1J5FD?=B.D/TW<<5YAJTI
MH



M01VV%P5P3*8










9V6



0H@2

M-'DB3G;S+(&W5/'
(@=1Q1^_N5HZ?)%:V@QOO;`6LG-*#NTL`(1T/`.FD[*O


_G!W.P6`;D*]I`GZ7\.X=@;/]GSN0VB]PYX`P\'7H<8:W^K;98



2]*QG]NT)&R?VM.[U=

M6(5Y4







M






XM)%WOL-G
4MS=*
ML]9)I;QU0^6WI[OU[8&S'Z7L6Z9$X4!/3T*M)E^G7P3KAY28T=M_Q,L,XB53
M!K43SK28(_]X#TH-M53$E'[X?WYR-6$MI^:5F@0P(7+S$QTIRQWSUGEB9BD
MR?2DW/.G%[A6`8A




A9

35N__ZW
/C^_DHTIKJ8$:R7W/\$1M$)M61*RX^O\:_7
M['O\T0.I^X\__^G/?S*
OR?1T8UM+Z2'7+$;W/NO:67]F3\+J)`^\#\^B!^S






57
;855]Z^

_=@.UQNAIWI8+3]=KFJ-LSQX.A)OO#P?JHU]J9MK+54[ZI





3U3&K)A/;

ME7`C-1`\S;L.D;@U[]IK]!YFZL8.&G54)B8K;WBI6.^KONGY^O7MRK@3A(=\



M!N-12_T1D[K;1Q/H7AF?Y-N^V6UWS/%0UV6HR=JVQ






M-+NIG=T





U
MV]F

M
D?]CCGN[RS.K2[%-A6E_=U%$;5'5W.=C2+=9G_0-]M#]:O]-=?9U'+97:J4


7I.Y%.$`-?_V]FG
MZY_Q
MO8C@K%\`27X^O_CMO7'G1BX=_X)5O7(9XM0O7?#&F#+/BQ;VU/5O?GS3YM\7
MMN.DWVW/O?%_?(



O=CB]S;]V+?-@T/QRQY`^JSM'HL)G]2FN7'DS




]

MOV-1S-A)

)VUSOTCI(TUWL7X5BT8FN
MLN2EY2^3_\



,&VW6X$T_CI_X00=RG.R&6\8)L?\TT*L3+)[BIE
M5Y5:8.U(HG+$HG(=`M%N5(S&0QE_]_@\%&9NB(G`FHH)S3QDHB$9XW%1F@JL
M*[G`PW#A;?F&5SQ=_+T)*E\HE%<-%LOUJ)%O
ZV$J\\FF[%G:.SK?C+H8'#
M2*ZM+!LY6LZSC.B^W!5=@
&X

4
M%\UPC

MA(%'Y]&YMPY2+P3_


MBWA%+N


.FBW1:^*%P7]!8WE!Q#XXCV9!







M:`*^*@(&(EB&L-P`.18XQ68/@C


+@/O-@AA772`4V[A3@T-V49^H-
AL&HED&L.%8U7(3=



0\]8;AGIL#/MEDS8-X@4O_%/EQ(=3K6W
MFL'@I!AZ)8![[2@V^E
]Y^$75HD_C2[B?5YPPY^YDO^*DOH2+V(78_J/PU-
MDJDU!VN.A07CV(V\49FLGS.D-4J%MKN@W8=BDDAD2/Y&L'.N='97?P;U:Q
M`]1B=E0VO:.$=-OD@#\HMM2QHQ5S2AJ2
C@3LME1['FZ9B\6GK=*X]A_#
+2

M&7

MX.5%=^RZ05;(Z9I9H+8(ZO*HT$&VCC$^F%?)V(-26X)4E]NPX:B]RBZQS\@#
%Q@IIOO)29F/;`B@W32YH;#$;
MJV:\_F25,9,;DHYD\9-#B<VQ4Z1W.&8CE8ZME0-/C3%95CEU@5CT^I+\8#P

MDAF9+A99?1
B21LIWXMX'GM)

M=Z9&AF7OP`X#A]SH(D



(/K^

L[/*Q



2+*@


*H186.(44S8!(OBSNXS#LP($B`_\8
M'/Q!%N!C7M!XL[Y



UN$FF1AO$?[U







`6YL3+&MT`P\`4L
NYS+_(V
U83#:+^QT!


#MJ




_5%H9P;DF^1#S




MQYM$4\D2JFBV^DR8?++./4JWK`%.A=HJ


M*K8'V'4-8

EE
M-C]3I*P)^5ZXBO04/L*\5KXB6)D`X2
EC)2]PH6HH`GW#3LZ=.LZ82C*$C?L
M.M&F]42W_A.&HF1QP_X3E83N79]\5KD;E3P[`7H36

MDE4R








M)S=QZH7B[^S+G^/T+P(4+N*[B-V+:9RH9R@*YKNF7:A$/QK%HNTI#5)H@C;(


M4+4;8$U3?B@&LN4IWYTU7


MO3&H?GA*(7[*[F^




\2=^]K1^Q
JPUSN=)W:MNU@P^Q$Z*YVTU5^


[`5

MZ?9L6VVP%




M[8AV7\4F+\5NG6KFJ9B(5$7(8








1+&M/5]H+M\]`S0N@T\OF!7$O.%;8<*U$LG`K)5CTCY63]'QP38TC/7Q
M#$5I[ZF?U5-T<C`U!R+QH\U+:ZNGZ,F@6Y8):VH\A54DOYO54QAN-2*6[*C

NO[
M8#%E19SS]]EUMO=/*:&1%^[B_*3=E;42
/7V10JGN2L`<RWU5@+7V=PK5PZLWV%X91)U\*FD9\FQO&SFOJ9N

T[77!U-[/=90'29INORJ

MW^;/;N0&V--TU/ZW\[.'OD/LF[I*_UMW?G9_H/?FK*OVO_'/'O
.L`
L[7V0
M^]__S][5-C=N(^F_PLK=9K-5EB-2?!W77I7M\4R\.V-/V4ZR=U^V:!&RL$.1


M#`IV56/W''6=1R*


16##Q]A637'7

MY?!

@87EV`
M&U0-84]@



M0N%[*ZK3JFK6%Y\&E]&Y/Z69'[85FR2Q(3BO`\\P%LLT[:/@;@C6/R/!A9]$


M?Z6MV

?@7B(C_X(P%#&JSGIIT+.BK!
M9BB6IHZM4R;!0[$%M8\0?EZ!&R-:C4&OB6K^.:5]T[?`

MXZM6%5F2LFV@IMTWP[HB

MHG@D9J7E.6N&FI82M!..5`RYV
)TUP@\O;80%.L+\3%`PVH6*MF22&H+Z+4F
MQAH6J-MWK'4#DT)IHIIJHC25DLE\T#DY+$]87%).Q4*76*IZDDK[UCSB-4



QT!(_1*P5


53U!5;





#*7$B\9`#+`P`&X]MY%2XDO8^.+/




MY\`FC7+XKO@QCMK


TGN1U=?EYB:+)FWWW$62D\42COM2IU(:I((NF'U
MYV)K0V





T1F)T-1S/

UA:


EPS-['H]U^--,HT)*-DSA_&&L43!OR/(V33,,3FGEM(_G7X[8\^09




M3R?:/R-_.HT?P&4&GS:#UXHAP7X?*5#T0'H!GCV=BY4UWV/--^@X8;V]:%#W
RGVCTAA6S0LAK8&IIKZ<&X..C._=:=!^/B



'M`_`=UO5A72\UOY<OZ0

M






MTBS)V46A\JC8Q

X([P-J'9R;PKGYL-$9X6V%


MF$54NH'!BG)2*US9W1DR#XAT0*0]0J2/;P*1BI7(X*58BLNQJ'QPE
238JL%




+[XYY
W%*
M&N^P:P#(07P/&$(PZL;0DCP/

$4...S0NH.X


M['=T[Z+8VV6J$Y3FL6G1:*XW50E7:PCT?9Z4ZYM=HM%(A./]V4]@^@[T(PUM
M!3:CT(`X:EQ@KF9'%=A@2VR^+MEQ)_A)F\2/V$LYNUBLX[]5
F7T^T?]?K^Y




M*6)N1;.Z+V`#3A

MJ684K%#2:5ENF/%=Y:8[KDF&IG
BF*5=&AA*K9@T2WST1WHA@A3W0IKP#VPG


M)

MY=7[BROF$8%#5%H+;00$%CA]B/[^`Q91HJ-9_2#05CVZUH/9*J4N[_H8F7^
M




M3\IMM&T
M^YDV(@'N\'&S#FTA-LW^DR

P
M6RTY7(W=OK




MEK0%7`'^X`V_X1I?\[8;B1Y2XZ7PKLFV?GDA3F3Y)

M

75$

_
*DO705



MMZ[J*:YD
















M=JU2A7O#UE_1K
`O'_C+`?ORD%*;\=Z*.E[*O).%O


M

&.TT&\F3*#Y+-C:@#_Q0\%3PE

K4
/X)G0=EU17(D0&0TL&\B2H



M8*#W^H-6@SNOSW^

_Q/K!'QVSIK=?$'





T+05_*YHD





9#2C^709

#'`A'C0

D4?N@S@ZGKC?J//N0+.IYX4@


V

*

V4^:#$TEY0P[$I






%P602AT_!'H7KXK':+6







^

6^YS*RF28^07=W9@9-/7DY._6%OV




M3LU#UQ$MCUA-B

M7D0SRJ2WG^HID&0P#VL3R=I*2`T[UC8GA5X%7BK!V^O,][F/&1CNN)?BW7


MT(5:`&H![+VN6RT`WWS]KZJHM\M/486FVUAH6H%;@;NQX&Z^DB[]*/#:K:O2
MVV55.B)R5)&6L8YV+0-]@\[`DC_0IPO`+^SG#&S!DD8#2ZE+O_-^;NX^?[A
M6_0_).4.H9$3?A+KQ'?.EZ4.7WV!OMG@_312!-%9'EYK8C.%P$C[#Y+L[?Y




Y/;;(K)0%Z#A-E^'8FN;G9;[TS(0)Y\+8;TOIX,&P[
M@B56R.6ZPR?S@$7N?[D2QO,JKA\1?XJG#U0\6#D8-74PC$';'0P9R%/X5?AM
MH#XNUT'&:L3!@C)0R/Y4\[`HHDT8NY\$[(XP)TP/5/;-=]KOG:O-(Y\M,MID
M(*]!0FZ_;H?5TX?5RCD%807AUT'8U`?=2K.Y9(PQ*JZ7-?Y):HZ*;C89I-.
WT!71);;^_<=


MS#M9R'O



D




MTWY*F[FD(27

V_DY+VDEE<+D


M]BQ:K[F'=ZYU7D1#GW\I@PKX.`&8IH-\1JL`DT=G*[6$+Q3+B20G\=QQ&
M[N1^QP/#MV,QPF2=:L1WP/#/5BHLSCY'%$\F*M-=#VCXF=
?F%)`_K*V]C:

\*FX%U$@4:%/-!(B+Y&+
Z1PJOX&/S!BQT1&@QA


MLO?J1;*W+/F:6X?%PC3W0)44?@E@L[1[F;4UR(0N3WW

M)^`U$






)

EL2C@WHRGB=1]=$2<XOHLI%&L&@()R`_TP@7I\#;`C(<A


M^`
X1D/'];E&OSVS[&
(T

%:0N8

*(MF





`NA#WP

M









C59HQ[*]8X


M]^8;#W/::3








MN_&5/ZY/#I0Q&;F@#(R#^E-7=4O5!__\/?=Q;Z4IVZ1CD$^3H=F&IFY)TYRS


'DN(Y702V
0BZH^M`JQX4B

586-K)6&IQ[*$:`RT)H=].X?L`WNQ:($?9`G#?KAUP&4_%


]N@J


MN#($-$!XEJMFOL;I]=

MY4I$SM4:_-DCH8Q;R
EU&(S^@JP!?G'.6$3&6H7A79`W:T/-3B5P^8^OA=@\

UZR(.7LP_.XU[


)U[B#2XTDOC%&?1X.!_]
-'^(1


ID;//\+
VI9$KQQU_(Q6F'_6&?1EP[;ZQ
HTY7&M



#NRBHIA<EF7[QJW8%UQ8<O;
XR-=]O&H.A


SUBYOLVB*1


M'-6/D[3

G7@K7^OA(1.&7RED.









MCX2%`67I'WXGHM^2N$#L3G?$[C;V^27]S1HI%-3Z:_WE74;;
7.I5\02V!07


MJZNJH
L5E[UK(O9YO6
HM32FW+#6O_;I7;=I9P-O&&FS33M=@

V`I%C0#F!0)RF83E:&5!Z)\8XY%&&+
M12AV)J$$6RQ!'(2M%^%^#<+.-=Y9%^%<IO;@.*%R1^Y=7QRL$$S$(0H5IT9



?+7S&PN^NN8T


4JHR3:6V=4^KW
M^IK6
J/U1O5&]6YQFM7L

C7U

8.IRW_P#9I0-*$HOS:-OOTRH9K\)O2=LI/?0U[DEK[1
Y(<_A9P^^_//O?_O[WQ3EG_7=41D%?@AOOI/)'P=7


;WX@]Z


M











J;)K8:':3*J)RX.+_


-LYY9;)]4J3+=(?MUWL]+5.)O2QUZ[S)(-<`GC(!+''G<R^JS


M
D@$4:N/3[^9!'XX?\H2ZW[)W/N7WB^






MP'C!Z3U=4N_JR5]C!PL87&Y.N$ZGA/2'J^_G%W2
LD=




)=+'
\B



ZD2+
M
`2
TB+6#UBG99.$^GV





BWEL.C7#/KT(M:NP6BG?-2






T130(PYF5:
#E#;R-

6`^`Q^V\%S/
N`5BZ\:0:M4PWAW`SS7/W:`0NP9V3MH-S]

:6U/E2:\[[
M6.\$5+EE5M;0C2V


?G*G(\M_Q+./



M

J*UHWE+4'+?VLGP#/

MCMBJ8GV

+.D;9([;NQ]5Y]]_T\KSMS71\$8`+ET\7

`710HBA=I$8

MH[ZKC.L?DYT8&
]ON+#?]Y[!7/UJMJJK3'+@MI9!D:D1FF2T-:G-0:.BAAQ`
M*U`C.#^?5B3
Y9:F


-COO`ACQ#%IAECP%ID/#78R38IDR[*DF(T^P





?.G]_(.()




(`8_*B$1
`).(B?DE$CYW




H$?\7\:L
M!%X$(+A&S\@'6OZZ)#@2B]]GL@(/'D(T_.R(P)SUAN@$#V05[\SDW$QPK





FIY\?
M;K'W#&-TZT
'T33
;VCPB'`2T;'?)X^1YWH0C^YAFK-)7]1Y]:*'[I.'W5N(






MWU1A4UW


B'QZ7D#^X@79B`B1CI^941=%



5]
:[?`?A^C
M/FTAW.P(+-MMLI!YV\$20`TB:L(+$/3M$]+W+(O)


M['N#FX3R4IEBEY9^9.Y+@K@Q(N3UE

MWC!*C9YY6O1D:IY+XF)'XWS











M)W+B$'_%83+


MZ2F)'_-8*I(?ZVOV:KIIV4J!_#A/T



M9XJDQUI+3]NT%+ML@G1&16UO\*X
]0BL*9*@]EJ5+5M&-:6!!'1G':(('^
M)4*TKL%D

MI^\WW0N@Z&#AC

MDFE

W]S%A2]*[D2%]DLY-/AOM_O8`FJ=5DKM
MI
?'!CX4_/+QM`7N6\-6![S+Q&&KJOQQ_)?I+\K']Q)-HX\2AYC?*


MQWT'I#FHR*7C#
E;`.QCE
;*X-T)Y4MG\OWD/7@AD=/T=1CU(:8ZE[['(\X-

M\$+&%O1V@C@3YE
KFL



_$7*-P3



M(!+:X\C)(
&9=


RWA

M&MHC

M4I+1
I=`C
M,UT+^'D#6#D:;'RR%4L:./Y_1Z2_U<X(+[HZ9(D/Y*-4AT^=D0AW5_R/Q$$
M6(




M3V_AW1Q(`O4

UF0N12
M\-/&&YN30KNZ:6P_(-3+-TMF^-FN1S-'-G8B=$N3).7?XKPH;'N#]MCK`\&(
68?*#AO
M'#B`#D6G!L/G;5-5QW3</AI#1(_T\<R)T&F-V.R@1Z\3'U1;=%ACHZ77F
MGU
/2=38M!OF
@(OMS19W3!C$D`;F5=+&5.4I!/MC)%
4UEHI)Z@OJ$)=J!'

7G)F[FDUN[H48S&O2Z
)8]

HO

=^E




IJX`Q#4]Y+EZ.FFQ4[!DXHR3K_3CH=N@E6Y!AHHBB\&^#`#;$
MIS.X.V]`/=@O[+B9C#@ILOO!C@`0XC=#*_&CIM!XZUM[J7N6LWST9F;9+



'#L;5835P
F*(;Z7

PSG+?0:.G04J+%-SFLU9[C%P[*Q.81B:

0U2E
NUE<HKAX?P[6(
M.`W!=B-X,2D!#ZLC\Z9BDD/FL/&83K\=



M]L@.-SB'6&

+0#LE5#)YUUW$+_/K#]
AYOB7OIK.
4



MT%;@7JS1F':`MB+W8HW%]`.R5;F7P1J


M[!F



M:=9&9(+T_;I!!WF`$/G60=R^`YLT]*[HHV5T2?P??J//NQ&=(.F/5WUQ3+
QC8!U\@D9H8HGH
M&VV$/

?`.E#5T*+HIC5^:TU1]DFPSS+


GX_&


HWSPRG?O
JTUD3EC!^![0
M-U]9T1=6HZ\W





M_6@GJ2R4WU$[X1SJ1*OLP7A=UZIR=(RX+C(


B]2D\X\
M6#Q??\EGOJ9R#&L:^;Q6.1'KZI#_!-;4@6%!854=TG6_6VP)AL5\!2T*0M;7

KZQ'?=N\
M=NLP+/02!(.7#=PQ:$W;7%_-M9N-83F6H&F:SHNUM


B&^3()8TM$&).Y\,B.\3BTJ\$/M3QPR1*4%N#


?(
M%T4K/R!1TWE#JR+:Z1!;Y]+]XOK$='!KT

M1U[4T@V$*DG2M`IE?;W\$$!%





L


MQQX770Q7M5AS'C7?1O9`
^AZ@@8R`PMTVSUN&TMQZ3S-&6P1MSJYB!4;Z2X&


<%A<2






DL/1RU1X`*..RG_VO6C

T=L)G'DP'^D@B9UIXB_ZT3(&R+L?]7.AT/[=^

MR0`F0(7=)X?%Y].[?#N\V.&0


=




](+K[&9@$:1X)Z



D
N'N3Y[P%6`









M2

FSPA#4D\8%7
<NVMEE



_


M46%32I)]!%^/JWT`DL%




1ZJ

M)7L%MI3/UR!/!2ZH`4$DZXEPKFKM#


!SRX-_5)95!-
#=KMHC53I9++N*#^&%E[FN1)*
Y
BT[BJT,;1XDY\-VXQKAEW&H!LDP;1D3F

:#&@S`#/`4$++D-_3[L)E'

M9`F#(11B?)





]&%FR


PU$K!RS!Q!$\B^Y(Z-$-A


RLDV/B=

SB)/TCD-6FO+XNP(;Z[X/]OL`

(OIK2T^ZJAL
3MNL:.MW:BLTTXZS8T11;6NG+

W8+42'+CE63U..S2E5+#UR

3P$`W1O1%P=


@!8BAR
&Y=AW\

TVTO=


8
MC@$Q5*!L0-Y5=T.Q#87,;H=L0R'M@*5'@DG,)(@6]ZVMVWF@Q\2:?PIK6^



MCZ?[8AIW7]J4
IIMZ.HUE`@$V!S[$*#?
8-`8``'+!Y!`9OX/LDR*K]9B2-Q

M+1SBR9.A).])8%)_@0*1/@\AD362Q-/E\%&/&*;14GXC`EVJM9\/S\H0VEF]






CJB-F_

`3[IZSV^A(?U78)ZN:SB;'5V

M+3(P
30P
S
X^VQ6S?__(T#P9+3&
2A1^.3E^='`UP





DH@3'

F0F
M?R#W`1[%

N)(A8[L@





MB+S2NP*^QXYH6?_L56(C/47QO=A-I_'P`:$%VU6?GAWC((GSOW!3G0U/3K--

M6QSP96.
:

MR


MW+920_R6V!V'3_DAZ`

&

IPC@'
%5%#Y

)WSB3R?QW5+EO1Q6$`IURJI[%N9`BN%

524].V74X#&Q4+!0#/0FP3O\1L

TPNV#1


57S`\^#(]\E*KC$B



_Q
M@F*/K*S
U)CSW.YOXE=3@:Z6M%\XFO4QGRYU.!R5#9
OYPM$Z%Q?V='WB]`
M[70R'Q]U!^J+CKQCFGNO%DMZ`+:M\F6N@NS6A&1
A7-U%\IXG%(4Q\KBD
C'Y3)E#;9*F@(UC_*

M^C&@V.[?QW-$O[L



]XR]QS?)U8-4E4$W38WYM)<
MHR2EHA'F+5Z@YZR7P9@R&



M^
87*0N1\#4)R3R=C[
8Z5S[P0QK#ATW9M2+9_[BKLC&/7#5QEKT=+C2&'


);[$6A


M-ME=TPT;X?

\`SN7TZ:Y.
M[B96-H7ZLSGYXQWUQMZ4Q72`H(`,&9T,%3:7RO4V-V96T469E;H$R3NK.`
MB)#R1

MC3*`KT56Q&8_Y'_+.BWP4F+V+\I.^;*OD\1W
UM\`:_A(\%
$P\TU[R0]54_L;&7?






(+SH.?Z'BT%4CN+*8


J



IT\C'U1RU/\QOO7
M*

MQ&AR0`H.(G+3AG%E0;.?


)X_P-02P



NR;I-O+
;


N&T`
#=_'
[^W<_OOGW[]I<8

O



K=$V-E\=
[

M*%/VP*


XKMJ.HWXZ_7D+GG
D@DH



M[$W8@/W%'HY!

*]9I5#SU
MDEL]5']1K_*2@='\*HQ0T
UI])R447K)P$KMMJ*8#+@)L6U7%*
1-R%XMWEB
M



U\`F-&1$V6FZZES.JAEJ)&



MX??$:

ML\2&X4

M/#
R9:MHD6&0DW

M@P
JY

MWHY#\796L7

)^(*6^K


VBN
M\FRLM2S


M




C`GXC6]VV

[%?



=F+K)Y
LY-
MSFN-ER5/'JI2[)SWN5@4`!3H$41YO
A*QEEAXHAP^T.CXVWU7'C0`S*G@KDZ
M;OA\/ZFQZNZ225J/C@DX.CP0)9\1F`(06H/E?LP?RS#A=+WIZ)B`=V5CA$K1

US*^J'
M92S^%/$




_90





^W2*Z6
MSO6.(Q*UZOO0*$=$K2JI3.:+HJBLJ9MU`I`$KK7TIZV)AEJ549F\UU59P*E)

MUCEXS'%1JV[:N;1P;`QZ`VPM\ZE8PR+6CW3AN`6]HRB%\#



YJ
D63'6F?0F:&()O1NGG59JVZ;YIYL2+*R;ZUH<;<I;JRT@(Q!S


QZLY;.1;[

$S+]X75C[E\<7L+
5.9[=ZDQ?V

:L([V;

MM^P%!(C2Z\D-SU\2\6F=Y_SZH0#]E6Q9#``QR@Q[CP;K]16WD6=[P

MJ2B3J;@Y\+5@DRH5)2(ZS0'9.$(5N[/








4S!
MUF?ZPKQ=^+<X*3JR=[`9U#4ZMR@X`L+2J(J)G_3LME[/F]'MFSQDFM?\P%
MH(1$[1#@FC1B!P&G[)$]BQ7E=OHVQ=`S)


7\&G4%

:))3.
M3;
*K;/:K+
2CJ$/3V\Y-^WJL;5:30Y5YH.
];!-#D

DI/X93)




MAJ





MB*USFZQ+CU`0S$\'_J;;30L9RE_(A)[GU_EF8B(@V[2VO2=K=`*IJS'`I5L
MG2^E(T@D0AW,N[(PY13@+)U?A

MA/%@'I76`]FKSS8I&-;T!+A;YT4Q@H0P&
Q_\AM+'I]`NN$+X]$CNZJ$1JXG

LAA`F1/;;4!0SM9Y5?H@1:;!09#\X?K:9U&/2J#LY

M=6F00:SJ-MH[O=0]S)972)A\?&U\5_F=5+,A@+8P0I8ZNE``NF=,.Y[K($


HRRFDA%S$B7@B&4_

OYQVM$(/

-S


3KYXHG[3(@/B]F[CXY?D)P.@`

Q0_CC$+4VV$Y]G\HZ'
M.#


*+$
M84W!$*+MKS(E30V0V'/CL_BBEJQF
\!!V^=D2U0;G-\@ZYFHPR^JQ^6\?@9;





XX[IH&Y

ME+L)87^`
U4?L5B!'22AJ?MON;
9-A\/-$/;TTUK8JUHC=@+YQV0P
^K3JT=



M4)/NH\%[K?+[?9#V#$//EO\EU/UFU`JWO'-N
(51#PI]IQW`4A




I#ED

M!GON0=3+/

=:7O
M)

MID\3*T7`$?-U-:74.D_:C04H&DXNG=X1NP!#1
S/Y8(F6@XNIWR1]7$UC1A1

;#I9A\ARE


Z_ZRUKH;A-WWT

M6=B;BR\1__W3



QOT2L9

USVFE\V

M



&#Z-M5

M$
6Z.GS/$J46%T@^YISGWY+LL;B-2JPZLTDWD'W;4H?
82&4N$U=EPMAD%VM
MZ@CRATT



MV-;D?0$Z`:^LZEO2;FPJ8`B7P6X2K.X&S0/GL+QA/
GC3UEL;&PB_0$Z@?RK

MQ3@`(9:%U8M0:)L!VN-JT$07.':


XM
M))G5I_ETFM3WYL\9&T[S2EUKU&P$@$_@]IFC[Q[%A]`;O')L$X2!R=5L#L`(
M7&7K87*UP2`L!?

MWQ`.!F&)5.6)#DNES3@B.UT$-F#1-AV=7U')M`PCI/9[UG0V'VPT8?!=KF.
M^D)%*'56.G-^51U+`IW_,\BR7;Z=MO((ET5F%@Y3.!N4:PIR+A=#A4U$$39
MKLI

MV@&4[?1$2%`@A`3S-^`GM?H5V!CVIS'\0_1H_E:':A!0PG;Z)FPA(CR[NHGS
M]G/7D_

M

V




M)!93KW;0U(^*7$^NGQFOD[U`=A$Y?6)E


U7::1L)S69]+30PW:?O1X/UQN+/J^(G%
M5;HX7']\K4746G)X+Y@L/H\U2K-.I5YL8=(`V04[;]//\7[8]QG5M[
(=?S*

VONGB+.

7=99UA1$)9A@7T`JPI78U!:?R[5?/\M-U7SLBF(2!AHI.:US`@


*.5B&B^)4#T42)Q%_%8Z?^7E)%Q#`^@!$

U+0B7AO@04L/%
M?OR32NO(Z)%=[3/?P0[^-SQY@=WA)HW&M1-16[Y2W@%`$KA
8_JIR:E4(4-H




M$K
L%@5_C*H)FW2'N4O@4H+][5-S;`BIX8HASF4M5B'4_Z-T].#=1A\.5QW
ML=1CPDA+YC;X*T:ZQQH?7.C6-;E5!6QU?8%R`3B*_8T&@)#N`SF/5B=='`N




N`%VH`X6QS;KZ&-]NTK]BW^I_4R:XF`P!X8@G+9JS:H$.H


P/A5/WB^_YG
6E974Q]UW2
R=Z6H5&(X`*J-8M<#%/)!/-BN]$*M$;R[]H*$\1CP
MQ=(HBF#%6&?2FZ)U;+?..TT$JM#\4_V!:69YZT61U]D:+TM(/@5;'\$!6Q
MNS8V9T7U`]O=

MV+`$0O\$(IT9ZV=+LD]R]+9+2PUDGW-9W=2!X()P%GM/.]4GN99J^&EB`
M##ZUK001;!!(1`^N[NHE-JC/-Y/`8%



RG\+52M^RA
Z!SW(2WA
Z]]#RM(Y5M`L)G3-


SNX-^P9?%-&F7B05?]L\



MR.O#Z1L


&;C9)*P6)_JAO6!;XM&F4N%_K$O7PF)6FJC:])H)1FZ98]N<JN



.(J;;55SHH963L_\C(D
RT


#
&I?.)(T%/+
MO.@



MU)1:9_!*.T!$(+U6\9G(V9%@(!;I7=K^'U^7?_Q[PCAHYNGUDKVP5+
#F@T`

M!M#:E`-
!;)A]*70%]ES518U^GWM'J[H!6@)!$$Z?*L:IC&DQ$+R];9F5*=^
KQ1PA_P\'G;;@W0F_N2K2X/2'\@Q\A?-D,G=NW*X0_L%V


M[*RU%N&B';E]J.9'CMM9J%K)T+(OQ%#:ZV%I`3S?X9DN-V%GR6
Z1X-_N&
M\;EHZ$J


==B+O'U)@O^[TFPGP
`6M7(G
]:%_5AKMH

M4@KBW

`=_Q&F[@CD=RR![

'Z$


/90&UK&L.0#;Q;**
MN#6
*P%A-YB;9EU2K04D[S`Z\'NSP-BZQ35OQE03#I*D$
R#XY`K6M:I.])T


_



L:C=)C%PW@*

%
O]I#YF<PQU%GN/7__,J*$M;:&S@CYK'V,0='
M/P.:W<0_:8Z#W&-(7
OF



D17.79VSK;+;#
M%_=Y&:7-?S_-B_(J+__%RELVSA^SY$]I2_OOSDZ.-Y]\\RS]I`)ZJKFYYKT



`I(C&0NAYJMWS,\]?F'#BG])

M\-UVICC1#S(Q7/G0.LGX-6
^ID9C6`%^QT\2;C2$3(^#(

DKK.-

WD!K-1X=O@^7C+Z01OLNV4I#$-FG

(R%*0VD;K77O.8
M?LV*9S9.)@F+]8\F87T`(;'J+FW](X2I(5%[)






M





B+Z#/1DQ3#B

M_UVIV+56H\

MRR_S[%&\`G!3\?%35+`W2VXXS2OE+21=5P!


\%6N?`&+
M&XU?LYCQ-]M%5$A/8C;;'NLOOFZ%?%UV@P`N`FX:ZT^LTB$O

ME



KF:YDP_5[7H!&[
M^.F%0%KA.3]









_8*W4%@*_A7GOV1]5DJJ5NM(&A+@![!6




A+&K5





$Z#

XYF@_(B+4F'F+%



MB%C-2Z=T$=O''/+FH9JEU.?P


S2RA2
M



MV4?6BD81N+O5)=7Q'1OG6;RD6:EE:5N0



M:D+9\J!GLPG0W5TI
VPU!/@(.-G-E8PC4

M@J7YGR7%K'2!
/B^1#&[SV?B7O/+9)K


P+
P12#?QBH'\MJ-03Y/@4C36N`H$H.5QY!3$++HJB8O%9Q9/L

ML]K/-

M#8!2N)S9A4
M*H0^9Z5OJ]H9



M]:7!L#Z`D
9E

M1@..6!U2%*N.0W5'P$K@X-:/2!.$Q



B@$OX_OW

.FS1W&/0OBW9Y;]533%
MRK5T&&5T=$CGY617UG%G/7A^_

%-[C^FL8FN2)LIK;M+VXIXT


M84=V^.ONT9?L^P(KSRLAK3;9MG18O

MPH_KI\:$YLMS%HN


MSC/E
ZCL
B^*ZVPVIWM
AO6A!
;`&28^^4;@$JNG88($E


*_C8;S]+X4]3^


M.?X%F.



6.4J7/]RXA2PB.60.2.
:.Z8
M





HC

[%&0818WKLR\%;*X8N7UY#[ZKJ#3



*?9)6IW
M24\V[




M9FN\5/[P(W


MG)07K\@P4

MS5*?NLQ`1=?1\1Z!;`5_3



V'P240
!3'
`LL-(/M1J_

7
;K%;#;!!

M


-Z

M\VBX*W$C$V`G
@@WE#D(BOP/\A+ZTR`R%8.Y$_OE8'I+:0=E$7`[^D]0=:$E

`'OJ7_FS?2`$.^J


KY(7N
M
`J7.^AY[G



M7&@)F5+!?&2?)A
V+J\GG[Z/Z^(;MU')KC.YEU$Q@6R&`440\)FY=J3::P9
ML'R(&TTHI@*-L.`(@BXY%Q/!7L-(%
A6!ZB'
$0EC_.7V%5TSWI8=0?H!/P
2C-8)<-K!

E97L/DM*9_0YUT13[R#D4$#!`RR'D0[U0
R$P(FU2WN





/93W\&NZ]5'6'A#Z=.WZ
M6A]Q*





MBU]O_*@J4*7K`@KN^V)V#\FQ():JN9#8IXTBC6(9JG%UJAN@V(48UC(@?9I&
MQ:*\CFGV[7H?T(O7!R.
0ED&Q
D7-1TL8O&LII3:L$B[L0#E-=7%/@

U7RL=96@`CH^E)B!R



$*#
MZH[I?_TB1G^(E8KX?\'4$L#!!0````(`$PWD0-?LQ[9ID``,)K``4`!P`

30P
S
Q7VQA8BYX;6Q55`D``UTUL5-=-;%3=7@+``$$)0X```0Y





MN&-)_E^_V1;%_D^__2UI__DIB[].L^??_NZ;;[[];=7P-ZSEGS[GJ-/Z]=NJ
M[;O?_J\/-P_A%NZMRC)BR`)&RK9HCNW0\__/!;^BMNFJ
_Y93^)@V#@JI*
MV2\@;$'^]K9J]I;\T]MWOWO[[;NO/^?1;[`.`/C/+(WA1[@!M`-_*HY[^%^_


19
6$OK?I;?;^


'#7OP



_'E!Q_`+;1J1_N4%.V%)HK^D*E^


'+.K#'R-N'-N%!42S&N)=3BX^RV[3LT5COV_9$H-NS[K-#
MCA*8Y^?I[@DE]+!)9WZ2DUFW6844?8A6S4&[O5=3C
ZP]#&G/R;VX/4!9L\P

^I,A06,#H/\JW6;*)'9LWD-*7H
M8ZTA`83&M\G!9&PJ()D/S.RPD3EO33HO@/S4C+D./?%IRE4E(:'716L
Z-4


M^I)-T.L^I$BSMZ0=(`U7X%


MA#`)
(NH*?OP*<GW
M

M*('7^(]:#JC5V)WW:?=8

M+*X_6*1_




L(,G_D-KB:S+P/[\K2L9-T64A`!3EJ=15I;-NC/Y9+D*
M+%=`2=W;B1G^N&EO!/CLV=9]!O<!BBX_[V&2D\R6=\469JRC:L/2HK9N57HR
M]:%74H&2C,XLE+V+R]
:YIPD)&Q97)*I0L9D3?69H#(OJD9P]'VY9+&:8YC

M24[F8#*02L$[2M9\!2A!G5EIS^)[EMM?:1U(&@I3_\R.(5T:JV'/SX*8[`C=
MFZN.$?#3D*X%.
^5*+%C(84ON0\%@!_


/#[L!N#H)=FA5E
MQ0MZ;OK[U3??_W'US3??LY/3[U????
=_JM79Z=N!MSNR:N^J?(GLJ9V:C]C

M3-UB
96'629




`$=`!D]67-8SKB
M78V0R
6K&K$$0X\U'E-_7]2825*DYJ]I++\[48!KX-6)%K)L[@4


`'*8V;P%OSE
MD
=LX]?



M04!3.9*:H4_LK0'(MQ`6@#S@I*^S0`ZQH9$GD


MV8&]7S_DAR.C^PQRRPXZ(O35FOZK(#P8[$5'P-2MG9GC7$?Z$_DL@HE#%A


@?H;H/P(:'^%1#IVOP.J#WD3Z[*XWBXE:7?LUMA:PI34


*_.Y[FJ&&W$F4QR#!H=BF&?H'C%;@&SIM_W[U!TS4
MG)+DD.08!VL0MFX[]MTO`41UQ'*A'HJ\P'\@+DTWW`\B=&OY#9^DEV_$-R
M['Q3%O!8_?$/OU]]_^TW4^
7+&=?%1G*0+95N97877^GB99M\TV=K+1[O1U:
ME6)





M_@=Z.P;]@HL'MW.



U
RREX1^


U2*XBCD4(HQ21RB!L#LV4R9XI2E!@J/








\_0)M9\'TTJM8].Y'Z68=/

I@F:NWS-I2#&L)\K+

[0&4/8KX`(MM&ETG+S!G%[.L=Q)@*NBL
M`U(EQW#Z4

?
MF

*'5'@UH+4:
MRJ$KCRSS?)L0,.Y?]^PB'#6)CJ=0):QTN$&FH#42?`I=A$N12RQVTY8:?
M298

=%*8-N$Z$F':+*X:
MM]A'V&VNX!/Q2/^VOHSDH7(MK;7_D)^LVM[4B[MP5N$C+%2!ML6G@UCXL
MW63:YQ9G:M4[Q
U%N@L0YP5DLE84[K%3]UT3/:R]C_CICH(204-#8#45156B
M]S8M(':




MI0?&2

@N$$LFO?]`47$BI96P%ITDDKO[GL'J!JV:LL;
B#<K+KOTF#*AGW?4#B
M4?'_H1#M1?Y5D\[J



M'8&T.H=@3LH$*L\;]
CM9]K0DXJOZ]LZLEMU3!3KD!#[';-L;AXGNV%3$#*
MI2`Q1NCHF5APLMC]ZGF,E[!H@V$OR\^T)O(S^K
/45N_1/T'EQ!PY``U^UI
MGV]:\&6%


S[NR/'J#13
M#R;;PFQ5=S%GSSV.*Q`4I0:JK3CY&\KS`]964*J'E41UOJ;['O;J[69'*_%
MZFD8XM=)7F34(JN2SA]Q;Q\*VF68D33JP3-WC-
N'F7`Q'Y--!

T

1Y8IVC1Q.FR^JX09BNV&5E;%9W66L:S\2#U\]
M))






M[O9I%F1'EKCS!OU*0E9H)CK:83@0O=).Q*A%;C\QIIY4_`5R2088W0JT*$%#

3+M%J5.D[$'-UK43LI/JV4:JK^
G$Z-$\?=<
M0@-=$EOQY42ZY+R.$)(X=XVA/OW(;M828\AG))ODO7&@'-+;G\O)W&-)

:;$*VT










6;3/4-DDZBW.^RSX#J

MU6)E@[W:&

M$!80Q27)MP4GFS6(2
19[+]0]N7R:)M.^]S:6!$(%89@=\+]$Z(5D+XQ\B@'1
M1*.DI)


M$?)%*


OX6E.NO2M_Y<2DEU+RQG*5:\`]3H+(B'
M&KO#BVS=U=1U]6OE)%:W$7.5S-U3SX&KQ^`F8HB/-;6-QM/L(<9B]0S(2

MJI6PHV'@-LS!M9SV
W8:8'8XBZ
MC(0.O&47[$@?N%6R774W3@)05[`P298*AN3J+RDS1YB]&?IS&IC(N7AL%F
M@V(D-+?QXO[`Q$W@
_G.B8AK-WK*P#;Y^ECPW2])/X(@YB4NWP?H(1T_ZY
M0/D^S0





*D[ZO
MQ&\H;.WQ-+O[F);'/\TVIB1R;Z$RC'-7=4J`VTSCEA=W&]J+AS26U[SOM720
MIJW?5_XE?DX?.+$P8-+(=1(VK1[C]4Y.


MKI['R]?(1&YLTTHFM+!


]+



MPP1P]BSH#J\^LPNR)`T1RZ6/.[@CY2?_
;@6;BE36K=AC2DZ4..DH`V#;.G
M%I5;*QHA$R=-H)3&I@7I8JYO0F:`LS@+I6GTBF)BV]=XYD\DVSXZSR'Q?5N



#F
^%@P'0R-OK/'
MG





M]*U[PIT/N#_?7(&6F;LRX0OT@B*81/D]9@JSC)0]2
-?)


NJ




E*C`^H^A#%FAJ?\








]F
M/5]@NL:_Q/`YB*OY&D_#$9F?21`_YDGFXNB`YV(V+9
_8L^7;@I(DE$76SQA




%\M5BR1S

M/%JI&NS*Y

M8*S`''B+_RUJ;FM?1`E9K_R-$ZN


Q
M/52P2W






MET-75EERCH8'D
#6OQ0=1N
LSM
Q8I`M'ADK.D?S-MQHI.TP963_V-E44NY@
M6@?&E-BSM![CQI@[XIXPP!;K2
*GXCK!/:4'7RI//-C:?OW(P3[+/.I-FCR_

M`&GJ3453/-]P*C5[@XQRD@H$8%SU`CCFH9QXTWLDGP$5-@9&XDTU_KK)8U?
M\+;Z/,.[Z^(J%&






9\(^5;
M
$%;JX

M')X7-
3Q




MUV!(94








DCN&B/F%K

\MBV;0M;00.5M_4AY_;USX?@L]H=VB.


;2#DTBQM(
MZ7H&EV!59_96`M6'



PB#J^A


@8GJ1:K.I(&/S5P:-$*C2NB

MD`.)CN*TV/J#:3TMF




6#V7K9L7[=`24`OQ
:3Q(
MD*8Q*MRJ07=(1J\7'K;8(9.5

MLZE:SW.



(!=F1G$F4FTA%Q08)C8N+!&'_

$
P








%&:39J7UD!42%:NR





MMJ`-)






M-TL*LP'K8V[


V

M=,=KN8WI`O(675$BF5@Q0K




=Q4EL5L[MR`@S5L:T6(!/B0N-0-KWVK'(-7!

8.?0F


R?
-#'*87QV*0P;+!
55

\F?X-!

].TCT^JU!&ON(QZ&!D`(!['VYT'#G]-#7DBJ7*D(W.&A
MWW
5(

P&A


28#I.]XX/'+#G-^NP0^H.)[I)'^7
MT%@_1I#UG[O<86U!U=CYBD%[$/J'9HCX!A&RGSM4BH_H1<J?3!M*)'#Q9
MMQB


7Z#VX(N;6QU^2:^YQ25MZB4$5+IO
M@T!/\18S4*$
C$$M$2
M&@$2#F

M;+$CY]]0)Q)A_^7%\@3P*`-/BD&)IR\0JR82''HVFEC^;RUVS_^J)7^[LDT
M-:C-[OFJ4)7NPH-O\#KHNH`[:8IO,8WS,.%V_S5A4ES0-M[L&Q5CH4J9E@P
M$/;0=)
FSX\PV]WC8=X&.6RZMMZE!^G#2S6I=6QI2-.'&%Y2VA`1=2VPHP


M_VZI_(+?=;,#4I][+)I!(*ZST?2Y_+U;W3(R'^*+01[&@OO46A%]JBT(0A

!T4*=A7RF*)TPE%

PTAKKR):M$8$[6SFO!:8R9DD9O+'<DAU^N:\-I1F](^PI2R<@K





MMN34OHL?CU9'RL'HXTAS)
9?2I=

`W
B'4'G3/CN^




M@ZWM6\5@GSD$X58K4+?S)A)?HG$.








M)L_Y`VZ^.[XG.2NR
P@SO
V^*[90GKY:E]@J&+4EZF.@(@2
$C!20&@!)@:4
MVOEV:*IX__XOW_[P'X
RDI.B5$-&6Y9@!LVVE8S!Y?CZI82C?*??;6*W1FFW
M=UP2'_JS)P
^I
E.V5&A&NV=(;




XTVNYL'M#+[
7731RGC
M#@A[T/`'=PEHO@#H)RH

MOI.#

&%A;#&`F[SW.`GA\\[FLT1):!(]R2TKWBW[8T7R-D*(Q@AB?@

M4Q(92?NN:-BV:%;]-(Z96\$=@'GAPP0J!1V7YD2-N`GE@MN\6]I[3%NZJU2G

=Y?Y@ZG\YE%1Z7H
14]




[HXW



-2IV[@\M163)/2.$<-$=A








FPS`&9]S%


M5#*@^2P9T!Y`,S$$V9CF$;8^

MJG%0G+X+!L%J):

M&3P/_*/.C*M#[(^'E
WC1Z-27K#YFVEW0^37^$
8FSO`]P[QZS(
FQRR9)
1PV\[R?I#@7M#YP#R)=Q%S4SK

**RS`ZNL+L4M9/5MV?+HX:O#X<1XS<Z./LOR;!?I\^



MP[0FC*R#RF=-1FV-
U`IE;OZ9X
R2'+VM-+W^W3HJ3$FPD)HJ@&9GN:I^8+H

45_]
&EQ
[N4'!$XI1
M@:YL8AH75J,4!ZIV;2H_HR


L




!$F$NR4[Y^#;
MVC_3&.@O=WY!VZQ`J]5\&?5/A^*(M4)J#3\;/US?KV_!*\P7N8G+;_:M&.


6IA^`4YV

^KVPJ<ZK2L/[P3[.06-Y9?4\OZK7GI4

V3X[W/EKVUWTNKVU\XTLJ17\_E%4-'U/!NX^/
M


M
L:@)3R;7D,XM`UVH#2+CTD+(HK3.(U\MD
1PTB(^E?Q36+JS?K^^ORK
M\EB)^$SBN
I`#%ZOI0Y;^D5)K6''/G8I=]:I8;:H+[/Y;E




-*1=1*1_Y#I_B6(B0TQ([@N


$_\
!_UOY
MHUZ!L+D^8/^1\5R:X2(I8


M1B]@0H[V\&1-G80HAE@FE@^!I()X3#7ET_`WRWS.[5Y]/JTI]N?UAVBFR&Y2

J@L@L
M14YF?Z*62S%P\54W)T=;-0&M_^+84J;(DFY`5
4X;&JA/$G-H`
U;E+2QID]

VS=A8-RE#*?NP+
E!1=\N

%OMQL($MO$&Y)
H-+-V46H?V3^Z-\(QX.T;Y7CD

F7M;D6-H
$V7


CDTBH
M:6J8`R`L0
-C5:X-9P^RG&IS!M(2L6@





M&!]!Q

=!96,?K5


-[2K=V_L\]C'O
M9M(S7U$_#E[JF
KX`[[X#G/-&/J0YOW\R1]33==5_YCJZOIV?7M^*L=4(ZU(
MT[-


M@
80F..+#'F5VGV+/=31H
O;T7-;1;+FBHIX+3(II9B30#I)V[9R):?7YS





M+G&M:3H\F5/K&9!/G56M2UKE^.HXPE@:(RWF5)11^B.#3P)C


$D/`;*4PJ..JN*0/(0TLQ_05Q5/KY.-FFV
;/0^3:-7
M%

9@LZHEVN_)]4T2_1D[Z[@LA:MO^[H,'%2]U)2,KX+).GD59'2


M


W_.1R__%O

ME

MKQ
\0=*-0VD&LHE'C][^)*

1V@A.2VH28%+5I_;QQF$#J=36BK$X4)
MBKE)P1S#B8`@ZM(8D[QZ]QS54[?7_MRY(X3N8QW8LW+7!9O%P+MS`ZQ-AV


MDI7[5NYUM*BMXUM/ICZ6*RIVC]S0@9+0[U6+P3CV$6L\B/;0N8YH4J^\C`LQ

MP.)ZVL?1)Y8NIF[B-XR&%=]'C4SKH\


0U%T0BT.;99NHRET8-:.FM#'F

&'B00$Y


MKNNEP7V6)BE9$[1NM/1WE^:L'*3J
C1
M&Q&2FR#`'[K;E`EF*VLZ7B?G:9)`&J'S$RJVK;SG]U7Z!AK@)]BOS,+9ZK9F
M'EUP[22*XEIJ#(NUXS)4JUA#0CO3CF#FCM+!N+NS<SNL&;J3)5<[V`(R],
M0-CHYI7HILX@$K:4U,LFXG`WN96I!!+&1.\\57E16,]91E^.`_QD=4'LG
M.[OWL9IA&Z_PB^

M$![FXP^&!7(:@KCF`A@;0/EX#&/9\&KC6#VV3A*);/JY3BX_E^]?JWPHLN-'
M
SXN4X=HR2G+D['A
^*`-S434''Y2IIBV5%N#/U!EB3%
!UA#_RRV0L'
S;^


:)1#0M4:T.8.4[*,DH`/B];N\R[
M8M!Y^N^MFILQR2
6TSQB^^TQ)YDNJ]O



M)-?$L=-8
A/-PMU1)9:I.ADNT*)^YD#+S);

[?W,_U,]K.<*&7&0W'+X_`ERN$RZD
MG[R29
C+WGI:<QT-=[KL.^0J7CHY4G]

@`N?LQI[&E/:*3L-;)ANCDI=()=__M<B=H01?E+\$S




`VR#%WS%JJ[A-8IVFZ



BIT;
S63C@<*'WL[7&^MY.%N

Y/3FO!IULPN@1
M.`@*5MB5OG`L4MR$/(FBK\T+N





OX)HN=M`:



M*+






3
MS+IT(GE8=AYDV1$O2E^#+




ECFS'@U+E?TT.F0R-494D3
7R29^$)F)8_$
M&&[NWG&HQD&+85N
S;#!0'\FUZ&!2



+SO*_TOS



M(IRXCNKDOIQ=2=.


7



M][K;:%BX*0
71:?U)!NHU4P)6;!$14HPKFG3EDLV&XS?0.EFX\$;7R^C\@@T
M:=EYXROP(C$]I_D


MN]W70CT=F=4D!0F\/201GGG(/\3X6V\+HI2Z3%38*(7;\3BV+6-8M^UM)*9=
MQ)$


()D@D9DX2.B+



RC/!@B]9XC
MT6#/1*Y0@@IX@UX@U\5V'9'2D
D['?9
A[W2D=C'5
;6C6.R)K@*[I3A6\J1
;3/O?BW\@55#OXWP./W\C-83?MH[+YC&:T*S#S0S2)A<`#C.)D
MU?#'R3H\)P/!G#PX);O+6S*?V$N*H..HYI&B*600M,<)EN-$_AN6\4I/)'HI
M3)\3](]NQH@-VA1;_/]Y&,3@2-9:FY34J*E^IP-2_95V;)7F'<8'TAY^*KP
M-6Y4)21/HCK]]@K$0?@+:;;?'G-$OD$2;!?T]?\KPE\.`,P1AMH&./.
%]

M+@[#=Z8!?2CY_5B4VSM]N

--0;
MG3ZZ3(;&?ABMP&EJ!
D**9V%P(IE



:O(4XJUIC?6D?1:C
MU;S2&U/N)W&

[\7




M!/WF$H`=((\SY

?1IVSAB5#57.HA/9T0$6G4.?WQ`JO@*D`9R3JV9*B(<4].+F3$7-=+AHYH
M/(6A30#I%]`K1;IQP4



MIZ8W1@\JRVQXKD##E:QY:KYD+4DX`\8:


M(P_NIJ:
?M_S3Q_ZR0[_`8;EA'





V.!'C#_G*AMP&]'13YM'L

G_^F7
H]IR43EB=FR`(M8'#]\03MN(WER6;
`]EG*T8OL\[(



M$LM)P(
K0H?.8S#LUZ7G.!V7W4H$=XTE0DF.0AK+_&Y!SRS[Z
DY8*D&K67C
MK#^]Z+





TW
MP8%\%-OELM(0+_+1:'2+ZX`_3K[Z#?]V!9:4^S3.YT@Y43MK635XJ1J
3]

M8H6!6)#T0Q%DQ3A7:G$LB!
M&Y(20$^UBLJ8\2

EHK+86JZ3*)34Q)
(K5Z
MW







?9
LR-HITW8ZQ%?`GKG_KLT4EU






*014JM8+Q%
M=D/B.CF[[V%6?ERX6A99[E2N=BU\L@X

!
MA-?*\N;H8G8M2=S_:Z7`H%1@M1PKKXU)98=R8O#YK&

&7

M[L/#I
KO1XII:'[T1+9^SB`UWD=



SC%`M



M#TY/S`;IC9X3,=H-(HN2ILG80A)01.^;=)LQ^:IYRZ;P&.]$BM(DE3FCZ6
M*C(6(T8)08L2_%S1.L:2R6UT60^4J8[@AR&7S^G+[^-(&*;`?R'_AX`_U/=
MDU8''@6QCO+FUFEZ+402AW\T-8.P:.C^@HP^GI?B0,HQ_A,SDJP5/H;;`3
M`62XJ55P'K+'6LQM]*T`Z2A6TC(%-V&@UK+RT+A'))]1'R=1/#S7^%1B@6N
MK0




M$H)2]:ZN6I0^^`B=
1I87F@/T-*[57*_K]BALB9.=J5E[X0[4?*['UO/MAZ'



MP$F%QC`LBYW[PU.



$N

MT=


M
2[[1O*
1$WB.C[[1O)T9#A&^\:'%R.Z8Z$(UA8



MRV))40QO(5ZZXU41).?4C^EYD&_OLY24P8W.CI]R&%TG=WN8!62EL0X+]((*


/6\&?632-Q34N

MPC`33WR`0
+Q%E_:]`K05;'+5?\D@4LQL?7Z;JLRC.I9IAJ@EM/@GI'$FN_3
M-

+I*


+8NK


30P
S
Q7W!R92YX;6Q55`D``UTU


MD+=L=SLMA^VLNF]


,\7CM)\@L]Y$I1G),`]G9$XJW.*
M$0UB8S.)F(]^FG^`0=A&#FH\UT0#V-CX4RGM/SX96Q72
IC#NB3^:==.I*5

O3K;<QZPW9GD]&PY.SWJM/G/4VY9U!MS'M.L)WF#<EC[I\.6=





MB1VDF[/WTV`Y/OSG#JN;83R+%K_.2@WZ)9C0:*40HS29UA+M8C:)-K(B@SDF
M

M6U84M
MC--.K5I-1'QFCQ$S._]$/9$Q95^F.'_PIZ*O+J\IX#X\1LCD-C&[;$K0\%D\

_


M=OPN77^S89&S?`,H/S;*.G(9'+426JUL0F,#)\0$[X4R`L,J[B/L9


A6W'=($]DI0FH?Q0


5T]DEJ3

(^



M[-
A-\E*OW3^A
U6HO%8GENS1A.V^$NVG@3ZM(XWRAPX6

M`E#.0V/!RKIY6S:;/:+Y0M(Q2;.J4

M


YJ@;*5H]?..G+HL

M%HJ6__400^G3:EDD]W&P

I@CDD2@?R^2S8RM58(O*.WO&1J\7GYC9@4U[

2^RE-=)/P5-M[)RB.)!R*%%SN@.A#PITE
MJ*]Q-B
\?PKV7Y.`1-_9.4#@:F2_9
M301X<NW49W)N0],X'FPV],XOG,;R*)CAT\B#8G33@Y'W^I9U!61B]`';3ZW
MVGLG*&XB/*)DE/)06

I/TP\:CW_S


VYK)MW@N(;;LJY$I*E=$$85OK*

M*H0N


<V]4Q064P5I




MK(0+B0
A<O7!L?68TY8O/4_I:Y.S$\9*P
MK0P$`O.'J8SO8K@CD$S'Z&7WA[SS[EK)6I$0,[:59[7,ZXE),J`IS3VCM'
M851K@6:^/HE$(%*3OJS+4IJZ6C$=E/O'(4E;V_JP
4O2.C203/@(`SI'
:C




[--%]HG*2E_.8RD6C#=E/O`H5A=6^ZP


M_OC-3TL#.Q.4D]3R6U/2

[?WEI0NM3



W2=$&JNP

.GXOIU$\_AJ-G




M\

TVN:
MS9+

+X8^9`



MTS2P$9RA=UN4=0&@'34(J%'9*FKNUBF0?*O()DUB^
^`5`Z@^MNSZ5!PSNF@



MDL6MU]$[.'(7P`R
E`?


MO%.9/83;'L2!XH;-(TE!YRX

MCE&\ATHX$WT0I8CZ$
OU/$G2G%4!OB:O^0O\FFKY\MJ#.%`\81HL7S&
/L1C


I]#X\%`GBB
EF::
A==0J(_
5G@2!G58
MN*?6/`YJ]`:1==!VJ`W
5G`3




4*4S(A\
@Q@MFGX(]5IM8'DKM;

KH
M.V@T#NRESLJDK_?[Y93-/H8[O0`




M?0.@O3P\?F&53

9
MC'F;I*M

MX6T

M%
5EL;$VU4#=B_V_?

M


+;,!LD#J/<?8&]R[.49S51J@LK4UPVTI+9E3!:O:1/C2&+!=<CPO%'3Y
ML6ZSL(\
OOEIJ*-MEG\)*

M!TX#+263
O)#


:W
6C))TZ=CYX)F/&P!.9
7_L













\D)JG/P@\'X93&E-WGF3E

M_V$^(6DUHIU!K]2NERB`JBL(X7-RDP#]%U9^[M:=!V%R]7^LALA=]A4(=5



$^S



M!48*1LROH4-ZWH=O/DTFN]7BYPV#/0DB0!@5J:_T=[CE2.!*''YH]78X35!
MO2E@U:[G8P(FRF1)-JAZ`FZJE3@N4@/U.VNA^)W0\`60#F(P_)@\%B^5:
M5!(=%GF6^S'+^*FO%O4&!










M



M^_!XQP



4%PI6]J/5@@M^60B2.#%

W?DDD/215D(_J
3'J2^L?=



M^CQ]



M;V1GROHF]4@`!5%1IT:_*BL&'K0?Q@V5I?*Q3V+%
_\).(!\4AK&ZS.LB1.'UKUJ^
MV\B?Z'B2ZRYG26<0`0H3B:7EK41JR3;2+MF/:1(607Y-WDB42*,V]#H=!3&
M$4LD2U'VR%^^AE.LK%XO2MZ@&101&%:W,EWX:%(6VR'^&$^(:E$6HUT.H/
M4D

M8##OZ!
*@U^+:B-%;BOQ

M(S%LU6E$T1U$AL)F:.4PHH55H!Z=K-[&60

M5:`@QI9)!#&_:E^`P^_'%^#HT\GWX@MP]`F%V:D&/XU]`4KH??`%D]_/CB

R38^*?*!]\&;0`)Z#?G!GZK3L1N.!+$;M/B
MLVZL/&+T-.W7Z^.PR


-N9S$A4P[3DJ^`



HML3CC
-A;N%H0_/%C?O`<U8B9AG/R)P
MSW@G



A@2;GYQ+BC_/S]FGSZ!#%.Z6$

R)<D
MSB<U=T*-@;T+'#G;]J).YN\_N@)$D5'&A:(R*;]\2ZSIYV(\DJ*DUMGU')#



/'':ETOKM:98MW=

P^2'P@YOIAIU

M
?IQ^\I7!FODV^R;_MN8R8)%!9%0[9%0-S&[-NAM'K%WU5F;WRCDQ*&QU
M9E1K@;(?X^_`XO%$6$Z*(?AE9]-W!LYVS@2\O^[^;/@K[Y$0OLTK!JR#L




JAM*'
_8V.N4!


,<6BVSW0
M:$'J@Y%T];9;%E48CI[S)/A#UU=ANX]W<.V=)







U!WQ.K9+&9
F!N
V



MKII


P2:)(







MV6P



MN[EW_`F%#U0-PL5P!!QW
V





M?II^`$;E$X6L&TBG:R8K?5@TKOL4%=Q%EW'-S^F-`'^AH@'@/DUE5[EB%&
M@6YTR\@EQ'PW6OR!A+_Y44'NXIOW@&35HHEUU$5C6)!N5XU@S6$+*J'L*[RU






\*Q
X\?O`!+!
M8=W1Y([/O`Q;+\J+ESZPY7

\?Z\2J:S)(8_9KH?95X_
MDL*`V33#[
8F^-*Z':XWX*G_#YSVWO')RA
F1JD\=F6H
)83OUW/X4;19[!
M/QQ(/\N[#0$4F.F1.*[GV$1#,?5TRVYK=(L3^EK43X'?_%#\K)XGAJF]W1*
M%Z;F*27']6F&B4K&HX

D9A



:P?97BD#[RR`:
M``2'XOFAZ;=!CD^@&
9VJAR4$


HQ&`X&B

M!(2$V2W(CRT&5N%I.&))M9-8=?94]@4YH7@)J:


9K51.:
M0`6Z91XLQ3(_M%3KN\P/

M%)=^1@/!7E![/._BK(/[0D.X`HUPFN%KZ95_\PXG6YJ1
O&O(A!AHRU`Z]@!
M3@'%5DG[-EAZ21Z+-)CX&:EH6[D1:54N-AW&NW#KO]&
9S.$R
M\D;+S2I)[V+X:_+BOY-LD=K<14[SU2RN:19$208[J$9<TDO[VS+.EC_6\KY





S3


M2#5UR2`.+TE

D$[_L@#_-@



MH



MS4$8*`QO==@5X['D@]H%!_(+]W8SDR^L/B9++J58'
CKW;Z-+Z$&8X.8\;NB



M\;)-7!+`32K24SN-UA^4B;;3WYG&T&VYD=H\BXJ7`GQ%:;HL]`L'*\$95'\`
MD(+;JN5-SI[&

M;17VORR):

4I?
MBYRI^TOR6
I9PRW/TB^`Y%$\U9MICE7P*-(
M:]VO'1+((-Y4HQ*\J5UCNJE



CE?IMFPR+







:727.5[F@'C#H7_%&Z=-Y.FK3#*SE@SA/9/
M[C6YK15A;Q:





+

MIZN'PB
M[-
%?\_J&['7C



/8%54?7*7MU(4]







-Q:NG.


K6)2RPI%Y[VQOI[(


[0&'




M
]OVU_K
MPN+ECE5ZP#R2=(%4%2D*LU&98+KCR\'7X6L2,C6$W9;)T$MD(LS4-56HS!




M[O%7+0^W;B5\WDE




M!3F@
+/)6!*\J?*ACMENFMI1P:2$)I]K&G:TAHG=LO192J*!)!NOFC3!
M[4V


MV2\Q.N2G

CZC?`
M=AWZMCV3)H
F8I8..



0$6MPMP_H@*@<G(5]



V/)G]F_9X!1ZC&O.P@3




60ZG\L4YG!5B%9Q*




MLM

M1.%%(B*7KPJU0%KR]
)@K=7$?U6D3/;-M64QD'=QBN)C7XO^1IJT(0!+GF0=
M4J2[^.5;\M_$3V7?&..Q0)HH3A?[5Z=M&5AR@.N61L&O$GLZM1H-)(KB8.-$
MJ[:D8

%K6E3GQW-E]M9C-
MHH_U=)5615Y[`(#B?:Z&U`676C'*/M@8]QW5='J(XMU.PJK1DZT08A\LE4VC
MEDX/


A^K





M6ZV\TV



/


0(BA9)'U4?WNWVWL5Y


J6XF\4(T&`6&@L`0;+^@Z
M


M!!+.YA/2B#K5ZN^=G1\Z



\3^EKD3
QO21\
M59=J@(T?`(GC



M-QJ2.)3DX-#K#Y)`89K48[D&-%MQ[2Y)GFMO4ZKGHWCGGU8'UL@O`K05JA[
M[3+/EOEOSW#GTFVB?5W/X5S3Y[=O)
TH-G:)6M+&^P
#C)$89_45Q*;N&U%





;EE#X7-/3C@+CSP%/+J=PO7UF@'#
MDS@KI?5$

M]&L)NZW


*V4N0[GE&0:








@-`WMB_J1'5RNX!0


MD/2BW.K.CG2O$2$M[@22Z8NQ;`N3XT*K+;&]SCXL2Y$NZP;2P6DNV^)/D_4=




MF4-



;M^YN$R\
&?Y2


MI4BO
V!'X=5A3)\)/%NO1=9/!.5




1/<1G*UJ]W,:LIMN^YP(441D5MKIN#


MB0OB1_9L]^*GYB^GJ=QLMYL!+A1V3`UQ-,7T&*A4HJ#X-OGXC4C?Q8P\@WL
M0SF#+[;




M!T!%0XW(LW/F10&PMC@K;D*OTKMH#
J9.05.!*;JH8

MC*5;G*@Y`'1JH5%(GF/1E`)Q'/7+SY8#WTH]DC@MO;
#I^858WZ$&!R'X7*I


GUK9N\YB`-'85PXU;C,56,HJ9I6V37X'

\V!DF@</(QY4ZM`55\MH([K=H`1R,:49CN<'2=/H)T(CJ[39-,80J4]_+.
M#E$X](B(X)@$=0#9BNFTR=\7/_WC9A'*?F6W=W=25GCM@5H*-QR]+F2P+`5


R+?R



MK;FW:0936JOK_)0Z/[U*'6[%W1AB%'=S4V8U@0FH[);EK'HT76!=;F#2XYJD
M&Q

+FH
\A:#D61+1D'D3K.S*\#&[\K/);91\RYRD*EQ.








2'XC7#P6'(2$*VTA`C.65O85\:
MM$#PA+XIO#=UNGOG.%)(F-*LJRPBQ(TS$B

M&@0$B

N7%N:/S*LCR0/?H?[#3&/$:(U@LHM7%=-/C_:H


U.(?&
MGM[Y0J[\?[HEPK5GT!;




(V:@GHC@/!0
MF)/-]

M8

Y:]%9@:620'HK+30
UL2H)@1X9




/I1EWX&G7KS\'M[Y&8X[



M
3*YK:TMF(0D;A``Y*V-5?WWZ\!DA(I$B`H*392RR^)10+@TWCP
MTMUH`#_][7GA.X^8!X31CT?M-R='#J8N\PB=?3RZGURU?CQR_O;7/__II_]H




M0U1-T-B`+H1


`*



!\XDG&N\%\L4`.)YC




TM4#[^U!GU&B8KF.S31Y7
M\77?S#[0\W*ZS4M_\&MO








H(\
!Y-1I]O
)I6TW7'V2$3\&G#1I_`83]!S:ORI7NII*ACH
M=Z/AKZ`&@Q$._







Q5)1T]L.1F';E
-V!8D%


0?V







P\$S



M



M(EU()X\\[6QE65-30%

M

B48&_`DIOR0GLK8P^1%)4T!@W#BWP\G&YO[I'(0%.5(YV-'7Y'Z*J*
#JX
M4A;VXB.!%WZ80T[N1@^XGZ^#.JCWDOR&4/GMX-7'P=IX%7+?084*5_P
6M`(

Y



/N'-$9)+UA/^*_`AJ\QN8S]](
M?E/\O%O71^&9M#O?EE1W)EQ+%_:

M]1T
]

(3Z31VU^-Y(KH:MT

M6(@3SY$M

MB$BU.@#?&T[7:D?GF;R\D\\+/W@$OBZ
HKR+LQ2=F227LM)?GPD%+)4_%H-I
M['7@B6?3T*J`I;1L

YX?:UL')4*MT8=
CP



9E

M*E@Y+`

M`C_:L]RE!*83I^/:`7J[GQ$Q:ED5DFC1*?4?D5XF]SZ.V/


P19Z!$MO



MIR^
6^

MMF:_3ADF]90JT7S!B%O6MXO0#&2PI7^785)U$!;Q;');6I$*EVJ]Z0G[C]A&
M0=3(E


1EI2HGQ
K/$E%0`I!WWL(VI-I.L6'(-ALB=#3?*#


^XIL@9P#HSQX


4B%/1:(2O.%OTGD/
*?+3

MX[![B\3=';CRJ!-1V@0]]Y[%X@:^P!1/26C/JD



$-P_

MO[C6=ZW`UVA0!Q-$.8)F\Z7-



DGO89*;A4D-T%9.W;6$\*T)I([

)J&OI78TP
V_?



UQA@LG,8+7RRWS:!C`K!!PLVTMT^*E5^#!LI/Q

*7+)4(X\#LE8+
MW4F6A5*':H.P@RGR2%(Q7Z2LOW;MT=4.\?W-6V)09\%\S*\^SDAI(DAS5G

I)BBMK$

RV






_-8

4``````A,-Y$H,,FL!A


M!@`4`!@```````$```D@1T`0!R;W@M
C`Q-#`S
S%?9&5F+GAM;%54!0`#


<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryRawMaterialsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ExciseAndSalesTaxes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.45in; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.6in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
<font style=font-size-adjust: none; font-stretch: normal;FONT-FAMILY:Times New Roman
 Times
 <table style=WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredTaxAssetsForeignCurrencyTranslations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredTaxAssetsAccountsReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredTaxAssetsTaxAmortizationOfIntangibles'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsSubsidiary'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeignSubsidiary'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SupplyCommitmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermPurchaseCommitmentAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesIncomeStatementContingentRevenue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LeaseExpirationDate1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ContractYearEnding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_LongTermPurchaseCommitmentPercentageAgreedToPurchase'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_LongTermPurchaseCommitmentPurchasedAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LeaseAndRentalExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_PaymentsUnderContingentConsiderationAgreements'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 - Between April 1, 2014 and June 25, 2014, the Company sold an additional&#160;<font style=FONT-FAMILY: 'Times New Roman'
 Shares pursuant to the Distribution Agreement, with total gross proceeds of $<font style=FONT-FAMILY: 'Times New Roman'
, before deducting sales agent and offering expenses of $<font style=FONT-FAMILY: 'Times New Roman'
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 &#150; On April 2, 2014, the Company called for cancellation all <font style=FONT-FAMILY: 'Times New Roman'
 unexercised 2011 Warrants pursuant to the terms of such 2011 Warrants after satisfying applicable conditions. Holders of the Warrants had until 6:30 p.m. New York City time on April 21, 2014 to exercise such Warrants at $<font style=FONT-FAMILY: 'Times New Roman'
 per share in cash. Pursuant to the call for cancellation, holders of all <font style=FONT-FAMILY: 'Times New Roman'
 unexercised 2011 Warrants exercised and received <font style=FONT-FAMILY: 'Times New Roman'
 shares of common stock. The Company received $<font style=FONT-FAMILY: 'Times New Roman'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_SummaryOfSignificantAccountingPoliciesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_rox_ReversalOfProvisionForObsoleteInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentDepreciationMethods'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillImpairmentLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWriteDown'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShippingHandlingAndTransportationCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdvertisingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyDisclosureTextBlock'
<div style=MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times
 <div style=CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman
 Times

